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A REASSESSMENT

The Senate Health and Human services Committee will hold
a public hearing on "AIDS in Ethnic-Minority Communities II:
A Reassessment" on December 17, 1991, the Committee's Chair,
Senator Diane E. Watson, Ph.D. has announced. The hearing
scheduled from 9:30-4:30, will be held at the Museum of
Science and Industry, Kinsey Auditorium, 700 State Drive.
For many years now, AIDS has been viewed primarily as a
white, gay male, disease. Unlike this myth, AIDS has
consistently been a disease which has disproportionately
affected ethnic-minority communities. In fact, the rate of
HIV/AIDS infection in people of color is approximately double
the rate of the general population.
It is expected that the numbers of ethnic minorities
with HIV/AIDS will continue to increase over the upcoming
years. While the white gay community has been fairly well
educated about the modes of transmission of the virus and the
types of behavior which must be avoided; the same cannot be
said about California's ethnic minorities.
According to the National Minority AIDS Council: "If
allowed to continue unchecked, disease and death from AIDS in
minority communities will continue to mount into the next
century; the social and economic impact of this projected
loss to minority communities is almost incalculable."
Continued---
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SENATOR WATSON/PR-127

The senate Health and Human Services Committee will
study the amount allocated for AIDS research, treatment,
prevention, education and outreach; the manner in which
funding is allocated on a federal, state and county level;
how and why AIDS is spreading at such an alarming rate; and
measures to improve the quality of life for HIV/AIDS victims,
their families and our communities. The committee will hear
testimony from AIDS experts, such as physicians, educators,
health workers and various organizations about the
recommended ways to increase the state's role in slowing or
halting the transmission of the virus.
"We know that we must improve our outreach efforts to
reach people with basic information about stopping the spread
of HIV and AIDS," Senator Watson said. She recommended,
Monogamous relationships, regular use of condoms, and refusal
to share needles would dramatically reduce the incidence of
AIDS. We as policymakers are taking a leading effort in
letting people know about the prevention behaviors that
people should adopt to put themselves at much lower risk of
getting AIDS."
The hearing will be open to the public.
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"AIDS IN ETHNIC MINORITY COMMUNITIES II:
A REASSESSMENT"
TUESDAY, DECEMBER 17, 1991

9:30 A.M. -- 4:30 P.M.
MUSEUM OF SCIENCE AND INDUSTRY
KINSEY AUDITORIUM
700 STATE DRIVE
Los ANGELEs, CA
OPENING STATEMENT
SENATOR DIANE E. WATSON

GOOD MORNING AND WELCOME TO OUR STATEWIDE INTERIM
HEARING ENTITLED "AIDS IN ETHNIC MINORITY COMMUNITIES
II: A REASSESSMENT." THIS HEARING IS SPONSORED BY THE
SENATE HEALTH AND HUMAN SERVICES COMMITTEE. TODAY, WE
ARE GOING TO HEAR TESTIMONY FROM MANY EXPERTS ON THE
HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND THE ACQUIRED
IMMUNE DEFICIENCY SYNDROME (AIDS), ON COMMUNITY OUTREACH
TO PERSONS OF COLOR WHO HAVE BEEN EXPOSED TO AIDS OR WHO
ARE AT RISK OF EXPOSURE, AND MOST IMPORTANTLY FUNDING
FOR THIS DISEASE (FROM PREVENTION AND EDUCATION TO
RESEARCH AND TREATMENT TO LONG-TERM CARE AND HOSPICE
CARE).
CONTINUED---
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IN 1987 (APPROXIMATELY 4 YEARS AGO), THE COMMITTEE
SPONSORED A SIMILAR STATEWIDE HEARING IN WHICH WE HEARD
TESTIMONY FROM EXPERTS ON THE MANY ISSUES THAT CONFRONT
OUR COMMUNITIES. SINCE THAT TIME, OUR STATE HAS SEEN AN
INCREASE IN THE NUMBER OF REPORTED AIDS CASES IN ETHNIC
MINORITY COMMUNITIES.

UNFORTUNATELY, THE RATE OF GROWTH

IN THESE COMMUNITIES IS CAUSE FOR ALARM IN CALIFORNIA.
FOR EXAMPLE, ALTHOUGH AFRICAN-AMERICANS REPRESENT

24% OF

THOSE WHO HAVE BEEN DIAGNOSED WITH AIDS, AND HISPANICS
REPRESENT 14%, THIS RATE IS GREATER THAN THEIR OVERALL
PROPORTION IN THE COMMUNITY (12% AND 6% RESPECTIVELY).
MOREOVER, AFRICAN-AMERICANS ARE THREE TIMES MORE LIKELY
TO HAVE CONTRACTED AIDS THAN WHITES.

THE STATE OFFICE

OF AIDS AND OTHER AIDS ORGANIZATIONS, WILL PRESENT DATA
ON THIS GROWTH DURING THEIR TESTIMONY.
OUR AGENDA IS ORGANIZED INTO SEVERAL SECTIONS,
BEGINNING WITH STATE AND LOCAL GOVERNMENT PERSPECTIVES,
TESTIMONY FROM HEALTH CARE PROVIDERS AND RESEARCHERS,
FOLLOWED BY OBSERVATIONS FROM COMMUNITY-BASED AIDS AND
ETHNIC MINORITY ORGANIZATIONS.

IN ADDITION TO OUR

OVERALL GOAL, WHICH IS TO LEARN MORE ABOUT THIS DISEASE

CONTINUED---
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IN ORDER THAT WE MAY BETTER SERVE HUMANKIND, THE
COMMITTEE AND PARTICULARLY MY OFFICE, ALONG WITH
MEMBERS OF THE SENATE LEADERSHIP, AND OTHERS WILL BE
DEVELOPING A MAJOR LEGISLATIVE PACKAGE (THAT WILL BE
INTRODUCED NEXT SESSION)ON AIDS. THIS HEARING WILL
SIGNIFICANTLY CONTRIBUTE TO THESE MEASURES.
IF TIME PERMITS, AFTER OUR EXTENSIVE AGENDA, WE MAY
BE ABLE TO HEAR ADDITIONAL TESTIMONY FROM THOSE NOT ON
THE AGENDA.

IF WE RUN OUT OF TIME, WE WILL INCLUDE IN

THE TRANSCRIPT ANY WRITTEN TESTIMONY THAT IS SENT TO US
WITHIN THE NEXT TWO WEEKS.
AGAIN, WE APPRECIATE YOUR ATTENDANCE AT THIS
HEARING, AND ANTICIPATE LEARNING MUCH MORE ABOUT THE
EXTENT OF THE PROBLEMS AND ISSUES ASSOCIATED WITH HIV
AND AIDS THAT CONFRONT ETHNIC MINORITY COMMUNITIES.
lASTLY, MAY I TAKE THIS OPPORTUNITY TO WISH EACH OF YOU
HERE TODAY AND YOUR LOVED ONES, HAPPY HOLIDAYS!

*

*

*

*

*

*
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DR. LENORE TATE:

We're going to go ahead and begin.

Senator Watson and

possibly other members of the committee should be coming in momentarily.

But

because we have such a long and extensive agenda, I think it would be best for us
to begin.
Let me say that all your testimony will be recorded, and all the committee
members of the Health and Human Services committee of the Senate will review this
recording, as well as all written testimony.

But because our agenda is so

extensive, Senator Watson has said we would like to start as an unofficial
subcommittee.

And so with that, let me just say that basically we're going to go

in the order of the agenda.

I think most of you have the agenda.

If time permits,

towards the end of our hearing, we will allow for testimony from other people in
the audience.
So at this time, I would just like to begin with Mr. Wayne Sauseda who is the
Director of the Office of AIDS for the State of California.

Mr. Sauseda.

Is he here?

MR. WAYNE B. SAUSEDA:
DR. TATE:

Yes, I'm here.

Okay.

MR. SAUSEDA:

Good morning.

My name is Wayne Sauseda.

I'm the Chief of the

State Office of AIDS for the State of California.
Dr. Tate and members of the audience, on behalf of the Department of Health
Services, thank you for the opportunity to discuss the state's AIDS program today.
During my testimony, I'm going to overview the programs administered by the State
Office of AIDS, to set in context the discussion of epidemiologic trends, and also
discuss state funding for education and prevention, testing, care and treatment,
and research.
You have my written testimony.
the table there in a black binder.

I believe that there are three copies of it on
I'm going to, for purposes of brevity, as well

as -- some of this information is somewhat dry in nature -- I'm going to abbreviate
some of my comments.

But certainly the written testimony there is provided for the

record.
DR. TATE:

Thank you.

MR. SAUSEDA:

As an overview of the Office of AIDS, the objective of our

office is to provide information and education, testing, epidemiological
investigation and surveillance, research, and treatment to address the public
health problems resulting from Acquired Immune Deficiency Syndrome.
-1-

The Office of AIDS provides a complete AIDS-case registry.

It provides

educational information for high-risk groups, health professionals and the public,
and policy direction and development of pilot projects for the care of people with
AIDS and early intervention of projects to provide services to HIV-infected
persons.
Additionally, the office conducts surveillance activities to identify risk
groups and patterns of transmission and epidemiology for selected cases.

The

office also administers a program which testa for the antibody to the AIDS virus at
over 100 alternative test sites, which are free and anonymous.

In addition to

that, we provide a substantial amount of HIV testing and confidential test sites
which number over 450 throughout the State of California.
Local assistance block grants are also provided to local agencies for AIDS,
epidemiological investigation and surveillance.
I'd like to comment briefly on five significant legislative measures which
were passed by the California State Legislature and signed by Governor Wilson.
These measures reflect the Governor's commitment to prevention, patients' rights,
integration of services, and expanded access to health care.
To begin with, AB 11, authored by Assemblywoman Hughes, which is AIDS
In-School Education, beginning with the 1992-93 school year, instruction for the
prevention of AIDS will be provided by trained teachers to students in grades 7-12,
at least once in junior high or middle school, and once in high school.
AB 11 fits into the current California Department of Education Healthy
Kids/Healthy California Project which is funded by the Office of AIDS to provide
training to teachers and school administrators on providing instruction on HIV
transmission to students in the 7th and 8th grades as well as high schools.
Studies on youth have shown increases in drug use and sexually transmitted
diseases, which are major co-factors for HIV infection.

Surveys on youth out of

mainstream schools indicate that nearly all of their health and HIV- and
AIDS-related knowledge and information was obtained from their school experiences.
SB 1070 was authored by Senator Thompson, known as the Patient Protection Act
of 1991.

This is a measure that deals with HIV-infected health care workers.

It

requires the Department of Health Services to develop written guidelines and
regulations as necessary to minimize the risk of transmission of blood-borne
infectious diseases from health care worker to patient, from patient to patient,
and from patient to health care worker.

SB 1070 reinforces the Department of

Health Services' leadership role in establishing consensus-baaed recommendations
for the prevention of transmission of HIV and Hepatitis B virus between health care
workers and patients.
-2-
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There are three other bills I'll briefly describe.
Assemblyman Friedman.

One is AB 305 authored by

It redefines the term chronic, life-threatening illness to

mean HIV disease or AIDS.

It also provides that the Department of Health Services

may provide supplemental funding to residential AIDS shelters and to residential
care facilities.
AB 1281 authored by Assemblymember Filante updates current law prohibiting the
use of HIV antibody blood tests as a prerequisite for determining eligibility for
health insurance.
AB 1287 authored by Assemblymember and Chairman of the Assembly Ways and Means
Committee, John Vasconcellos, with respect to HIV test disclosure, ensures that
those individuals who are involved with HIV -- or AIDS

vaccine clinical trials

as a volunteer who test HIV antibody positive or negative as a result of their
participation in those clinical trials -- will not be denied health care,
disability, welfare, or life insurance coverage.
one other item I'd like to highlight for you is this last November, the Office
of AIDS, in keeping with its theme of prevention, secondary and tertiary
prevention, also was successful in expanding the AIDS drug program Formulary.
Previously, the AIDS drug program consisted of two drugs only.

We added an

additional 11 drugs, and we also are now the largest state AIDS drug program in the
United States.
California's contribution in state funds is $9.1 million which also is the
largest state contribution of any other state in the United States.
I'm going to briefly go to epidemiology.

To place my testimony into

perspective, I'd like to give some information about the scope and course of the
AIDS epidemic in the state and Loa Angeles County.

As indicated, I'm going to

abbreviate some of my comments in this section particularly.
As of November 30, 1991, 38,660 cumulative cases of AIDS and 26,369
AIDS-related deaths have been reported in California.

As of this date, Loa Angeles

county has reported 13,672 cases of AIDS; and deaths totaled 9,576.

Statewide,

during the most recent 12-month period, 7,683 new cases were diagnosed; and 6,036
deaths were reported.

An average of 640 new AIDS cases were diagnosed and 503

AIDS-related deaths reported each month.
There are an estimated 12,500 Californians living with AIDS at the end of
1990.

At the end of 1993, two short years from now, there will be an estimated

16,200 people alive with an AIDS diagnosis.
The incidence of AIDS continues to increase in all ethnic and racial groups
within the state.

Of the cumulative total AIDS cases reported in California

through this past June 1991, whites have accounted for 71 percent of the total;
-3-

African Americans, 13 percent; Latinos, 14 percent;
percent.

and Asian/Pacific Islanders, 2

In contrast to statewide racial and ethnic distributions, 62 percent of

AIDS cases reported in Los Angeles county

again, that's compared to a statewide

total of 71 percent in Los Angeles County

62 percent have been among whites, 16

percent among African Americans, 19 percent among Latinos, and 1 percent among
Asian/Pacific Islanders.
Between 1986 and 1991, you can see a very dramatic shift in the proportion of
AIDS cases reported among whites in California decreased from 77 percent to 65
percent.

conversely, among African Americans, the percentage of new cases

increased from 10 percent in 1986 to 14 percent in 1991.

Latinos accounted for 11

percent of new cases reported in 1986 and now represent 18 percent in 1991.

The

percentage of new cases reported among Asian/Pacific Islanders also increased from
1 percent in 1986 to 2 percent in 1991.
The proportion of new AIDS cases among different transmission categories,
however, has remained relatively stable over time.

The majority of new AIDS cases

continue to be reported among gay and bisexual males.

Approximately 83 percent of

California AIDS cases diagnosed in 1991 were among this group.

Cumulatively,

nearly nine out of every ten California AIDS cases have been diagnosed among gay
and bisexual men.
The number of cases attributable to heterosexual injection drug use continues
to increase.

Nearly 1,250, over half, of the 2,211 cases in this transmission

category, that of heterosexual injection drug use, have been reported in just the
last two years.

Notably, African Americans account for 12 percent cumulatively of

all AIDS cases in California, but 40 percent of all cases among injection drug
users.
The number of new cases attributable to heterosexual contact with an infected
person also continues to increase.

As of November 30, a total of 702 AIDS cases

have been reported among persons who cite heterosexual contact as their primary
risk for infection.

More than half of the reported cases have been diagnosed in

the past two years.

To date, 204 cases of AIDS have diagnosed among hemophiliacs;

802 cases have been diagnosed among transfusion recipients.
Children, 258 AIDS cases diagnosed among children in California being evenly
distributed among white, 34 percent of those cases; African American, 29 percent;
and Hispanic, 33 percent.

Because of under-reporting and mis-diagnosis, the actual

number of children with AIDS may be as much as 50 percent higher.
We estimate that there are currently 146,000 Californians living with HIV
infection in California in 1990.

An estimated 83 percent of the people are gay or

bisexual men; 9 percent are heterosexual injection drug usuers; 2 percent are women
-4-
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infected through heterosexual transmission; and 6 percent transfusion recipients,
hemophiliacs, men infected through heterosexual transmission, or infants infected
perinatally or vertical transmission.
The National Centers for Disease Control estimate that at least 40,000 new HIV
infections occur each year nationally.

This could imply that as many as 8,000 new

HIV infections occur each year in California.

An

estimated 100-150 new infections

occurred annually in newborns as a result of perinatal HIV transmission in 1988 and
in 1989.
We estimate that AIDS cases will continue to increase through 1993, 9,700 in
1993.

And by 1993, the cumulative number of AIDS cases diagnosed in California --

recall that currently we have an AIDS case of a cumulative total of 38,000, that by
the end of 1993, without any changes in the CDC definition of the AIDS cases, that
there will be as many as 68,000 individuals in California with an AIDS diagnosis or
have -- excuse me.

I should say that there will be as many as 68,000 cumulative

AIDS cases reported in California.
I'd like to move quickly now
DR. TATE:

Yes.

Cumulative.

yes.
So are you saying from the time that the state

started collecting data, the numbers-- so from what?
MR. SAUSEDA:

1981 or •••

Prom 1981 till now, there have been a diagnose and reported

38,000 cases of AIDS in California.

By the end of 1993, what we've seen in the

first ten years we will see again within two years; and we'll reach, we're
estimating, 69,000 cases of AIDS •••
DR. TATK:

And then out of -- so that's basically almost double?

MR. SAUSEDA:
DR. TATE:

Almost double within the next two years.

Has your office at all looked at what types of people will be

acquiring the disease though?
MR. SAUSEDA:

Will it still look similar to the way it is now?

The epidemic is changing.

We're seeing -- although I've

indicated in my testimony previously, we're seeing the cumulative number of cases
being relatively stable among different transmission categories.

We are, however

-- and that's because of the sheer volume of numbers early on in the epidemic -- we
are seeing the increased numbers being reported among heterosexual injection drug
users and also heterosexual, either through heterosexual injection drug -- excuse
me -- injection drug use or heterosexual contact as a means of transmission.

That

increase is particularly increasing in communities of color.
DR. TATE:

Thank you.

MR. SAUSEDA:

With respect to state AIDS funding, the funding for AIDS

programs administered by the state -- and I should qualify that by saying that
there is direct funding that's provided to certain localities within the State of
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California, including the major metropolitan areas of San Diego, San Francisco, and
Loa Angeles.

But of the funds that are administered through the state, that total&

$124.6 million for 1991-92, the current fiacal year.

Of thia amount, $76.6 million

represents state funds, and $48 million are federal funds.

And there are aome

attachment& that provide aome graphic representation of that.
Funding for education and prevention projects began during fiscal year
1983-84.

At that time, $450,000 was available.

Since then, the education and

prevention budget has grown to $16 million for 1991-92.

While the specific numbers

of client& served are unavailable at the moment, the numbers of education and
prevention contractors increased from 15 in 1983-84 to 137 in fiscal year 1991-92.
The Office of AIDS began diatinguishing between education and prevention
services to minoritiea and other groups during fiacal year 1988-89.

During that

fiscal year, the total education prevention budget was $16 million, as it is today,
of which 38 percent waa targeted for minority projects.
the amount available again is $16 million.

In fiscal year 1991-92,

Of the 137 contractor& funded, 52

percent are from minority-owned and/or serve more than 50 percent minority
populations.
State-funded HIV antibody testing is provided through various sources in the
state.

Free and anonymous testing is provided through the alternative test site,

also known as the Anonymous Teat Site program. Additionally, confidential HIV
testing is provided through various county primary care clinics and other
free-standing community primary care clinic&, such as family planning clinics,
rural and community health clinics, and the State Department of Alcohol and Drug
program administered testing sites.
Of all testing and counseling services provided during January-December 1990,
that is, calendar year 1990, 25 percent of the aervices were received by Latinos,
and 13 percent were received by African Americans.
The testing program is also conducting an outreach campaign to provide
information on testing and the services available to the public.

Of the $300,000

earmarked for this campaign, one-third is being used in the Latino community, and
one-third is being used in the African American community.
I might comment briefly that this past year, aa part of our campaign for
testing, we ran, in certain parts of the states, including Los Angelea, a teating
campaign.

As a result of that, and we recognized that there was a aubstantial

increase in testing, we were able to measure it before the campaign started with
testing activity at testing sites in those locations of the testing campaign.
as early as October, we noticed a tremendous increase in testing.

And

Since that time,

of course, the disclosure by Earvin Magic Johnson has further driven up demand for
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HIV testing services.

I believe in Los Angeles COunty, I understand that what was

a two-week waiting period at one time instantly turned into a two-month waiting
time for HIV-tested services.

Many testing sites were faced with the prospect of

running out of funds for testing, turning away people who sought to find out their
HIV status, people who might not otherwise have presented for a test.
We have gained the support of Dr. Coye, the Director of the Department of
Health Services, and Mr. Russ Gould, the Secretary for Health and Welfare Agency,
to push forward for increased funding for the testing program to ensure that people
who are interested and who have examined their behaviors and believe that they have
a reason to test are provided the opportunity to find out their HIV test status.
The Early Intervention Program provides behavior change interventions,
paychosocial support, health education, case management services, and early medical
aasessment and treatment to HIV-infected persons.

The goal of the program is to

prolong the healthy and productive lives of those infected with HIV.

Statewide, 22

percent of the EIP, or Early Intervention Program, clients are Latino; and 11
percent are African American.

These percentages are even higher at some location&,

auch as the Early Intervention Program in San Francisco where 52 percent of the
clients are Latino and South/South-central Los Angeles where 49 percent are African
American.

The total funding for the Early Intervention Program is $2.6 million.

Pilot care and home and community-based care projects began in 1985-86.
the time, the budget was $1.6 million.

At

Since then, the budget is now $6.6 million.

The Pilot Care Prject Program has officially targeted 25 percent of their funds for
aervices to minorities; however, the actual percentage has been over 35 percent
aince fiscal year 1988-89.
There are a number of projects throughout the state which our office funds
addressing ethnic minority groups, including Latinos, African Americans,
Aaian/Pacific Islanders, and American Indians.

All minority-based projects provide

education and materials in the target groups' native language with a special
emphasis on cultural values.

Some examples -- I'll pass over this -- identified in

my testimony -- certain examples of AIDS-funded minority projects, including the

Minority AIDS Project, or MAP, in Los Angeles, as well as others in Los Angeles and
other parts of the state.
I'd like to comment briefly on other Office of AIDS' efforts.

The Office of

AIDS began working last fall to develop a comprehensive plan in response to the
Ryan White comprehensive AIDS Resources Emergency -- or CARE

Act of 1990.

As a

reault of that, we sought to include a very representative working group to advise
the state on the appropriate allocation of resources.

Fifty percent

of that

working group, representing a very geographic distribution, was represented by
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communities of color on that working group.

Also, as part of the development of

the formula, we identified eight factors that would impact how the formula would
actually translate into services in a local community.

In recognition of the

Lmpact that HIV and AIDS has taken into communities of color, one of the factors,
weighted at 20 percent of the total, was a non-white index factor.
The Minority AIDS Resource Center is a program funded by the Office of AIDS
providing information, training, and technical assistance to our education and
prevention contractors.

It includes a library, a computer database, bulk

literature, and a resource guide.
The Office of AIDS also provided funding to Multicultural Training Resource
center in sponsoring multicultural AIDS consensus and collaboration workshops.

The

participants are Office of AIDS contractors currently providing direct education
and prevention client services.
The purpose of the workshops is to discuss barriers and find solutions to
providing quality and education and prevention services to minority communities.
Workshops focus on barriers as they pertain to rural, urban, communited-based
organizations, and health department issues.
The Office of AIDS also provided funding for a statewide "People of Color"
conference this past summer of 1991 with the goal of improving the survivability, a
very real issue,

for service providers in minority-based communities and focusing

on strategies to improve outreach and prevention activities to ethnic minority
populations.

At the conference, the group elected representatives to serve on the

newly formed Office of AIDS Multicultural Liaison Board.

This elected group, which

is composed of 12 members, 3 each from the major ethnic racial minority groups -African American, Latino, Asian/Pacific Islander, and Native American -- will serve
as an effective

and important liaison between the Office of AIDS and multicultural

providers and community.
Before I conclude with my remarks, I'd like to comment on another issue which
impacts on the issue of survivability of service providers.

The Department of

Health Services this past year, because of budget reductions, reduced over 500
positions in its department.

It would equate roughly to about one of every five

positions that are state funded.

The Office of AIDS took a commensurate cut.

One

of every five positions state funded were reduced from the budget.
In order to try to continue to provide funding in a geographically balanced
way, the contractors were reduced also in local assistance because of the trigger
reduction, because of the state budget crisis.
The problem has occurred, however, that because of the department's cuts,
because of the threat of potential layoffs, the department is also, as many
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positions that are unfunded in the Office of AIDS alone, we see after our budget
cuts, we still have a 40 percent vacancy rate overall which is having a very
dramatic impact on those contractors and providers in the community we work with.
From a department-wide perspective, it also means that contracts are slowing
down, that payments to providers are slow, slower than is reasonably to be
expected.

And that threatens very seriously the survivability of community-based

organizations, many of whom do not have the financial resources to float the money
necessary to provide periods of service, sometimes long periods of service, without
reimbursement.

Dr. Coye has convened eight of her top managers who have experience

in both programmatic issues, as well as very expert knowledge of administrative
practices, both at department level, as well as control agency levels.

I'm

fortunate enough, in representing the Office of AIDS, to be one of those eight
individuals selected by Dr. Coye.
The purpose of this -- the objective of this group is to try to streamline the
contractive process, to try to expedite the invoice processing, and reimburse our
providers in the community who, without whose support, without that infrastructure
out there, the services to communities simply would not take place.
We have a commitment to our providers.

We are going through a difficult

period of time because of the state budget process.

Dr. Coy and our office, as

well as other offices in the Department of Health services, are very committed to
correcting what we believe to be currently an intolerable situation.
In closing, the Office of AIDS is committed to stopping the AIDS epidemic in
all parts of California, particularly in communities of color.

We recognize that

this must be done, not in isolation, but in concert with a comprehensive approach
to addressing overall health care issues and needs.
I'd like to thank you for this opportunity to appear before you today.

I'm

available to answer questions from the audience.
CHAIRPERSON DIANE E. WATSON:

I want to thank you, Mr. Sauseda, for coming

here and giving us this comprehensive update on what the Office of AIDS is doing.
I want to apologize to the office for being tardy, but we were on another issue as
epidemic as AIDS is, and that was breast cancer; and we had to be out at UCLA for
that.
I think that you probably have addressed many of the concerns that I have, but
I'd like to fine-tune some of them.

First, I'm concerned about the amount of

dollars that has been targeted into minority communities.
exact amount.

You did give us the

I'd like to know what the department can do in terms of limited

funds to address the growing need, particularly among African Americans and
Latinos, of AIDS.

The Minority AIDS Project sits in my district, and we've been
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working closely with them for several years now.
There is some lack of immediate response to the pain of their claims.

Since

Magic Johnson made his announcement, they were getting thousands of calla per week
asking for testing.

Now because it is a community-based organization that grew out

of the grass roots, the expertise to fill out the forma, the way the Department of
Health would require them, and the ongoing expertise to be able to handle the
paperwork within your framework is sometime, most oftentimes, very difficult.

But

these are serving the people and they're serving the need.
can you respond to what the Office of AIDS can do, and I know 500 positions
have been cut.

But can you respond to what they can do to get the funds to th. . in

a timely fashion, to keep those doors open, in spite of the paperwork, and what
kind of commitment will be made in the year '93, or 92-93, to MAP and other
organizations like it.

It's not the only one suffering from lack of funding, but

they all have the high-risk community of major concern.
MR. SAUSEDA:

How can you help?

I agree with, Senator, agree with you completely.

Even before

the budget reductions, I think that the contracting process and the invoice, or
reimbursement process, was slow.

Minority organizations and other small

community-based organizations don't have the resources to effectively front the
money for services that are being contracted in good faith by those organizations
on behalf of the state.
In our office, one of the things that we've done just recently, because it did
reach an intolerable perspective, proportions, although we could not recruit
individuals into our office because of the threat of overall layoff, we did provide
additional resources to the department's accounting office directly, devoted
exclusively for our contractors.

Now that doesn't solve the problem for other

contractors outside of AIDS contractors.
commitment to our contractors.

It did for us, and that was our

And I do have a chronology of what occurred in the

invoicing process or the contract process for the Minority AIDS Project.
a very prime example of what was occurring.

But it is

We've now made the resources available

to both our contact management section of the Department of Health Services, as
well as the county section, to expedite our claims, our contracts, to ensure that
we can now work for the State Controller's Office who are also a key, a player in
the process, to get the funds out to community organizations.
An overall issue that the department is addressing currently is that of
categorical programs.
state.

we have a tremendous number of vertical programs within the

one contractor may have several contracts with the state and subject to

many different rules and regulations and payment timetables.

What we're looking at

is some way of being able to minimize administrative burden that places on
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contractors, to try to remove, to truly try to identify those things we need to
have to be accountable as a public steward of funds and those things that we really
don't need to have that only serve as barriers to providers who have spent an
inordinate amount of time on administrative paperwork instead of delivering the
services.

So we're taking a very hard look at that.

I hope to draw from the,

benefit from the expertise of those providers in reworking our RFP process -- let
me digress for a moment.
This last year, it's still not perfect, but our RFP process, or Request Por
Proposal process, for education and prevention projects was tremendously
streamlined.

It's going to get better next year -- excuse me.

not going to -- in fact, next year -- it got better already.

Next year, we're
We didn't do one.

In

yeara out, we have established an education and prevention evaluation group who's
looking at the relative success of education prevention efforts but who is also
looking at different ways of getting money out to the community, ways that are less
cumbersome, ways that are less time consuming, and ways that do not just impose or
interject barriers to the provision of service.
CHAIRPERSON WATSONt

I appreciate that response, and I have a lot more faith

and confidence in the Department of Health Services now that Dr. Molly Coye is at
the head; and we've worked together on other projects, and we will work together in
the near future.
I'm pleased to know that you're looking at the obstacles in the way.
there's too much bureaucracy.

I think

I think the need is documented over and over again,

and I would hope that we would find some way to provide contractors with resources

without all the paperwork because of the need.

If these community-based,

graaaroots projects have to close down, who's going to aerve those in need?
hoapitals can't do it; public health can't do it.

COunty

Those programs that you've

listed here, and I do appreciate your summary, are those that are fashioned to
aerve that particular clientele; and we've got to give them the support.
to call all the time to help MAP and other programs to get their funding.
they're having to turn people away.

I've got
And

There are people dying in their homes without

the kind of care that they can give them through some of these programs.

So

whatever you can do to strengthen that effort, we would appreciate it.
Let me go and backtrack over some of the things that you had mentioned.

I'm

concerned about what the department is doing on promoting information about safe
behavior for our youngsters.

Now we have battled in the legislature, as you know,

over the years trying to implant in the educational system a program that would
follow the child through primary, elementary, the middle, and the senior high
school, somewhat to very little avail, because of the resistance we get on the
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But how are you planning to promote a safe sexual behavior and about the

way to ensure protection against the HIV virus, and how it's transmitted?

What are

you going to do as a department?
MR. SAUSEDA:

Let me first, and in responding to that question, indicate that

this, of course, is a tremendous issue of need.

In the past legislative measures

that would discuss HIV and AIDS within the public education system failed.
were -- they didn't failed passage in the Legislature.

They

They failed signature.

This year •••
CHAIRPERSON WATSON:
MR. SAUSEDA:

Let me just interject this here --

certainly.

CHAIRPERSON WATSON:

-- because we're talking about strategy now becauae I

know where the policies are made.

So I want to talk with you about how we do it.

Would you be willing through the department, your unit, the department, Molly
COye, to sit down with the Governor and talk about the need to train our
youngsters?
realistic?

I don't think any sex is safe.

We talk about abstinence -- is that

But we ought to have a strategy worked out from the Office of AIDS, the

Department of Health Services, to the executive branch.

we in the legislative

branch will do our role and play our part, me in particular.
holding the hearing.

That's how we're

But I think more effective and putting more clout and force

behind it would be for your department, your unit, working with the administrative
executive branch, saying we've got to do it.
contracting AIDS.

There's no reason why youth should be

They understand the risks they're under.

you know where it's been blocked.

We need help because

So I think that approach, if you feel, could be

feasible.
MR. SAUSEDA:

Let me just say that there's no question as to the willingness

of the department to do that.

Dr. coye this last year, let's say, cycle, talked to

the Governor personally on four measures.
One of those measures was Assembly Bill 11 authored by Assemblywoman Hughes,
that provides for education in schools for BIV.
the Governor.

She strongly supported that with

We worked with the Department of Education, shepherd the bill

through, joining not only the executive branch, of course, but the superintendent
of education.

We joined forces together in helping to secure passage of that bill.

Dr. COye is very committed to that; we are committed to that in the Office of AIDS.
We recently negotiated a memorandum of understanding between our office and
department and the State Department of Education to ensure in fact that students in
school and teachers who are very critical to this process are trained in BIV and
AIDS effectively to educate our students in school at an early age.
It's very clear from the information that we've seen and the number of
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individuals who are diagnosed with AIDS who incur their infection as a teenager,
particularly those people who are homeless -- excuse me -- I should say the
homeless youth or out-of-mainstream youth, those who are runaways, or also some are
considered throwaways -- that most of these individuals receive their health
education in school before the eighth grade.

So that very clearly points out the

fact that if this particularly at-risk population of young people are going to get
the message, it has to occur at an early stage.
CHAIRPERSON WATSON:

Right.

Let me respond to a strategic point.

the Governor on a specific piece of legislation.

You went to

What happens there is that you've

got provisions in that piece of legislation upon which the Governor can respond to,
well, I don't like this provision or there's not abstinence at the top of the list
and so on.

What I'm talking about is a philosophy and a strategy attached to that

philosophy, going to him and saying, look, let's come out with a position for the
State of California as to how we approach AIDS education, outreach, and so on; and
then let's go find members to carry legislation.

So what we want to do is try to

build the attitude in the executive branch, that we've got to do something -- we've
got to start early.

Why deprive youngsters from the knowledge about their own

safety, about sexual practices, about their own biology?
from that information?
Governor Wilson.

Why keep youngsters away

That's the kind of approach that I think might work with

I do believe he is committed to prevention; he is committed to

services for children; and I think if you approach him, not on a particular piece
of legislation but on overall philosophy for the state, it might bold some promise.
Let me move on because I don't want to keep you on the hot seat too long.

We

have other witnesses here.
I'd like to know a little more about the type of set-asidea for the ethnic
minority provider& in terms of outreach.

I think what we experience ia that the

four major ethnic communities -- Latinos, African Americans, Asian&, American
Indians, and others -- what we find each one of thoae ethnic categories respond
differently, understand the problem differently, or lack the underatanding of the
problem.
What are you doing in terms of aetting aaide resources to meet the outreach,
the education, the treatment, and ao on?
KR. SAUSEDA:

Certainly.

Can you briefly •••

Thia last year, in developing the request for

proposals for education prevention and efforts, we for the very first time, and
it's hard to imagine but I've got to say that for the first time, the Office of
AIDS combined epidemiologic information and targeted those to where we were seen
the trends of HIV infection in AIDS-case diagnosis.

And our epidemiologic

information suggested that there are three primary groups of emphasis, and those
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being women of childbearing age, particularly among women in communities of color,
those homosexual, bisexual men who are closeted, or not necessarily gay-identified
men, and then also adolescent youth.

so for the 1991-92 fiscal year, last year,

and we developed our RFP, we specifically targeted those three groups of emphasis
so that contractors who would be competing for funds and who are on a competitive
basis would tailor their proposals very specifically to these three groups of
emphasis with specific risk behaviors.
CHAIRPERSON WATSON:

How's the RFP drafted to catch the attention of these

categorical groups that might come after those funds?
MR. SAUSEDA:

It's broadly distributed to existing contractors, as well as

through other publications we have through the minority-trained resource center and
also through our contract monitors working in different parts of the state.

There

was also some public notice regarding those, and also within the California AIDS
information network.

So I believe that there was a substantial distribution of

that.
I'd like to further indicate that we very clearly acknowledge that there are
barriers to successful education-prevention programs in communities, particularly
communities of color.
CHAIRPERSON WATSON:

Yeah, let me just interject these things because your

explanations are in depth and I appreciate those.
The contract monitors, I don't sense enough real community work.
sense that grassroots people understand the risks.

I don't

In fact, I know they don't.

And what really concerns me is how we get into the community by people who reflect
the ethnicity of their community, the language patterns, and behavior patterns.
That is something I just want to put on your mind if there's a gap.

And I know

you're trying to do the right things, but it's still coming from a bureaucratic
level of how it should be done.
We've got to probably recruit people off the streets, like we do drug addicts
and we give them treatment and then we train them to go back and be workers in the
community.

We've got to get people that live day by day, that experience, and try

to get them to talk to like kind.
Look at this room, practically, empty.
talking to each other.
packed.

Everybody in here is an expert.

What we're saying, we already know.

We're

This room ought to be

We still haven't found yet the way to reach that particular level.

Dr. Jordan was just in here, but I was appalled when we had a hearing with
him.

And there was a woman who had three children, was HIV positive, and was HIV

positive by diagnosis before she even had the first one.
missing out.

so somewhere wa are

And the people who he brought in to talk to us had no clue as to how
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they contract this, regardless of what we do on television and the paper and what
you do.

So I just share these things with you.

We have a serious problem, and I'd like you to get out on the streets; and if
you haven't visited these programs, do so.

I know I took a bit of Dr. COye'a time

when she was trying to spend a day out here in the streets.
but you've got to do more of it.

And I commend that,

And I know we're short-handed.

We're all working

together to try to solve this problem.
One last question, and you can be very brief, we're hearing, now that there's
an increasing number of people acquiring BIV from tattooing and ear piercing,
particularly among teenagers and other various youth groups.
that?

Can you comment on

Do you have any evidence of that?
MR. SAUSEDA:

In the interest of being brief, I'm going to have to say that we

are aware -- we have anecdotal information indicating that needle sharing, not just
the injection of drug use, but needle sharing does carry the risk of transmitting
HIV.
CHAIRPERSON WATSON:

When they use that same needle to do the tattooing, is

that what you mean by needle sharing?
MR. SAUSEDA:

That's correct; yea, that's correct.

CHAIRPERSON WATSON:

Yeah, we better be real clear on that because needle

sharing meana you're injecting aomething aa we formally have used -- you're
injecting aomething into your veins?
MR. SAUSEDA:

Injection.

CHAIRPERSON WATSON:

But when we talk about needle sharing, I think you've got

to be real specific, saying that needle that they use over and over.
sterilize it, in quotes, but they use it over and over again?

They

That'a the needle

you're talking about?
KR. SAUSEDA:

Right, right.

CHAIRPERSON WATSON:
KR. SAUSEDA:

Okay.

And that's occuring not only on the street; it's occurring in

detention and correctional facilities as well.

It's very important that as we

communicate needle use, that we don't just atop with, as you've pointed out,
injection and drug use, but all needle, or needle-aharing behaviors, including
tattooing and ear piercing.
CHAIRPERSON WATSON:

Can you do something out of the Office of AIDS that will

clarify what we mean by needle use or sharp-instrument use on the akin, of
penetrating the akin or in the veins and so on?

I think we need to broaden that

out.
KR. SAUSEDA:

As we develop our material and review our existing material,
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we'll keep that in mind.
CHAIRPERSON WATSON:

Because I know in prisons, you know, that's the thing to

do, and California Youth Authority, the thing to do is come out with all these
tattoos meaning you belong to this set or that set or you've been through this
experience and so on.

our kids really don't know what they're doing.

So if we can send something to the Department of Education that can at least
get this out, whenever you puncture or scratch the skin with a sharp instrument,
you're at risk.

And particularly where fluids are being exchanged, I think

something like that would be a beginning.
one last and final question, audience, to the current speaker, and what is the
Office of AIDS' role in ensuring that, and the department's role, ensuring that
experimental drugs, will be made available doing clinical trials to low-income
persons who might be on Medi-Cal, Medicare, or those who don't have any health
coverage at all?
MR. SAUSEDA:

That's my final question.
That's an area that we've not yet covered, I think, in terms of

our efforts, and we're looking at doing that.

I believe that one of your witnesses

today is going to comment a little bit more specifically about the representation
of ethnic and racial minorities in women and children in AIDS clinical trials.

I

believe Mr. Alan Harris will be covering that.
Let me just conclude my comment by saying that the Department of Health
Service& does have some research funds, the AIDS vaccine research and the Block
Grant Fund, AIDS Vaccine Clinical Trials funding.

This, laat year, in awarding our

contract to CYRON Corporation, for the clinical trials, we made as a stipulation in
that contract that they have very aggressive outreach to women and ethnic and
racial minority communities as participant& in their clinical trials.

We are now

verified with them -- in fact, it is the role of individuals that they are in fact
are aggressively recruiting individuals.

It's a very important need, not just

because of the vaccine perhaps that they're being studied for but because by and
large these research groups gain access to a wider variety of health care, health
care that they might not otherwise be able to access, very important resource to
the communities.
CHAIRPERSON WATSON:

Thank you so much, Mr. Sauseda.

We appreciate your

in-depth presentation this morning, and we'll be looking forward to the continued
work with you and the Department of Health Services.
MR. SAUSEDA:

Thank you very much.

CHAIRPERSON WATSON:

You're welcome.

I'd like to ask for these three people to come up at the same time.

Jim

Kooler, Dr. Kooler, is the Deputy Director, Prevention Division, with the
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Department of Alcohol and Drug Programs; and Eddie Yamamoto, Program Analyst IIJ
and Askia Abdulmajeed -- is Askia here?
DR. JIM KOOLER:

Askia is not with us today.

CHAIRPERSON WATSON:
DR. KOOLER:

Okay.

Thank you.

Fine.

Thank you.

Good morning.

Dr. Kooler.

I'm Dr. Jim Kooler, Deputy Director

for the Prevention Division for the Department of Alcohol and Drug Programs.

And

as you mentioned, Eddie Yamamoto is a Program Analyst working on our AIDS/HIV

Counselor Program.
You have before you the written testimony.

I would like to summarize some

points of that for you, specifically around some of the principles by which our
operation and our departments work, and that is, to provide a statewide effort, we
must be focusing on a partnership of community governments, private and public
agencies, and groups of individuals.

And the cornerstone of our effort is the

California Master Plan, one which you are very supportive of in that developmental
process, that our emphasis reflects an awareness that effective policies have to
come from local communities, and that we need to honor and respect local
communities and counties in their ability to select the programs and policies that
did beat for them.
Currently, 55 counties have been participating in a Master Planning process,
and Los Angeles is one of those counties in Phase VI; and their Master Plan is due
to us in June of '92.

Thirty-one counties are in Phase I and Phase II.

And at

this point, of those 31, almost a third of them have focused on HIV and IVDU,
Intravenous Drug Use, as priority populations in their community.
In regards to the HIV/AIDS issues, the department formally addressed this
first in 1986.
place.

And we did that with some emergency regulations which are still in

The first of those is allowing programs to exceed their capacity by 10

percent when the need is documented.

Secondly, upon our approval to waive the

requirement that the clients document that they have at least two years of narcotic
addiction.

And finally, again with our approval, to waive that they must document

two unsuccessful attempts of withdrawl and having return back to narcotic use.
By the next year, we started to use our ADMS, Alcohol and Drug (Abuse) and
Mental Health Services, dollars specifically targeting again the IVDUs.

This

process brings money to the counties through the subvention process reflecting our
relationship with the counties and the state.

our hope is to give maximum

flexibility to the counties in determining the best way in which they can use those
dollars while still meeting the federal regulations.
During 1987-88, a total of $5 million was allocated to the counties of which
Los Angeles County received nearly $2 million of those.
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currently, 35 percent of the department's total Alcohol and Drug (Abuse) and
Mental Health Services' Block Grant is dedicated to drug programs.
set aside specifically for the IVDU.

Half of that is

Right now, the department has over $23

million available for this, a 360 percent increase from just four years prior.

And

of this, Los Angeles County receives over $8 million or a 300 percent increase
since 1987.
In addition to those IVDU set-asides, there are several issues which may bring
other funds, versus the AB 1903, the augmentation to the Budget Act of 1988.
CUrrently, there are approximately $1.2 million allocated to counties of which Los
Angeles received nearly $400,000.

And this money is allocated to those counties

which have the highest numbers of AIDS cases.
The next is our HIV/AIDS counselor program which is an inter-agency agreement
with the Office of AIDS.

We have approximately $1.8 million going to this program

to do training for counselors, to do precounseling, to do the tests, and do the
post-counseling, allowing clients to access services more readily.
operates in 20 countiea throughout California.

This program

Of those populations, approximately

12 percent of the clients are Black, 27 percent Hispanic, and the other 4 percent
representing 43 percent of the clients in that program of people of color.
Statewide, we have an AIDS-training program for counselors and people working
in the treatment programs to be trained to understand the HIV/AIDS issue.
operates on ADMS funds, approximately $100,000 a year.

That

That program is in its

third year, and we're currently doing an RFP to put that out to bid for another
three years.
And finally, our Continuation Waiting List Reduction Program, the intent of
this grant was to rapidly expand treatment capacity here in California, and that's
consistent with the National Commission on AIDS Report earlier this year.
Approximately $13 million of continuation funding is available through this
program, of which $2 million must be targeted to IVDUs.

For this year, Loa Angeles

received approximately $3.7 of that continuation funding, and $750,000 of that
targeted towards IVDUs.
So in closing, the department funds approximately $28,000,000 in programs
targeting IVDUs throughout the state, Los Angeles County receiving approximately $9
million of that.

For California, that's a 460 percent increase; for Los Angeles, a

450 percent increase.

our department looks forward to continuing to focus on the

issue, and I appreciate the questions that you brought up earlier around the youth.
There are some areas in which I think we as a department can participate in
bringing information to young people.

To those would be through our Club Live or

Friday Night Live Program which are intermediate and High School Programs reaching
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approximately 1 million high school students, another 750,000 intermediate school
students, bringing to the coordinators who work in the 44 counties who provide that
program, I think, that we can raise the issue around HIV and AIDS to our younq
people in ways that have not been done before.
CHAIRPERSON WATSON:

Thank you very much.

Have you discovered in the 58

counties programs that you feel are effective are doinq the job; and if so, can you
describe just very briefly what the elements are?
DR. KOOLER:

For the elements for the prevention efforts or for the •••

CHAIRPERSON WATSON:

Yeah, prevention efforts, the outreach programs, those

particular efforts reaching ethnic minorities.

Do you know of some particularly

effective programs throuqhout the 58 counties?
DR. KOOLER:

Well, many of those would be here in Loa Anqeles, as you've

already described.

They're effective in workinq from the qrassroots level.

OUr

belief is consistent with yours, that before programs to be effective, they must be
baaed in the community; and they must have people from that community providinq
those services.

I believe that's consistent with our Kaster Planninq process.

I

personally could not hold up a particular program other than to reinforce the
philosophy by which we concur as to how best programs can operate in communities.
CHAIRPERSON WATSON:

What do you see the difference between tarqetinq

programs, say, to the broad general white male qay community versus the ethnic
minority social, lower socioeconomic communities?
approach?

What's the difference there in

Have you been able to fiqure that out?

DR. KOOLER:

The approach must reflect the participation of that community,

that we've qot to make sure that the people working in those programs are from that
community, that they understand the issues there, that programs in different areas
were developed to meet the needs of those different areas.

So specifically the

difference between a white gay male program and a program centered in the black
community would have to reflect the differences in those areas.

So I could not

qive you the programmatic differences that we would outline and develop a criteria
by which •••
CHAIRPERSON WATSON:
DR. KOOLER:

They'd have to qrow out of the efforts?

out of that community itself.

CHAIRPERSON WATSON:

Your opinion now.

I carried a bill last year that dealt

with needle exchanqe and allowinq a test pilot to do needle exchanqe.
as to:

Your opinion

(A) Do you think it would go a distance to prevent contracting the spread

of AIDS; (B) Is this an effective approach; (C) How do you sell it to the other
communities?

Opinion.

DR. KOOLER:

Thank you.

And we are also addressinq and doing the research
-19-

0~

within our department, along with the Office of AIDS, as to the feasibility of such
an effort.

The research, I think, is showing effectiveness in reducing the

transmission of the disease.

So the implementation of that type of program is in

the interest of the public health slowing down the transmission of the HIV disease.
The political issue as to whether you are encouraging more drug use by making
needles available will continue.

The use and the selling of that kind of program

to a community is a difficult issue.

some communities will view it as a moral

issue and that the drug abuse is the issue that we want to address; and if you're
providing needles, you're encouraging drug use.

Other communities will say that if

you provide the needles, you will slow down the transmission.
In my opinion, we have to fall back into a position of honoring communities'
needs and listening to them.

I think one of the things that we can look at as a

state is getting out of the way of those communities who feel that it is most
appropriate for that program to operate in their area.

Right now, we don't have

that opportunity because of statutes and the availability of needles.
CHAIRPERSON WATSON:

I intend to reintroduce that particular bill again.

I

think even more so, because of the discussion I just had with Mr. Sauseda about
sharp instruments scratching the skin, and I think that the -- we know how AIDS is
contracted, and we know how it's spreading rapidly and why it's spreading rapidly.
We know all that information, we who are enlightened, know it, and we're afraid to
enlighten others and to provide a safer way.

I guess it's like the condom whole

thing.
DR.

~LER:

The condoms at high schools.

CHAIRPERSON WATSON:

You're up against these archaic attitudes.

I'd like you

to start exploring ways of dealing with the community on that issue, also dealing
with the Governor on that issue.
particular one.
these people.

I don't know if he's going to be a friend on this

But I'd like your department, a preventitive sense, to get real of
You know, we've got to come and face reality as we find it on the

streets.
I don't care -- you know, those of us on high who make the policy -- many of
us don't have a clue.

You've got to come down here and face what's going on.

AIDS among, particularly black women, heterosexual women, is epidemic.
DR. KOOLER:

And listening also to our young people.

Youth Council which is planning a conference.
chose themselves was HIV/AIDS.
CHAIRPERSON WATSON:

And

So •••

We have the California

And one of the tracks that they

So we will open the doors •••

You know, if we haven't gotten the word to Magic Johnson,

then we're in deep, deep trouble.

And I think that we're going to see funding from

the athletic associations nationally; because if the thought is in their minds,
-20-

034

like it's in mine that AIDS can spread through their whole team -- and the industry
of athletics in this country is like next to the entertainment industry -- they
both can be lumped into the same category

it's entertainment.

And the threat of

AIDS running through a team, I'm sure, will probably motivate them to share
resources with those of us in the public sector.

I'm hoping that that will be the

case.
But I want to come back again, and I'm going to come back again and again
until we can catch the attention of all those people that beat us up with the
bible, beat us up with, you know, the morality and the ethics of all this.

I'm

dealing with science.
DR. KOOLER:

From a public health perspective.

CHAIRPERSON WATSON:
DR. KOOLER:

Thank you very much.

Thank you.

CHAIRPERSON WATSON:
DR. TATE:

From a public health perspective.
Yes.

I just have a very short question.

With regards to Friday Night

Live, I understand, I think you said, that it reaches over a million high school
kids, maybe even more, but moat of those kids are Anglo kids, middle-class Anglo
kids.

What is the department doing to outreach to kids of color or low-income kids

for Friday Night Live and those sorts of outreach programs?
DR. KOOLER:

A great deal.

And the perspective that it's a white middle-class

program is reflective of where the program began in 1984.

I think, if we take a

look at where we are today, there is much more going on in ethnic communities.
Here in Los Angeles, just last month, there was an event here at the Palace in
Hollywood where they bussed in 1,300 kids from all over Southern California; a
tremendous mix of young people had a chance to see Boys to Men.

It was Doritos'

25th Anniversary, a great event, mixing young people from all over.

So we're doing

some good •••
DR. TATE:

Is the State Department, though, doing any very specific outreach

to ethnic minorities to that, you know, for them •••
DR. KOOLBR:

One of the ways that we're doing that is, again, consistent with

the Master Planning process, working with the 44 counties, to make them available
and doing that kind of outreach because it's not a state-operated program but a
locally operated program which we're a partner in.

So part of budget language

talks about any new programs going specifically into high-risk communities.

So

we're supportive in encouraging that we focus in those areas.
CHAIRPERSON WATSON:
DR. KOOLBR:

Thank you so much for your testimony..

We appreciate it.

Thank you.

CHAIRPERSON WATSON:

I'm going to ask for the next four panelists to come up
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as a block.

First, I'm qoinq to ask Alan Harris, AIDS Regional Coordinator,

u.s.

Public Health Services; Bob Frangenberq, Director of AIDS Program for for L.A.
County Health Department; Phil Wilson, AIDS Coordinator, City of Los Angeles; and
Galen Leung who will take the place of Sandra Hernandez, Director of Office of
AIDS, City and County of San Francisco.
I'm qoing to ask that we indulqe Mr. Leung because he must leave.

So if that

panel will come up now, and we'll lead off with Mr. Leunq.
Would you repeat your name at the mike, please.
MR. GALEN LEUNGa

Yes.

My nama is Galan Launq.

Honorable Chairwoman Watson,

Members of the Commmittea, Ladies and Gentlemen, and invited speakers.
said, my name is Galan Leung.

As I've

I've come to testify on behalf of Dr. Sandra

Hernandez who's Director of the San Francisco Department of Public Health AIDS
Office.

Dr. Hernandez sends her reqrets but wanted to make the most of this

opportunity.
Of all the HIV-related issues facinq San Francisco, five stand out.
one.

The funding trends for prevention and health-related services has not

kept up with the epidemic.

Chairwoman Watson, you have alluded to thia already.

What is of particular concern is the shift of prevention funds to health services
thereby cutting funds for behavorial surveys and major prevalent surveys.

This

comes at a time when prevention efforts must be focused on the most
difficult-to-reach populations -- communities of color, injection druq users,
youth, men who have sex with men but do not self-identify as gay or bisexual, and
last but not least, women.
So basically what I'm sayinq is that we have very little or no information to
guide us as to what kinds of programs, educational messages, prevention messaqes,
what sort of media, how to qo about tarqeting many of the prevention messaqes that
we would like to make, that we have services out there that we've been talkinq with
the communities; but we don't have anything to strongly guide us as to which would
be our top priority.

problematic.

We have a million priorities, and we have ten but it becomes

This is of particular concern because of the cutbacks at the centers

for Disease COntrol.
As you are probably well aware, the centers for Disease control reduced
funding to contracts throuqh the Office of Minority Health for prevention messaqes
to minority communities.

And that had a direct impact in San Francisco and with

the Black coalition on AIDS and several other contracts similar to those.

So we

are trying to find the resources to make up for the lose of funds there.
Two.

The needa of the communities of colora for culturally and linguistically

appropriate AIDS services, both prevention and health services, will continua to
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grow exponentially while resources remain limited on the national, state, and local
levels.

All three levels face deficits.

And we don't -- we are not optimistic

about increased levels of funding, as in the past, in terms of percentage
increases, which means we then have to turn around and re-prioritize, re-evaluate;
and we are spending as much time as we can possibly do on evaluating and
re-evaluating our programs today.
As the epidemic shifts and more people of color are affected, resources will
have to shift and providers will need to be trained to serve the HIV-infected
individuals in their community.

This is basically the focus that we are going

toward, to train providers that are in the community, already existing in the
community, on HIV, on issues of transmission, on issues of what is available in San
Francisco related to early intervention, support services, issues related to death
and dying, a whole gamut of issues.
We are fortunate in that many of the providers that have participated in the
past are fairly up to date about the latest breaking news.

However, this tends to

be a little bit more on the technical, medical side as opposed to the let's provide

the information and resources to the physicians and other providers as to what is
out there in terms of social workers, case managers, support services, et cetera.
This is a stop-gap measure at this point.
we will be straining our resources.

that right now.

As the epidemic continues to grow,

There will be waiting lists.

We are facing

They come and go, and they are in different groups -- or in

different communities, I should say.

And right now, with the district health

centers that the department runs, some of our district health centers do have
waiting lists related to HIV-related care and others do not and in fact have some
capacity to spare.

So we are also looking at re-programming or shifting resources

around and trying to accommodate where the demand is as opposed to where the
resources are at this point.
DR. TATE:

Let me ask you, is there a greater demand -- what communities have

the greatest demand and the longest waiting list in San Francisco?
MR. LEUNG:

currently, the greatest demands are still at our district health

center number one which serves the castro/DuBois triangle area.

The second

greatest demand area is the area served by Western Edition, which is a -- in terms
of the number of living cases of AIDS, it's the second highest neighborhood in San
Francisco.

We curently have about 500 there and we have about 500 -- I'm sorry --

600 in the castro/DuBois triangle.
In terms of our capacities, they are in, remarkably enough, in the Chinatown
area and Potrero Hill, Bayview, Hunter's Point area.

We are not sure if that has

to do with marketing, a perception, in other words, that these clinics only provide
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a certain kind of service as opposed to the full range of services or if there is
possibly -- and I'll address this later

a stigma attached to going to the local

one or going away from your local area and your local provider to a place that is
known as a place where HIV is treated and AIDS is addressed.
Three.

The twin epidemics of substance abuse and AIDS may intertwine and come

up over and over again.

But the funding -- this is very important -- the funding

must be unlinked in order to provide enough funds or resources for both epidemics.
In San Francisco, the Department of Public Health has drafted a comprehensive
plan to prevent transmission of HIV among injection drug users.

This plan calla

for the involvement of community members, the expansion and enhancement of
susbstance abuse treatment services, repealing laws which hinder needle exchange
programs, augmentation of activities, and a round needle exchange, like the
provision of bleach kids, and providing treatment information, slot information, et
cetera, what is available, and referral slips.
The plan also calls for utilizing needle exchange when it is legalized, either
as a pilot program, as your bill had proposed, and basically as a bridge to reach
two out-of-treatment injection drug users and bring them into treatment or bring
them into the system and provide information, whether it be prevention information,
treatment information, early intervention information.
Drug treatment on demand is the most effective strategy for reducing HIV
infection among injection drug users.
about it.

However, that costs a lot of money, no doubt

Estimates at this point for San Francisco are $30 million in terms of

our comprehensive plan.

But San Francisco is roughly 700,000 people.

It could be,

if you tried to expand it statewide, it would be quite a lot of money, no doubt.
And we understand this, and so we have in the plan taken -- it calls for -- excuse
me.

It calls for steps that can be taken right now; for instance, more efficiently

utilizing the current slots that are available, identifying them, and making use of
them.

And we can expand from our current treatment slot capacity of around 3,000

by an extra 400-500 depending upon the numbers of people that we actually do bring
into treatment.

We currently serve about 6,000 people in treatment.

There's an

estimated 16,000 injection drug users in San Francisco.
A privately based underground needle exchange program named Prevention Point
does exchange around 9,000 needles a week.
around 900 people in that week.

They estimate that they serve actually

So depending upon your estimates, either reach all

those people we do not reach in treatment right now through this underground
program, or we actually have an extra, let's see, 4,000, 5,000 people left to
reach.
Going on with our plan, our comprehensive plan, the department supports a
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significant expansion of treatment slots.
additional treatment slots, no doubt.

The resources must be identified for

And because the plan calla for

comprehensive, integrated-linked services, it actually does build upon services
that are already in place, namely, street outreach, HIV testing, and early
intervention services.
Four.

Like the National Commission on AIDS, we believe that universal health

insurance must be enacted or else the problems of financing that we've seen so far
will only double and triple in the next two years.

Dr. Sauseda has spoken about

how the caseload of AIDS will go up by roughly 30,000 to 35,000 people in the next
two years, and most of these people will be living in the next two years; and many
of these people will be coming from socioeconomic statuses that are lower than in
previous years, and they will have a great impact on Medi-Cal as well as general
assistance.
The policies, however, of Medi-Cal, Medicare, and the Social Security
Administration for disability will in the next few months actually go into flux.
In fact, the announcement today of the Social Security Administration's new
policies, it's actually being printed in the register, and they're going through
the two months' worth of open-comment period.

It's all being driven by the new

definition of AIDS, and that new definition is going to strain our resources
because we will basically see a doubling in the number of cases of AIDS, defined
AIDS, in San Francisco.

We're estimated to go from 3,300 current living cases to

about 6,000 cases overnight.
So social security and Medi-Cal, Medicare, all have an incentive to redefine
their definition of AIDS and who is eligible, not to say that these policies are
naturally rational; but this will cause more delays in trying to find resources for
people with AIDS.

If Medi-Cal does pay for case management for persons, then how

do we get them onto Medi-Cal if their definition of AIDS is different from a
medical definition, et cetera?
With relation to Medi-Cal and irrational policies, San Francisco does have an
example of one that is very unusual.

Gangcyclovir is a pharmaceutical product, is

reimbursable, if given on an outpatient basis.

However, the first two weeks of

therapy are normally an inpatient infusion therapy.

And because it's inpatient, as

opposed to outpatient, you can't get reimbursed; so we're left high and dry.
However, if the reimbursement does become available for the outpatient, for the
inpatient aide, it's not necessarily going to be able to cover our costs.

And that

is one of the other recommendations of the national commission, that in the
interim, before, if

the next steps before the universal health insurance

reimbursement rates •••
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CHAIRPERSON WATSON:
MR. LEUNG:

Let me ask you, is that a state-reimbursement regulation?

The reimbursement regulations related to Gangcylovir or overall,

yes, it is a state •••
CHAIRPERSON WATSON:
it seems a bit ridiculous.

Now can the department do something about this?

I mean

You're trying to keep people out of the acute-care

facilities, and then we have •••
MR. LEUNG:

In order to start, you have to have a 12-hour period of infusion

therapy, which is normally given on an inpatient basis.
CHAIRPERSON WATSON:

Well, Mr. Sauseda, this is something that you might want

to take a look at.
MR. LEUNG:

The National Commission did call for the amounts of reimbursement

to be at least commensurate or at least enough to bring out of the woodwork
providers who would then be willing to participate because what we would then find
is that people would then go to their natural provider, their neighborhood
provider, as opposed to overfilling to above capacity, the local health district
clinics, the county hospitals, et cetera, which is what's happening right now, that
we have waiting lists and waiting lines at San Francisco General Hospital for our
clinic services primarily because Medi-Cal's reimbursement rates are so low that
nobody could even barely make the costs of producing the forms at $9 an hour and
things like that.
one last thing to consider in any legislation or measures related to universal
health insurance is an examination of appropriate profit margins for therapies and
for drugs that have been licensed to date.
AZT and the related drugs -- DDI, DOC.

Most of the focus to date has been on

But other drugs are also now becoming part

of the arsenal in the fight against AIDS.

Brythropoitin, or BP, is a drug used to

fight anemia, and AZT tends to bring on anemia.
AZT, about twice as expensive now.

That drug is more expensive than

That drug was originally licensed for end-stage

renal failure, people on kidney dialysis machines.

But once it got approved, it

can be prescribed for other illnesses, for instance, anemia, from taking AZT.
The appropriateness of the cost -- I'm sorry.

The appropriateness of the

charge allowable for that drug is subject to review, but it hasn't been reviewed by
the FDA because they have other things on their docket at this point which is part
of the problem that we all face now.
And in conclusion, I'd like to say that we are quite honored to have been
invited here to testify before you.

And with regard to what San Francisco provides

and things like that, I can provide you with some of that information.

And again,

I am sorry that Dr. Hernandez was not able to attend and she does send her regrets.
CHAIRPERSON WATSON:

I think that you have pointed out some critical obstacles
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that tend to be somewhat bureaucratic, that stand in the way of treating this
deadly disease the way we should.

I'm hoping that our efforts would result in a

higher priority and less in bureaucracy and more understanding.

And let's cut

right through it and get right to trying to find ways to treat and to prevent, as
well as cure, this dreaded disease.
Thank you so much.
MR. LEUNG:

Thank you very much.

CHAIRPERSON WATSON:

Now we're going to get back to the agenda, and we're

going to call for Alan Harris to make comments now.
Thank you.

And I hope you catch your plane in time.

MR. ALAN HARRIS:

I am Alan Harris, the AIDS Regional Coordinator for the

United States Public Health Service.

I'm also a commissioner on the Loa Angeles

County Commission on AIDS and a Member of the Los Angeles County HIV Health
Services Planning council.
I want to thank Senator Watson and her staff not only for the invitation to
share with the committee preliminary Public Health Service fiscal year 1991 AIDS
financial data for California recipient organizations but also for the leadership,
Senator, that you and the committee have provided for public health in this state.
We certainly commend your efforts in that respect.
I hope the information that I'll be sharing today will be of some interest to
state government, local governments, and local AIDS planning agencies prepare their
budgets in 1992 for the forthcoming year.
Based on preliminary data, for federal fiscal year 1991, which was the year
that ended September 30, 1991, the Public Health Service awarded nearly $191
million in support of AIDS program activities among 348 California organizations.
At that level, California received slightly more than 10 percent of the $1.885
billion 1991 national PHS AIDS appropriation.

our support includes new financial

and direct assistance -- direct assistance is personnel, equipment, and supplies -which is provided prospectively for generally a 12-month budget period in support
of AIDS and related activities.
our assistance was provided through grants, cooperative agreements, and
contract&.

In some cases, particularly for reserach projects, the financial

assistance includes program funding from appropriations other than AIDS.

In all

cases, the financial assistance does not include previously awarded and unuaed
funds which PHS generally would reauthorize to recipients in support of subsequent
years of their multi-year projects, which generally are three to five years in
length.
I've prepared two exhibits that describe the preliminary PHS '91 funding.
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there are some extra copies here for members of the audience as well.
The first exhibit outlines the fiscal '91 preliminary funding by PHS awardinq
agency and by general purpose.
The second exhibit describes that funding by awarding agency in contrast to
prior-year levels fiscal '89 and fiscal '90.
OVer the three years, you can see the public health services provided more
than half a billion dollars in assistance to California orqanizations for AIDS and
BIV-related activities.

The largest share of that money has been provided by the

National Institutes for Health at $261 million over the three-year period.
Givan questions that have come up earlier, as well as the focus of the
committee's hearing, I'd like to identify very briefly the service that the
National Institutes of Health AIDS Clinical Trial Groups are providing to
cumulatively nearly 3,500 adult and adolescent volunteers who've enrolled in those
clinical trials and 182 children who've enrolled cumulatively in California's
Pediatric AIDS Clinical Trials and trial groups.

These eight clinical trial qroups

are university and medical school organized networks of hospitals and clinics whose
participating physicians accept patient volunteers to enroll in clinical trials of
experimental therapies for HIV disease and for opportunistic infections.

Specific

clinical trials of AIDS and HIV experimental therapies are sponsored and supported
by the Rational Institute of Allerqy and Infectious Disease, which is the aajor
AIDS component of the NIH.
These statistics that are reflected in the last two exhibits, one on children
and one on adults and adolescents, indicate that in all cases, except for women and
for blacks who were under-represented by comparison with California's cumulative
AIDS cases, the ACTGs were generally the volunteers, or the enrollees in the ACTGs,
were generally representative of California's cumulative AIDS cases.

That's amonq

adults and adolescents.
Por children, the representation was, in my opinion, fairly representative
across the board, both on sex and race characteristics.
It should be noted that California's adults and adolescents in volunteers
represented 23 percent of all of the volunteers who enrolled in clinical trials
nationwide.

And the 182 children from California represented 16 percent of the

cumulative nationwide enrollment.
I hope this information has been interesting and may be helpful.

I look

forward to answering any questions you may have now or working with your staff in
the months ahead.

Thank you.

CHAIRPERSON WATSON:

In looking at the California AIDS 'Clinical Trials, when I

look at the African American group, it looks like the clinical trials are very low
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comparatively.

Almost no research is going on at a time when it seems like this is

one of the highest risk group at the current time.

Maybe that's the reason because

very few of the clinical activities have really addressed the African American
community.

Can you explain?

MR. HARRIS:

These are only the AIDS Clinical Trial Groups.

They do not

include volunteer enrollees and the Compassionate Youth Trials, which are sponsored
by individual drug companies.
CHAIRPERSON WATSON:
HR. HARRIS:

They do not include volunteers.

Do you have any of that information available to us?

No, I don't.

CHAIRPERSON WATSON:

I can't •••

Can you get what's available and share it with us,

please.
HR. HARRIS:

I can try.

CHAIRPERSON WATSON:

I'm not aware that it's generally available publicly.

See, I guess what I would surmise from all of this is

that the clinical drug trials done in the private sector and in the academic
community have not really been addressing what's going on in the minority
communities.

And I guess what we see with the increases is a result of the lack of

the trials dealing with those communities.

And I would say to the private sector

why7 and I would say to academia and the public sector we've got to do something
about it.

We've got to increase the study groups.

You've got to go out there in

the grassroots, bring these people in, and have them be part of the study groups,
if we're ever going to get a clue as to how we addresa prevention and treatment and
other kinde of activities relative to AIDS.
HR. HARRIS:

My thought and suggestion would be that it's terribly important

for the King/Drew Medical center to be able to participate in clinical trials.
CHAIRPERSON WATSON:

It certainly is.

going to testify a little later.

And Dr. Jordan who is in the room is

I don't think there's anyone that knows the

dearth of activities in this area any better than him, and particularly the few
number of doctors even willing to treat these cases, it's appalling and it's really
scandalous.

And I can understand why AIDS is raging throughout our community and

other communities like ours because of the lack of attention.

I wanted to bring

that to your attention and ask you to take a look in this area, supply us with any
information you can gather as to what the pharmaceutical companies are doing.
HR. HARRIS:

I will.

CHAIRPERSON WATSON:

Thank you.
All right.

to go on to the next presenter.
HR. ROBERT E. FRANGENBERG:
CHAIRPERSON WATSON:
HR. FRANGENBERG:

Thank you for your testimony.

And I'd like

Bob Frangenberg, Director of AIDS, L.A. COunty.
Good morning, Senator Watson.

Good morning.

I'm pleased to have the opportunity to address you today,
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and I'm going to go through some statistics as well as both about the disease
itself and about the funding of the disease here in Los Angeles County.
Los Angeles County is the second-ranking metropolitan area in the United
States in terms of both the present and cumulative AIDS cases.

As of OCtober 31,

we have approximately 4,000 individuals living with AIDS and about 36,000 people
who are infected with the virus.

our cumulative totals are 13,647 cases.

The County Department of Health Services has two mechanisms that fund AIDS
programs in Los Angeles.

one is through the AIDS Program Office, and the other is

through the medical facilities, particularly four facilities.
The AIDS Program Office is responsible for policy and program development of
prevention and treatment services, while the department's medical facilities
provide direct patient care to persons with HIV/AIDS.

The majority of funding for

these services fall into the budget of each individual facility; however, soma
funds for dedicated outpatient services are provided to certain facilities through
the AIDS Program Office.
Projected expenditures for fiscal year 91-92 for the AIDS Program Office is
$38 million; $14 million of this, or 37 percent, comes from county funds, $18
million from federal funds, and $6 million from state funds.
The county funds expended through the program office are for education and
prevention programs, community-based outreach clinical services, case management,
home health care, residential care, drug-abuse treatment for people with HIV, day
care, and dental care.
The $18 million in federal funds will be spent in two broad programmatic
categories.

Ten million of this money comes to us through the Sutters Disease

Control for prevention and education activities, counseling, and testing
activities, and surveillance activities.

And nearly $8 million comes through us

from the Title I of the CARE Act which support medical outpatient services by and
large and some other support services and outreach services.
Seventy-one percent of the CARE Act Funds are being expended on patient
services through contracts with community-based organizations.

Twenty-four percent

are supporting services in county facilities, while the remaining five percent are
for administrative services.

We already know that our 1992 CARB Act Formula grant

will be $5.4 million, up from $3.9 (million) for next year, and the year starts
February 1, 1992.
The State Office of AIDS allocates money to the county.
our anonymous test

si~es.

funds a variety of drugs.

we get $737,000 for

We get about $4 million for the AIDS drug program which
And then we have $287,000 that go to Martin Luther

King/Drew Medical Center for primary care or early intervention services.
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another $1.1 million from, through the State Block Grant, and that goes for a
variety of services as well, including counseling and testing in juvenile halls, a
prevention center at the Gay and Lesbian Community Services Center, an injection
drug use program with the Los Angeles center for Alcohol and Drug Abuse, and in
some surveillance and epidemiology services in our department.
HIV- and AIDS-related expenditures for inpatient and outpatient care at the
county medical facilities are supported by several revenue sources.

The primary

revenue supporting care is Medi-Cal whose smaller amounts come in from Medi-Care,
patient revenue, and insurance.
During fiscal year 1990-91, the medical facility spent a total of $34 million
on HIV- and AIDS-related care, with $9 million spent on inpatient care and $25
million on outpatient care; and, $16 million while $34 million total was spent out
of general funds, county general funds.
It is important to note that a trend toward greater reliance on outpatient
medical services rather than inpatient services have been taking place in the
county.

This should inherently provide a more effective and efficient use of our

financial resources, even though it provides inpatient services, that is -- I'm
sorry.

OUtpatient services provide a lower reimbursement from Medi-Cal.

Average

is about 80 cents on the dollar, inpatient; and about 20 cents on the dollar,
outpatient.
Thirty-seven percent of the cumulative adult AIDS caseload in Loa Angeles
County is comprised of people of color.

When you relate that to the county census,

you have 11 percent of the county residents are Asian/Pacific Islanders and Native
Americans; and 2 percent of the AIDS cases are among that group, those groups.
Hispanic represent 38 percent of the county population and 20 percent of the AIDS
cases.

African American people represent 11 percent of the population and 16

percent of the cases.

And whites represent 40 percent of the population and 62

percent of the cases.
The behaviors which put adults and adolescents for all ethnic groups at risk
in Los Angeles County are as follows:

Male-to-male sexual contact is 80 percent of

the cases coming from that behavior; male-to-male sex with injection drug use is 7
percent; injection drug use 5 percent; transfusion recipients 2 percent;
male-to-female sexual contact 2 percent; and hemophilia or coagulation disorder
less than 1 percent.
CHAIRPERSON WATSON:

Excuse me.

Which category would you put the transmission

of AIDS from a professional health provider to a patient?
HR. FRANGENBERG:

I would say that it's not in here, I suppose.

I mean these

are -- we don't really have a category that's outlined, you know, that keeps track
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of that.
CHAIRPERSON WATSON:

We ought to start looking at that category, since we've

had a case and a death and who knows.

Maybe we can start at least bringing aome

attention to that particular category too.
MR. FRANGENBERG:

Los Angeles is significantly different from East Coast

cities and somewhat different from other cities in California in the lower
percentage of cases which are related to injection drug behavior.

Even when the

behavior categories are examined within each ethnic group, gay and bisexual men
comprised the predominant group affected by the BIV epidemic and at risk for HIV
infection.
For example, 68 percent of the African American adult and adolescent caaea, 73
percent of the Hispanic cases, and 80 percent of the cases among other people of
color are attributable to male sex.

An additional 10 percent of African American

cases, 6 percent Hispanic cases, and 3 percent of cases among other people of color
are attributable to a combined behavior of male-to-male sex and injection drug use.
The statistics are useful •••
CHAIRPERSON WATSON:

Excuse me.

Your last statement on page 6 says:

"Loa

Angeles ia significantly different from--" other "--Bast Coast cities" and eo on.
What's the backup information?

I didn't know whether the following paragraph

would back that up or if that stands alone.

If it does stand alone, you might want

to expand on it.
MR. FRANGENBERG:

Okay.

We've been doing studies in Loa Angeles County for

sometime on people in treatment.

And ever aince 1986, we have found that about 5

percent of those people have been, 5 to 6 percent of those people are infected.
In the studies that we've done in people outside of treatment, on the street,
we've done some studies, and we find that that number is about 8 percent.

In Mew

York, the number of people who were infected through injection drug use or aharing
of needles is 60 percent, eo it's dramatically different on the Bast Coast, in Mew
Jersey and New York.

San Francisco, I don't know precisely what the percentage is,

but I think that it's more in the 15 percent range than it is in the 6 to 8
(percent) that we have here.
CHAIRPERSON WATSON:

So that's the basis for that comment.

Is your point here that the instance of AIDS being

contracted through injections is lower here in Los Angeles?
HR. FRANGENBERG:

It seems so.

CHAIRPERSON WATSON:
MR. FRANGENBERG:

I'm sorry?

CHAIRPERSON WATSON:
MR. FRANGENBERG:

More than other cities in Los Angeles?
Lower than other cities in Los Angeles?

In Los Angeles County or •••
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CHAIRPERSON WATSON:
MR. FRANGENBERGz
than San Francisco.

Excuse me.

In California.

I'm sorry.

In California, yes, it's my understanding that it is lower
I couldn't tell you about other

cities in California, but I can tell you about San Francisco and Loa Angeles.
Well, we used these numbers that I've just given to you to look at trends and
to target our prevention and education program.

Prior to 1987, 83 percent of the

adult cases for all races were attributable to male homosexual/bisexual contact.
This figure now has dropped to 77 percent in 1990.

conversely, the percentage of

cases linked to injection and drug use rose from 2 percent prior to 1987 to 6
percent in 1991.
Over the same period, cases linked to injection and drug use, in combination
with homosexual or bisexual contact actually dropped from 8 to 6 percent.

Cases

attributable to homosexual contact rose from 1 percent in '87 to 2 percent in 1990.
Thus, though, homosexual and bisexual contact may be viewed as the riskiest
behavior for HIV transmission, injection drug use and heterosexual contact have
increased in recent years.
The ethnic distribution of new cases has also changed over time.
1987, 70 percent of new cases in the county were white cases.
percent of the new cases were diagnosed in whites.

Prior to

And in 1990, only 56

These statistics for African

American are 14 percent prior to 1987 at 18 percent of new cases in 1990.

For

Hispanics, they are 15 percent prior to 1987 and 23 percent in 1990.
Another way of looking at these are through the trends of the incidents.
as you can see in the white community, the incidents have changed.
was 22 per 100,000; and in 1990, it was 89 per 100,000.

And

From 1984, it

For male, African

Americana, the statistics were 19 per 100,000 in '84 and 122 per 100,000 in 1990.
Hispanics were 7 in 1984, 7 per 100,000, and 53 per 100,000 in 1990.
I don't have earlier statistics for women, but I have the 1990 incidents for
women.

It's 2 per 100,000 for white women; it's 4 per 100,000 for Hispanic women;

and 9 per 100,000 for African American.
Primary behaviors which put women at risk are heterosexual contact, which is
33 percent of the cases, injection drug uses, which is 28 percent, and transfusion
recipients which constitutes about 23 percent of the female cases.

And moat of

these transfusions occured prior to the assessing of blood supply.
As the local face of HIV/AIDS has changed, so has our approach to the
prevention and related medical services.

For instance, community-based

organizations serving people of color and women now constitute a majority of our
contractors for our HIV education and risk-reduction programs.

We firmly believe

that our preventative aspects on high-risk persons of color will be maximized
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through the expertise of community-based organizations.

These organizations have

vast experience in targeting programs to their communities and providing effective
outreach at a culturally adept context.
We have 15 contracts with community-based organizations that are specifically
targeted to people of color.
won't read them.

I've listed them and I put the targets down, but I

And I've listed also the number of, the amount of money that goes

to each contract.
CHAIRPERSON WATSON:
DR. TATE:

Bob, I have a question.

MR. FRANGENBERG:
DR. TATE:

Yes, there's a question.

Sure.

You mentioned earlier in your testimony that approximately 38

percent of individuals in Los Angeles County are ethnic minority.

And you've given

the providers and the amount of allocations you give them, but generally speaking,
approximately what percentage of your budget is dedicated or given to ethnic
minority providers?
MR. FRANGENBERG:

I think it's a little later in the speech, but 65 percent of

the prevention and education and education money goes to minority providers.
DR. TATE:

So that's prevention and education.

MR. FRANGENBERG:
DR. TATE:

That's correct.

And then does the county also do, give money for treatment?

MR. FRANGENBERG:

Yes, we do.

I have indications of what that would be, but I

don •t have •••
DR. TATE:

Yeah, I would just like, even if it's just a ballpark figure in

terms of just like a percentage of your budget.
HR. FRANGENBERG:

Well, what I have is the percentages of people who are

getting AIDS drugs through our medical facilities.

And, for example, at Loa

Angeles County, USC Medical Center, 47 percent of the AIDS drugs that are dispensed
through there are to African Americans; 35 percent are dispensed to whites; 12
percent to Hispanics; and 1 percent to Asians.

So that's an indication at LACU.

You see, there are four different locations that I have, statistics like that on,
but it's an indication of who's being served, what ethnic groups are being served
at those facilities.
DR. TATE:

Just one last question.

MR. FRANGENBERG:
DR. TATE:

Sure.

Then I'll let you continue.

In terms of treatment, do you define

treatment, or could you define what treatment is for AIDS victims?

Is it just the

drug, or do you also provide counseling, other kinds of forms of therapy, mental
health?
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MR. FRANGENBERG:

Well, yeah, that's a very good question because it's

changing pretty dramatically, I think, not only here in Los Angeles.
it's a broad spectrum of services that are available.
Angeles, we have a fairly good continuum of care.

But actually

I mean we have -- in Los

It has -- it's very spotty in

some ways in terms of what, whether or not there are enough slots available for
residential care or primary care or mental health care.
something happening all along the continuum.

But there's at least

But that's the challenge here, at

least, ia to not only increase the alots that are available in each of thoae kinde
of care.
One of these we're finding is that people are much more acutely ill when they
first come into the system than we had anticipated.

And we're finding that many of

them are coming in with T-cells that are below 200, generally indicating that they
are going to need and would require pretty extensive care, not always, but
generally speaking, you can say that they would provide, be in need of more care.
So that's been something that we've had to try to work with, especially with our
CARE Act dollars which are funding primarily primary care.

And by primary care, we

mean whatever that person walks through the door with. I mean if they have needs
that are HIV-related, they're to be taken care of in our primary-care centers.
DR. TATE:

Thank you.

MR. FRANGENBERG:

Well, I would also say that we have a variety of contract&

that are not specifically contracted with minority-owned or specifically for an
ethnic group.

But many of the contractors work with people of color as well as a

broad spectrum of people.
CHAIRPERSON WATSON:

Let me ask this:

How much effort have you been placing

in finding people of color to contract with for these programs?
MR. FRANGENBERG:

In my view, a lot.

We have worked with the community and

with advisory groups, the AIDS Regional Board, our own HIV Planning Council, the
CARE Act Planning Council, the Commission on AIDS -- I mean a whole host of
providers to try to identify community-based organizations that can, are interested
in, can and are willing to contract with us to provide services.

We do it on a

sole-source basis in some cases, and we also do it through an RFP process.
CHAIRPERSON WATSON:

What is the percentage of non-minority providers that are

working on the minority communities?
MR. FRANGENBEG:

I'm sorry.

CHAIRPERSON WATSON:

I would be interested in knowing that figure because I'm

seeing maybe a pattern here.
these minority groups.

I really don't have a figure of that.

Number one, there's been very little research done on

contracts are going probably in larger numbers to

non-minorities that deal with the minority community; and the gap that is occurring
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in outreach, knowledge given to the people in the streets about their behavior and
how to prevent certain things from happening.

So I'd like to be able to document.

I'm just seeing a pattern, from what I'm hearing this morning, trying to figure out
what the problems are and how we address those problems.

And I think the

information that you could provide would be very helpful.

Maybe if we could give

extra points to those minority providers and an extra effort, we might be able to
find like kind that can relate better to the problema that are faced and the risks
that are running rampant in our communities.
MR. PRANGENBERG:

Well, I'm just going to touch on anonymous testing briefly.

We have a contract with the State Department of Health Services and then contract
with community-based organizations ourselves to provide anonymous testing.

And

they are Regional center in East Loa Angeles, Valley community, and North
Hollywood, South Bay Clinic in both Manhattan and Gardena, Bast Valley Community,
and Minority AIDS Program.
We're very interested in some of the things that Wayne talked about this
morning, about the additional funds that he's trying to get for these projects
because it's very important.

As he mentioned, some of our waiting times before

Magic made his announcement, we didn't have any waiting time in some of our
clinics; and now we have two-month waiting periods.
To give you an idea about who are going for testing, about 2 percent of the
people who are being tested in our anonymous teat sites are Native American; 4
percent are Asian and Pacific Islanders; 6 percent are African American; about 20
percent are Hispanic; and about 67 percent are white.
This is a little bit of what we're projecting as an unmet need in our 92-93
budget.

We approximate that we have a $29 million unmet need for AIDS and HIV

service in Los Angeles County, and we think that that's roughly in these kinds of
categories:

$3 million in education and outreach and prevention services, $23

million for outpatient and inpatient services; $2 million for testing, about
$900,000 for residential, and about $800,000 for dental care.
We have tried to look at these and make some decisions about which groups we
think need to be addressed, and we think that those groups are adolescent women,
substance abusers, gay men of color and gay white men.
CHAIRPERSON WATSON:

We were just commenting on page 13 at the top.

And for

the month of October 1991, there's a picture that you provide of the racial
distribution for anonymous testing and counseling services.
MR. PRANGENBERG:

Right.

CHAIRPERSON WATSON:

Sixty-seven percent of those receiving services were

Caucasian; only 6 percent were African American.
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I think that tells a story; and as I mentioned before, it's a pattern that I
see occurring here that says that we, rather than neglect these areas, we've got to
increase the services to these areas or else the numbers are going to grow
epidemically.
MR. FRANGENBERG:
numbers.

Yes, I agree.

We saw the same thing when we looked at these

And one of the things we're also interested in and concerned about in

trying to get some strategies to deal with are the high rate of infant, African
American infants, that are born HIV-positive.

And we're going to start to work, or

one of the ideas is to work with the WICK Program because in Los Angeles county,
for a variety of reasons, most of the African American women do not come to county
facilities for prenatal care.

And so we have to find other strategies to try to

reach young African American women and at least provide them with counseling and
testing information about how the virus •••
CHAIRPERSON WATSON:

That's the reason why you'll hear many of my questions

going to outreach because it's becoming clearer and clearer to me that a concerted
effort has to be made to meet the needs of these high-risk communities.

And as I

understand it, that the fastest spread of AIDS is among African American women
during their childbearing years.

We're seeing them in the county hospitals now,

the neonatal wards, costing us up to $100,000 a year to keep them there.

And I

would certainly hope that you could design a program in the county which gives a
priority to these underserved communities who are at such high risk.
MR. FRANGENBERG:

We do have outreach programs, Southern California Youth and

Family Services •••
CHAIRPERSON WATSON:
MR. FRANGENBERG:

Yeah, I know you do.

We do have some.

CHAIRPERSON WATSON:

But your own statistics are saying that probably you

don't have enough of the programs or they're not well funded enough or you don't
have the expertise because of -- even with your own distribution of testing, it's
very, it's the lowest among the top three groups.
MR. FRANGENBERG:

I agree.

CHAIRPERSON WATSON:

I understand.

And so something is not right with these figures.

Maybe

something's not right with the priorities you've set.
MR. FRANGENBERG:

We're certainly aware •••

CHAIRPERSON WATSON:
MR. FRANGENBERG:

In spite of what you have already, you've got to do more.

Let's see.

CHAIRPERSON WATSON:

Can we skip over to 15.

We're going to have to move

along.
MR. FRANGENBERG:

Sure.
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CHAIRPERSON WATSON:
MR. FRANGENBERG:

Let's talk about unmet needs.

Oh, I'm well into unmet needs.

CHAIRPERSON WATSON:
MR. FRANGENBERG:

Page 15.

I was ready for unmet needs too.

I really just, I've really told you that we have a $29

million unmet need, and I've sort of outlined what they're in.
I think that some of your comments are relevant and important.

I do think

that there have been some significant progress in Los Angeles County over the last
few years.

I think there's a long way to go, and I think there are a lot of things

that can be done and need to be done.

I think that some of the initiatives that

the state has done, and also the federal government, especially the CARE Act, has
at least helped us get additional resources to provide additional services, both
prevention and services and treatment services.

And I'd be willing to answer any

questions you may have.
CHAIRPERSON WATSON:

Yeah, I would agree with you that you've done, made some

progress1 and I think we have to make more and, in terms of the funding.

We don't

have enough funds, but we've got to look at the funds we do have and the equitable
distribution.

Now some communities require more than others.

But I think the

emphasis in the beginning, in the early '80s, was on the white male gay population.
And trying to turn that around -- because they went after the problem immediately.
And we saw almost immediate decreases in the spread of AIDS in the white male gay
population.

And at the same time, guess what?

in terms of the infection of HIV.

The other groups started to expand

And I haven't seen the state, the feds, and the

county turning around and looking at where the greater spread is.

So what I would

encourage the county to do is to start looking at your own figures and looking at
the•• unmet needs and set some priorities that can go after the problem in theae
under-represented groups, giving them a top priority.
I think I've made that point several times now, and I think
MR. FRANGENGBERG:

have it.

I think I do.

CHAIRPERSON WATSON:
MR. FRANGENBERG:

yo~

So thank you for your testimony.

Sure.

CHAIRPERSON WATSON:

All right.

We'd like to call on now is -- I want to

follow up with the county's testimony with Dr. Phil Jordan who is Director of the
AIDS program at Martin Luther King Hospital.

And following Dr. Jordan, do we have

Phil Wilson here?

And then we'll take Dr. Tuckson.

he here?

Okay.

I didn't see Phil.

Okay.

Is

Fine.

Dr. Jordan, if you'll come right up, please.

And then we'll follow down the

agenda with Cleant Stain and Germaine Maisonnet; is that correct?
Jordan, please.
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Okay?

Dr.

DR. WILBERT JORDAN:

Good afternoon, Senator Watson.

I think we have to look at AIDS when we're dealing with the minority
communities and to have an approach that emphasizes keeping the HIV negative,
negative, as well as providing adequate and appropriate care for those who are
positive but not waiting until the person becomes positive before we've done
something to prevent them.
As of December 30 in my practice, in both King Hospital and in South central,
I had seen 37 women; that was December 30, 1990.
increased to 72 women.

As of June 30, 1991, that

Two of those women had gotten infected through blood

transfusions and two through IV drug use.
heterosexual transmission.

Six to eight had become infected through

Of them, a great number were partners to men who are

bisexuals and they did not know it.
There are two issues when one looks at the issues of women.

When that woman

learns she's positive, moat often, in about 35 percent of our cases, they learn
second-hand, i.e., that a child is born ill and they learn because the baby is sick
or friends may tell them.

What she learns, she learns that her male partner has

known he was positive for sometime, maybe even being treated, and has never told
her.

So she has to deal with several issues:

One, she has children; two, she's

positive; three, her husband, her male partner, is bisexual -- she did not know it;
and four, he has known that he had a deadly disease and never told her.
a lot of psycho-social support.

She needs to see a psychologist or a psychiatrist.

Moat of the patients we see come in with nothing.
that's a plus.

She needs

If they have Medi-Cal,

Psychiatrists don't take Medi-Cal; psychologists don't either.

she is faced at that point with a great need.

And

She has several severe, big pains to

deal with.
CHAIRPERSON WATSON:
you this.

I just want to interject this; I can't help but telling

A friend of ours son committed suicide about three weeks ago.

companion did not know, A, that he was black.

He was living as a caucasian.

she had had a baby and he was afflicted with HIV.
there.

And she's devastated.

His
And

So she got a triple whammy

And I don't know if, out where she lives, way out

near San Gabriel, somewhere there, if there are programs available, I do think the
psychological punch that carries, or that's carried with kind of revelation, is
addressed.

We carried legislation several years ago to provide a whole aeries of

treatments.

And number one, just by the fact that there's a revelation that my,

God, this person that I had contact with is this, is this, is this, and I think

that's a major part of the reason why people succumb so quickly because, number
one, they don't have the strength to be able to stand up and cope and fight because
they've been so devastated; and we haven't looked at providing the services.
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glad you raised that issue.
OR. JORDAN:

Thank you.

CHAIRPERSON WATSON:
OR. TATE:

I just had to say that.

Or. Tate.

And I just want to piggyback on that because when Mr. Prangenberg

was up here, and he mentioned about the continuum of care that's offered, I mean I
would like you to talk about the real world then and these women that since L.A.
County says that they do offer this continuum of care that would go from testing
to, as far as I'm concerned, the psycho-therapy of some sort to hospice, why isn't
it available for these women?
OR. JORDAN:
OR. TATE:

Maybe it's not a big deal.

Let's see.

Yeah, you know, what's going on.

CHAIRPERSON WATSON:

Being hit from you is what you're saying.

(Gap in tape) ••• half of my patients.

OR. JORDAN:

has been done definitely as a study.

But I cannot say if that

But we need to be able to either make a

decision of testing all women, record their blood and see if they're positive, or
being able to profile who is at high risk so that both they and their physicians
will know who is at high risk and test those so we can identify them before it
becomes too late.

We're losing a lot of time.

CHAIRPERSON WATSON:

What I hear you saying is that you don't know of any

studies that are focusing on women of all colors?
OR. JORDAN:

correct, that identify which of these --

CHAIRPERSON WATSON:
OR. JORDAN

As a category, women as a category.

-- are at high risk of being HIV-positive.

CHAIRPERSON WATSON:

Okay.

something I'm very interested in.
talking about breast cancer.
prior to the '90s.
with AIDS.
body.

Would you make a note of that, because that's
And I just left a press conference where we were

Most of the cancer research has been done on men

And breast cancer is at an epidemic level.

So I equate cancer

I think it's really kind of the same form of disease that attacks the

I think you're pointing at something that is a great need that we have

really not focused on, so we're going to follow up.

We'll try to see what there is

going on in the country, and then we might have a proposal or resolution or
something.

Thank you.

OR. JORDAN:

These are my black patients.

And this date, I've shared with you

previously, but I have not, because I'm the one doing it
it -- my white, Hispanic, and Asian patients.

it may have to do with

Bighty-seven of my patients are

married men; 23 of the wives know it -- they have married knowing they're husband
is bisexual; and 64 of the wives did not know that their husband was bisexual.

And

again, so you have a large group, and this is an issue that has to be dealt with.
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When you look at the 341 men who are homosexual of this group of patients as
of December 30, 202 identified as being bisexual; 105 identified as being strictly
homosexual; 34 said they were neither, though they were having sex with men.
found that interesting.

When you look at where that group at 34 had that initial

sexual contact, it was in jail.
Black community.
have been in jail.

And I

And again, jail is, jail is an institution in the

We have to deal with that.

That's a fact.

A lot of Black men

To be very graphic, if I'm married and I'm put in jail and

three men grabbed me and threw me down and have sex, I am not going to go home and
tell my wife.

That's the last thing I'm going to tell her.

You profile that

person what he will do when he gets home, he will be rougher but very sexual to
reaffirm his manhood.

But if he does get infected, if he does go in and out and if

he does play the part of the passive role in jail, when he comes home, she may be
happy because he seems to be so amiable and sexual but he's also infecting her.
I think it's important to understand that in terms of infection, the female is
easy to get infected from a male than visa-versa.
CHAIRPERSON WATSON:

I'm becoming more and more cynical as the minutes go on.

And what I think I might do is ask the Department of COrrections to do a study on
sexual contact in their facilities, both at the adult level and at the CYA level.
You know, they will tell you that, oh, we can't dispense condoms ·because it's
illegal to have sex in prison.
DR. JORDAN:

That was my next point.

CHAIRPERSON WATSON:

Thank you for saying that.

I think I'll put the responsibility on the Department of

COrrections because they have supported bills that would require testing throughout
the entire system without a program to address.
are you going to do about it, was my question.
except we'll isolate them or quarantine them.
treatment.

Once they have all this data, what
I got no satisfactory answers,
But I didn't hear the steps in

And so I think that what I will do is hold the department responsible

for giving us a picture of sexual activity.

And then we can get some other

community-baaed group maybe to do research on what happens when these people return
back into the community.
DR •. JORDAN:

Thank you.

That's very important, because the two other points I

wanted to mention, in terms of jail, is one.
because, again, men don't have sex in jail.

Some jails do not provide condoms
I think it is stupid for us to allow

that philosophy to go on when we know it does happen, and these men are coming back
out to your sisters and your daughters, and in some instances, you know, and once
in his room.

That's important.

The other issue is drug users.

And though we're seeing an increasing number

in drug users, again, as Mr. Frangenberg stated earlier, it is less than on the
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we have a problem.

When I have a patient who's a drug user, I can scare the

hell out of him and make him want to go to be treated at that moment.

But most

times, if at that point in time, he says I'm ready to go

let me go get rehab

right now, dry me out -- I have no place for him to go to.

So if I succeed in

getting him to where he wants to now and then he has no place to go for six weeks,
or sometimes longer, in that period of time, he's going to spend drinking or
drugging himself worse because he's scared even more.
If I succeed, and I'm lucky to get him into a place and he comes out dry, I've
done very little but prolonged time because in our situation, we're not talking
about one person in a very middle-class structured Beverly Hills environment where
he or she is using drugs but the rest of the family are stable and are good
supports.

We're talking quite often about one person who happens to be HIV

positive and using drugs.

But he has a whole support system who are also HIV

negative but also using drugs.

So when he comes out and goes back to the same

support system, what are we to expect?

How do we really expect him to go out to

the same group and refrain when his whole support system are all using drugs?
We have to deal with drugs in this country like we did smallpox in India and
Africa.

We vaccinated around the infected group.

The best way is not just to deal

with getting that HIV-infected patient into a program but getting his whole support
group into a program.

Either we decide that they all are worth it or not.

It is

costlier to have them go back and forth in the hospital, getting medicine, being
treated for AIDS, than it would be to put him and his whole support group in a drug
rehab program.
CHAIRPERSON WATSON:
worth it or not?

I think a key word, I just heard you say is:

I think we have to do a lot with that attitude:

Are they

Are they worth

saving?
DR. JORDAN:

Yes.

CHAIRPERSON WATSON:

And if they are worth saving, then you're going to see a

redistribution of resources.

And I think that's the main question.

As I see it

within this area of California and in this county, that question comes up time and
time again because I don't see the resources going to those poor people.
poor people -- we were out at Martin Luther King yesterday.

And we're

That's a hospital that

serves nothing but minorities, and we don't have the same resources that we have in
some of the other hospitals.

And I guess it all boils down to is what the concept

of worth is by the people making the decisions and how then we distribute the
resources.
So I think fundamental to everything you're saying is the question of, do they
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feel they're worth it.
DR. JORDAN:

It's very important.

an Lmportant issue.

Mental health, as I mentioned earlier, ia

And just in the community itself we need to have more

available mental health practitioners to be able to work to help those persona.
Now two other issues I want to mention.
clorithromyacin became FDA approved.

About a month ago, a drug called

It is a drug that you use to treat a

particular type of infection in AIDS patients.

Before then, there were several

drug, combination drugs, you had to use and you got very little results.

MAI was

one of those illnesses that when the patient got it, it was bad news because it was
very hard to treat.
Well, about a year-and-a-half before this drug became available, it was
available.

It was made by Abbott Laboratories -- it's still made by Abbott

Laboratories in Indianapolis.
come back here and take it.

And if you had money to fly to Ireland for it and
Congress has passed legislation that allows for AIDS

patients to be able to buy these kinds of medicines for their personal use.

And we

have established in most of the major cities' buyers• club as the only buyers' club
here, that for those persons who could afford it, they could get it.

And so what

has happened for the past year-and-a-half prior to this past month, those
middle-class patients, and moat of them are white, were able to buy it.
coat about $450 a month.

And it

It went down, at the end, before it became available, to

$300 a month.
Of all the patients I had, I had only four who could afford to get it.
other patients that I got it for, I paid for it myself.
for DDC.

It's available through a buyers' club.

The

The same is true right now

And my point is we're going to

see a lot of drugs becoming available that are effective.

But unless the person

haa the available funds, we're going to see the drugs available for a year or
year-and-a-half but only those who can afford to purchase them be able to take
opportunity of it until it finally becomes available.

And the majority of people

who will suffer or who will still die when they could be alive will be minority
patients.

And there has to be established to me some kind of slush fund that would

address this issue and allow those persons to take advantage of those medicines too
when it's there.
I do not think we can really make the impact we have to make in the minority
community unless we also deal with self-esteem.
Live Program is.

I don't know what the Friday Night

I understand it's in some of the middle-class areas.

Sunday through Friday Night Live Program in the minority community.
about kids who have no self-esteem to offer.

We need a

We're talking

And when one self-esteem is

destroyed, is low, et cetera, often their sexuality is the one thing they have.
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And we have to understand it and deal with that.
with empowering patients' self-esteem.

And education has to be coupled

And we cannot provide the same kind of

educational model that works very well in Beverly Hilla, that works very well in
West Hollywood and put it in Watts.
with jobs, but it will not work.

It will not work.

And that's important.

It may provide some of us
The issue here is keeping

those HIV-negativea, negative, not simply providing some of ua with joba.

And if

we do not deal with self-esteem in a way that we need to deal with it in South
Central, it won't work.

And what will work in Watts may not work in East L.A.

It

has to be flexible enough that public work in those communitiea, they can use it,
rather than being forced to adhere to one structured program.

That makes no sense.

And when we keep doing that, we lose out, particularly, minority communities.
It was mentioned earlier that the definition of AIDS will change.

Many of the

patients we see come in with low T-cells.

And we will see an increasing number of

AIDS patients when the definition changes.

The problem we have now, if a patient

comes in with 200 T-cells and he has pneumonia, that qualifiea him, pneumocystis
pneumonia, for AIDS.
hospital.

He then, if he has been diagnosed, he can get to the

If he's been lucky enough to not get an infection and he or she comes in

with a T-cell count of 10, which means they have much leas of an immune system,
which means if they get an infection, the chance of living through it then is zero,
so you want to do everything you can to keep that person from getting an infection.
At the same time, they become penalized because if you keep them healthy, they
can't get that benefit.

And if they don't get that benefit, Medicaid follows

social security disability.
sort of trapped.

So if disability says no, Medicaid says no, so we're

If I sit back and let this patient get an infection, which would

then qualify him or her to get the Medicaid, we're paying severe Russian roulette
with five bullets in the gun.
face all the time.

And that is a huge problem that minority patients

We need to have that system changed so that patients whose

T-cell counts are 200 can get their benefits without having to run the risk of
dying from a disease, which is what we're doing right now.
CHAIRPERSON WATSON:

Let me raise this question with the Office of AIDS.

Is

there a treatment model, comprehensive treatment model, for the minority community
based on all the elements that have been described by Dr. Jordan as being
necessary?

Is there anyone in the Department of AIDS who has the same kind of

knowledge on what's happening in the minority communities as Dr. Jordan?

Can you

respond?
MR. SAUSEDA:

The second part of your question is easier for me to respond to;

and the answer is no, we don't have anyone in our office that's as familiar as Dr.
Jordan is, clearly.
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CHAIRPERSON WATSON:

Why don't you give Dr. Jordan a grant to do a study, to

provide you with the information or you can then model a program that will meet the
needs of this community that clearly has not received the kind of resources?

And

our hospitals are filled with the babies born of the mothers that have not the
information and know how to take care of themselves.
br~ng

Could you

him on so that he can -- he's the only doctor that I know in the African

American community that has the information.
look, this is the picture.
be~ng

Could you do that?

done.

He came to me years ago and said,

And we've been going on the road, but there's nothing

I don't know of anyone else in the Department of Health Services

that's been able to describe the program needed and the problem as existing in Dr.
Jordan.
MR. SAUSEDA:

I agree with you.

I think that the kind of experience, the

day-to-day experience that Dr. Jordan has, is tremendously important for us in
developing our programs.
CHAIRPERSON WATSON:
MR. SAUSEDA:

You ought to be talking to him.

Yes.

CHAIRPERSON WATSON:
have done.

I certainly

You ought to sit down and spend hours with him, as we

You ought to get into his psyche because, believe me, he is closer to

the problem than anyone.

There are only two doctors out in the Watts area who are

willing to treat patients.

And one doctor was shakey.

So if the department really wants to do something, you ought to be talking to
Dr. Jordan

forget the other one.

You need to be talking to that man.

Any other

contracts you put out there, in this area, are not going to be as effectively
researched as the one that you put into the hands of a man that's been doing this
on his own, with no outside help.

And he's been clamoring at our doors, you know,

knocking, would you please listen to what I have to say?

And finally, we got moat

of the members of the Black Caucus to come down and sit for a few minutes to
listen.

This man knows it, and he's described it better than anyone I've seen.

And the bureaucrats need to really start listening to someone like him because he's
given you the clue as to how you put together a program that will meet the needs of
the people who are carrying that virus, who are at risk of carrying that virus.
you don't need to respond.
MR. SAUSEDA:

So

I'm just giving you a message.

The point's taken.

CHAIRPERSON WATSON:

Thank you.

Did you finish, Doctor?
DR. JORDAN:

One last point.

And thank you for the nice words.

What Magic did, it obviously shocked all of us; but it finally made many
people care.

And unfortunately, if people had cared ten years ago, as hopefully as
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many people are caring now, maybe we wouldn't have had to have Magic do what he had
to do at this point in time and deprive us of many more years of fantastic
basketball.
I think it's important for us to understand that we have to learn to take an
attitude of not being so judgmental as a "civilized society" and in the process
forgetting how to care.
CHAIRPERSON WATSON:

But you know what, doctor?

Magic because Magic told you what he was doing.

We've got to stop glorifying

You know, he got calls and letters

and comments from all kinds of women that wanted to have sex with him just because
he's Magic Johnson.
going to die.

He says I feel good.

Once that virus is in the body, you're

And he might be feeling good at that point in time, but I think much

more needed to be said.

And I resent Wilt Chamberlain saying, well, I had sex

maybe with 22,000 -- you know, the cavalier way that this is being treated and the
glorification.

Yeah, we all love Magic, but he's got AIDS because he ignored --

and he's in a position to have the information.

And I think somewhere along there,

we've got to stop glorifying this -- and women throwing themselves at the feet of
these people.

What kind of message is that sending out there, women who are the

bearers of our children, are saying, I'm willing to run the risk.
sick.

It is really sick.

And when I saw that, I said, oh, boy.

My, God, that's
All these little

k;ds are going to say it's all right to go out there and do the same thing because
we all want to be like Magic Johnson.

That's real sick.

I think Magic's lifestyle was wrong, and you can tell everybody you heard it
from me.

And I think all these other athletes who, you know, start putting the

stripes up their arm because the women throw -- boy, we've got to turn that around.
And now all these athletes are drug addicts.

You know, I mean, my, God, no wonder

our kids are nearing the same behavior because look who gets all the attention and
the gratification and the bucks.
You see, we equate our success in life by the amount of money we are paid.
And athletes and entertainers are paid more than teachers and doctors.
better start changing these messages around.

And so we

Those of us that get the press better

start telling the true story or else we have a lost generation, and particularly
the esteem level of our kids.

We're losing them; we're losing this whole battle.

And, you know, I'm talking to the general audience.
You have been able to point some of these things up, and I get a little angry
when I see us talking about the glorification, you know.
and that's one thing that really came across.
get it.

Magic is a human being,

And if he can get AIDS, anybody can

But he did a little more to go after it, okay?

He went after it, and he

knew, we've been saying, you know, you guys better be careful.
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you better protect yourselves.
DR. JORDAN:

Thank you.

Getting back to the point of self-esteem again, until

we do something in terms of incorporating self-esteem in our education program,
teaching kids that they are important, not someone else, but they are, and allowing
them to see the beauty in themselves, this will continue, which ia why it's
ultimately important that we appreciate self-esteem.

The patients that we've done

the beat at King have been those who we've sent to a self-esteem section.

Those

patients have behavior change; those patients see themselves differently and act
better.

And until we can do those things, we are not going to see a significant

change in a large number of patients because they don't aee themselves as being
worth anything.

Thank you.

CHAIRPERSON WATSON:

Too many people laughed at John Vasconcellos when he's

talked about self-esteem -- we need to study it.

And there were cartoons that made

fun of it; there were people in high places that made fun of it, and I would say
the general public did.

But he proved them all wrong.

And I think what you're

telling us is getting to the truth of why we're at such risk.

And as long as you

don't care a thing about yourself -- you don't care a thing about others -- that's
why this guy on the news today could spit blood at everybody else -- he didn't care
about himself -- he knew he waa dying.
him.

So he's going to take a lot of people with

And I think that's the mentality of a lot of our kids:

worth nothing; and when I go, I'm going to take you with me.

You know, my life is
I'm going to dust

you, and too much of that's going on.
Thank you so much for your sensitive testimony, and I would hope that the
people in the Department of Health Services and the AIDS office will talk to you
and will spend time with you and will bring you in aa an in-field expert to advise
them.

Thank you, Dr. Jordan.
As a word to the wise, I'd like to call up now Cleant Stain, Director of South

Central AIDS Program, Watts Health Foundation.

Is Clement here?

Germaine Kaisonnet, Director of the AIDS programs for Vacaville.
All right.

Is there a Phil Jackson?

I thought it was Phil.

All right.

Dr.

He's not here.

I don't think Phil

is Phil Wilison here?
Okay.

Then we're going to move into -- no, he's not here -- our

community-baaed organizations.
Okay.

I don't see Doctor -- or the Reverend Carl Bean.

Blma Colbert is represented.

Valarie Taylor.

All right.

We have -- I know Paul Davia,

Would you like to come up in lieu of Dr. Bean?

If so, just come

right up to the mike.
All right.

You may decide who's going to apeak first.

MR. DARRYL LUDD:

I will start first.
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miaprint in the agenda. I'm Gerald Ludd, the Operation& Adminiatrator for Minority
AIDS Project.
My main concern here is dealing with the financial aspect of AIDS and the
funding.

I want to thank Dr. Jordan for hie preaentation based on his information

really led into what my concern is, your comment& to Hr. Sauseda and to
Frangenberg, also with the statistics, really led into what I have to say.
I primarily deal with the financial aapect and the funding of the Minority
AIDS Project and the concern• of other minority project& within South central.
our main concern ia in the fundera themselvea and their proposals and what
they're requiring in those proposals aa it relate& to thoae people in the
people-of-color arena.
people we aerve.

We say South central; we have no boundaries as far aa the

But we primarily serve aa minorities, and a majority of these

minorities are comprised of the people out of the prison system, homelesa, and what
have you.

So we're also not dealing with just HIV, but we're dealing with dual-

and tri-diagnosis which is drug addiction or alcoholism.

But as the funding

sources prepare these grants for you, they write them in such a way that it'a a
general grant.

That's for overall AIDS agencies, but they're not really addresaing

those issuea in the minority arena.
As we write and ask for these funda, we have to write them in such a way that

we can get the grants themselves.

But along the way, the funding that we need from

direct -- indirect aources -- corporation&, and what have you -- need to take up
that slack.

But in the funding sourcea themselvea, you need to re-look at the

people of color themaelvea and the need, which I've heard aeveral timea here, the
need which is necesaary to aervice theae people.
The funds, as far as a percentage, we have increased in Minority AIDS Project,
are in the South Central area as far as the people that we're aerving.

But whether

they're men, women, children, which we do have our increase in women and children,
but the monies have not increased.
to addreas today.

And thoae are the type of things that we want

And as we write these propoaals and as the fundera actually make

theae funda available, they need to take into consideration the need is not the
same; the need is different when you're dealing with dual- and tri-diagnoaia and
the method in which the funding actually pays you.
OUr problem is in the Black community; and why a lot of the Black buaineaaea
close ia because we're actually open to fail based on how society or how the
grantors set up the actual perimeters for, or your guideline• for, that particular
program.

We don't have the money to wait two to three, four months to be

reimburaed.
with.

So we have a reimbursement problem at all levels that we're dealing

Primarily, that's my main concern.
-48-

And we do and we are planning on writing

062

up some type of statistics to send to you and others in government so that they can
understand what we're talking about when we're talking about figures covering
expenses.

I think you know a lot about what's going on, and we're trying to

readdress it so that if we really spoke the way we wanted to speak to some of theee
grantors, we

I don't think it would be funded.

CHAIRPERSON WATSON:

You know, I get real tired with the department coming in

and saying but they are not sending up their proposals correctly.

You know, we've

got an epidemic out here, and I'm saying to the department, hey, don't bring that
1n to me.

What you need to bring into me is how we're going to get the funds where

they're needed.
the proposal.

We've got X number of dollars, and you find some way to correct
You find some way to have the application look like you want it to

look. You find some way to have them account for those monies, but get the monies
down there in a timely fashion so that we can try to save lives, apply treatment if
we can; and, if we can help people as they go through their demise because of AIDS.
And I think to use the excuse, well, they didn't dot an "i" -- they' didn't cross a
"t• or put a period in the right place, or they didn't write in the right box -- is
an excuse for not doing much.
So I would agree with you

and I've had to say this to the department and

the Office of AIDS -- don't spend your time talking about the deficits.

You spend

your time with me talking about how we're going to solve the problem and get those
monies down so services can be delivered.
KR. LUDD:

Thank you, Senator.

Paul Davis, head of our Health Education

Department, and Valarie Taylor, our nurse, will cover other aspects.
KR. PAUL DAVIS:

Good morning, Senator, and members.

One of the things, in terms of education and prevention, is over the last five
years, the numbers in terms of people-of-color community is increasing.

And one

may say, well, we've been doing education out here1 and therefore, for 1991,
everyone should know AIDS does exist and how you're able to transmit it.
But in the people-of-color community, we are still behind.

And when the

announcement of Magic Johnson came out and our phones began ringing off the hook,
there were still people thinking that it was caught by mosquito, that it was still
toilet seats and so forth.

And so that sort of gives you a level of there is still

a large amount of education that's needed in the people-of-color community.

I know

to a large degree that a lot is basically going to treatment and not saying that
there's not money needed in that particular area.

But particularly in the

people-of-color community, there is still a great need for education.
And one of the things I think we've made a misnomer is that, yea, it's on TV.
But one of the things I've observed in terms of the people-of-color community, they
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don't watch the 6 o'clock news or the 5 o'clock news or the 7 o'clock news.
turn to Channel

s, Channel 9, Channel

They

11, and get the reruns of Lucy becau. .

they've seen enough problema in their community already that they deal with on a
daily basis.

And it's like I don't need no more bad news.

don't get this type program.
so forth.

So a lot of times, they

They don't necessarily watch the specials on AIDS and

And it took some of us a long while to begin to realize that in 1991

persona should know all of this information.
periodicals and magazines.

Many of them don't read the various

Many of them cannot read, period.

And we need to take

that into account when we're talking about the whole thing of education.
When we're particularly talking in terms of the undocumented population, which
is a population we work with in our AIDS project, again, if it is not in the
appropriate language, they have not gotten the information.

So a large media

campaign to a large degree in our community does not work.

The beat that we've

found is the one-on-one, meeting with people, talking with them in small groups.
Bolding group meetings, we've done that1 we've tried that.
persona in our community are not coming out after 6 o'clock.
day1 they are tired.

But a lot of

They've worked all

They're not coming out because they're afraid of the whole

thing of ganga and so forth, and they have to ride the bus.
South Central is a very large area baaed on -- let's say, if you take from
Pico on south.

So it's a very large area.

People are not necessarily going to

come out in large groups that you may find in the West Hollywood or Hollywood area.
So you don't have the advantage of getting that information.
one of the populations that we service at the project very heavily is the
population of the homeless, which I feel is a very under-served population.

And it

is an invisible population within our community because in some cases you cannot
clearly distinguish those persons are homeless.
The homeless today are no

But in fact, they are homeless.

longer the stereotype of the whino in a doorway, and

they are found all through South Central.
To a large degree in this particular under-served population, you have a
problem of not just being you tell the person you need to practice safe sex.
the person is homeless, he has no money for condoms.
budget.

If

condoms are not in his

And that's one of the reasons we need a program where we constantly visit

certain areas of the homeless in passing out free condoms.
Bven if the person feels that they are at risk, they do not have the money to
go to get tested.

I mean it requires $1.15, $1.25, to take that bus to come over

to the Minority AIDS Project to get your test and then the same amount to come back
the following week.

And if. you're concerned, in terms of wpere you're going to eat

and where you're going to sleep, that is very important.
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Even if you find out somehow, if our van picks you up and you find out and you
get your results back that you're positive, how do you go for treatment?

For a

long time, the only place we could refer persona is to Dr. Jordan's clinic which is
all the way in South Central.

Again, you have the money of transportation.

There's also, I think Dr. Jordan raised, in the question of self-esteem which
I think is an important part in the people-of-color community in prevention and
education, that that is a piece.

That needs to actually be worked on.

And even if

you say, well, the person gets G.R. here in L.A. County, the amount of money that
person gets in G.R. usually only lasts the person for the first three weeks.

And a

large number of them, we find that, for that last week, they are on Santa Monica
Boulevard to try to get enough money to maintain their room for the last part of
the month.

So those are some real issues that we have to look at in terms of that

whole population.
Even if we look at the issue of reaching gay men of color, we have to look at
different strategies because the traditional strategies do not work.

A large

percentage, first of all, there's a very diversified community there; and secondly,
that you have to look in terms of with that community how they perceive themselves.
And a lot of them do not perceive themselves because early on in the whole thing of
education and prevention, we made some major mistakes.
groups.

We talked about certain

We talked about persona being gay, and we talked about persona who are IV

drug users.

And a lot of persons in the minority community says that's not me

because there are a number of men who have sex with men but do not consider
themselves gay.
We need to look in terms of the PR that we have out because a lot of persona
do not see people of color on the posters, on the brochures, in terms of -- so
that's an area that needs to be looked at.
Again, in terms of the basic needs in this area, more one-on-one street
outreach to go where people are, to go out to the bars, to go out to where the
homeless are, to go out to the parka, the people who are hanging around the liquor
stores, and do a one-on-one in terms of getting information to them.
Also, in terms of testing, we need more testing sites in the minority
community.

One of the things that happened after Magic Johnson made his

announcement where we were doing testing at the project, about 15 people on a
Saturday, the first Saturday; it increased to 115; the second Saturday, it
increased to 123.

And we've had to expand now to Tuesdays and Fridays, and the

phones are still ringing in terms of people who want to come in.

There's a backlog

in L.A. County of people who now want to get tested and cannot because it ia booked
up for three months, so that is an issue that needs to be looked at.
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the other things in the minority community is there is a need for more monies in
terms of grants because most agencies do not have large sums of money that they can
pay staff, pay the rent, and so forth, even if they get the grant, and then wait
for the funding source to reimburse them; so some way of not looking just at the
fee-for-services but some way to give an advance up front to get the agency off the
ground.

Thank you very much.

CHAIRPERSON WATSON:

Thank you.

MS. VALARIE TAYLOR:

Good afternoon, by this time, Senator Watson.

Can you

hear me?
CHAIRPERSON WATSON:
MS. TAYLOR:

Yes.

My name is Valerie Taylor.

I'm currently the nurse case manager,

acting Minority AIDS Project, and Director of our In-Home Nursing Services.

We

have -- that's called Pilot Care Program, and another In-Home Nursing Service that
we are providing at the project is Medi-Cal Waiver.
I'm here for a couple of reasons, one representing client services -- our
project director was not able to be here.
advocate.

And the other is a patient-client

By the time clients get to me, they're very depleted.

no longer just home-bound; they're bed-bound.

These people are

Home-bound is one thing; bed-bound

is quite another.
My two programs, one is funded by the state, which is a pilot, CURB, and the
other Medi-Cal Waivers, is funded by BURSA.
CARB programs.

1991 was a devastating year for Pilot

Anyone who was, who took the risk to even decide to provide In-Home

Nursing Services took a risk in itself.

That's a very costly thing.

Health care

is is costly; nursing hours are costly.

1991, we were told we will provide you

with these hours, but we'll also cut those hours.
When people come into, when my clients, people of color and minorities come to
the point that they are bed-bound, they're coming into the system very late.

There

is no longevity usually once they get to that stage, so aggressive intervention
needs to happen once we have taken them out of the acute facility who at this point
want you to take them out of their bed.

It costs a lot of money to maintain a

client like this in the acute setting.

So once you get that person home, we're

obligated as health care providers to be an extension of what would happen in that
hospital.

We need to provide them with levels of care that the state or might the

state is not willing to or is unable to provide us with.
If we go into a home and a person requires eight hours of care and we can
only, with the dollars available to us, provide four, we're either saying we'll
give you four and hope and pray that you live to the next day; or we'll give you
what you need, and we'll hope and pray we get reimbursed for four hours when we
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gave you twelve.

I have difficulty making the compromises in these areas.

back to are they worth saving.

It gets

I thought that that was integral when that was said

in this room.
I've been a nurse for 25 years next month.
arena, I hear that question a lot.

I've never, in this particular

Who's to say that; who's to judge?

Most of my

clients coming on into the program here, at the Minority AIDS Project, 35 percent
of them have no health insurance.
base has no health insurance.

When they come to me, 80 percent of my client

So that isn't even an issue.

but it's a need that the entire country has.

It's a big, big need;

We have a health insurance; we have a

health problem and a health care system that is not working.

Even with that, with

no health insurance, if you wanted nursing care, we went into something called
Medi-Cal Waiver to at least give us the luxury of saying we can provide you with
this care; we know you need it.
this.

And the government said fine, we'll let you have

But before you can have this, you need to have a Medi-Cal card.

don't have Medi-Cal cards.
project.

My clients

They can apply, and we do offer that service at the

It takes 30 to 90 to 120 days just to get that application through, and

usually it takes six months before they actually have the card in hand.
Unfortunately, moat of my clients have already expired.
We have, but that's the option.
you can use it.

We've given you something; and we told you,

But you have to be alive to use it.

I don't know how fair that

is, and I'm losing my -- this has been going on for two days, so excuse my voice as
we go through this.

But that's the option that we're left with.

So either we

provide care with not enough hours and not enough money, or we say, fine, the
government will give you this if you can live long enough; and that disturbs me
greatly because then I don't knQW are they worth saving.

I think they are.

The state is going to, again, in '92, we will be experiencing again another
cut in nursing hours provided.

The government on the Medi-Cal Waiver system, we're

being forced to use a system that I really think is there but my clients are not -I can't get them in it because the cards are not available or they can't get in the
system to get the cards.

So if we went to the Medi-Cal Waiver system, the

reimbursement for a care-giver on that system for just an in-home attendant is $4
less than a home attendant can make going through another agency.

Why would you

come to a community-baaed if you can get $4 more going someplace else?
So you're saying, I've given you a card if you can get it.

Now that you've

got it and you live this long, I can't get you a nurse because the nursing
services, they're in business, not that they're not compassionate, but they're in
business.

The reimbursement for those kinds of care-givers aren't really

creditably licensed; home-care services is $4 below.
-53-

our project has been

06?

absorbing that cost.

That ia not a long-term aituation.

It is certainly

short-lived with us because we don't have the funds to do it.
people who are now not only just home-bound -- bed-bound.
very visually, they are in fact dying.

But we are leaving

And In fact, as you said

I don't know what happens when people get

bedbound.

Is the quality of their life considered leas worthy -- because you don't

see that.

They're at home; they're in a home.

You don't see that.

But the nurses

that are there and wanting to help and the programs we must have in the minority
community, there's only one pilot-care program in South Central.

It's ours.

I receive referrals from other agencies, and I'm not at liberty to say the
other agencies at this point, and they are referring clients over because they will
not absorb the cost, and they can't.

But it has been our philosophy and our

mission; and not just since I came to Minority AIDS Project, myself as an
individual, health care provider and registered nurse, I could not in good
conscience turn someone away because they cannot pay and because they don't have
health insurance and because they don't smell so good and because they can't get
anything else.

That has never been the mission of the project.

It has never been

my own personal philosophy.
And I'm here to say as the advocate for my clients who could not get here.
they could get here, they'd be here.

If it was on stretchers, they'd be here.

If
If

you're going to say we'll give you nursing in your home, let's do it the right way.
If you say we're going to have hours, make the hours available.
going to say we're going to give you a Medi-Cal card, give it.

And if you're
But when people get

to this level, you shouldn't toy with them.
I thank you.
CHAIRPERSON WATSON:

Thank you very much.

We certainly appreciate that

testimony coming from one of those projects that's in the community and dealing
with people who are dying every day.
MS. TAYLOR:

Thank you.

Thank you for your time.

CHAIRPERSON WATSON:
here.

It baa a great impact on us.

Yea.

I'm going to go through my agenda just to see who's

I'd like to first ask Dr. Elsie Lu to come up; Blma COlbert, Cynthia Davia,

Suzie Rodriquez, Mario Solis-Marich, Mike Neeley, xazue Shibata, Helen Fitzgerald,
Joel Tan, COrinne Tanon, and Paula Starr.
may come up now to the table.

If any of those people are here, they

And be sure that you identify yourself.

If you cannot sit here, then please sit in the front row.

Great.

Then that will

indicate to me that we have people here that are on this list.
We'll start with you, Dr. Lu.
DR. ELSIE GO-LU:

Thank you very much, Senator.

It's always an honor and a pleasure for me to speak before you and to provide
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some information that may be helpful in decisions that you may be makinq.
Specifically, I'm the Deputy Director for L.A. county Department of Mental Health.
And I have primarily the forensic mental health services which relate to the
incarcerated mentally ill as well as my responsibility for the HIV mental health
services for the County of Los Anqeles.
I also sit as an advisor to the AIDS COmmission of L.A. County for mental
health issues, and I'm a member of the AIDS reqional board.

So I come to this

committee basically very briefly to tell you about the HIV mental health needs in
the ethnic minority communities.
The State Department of Mental Health throuqh the state budqet and the state
legislature provided fundinq for mental health services four years aqo for about a
million dollars for mental health services for the State of California.
then, there has been no auqmentation in that budget.

And aince

L.A. County obtained $376,000

of that to provide services for all of the mental health needs here in Los Anqeles
county.

And that is actually insufficient fundinq, so we have primarily used some

BURSA funding, have worked with the AIDS program office, have gotten another
$100,000 for the AIDS program office, to provide some services.

And during this

past year, throuqh the Title I of the supplemental funds, have actually lobbied to
have another $641,000 added to the mental health needs of the people with HIV.
Let me just tell you about what the funding currently provides for.

We have

actually provided funding through community mental health CBOs -- the Gay and
Lesbian center, APLA, Minority AIDS, Milagros, sort of a little piece of fundinq
spread out through the community, sort of like seeds so that they could spread and
have some impact on the population.

And yet we feel that barely scratches the

surface of the great need that his here.

Por example, of the population that we

have in our HIV day treatment proqram, 29 percent of the population is
Afro-American, and 29 percent of that population ia Latino.

The rest of them are

white and a small Asian qroup.
But basically for someone to be mentally ill, that is a stiqma.
then to be HIV-affected, that is an additional stigma.

Por someone

And for usually someone

that have mental health needs, they are multiply diagnosed also with substance
abuse.

And, of course, added to that, is if you end up being mentally ill and

having HIV and then beinq incarcerated, you have actually a lot of problem with
almost very little help, shall be qiven to you.
A couple of years aqo, we participated with the AIDS Proqram Office in a
HIV-strateqic plan.

And we meet a needs assessment for the mental health needs and

a comprehensive plan also.

If we have the money that is truly needed from this

community, this is the level of services and programs that are needed here.
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just to give you some ideas of the target population that would be served, there
are those that have advanced HIV brain disease.

And that would cut across

different ethnicity.
For a specific purpose, for example, what we were able to help is someone with
early dementia.

They may need a psychologist or a professional person's help.

In

order to get them SSI or actually in soma cases, they may have been driving around
and have forgotten their driver's license several times.

And instead of being

incarcerated, basically we could help by having diagnosed them and said that their
problem is due to dementia.

So to have sufficient mental health professionals to

provide the psycho-neurological assessment in order to determine this would be very
helpful for this population.
Then we have the chronically mentally ill who then get affected with HIV.

We

have provided a lot of training to board-and-care facilities in order for them to
be able to deal with this type of problems because they are mentally ill,
chronically mentally ill, that are in board and care who are basically in board and
care.

You realize that there is consentual sex relationship that therefore you had

to teach the board-and-care provider how to be able to deal with this kind of
problem in order to have AIDS prevention.
in.

That's one of the areas we had focused

And as I talked to you about the persons with multiple diagnosis; and right

now, actually in all the programs that we have, there is very minimal mental health
services in those programs.
We have primarily concentrated on a lot of educational programs in order to
use the minimal funding that we have.

We have provided training to our own mental

health clinics as well as the private clinics that have contracted with the county
in how to deal with this population and deal with the services.
The plan itself go into a full range of services from acute •••
CHAIRPERSON WATSON:

Let me just ask this -- in listening to Dr. Jordan's

testimony, he, providing services in Watts, are there programs

are there places,

facilities where the people he described can go, the people that he realizes are
dealing with the psychological shock, where do they go and can they go into these
programs?

Are you training the county health professionals?

you training them in the mental health program?

To what extent are

How many are available to treat

the people that he described?
I got the feeling from listening to him that there was almost nowhere for him
to send these patients.
DR. GO-LU:

Actually, what he •••

CHAIRPERSON WATSON:
DR. GO-LU:

Yes.

Or that the waiting list was long.

He is actually correct in what he had presented to you.
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issue, as you're aware, is with the diminished funding in the community mental
health programs, that we have to focus our services to a target population of the
chronically and severely mentally ill.
We have, primarily in our master plan, included crisis intervention.

And we

got it in through efforts of the CBOs and the HIV resource mental health group,
that at least for those that have HIV-infected, that there will be eight crisis
intervention sessions available to them.
CHAIRPERSON WATSON:
DR. GO-LU:

How many sessions?

Eight sessions.

CHAIRPERSON WATSON:
DR. GO-LU:

But, of course •••

And where are these sessions?

That would be at county-operated clinics.

Of course, then there

is a priority listing and the waiting list is long, as Dr. Jordan presented.

They

may be waiting a long time, and depending on where that availability of services.
CHAIRPERSON WATSON:

Yeah, I guess what you're doing is supporting the

contingent, if there is a serious problem here.

There's not enough of this

training and not enough people to deal with the patients.

The waiting lists are

too long, and they're going to have to wait and maybe their lives will not last
long enough to be able to be treated when they need the treatment.
As you say, crisis intervention, and my definition for crisis is something
that is happening right now.

And if this is crisis intervention, then I think

what's being offered cannot really deal with the number of people who are in
crisis.

That's one point I want to make.

The next point is -- and I'm not blaming you.
DR. GO-LU:

I understand.

CHAIRPERSON WATSON:

I'm trying to describe the problem and the emergent needs

aa they relate to that problem.
We just realigned the way we appropriate monies to the county for mandated
services which no longer are going to be mandated, but they are required of the
county to deliver; and one of the areas is in mental health.
How the counties appear to be elated over being re-aligned.
that elation.

I never showed

I think you were up there when we had some of these discussions

because the reality is you're going to get a smaller pot of money, and they said
that's great.

But what we did, we took our oversight away.

mandates, to be sure.

There are no longer

How maybe you're going to do the right thing, but I'm

worried about the other 57 counties.

In reality, I was worried about my own county

because I've not seen a lot of evidence in the past that they were going to do the
job the way it needed to be done.

But, however, all we're asking for is date of

collection.
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What I'd like to say, and I hope that you can do something along theae linea,
ia lay out of a plan, a model for us, aa how you're going to -- the dollar• will
not increaae, as you know.

They probably will decrease.

those dollars differently.

It'a atump money; we put it on the stump; you run up

and grab it.

And we're aaying that thoae dollar• have to be spent in thoae

categories for which they were attended.
that money.

But now you can handle

And you can only comingle 10 percent of

So what I'd like to see ia count the county ahowing aome kind of model

or strategy for taking those aesaions you're talking about to the people.
If we really zero in on the problems, you know, transportation problema -- not
wanting to travel at night -- the fact that the atreeta indeed are dangerous and
these people indeed are at riak, then how do you solve that?

Bow

do you put thoae

program• for people who are in criaia to receive?
DR. GO-LU:

I realize that we went from 40 county-operated clinics to about

22.

CHAIRPERSON WATSON&
DR. GO-LU:

Yeah, yeah.

So that there is a greater geographical distance.

But on a

monthly basia, from the funding that we did receive from the atate, we have every
clinic identify a HIV liaiaon who comea; and we provide updated training to them.
And in order to be at least aware of the most current way to deal with the HIV
affected and their mental health needs.
CHAIRPERSON WATSON:
DR. GO-LU:

One area.

transportation need.

Yeah, but you're identifying one.
In our day treatment program, we are aware of the

But basically, we know that.

And ao we have a van.

We have

about a 20 --there's a certain radius you can pick up here only in L.A., and we
need those day treatment center one exactly here in this community; but there is no
funding currently right now for that becauae we do have that and that'a located
in •••
CHAIRPERSON WATSON:
saying:

Well, that'a going to be your deciaion, you know.

We're

This is money for mental health; now you run the program.

DR. GO-LUz

I wasn't aware that in the target population HIV waa one of the

ones, but maybe that'a •••
CHAIRPERSON WATSON:
DR. GO-LU:

Uh-huh.

CHAIRPERSON WATSON:
DR. GO-LU:

Well, I think you're hearing the need --- expresaed today.

Okay.

CHAIRPERSON WATSON:

You can't really separate them out any more.

When we

start targeting a population, we talk about mental health services, they ahould go
to the homelesa, the HIV-positive, the person with cancer, you know, and all, that
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whole radius, categories of clients out there that have real emergent needs and are
in crisis; and I think that's where you're trying to zero in.

How do you address

the crises that they're in?
DR. GO-LU:

I understand that.

CHAIRPERSON WATSON:
DR. TATE:

Dr. Tate?

Yeah, I just wanted to piggyback on that because the dilemma that I

think the county is in is that now, because funds are so tight, this targeted
population definition that they're operating under is so, so narrow, that those
people don't fit crisis as defined now by the county, that crisis now means, excuse
me, however it's so narrowly defined, that, you now, you have to have, I don't
know, hallucinations, delusions •••

DR. GO-LU:
DR. TATE:

Danger to self and others.
••• dangerous to self and others, and, you know.

So I think that

when you look at re-aligning L.A. County and appropriating dollars for various
types of interventions, that, as the Senator was saying, certain populations, I
think, need to begin to come to the forefront as really maybe opening up the door
in some areas for crisis intervention for particular types of services so that when
we integrate the Department of Health Services with the Department of Mental Health
and the Department of Corrections and other county departments, we're working
together in a whole continuum rather than a fragmented service delivery system
specifically for HIV-positive and AIDS individuals.
CHAIRPERSON WATSON:

We have in our hand a double-edged sword.

when we sent some programs out to the county years back.

I remember

And one of the counties

said they took the definition, and they revised the definition and said we simply
don't have any of those.

So therefore, there was a whole population that went

untreated.
I am hoping that in L.A. county, the largest county with the most number of
cases, that you might start to look at the definitions and see how restrictive they
are and how can we broaden those definitions to serve people in crisis.

And you'll

have that in your hands.
DR. GO-LU:

I will have that; and as you're aware, I will be presenting this

to our new mental health director when she arrives.
CHAIRPERSON WATSON:
DR. GO-LU:

Now the new mental health director is •••

Dr. Areta Crowl.

CHAIRPERSON WATSON:

Yeah.

All I know about her is what's on paper, and I

would hope that we could meet with her and talk about designing a program
DR. GO-LU:

I will convey that to her.

CHAIRPERSON WATSON:

-- for meeting the needs of people in crisis, you know,
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and particularly those who are in crisis because they learned they were BIV
positive, as well as some of the other areas too.
DR. GO-LU:
DR. TATE:

Thank you for that support.
Just one other question, Dr. Lu.

Before you arrived, Dr. Jordan

spoke a little bit about studies, or the lack of studies, of prisoners and their
sexual behavior, as well as BIV and AIDS victims and what we don't know about
what's going on in the prisons.
DR. GO-LUa
DR. TATEs

Since you're in charge of forensics •••

Forensic mental health.
Okay.

Just with regards to forensic mental health at the county

jail, what's going on, if anything?

Do we have any knowledge base, any data, with

regards to BIV AIDS?
CHAIRPERSON WATSONa
DR. TATE:

Are cpndoms available?

Yeah, are condoms available?

What about sexual activity?

Just

generally, can you give us a picture?
DR. GO-LU:

The medical director for the Sheriff's Department medical services

actually is the person that works and establishes the policy regarding AIDS in L.A.
County jail system, and he has collected some data.

But you're aware that there is

no required testing; and therefore, it would be only for those that had
voluntary •••
CHAIRPERSON WATSONa

I think she's going in a little different direction

because I raised the question with Dr. Jordan.
DR. GO-LU:

Okay.

CHAIRPERSON WATSON:

And my question was -- well, he really started it.

Be

said, you know, in the prisons it is acknowledged by some of us that there is
sexual contact, usually forceable sexual contact.

These people come out of the

prisons and the jails, and they go back to their partners in civilian society; and
this creates a problem.

So we were trying to find out what are they doing to

acknowledge the fact that there is sexual contact in jails?
Now, you know, I've heard this -- I'm putting you on the spot, or. Lu.
we've gone through this in Sacramento.
sex is prohibited.

We get people in from corrections that, oh,

So this is a game we all play.

I'm playing right now by asking these questions.
DR. GO-LU:

And, you know, this is a game
I know what the answers are.

My personal opinion is, yes, I do agree with you.

behavior do occur in the jail.

But

Those types of

But you also realize that anything that is not

given to the inmates by the sheriffs are considered as contraband.

And therefore,

until the sheriffs approve condoms, it cannot be brought into the jail setting.
And actually, it could be used for a lot of acts that may be dangerous also to
others.

So I think that's part of the rationale provided.
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CHAIRPERSON WATSON:

Well, why does the administration allow personnel in the

jails, the county jails, to allow this behavior to go on and do nothing about it?
It goes on.

I can bring you any inmate will say that he hears screams and all.

they hear it, why don't the guards hear it?

If

And why doesn't the administration of

the county jails do something about the problem?

Do you have any idea?

I know

you're the wrong person to ask, but you hear rumors.
DR. GO-LU:

I believe that the -- if it's heard -- this is what I'm told, they

do prevent it from occurring.
CHAIRPERSON WATSON:

But they don't hear it.

They all of a sudden have a

hearing loss.
DR. GO-LU:

The ratio between a deputy and an inmate is very high in L.A.

mean you have two deputies observing and watching a cell of 250 inmates.

I

And if

you have not come and visited the jail where the ability to see and hear all the
time of every cell is not quite visible at all the times.

But I'm told, and we

have approached the subject, that when they hear it, they do prevent that too.
CHAIRPERSON WATSON:

Well, I don't understand how three or multiple inmates

can get one inmate, and to have a sexual act.

And the people who we pay to guard

do not know that.
If I know it on the outside and if I know that at any given day, you can have
over 500 prisoners test positive for RIV, something's going on in that environment
and somebody ought to be aware and doing something about it.

You just happen to be

the person here from the county who's on the hot seat, Dr. Lu.
DR. GO-LU:

I understand.

CHAIRPERSON WATSON:

And I'm not holding you to blame for these situations,

but I'm making some statements that I hope will be heard.
Okay.

You wanted to finish.

DR. GO-LU:

Well, actually, I just -- you had asked if there was some kind of

plan, and I believe that I'd like to share this strategic plan, the mental health
piece of it, with your committee.
CHAIRPERSON WATSON:
need to go over in detail.
DR. GO-LU:

Thank you.

And we'll have someone pick it up.

You don't

Just tell us.

No, I won't do that.

Well, I thank you.

And if there are any

other questions, otherwise •••
CHAIRPERSON WATSON:

I think I've raised all the points that need to be

raised.
DR. GO-LU:

I think-- I heard you loud and clear, and I'll convey this to

both the Sheriff's Department and to my department.
CHAIRPERSON WATSON:

You know, years ago, I carried a bill to extend the
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Robbins rape laws of evidence to prisons and jails and so on because I was alarmed
at the number of homosexual rapes and the number of sexual contacts within lockup
facilities.

Most people here are going into the county jails -- the homeless, the

mentally ill -- are going there, people with some kind of addiction and so on are
going into the county jails.

So I guess if we're going to look at a facility that

is closer to home, we're going to look at the county jails.
what goes on inside.
DR. GO-LU:

And I'm alarmed at

It's scandalous aa to what goes on in the county jail.

In addition to what you say, it's also primarily the largest

ethnic population.
CHAIRPERSON WATSON t
DR. GO-LU:

You've got it.

And the county's concentrated in the jails.

CHAIRPERSON WATSON:

And when we use the figure one out of four African

American males, a lot of them are sitting there; they're sitting in California
Youth Authority; they're sitting in the state and federal prisons.

And we're

seeing the AIDS incidents going up, particularly in this population.

We've got to

start being sensitive and doing something, ao you've got the message.
DR. GO-LU:

Thank you.

CHAIRPERSON WATSON:
list.

Blma Colbert.

All right.

DR. CYNTHIA DAVIS:
CHAIRPERSON WATSON:
DR. DAVIS:

Thank you.

All right.

I'm going to go right down my

Cynthia Davia.

Blma'a right here.

She's coming.

I beg your pardon.

There's Blma.

CHAIRPERSON WATSON:
MS. ELMA COLBERT:

Oh, okay.
Hello.

Blma Colbert.

I'm Elma Colbert.

I'm with Charles Drew Medical

center, NOBCO, Southwest College.
CHAIRPERSON WATSON:
please.

You want to pull that mike right up in front of you,

Just pull it right over so it's in the direction of your mouth.

Thank

you.
MS. COLBERT:
do outreach.

Okay.

In Southwest College.

I'm a community worker there and I

And I'm also a counselor for testing.

CHAIRPERSON WATSON:

You're talking in this direction.

You're mike is in that

direction.
MS. COLBERT:

Okay.

Okay.

Is this better?

CHAIRPERSON WATSON:

We're trying to pick up your testimony.

MS. COLBERT:

And I'm also a person that's living with HIV.

Okay.

I guess,

first of all, I should say that my concerns are that more studies should be done
for women.

And it's too many times that women teat HIV or women are HIV-positive;

and other things have gone on; they're not tested for other things.
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I'm a person that's been, received January 1, '84, and I have to yet, be, have
GYN services or any other services through the county which I have been a patient
there since being infected with the blood.
DR. TATE:

Excuse me.

MS. COLBERT:
DR. TATE:

Sure.
I will.

I received blood January 1, 1984.

Okay.

MS. COLBERT:
DR. TATE:

Let me understand that.

Repeat that again.

MS. COLBERT:
DR. TATE:

There are 10 to 26 •••

They informed me that the donor had died in '85.

Uh-huh.

MS. COLBERT:

At that time, I had been under medical care since '85.

And

since '85, not one doctor, not one, has given me a smear -- I haven't been to a GYN
clinic.
DR. TATE:

You haven't had a Pap?

MS. COLBERT:
DR. TATE:

No.

Is it because they won't accept you because you're HIV-poaitive

or •••
MS. COLBERT:

I just think that we're on the back burner.

CHAIRPERSON WATSON:
MS. COLBERT:

Pardon me?

CHAIRPERSON WATSON:
MS. COLBERT:

Have you requested •••
Have you approached the •••

Yes, yea.

And if it had not been that I have a friend that's a

medical doctor, that has no knowledge about this disease, if not for him, I would
not have had any physicals or anything else since I've been diagnosed as being
positive for the virus.
You complain; you talk about things that are happening with you.

There's no

money or they can't do anything about this until something, more major happens to a
person.
cella?

How much more major can a person be than to be a person that has ten T-4
I have ten.

I have one helper cell, and everything else.

I'm totally

without moat things that would make a person function or make the immune system
function.
I'm an advocate for women, and I should say because I hope that not one other
woman that's infected with this virus has to go through or deal with the same
things that I've had, that I've gone through, or not being listened to or not being
heard.

I think that if you have one person that has ten T-4 cella, and then you

have another person with 200 T-cella, the person with ten is alive, doing well,
that more studies should be done on that person than opposed to the person that has
died already with 200 T-cells.
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I hope I'm not sounding selfish, but deal with us that are living and that are
doing okay because when I say I have ten T-cella, you would expect me to roll in a
wheelchair at least, you know.

So find out why we're doing well.

More studies

should be done for women; and then the ones that are doing exceptionally well, more
studies should be done on that as opposed to just dumping us off with a bunch of
medication that has been basically tested on men, not on women.
so far that it's not causing other problema to happen.
now.

We're just lucky

I'm on a new medication

So sometimes it's, for the last three days, I'm sort of high and low.

what's happening right now.
long time ago.

That's

I'm on I and B, which I feel I should have been on a

But due to the backup and due to the fact that I wasn't physically

having any problema, then it was overlooked.

It was something that just was not

dealt with.
So I'm sorry for the up and down.

But a person that's living with this virus,

we have a lot of concerns; we have a a lot of issues.

I was sitting there laughing

when you were talking about Magic because we have a lot of support systems that we
kind of deal with each other.

And we're all having negative and bad feelings about

that because this man was getting glorified for being BIV-positive.

And we then

have been living with this disease all this time, still can't come out of the
closet, you know.

Issues where -- I work at southwest College.

that campus is so unaware.

The women there on

More education, more understanding, more

know what more could you give them.

I don't

But they need more because when we go out to

lay out literature to talk about AIDS, it's even to the point -- some people feel
like if they read that, if they touch that, then they're going to get the virus.
That's how unaware they are, you know; as opposed to, and I go no, it's if you pick
it up and you read it, then you'll find out how not to get it.
Women need to be more in charge, more control.

In my situation, my being in

charge or my control would be me talking and demanding and asking about medications
and things that are available for me to take.

A woman that's not positive for the

virus, her taking charge and her control would be being able to get more skills and
communication to deal with partners.

And women don't have that.

surprised when I got to southwest College.
with.

And I was really

More things like that need to be dealt

Women need to see and hear more about how they can communicate and negotiate

skills to deal with their sex partners.

And women need to know that they have that

control, they have that control, without hearing it repeatedly and someone
continuously reassuring them and reaffirming the fact that if you stand up for what
you believe in and what you think is right, I think leas women would be positive
now because they would not submit to doing anything with their sexual partners that
did not feel right or did not set well with them.
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that happen not to be a person that was infected sexually.
stands.

But the issue still

The majority of women that are becoming infected today are women that are

infected through heterosexual relationships, and they just need to take a better
charge and a better stand.
CHAIRPERSON WATSON:

Thank you so much for your tetstimony.

It is reaching

home, and I think we've come to the same conclusions pretty much at the same time.
All right.

Cynthia Davis.

MS. CYNTHIA DAVIS:

Right here.

First of all, I'd like to thank Dr. Tate and Senator Watson for giving me the
opportunity to present to you this morning.
My name is Cynthia Davis.

I'm a health educator.

I work for the Charles R.

Drew University of Medicine and Science which is associated with Martin Luther King
Hospital.
I have worked in the community since 1984 developing family-life education,
sex education programs, primarily for at-risk youths, Blacks, and Hispanics.

I am

currently coordinating two AIDS education and prevention programs for the National
Organization of Black County Officials which is based in Washington, D.C. -- that's
NOBCO.

They received a grant from the Centers for Disease Control in 1987 to

develop a model program targeting the Black community that could be replicated
around the country where they had their constituency.

So I coordinate two projects

for NOBOO, and I provide technical assistance to two other programs.
On a local level, one of the programs that Elma Colbert works for, I wrote the
grant or wrote the proposal for that program at Southwest College which is
primarily targeting women of childbearing age and a local program that's funded by
the Department of Health Services, Office of AIDS, primarily targeting school-age
populations in South Central, incarcerated populations in the general community.
In my written testimony, I'm going to sort of skip around, since you have it,
and you can refer back to it.

In the packet of information that I've left with

you, I've given you reference material focusing on AIDS and HIV and its impact on
adolescents, young adults, and women because those are the populations that I
primarily serve.
Just as background information, as of October of 1991, there have only been a
little over 758 cases of AIDS reported among adolescents.
19-year-olds.

That's on a national level.

That's 13- to

And locally here in L.A. County, we

have approximately 30 cases of AIDS reported among adolescents.
I think, that even though the numbers are low across the board, both on a
national and local level for adolescent populations, that we should still be
vigilant in terms of providing comprehensive education to that population, given
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the fact, that with the long latency period, from the time of initial infection
until one is diagnosed with AIDS, which can be from one to ten years, that many
people who are in their 20's probably contracted HIV in their teens.
long, HIV has been considered a gay, bisexual, white male disease.
community, that still is a misnomer.

For far too
In our

Again, I've been involved in doing direct

community outreach for close to eight years now with school-age populations
primarily in the Compton Unified School District and the L.A. Unified School
District.
When we first went into those schools in grades 5 through 12, just coming into
the room, a lot of the students were thinking, well, why were we there?
have AIDS?

Is that why we were there?

Did we

There was a lot of misinformation

concerning how the virus was transmitted, thinking you could get it from the toilet
seats, mosquitos, et cetera.
From anecdotal information that we have gathered, many of the kids are
engaging in at-risk behaviors through sexual activity because of drug use.

Kids

who are in classes for mentally disturbed kids, we're finding that a lot of those
kids are being, have been sexually abused.

And so we know that it is going on.

If

you look at the rates of teen pregnancy in L.A. County, as well as the rates of
sexually transmitted diseases among adolescent and young adult populations, we're
at epidemic proportions.

And as far as STD goes, the rates of gonorrhea and

syphilis have been at epidemic proportions in South Central since the mid-80's.

So

it's all of these things are indicating to me that we have a whole community, a
whole generation at risk for HIV infection.
DR. TATE:

Ms. Davis, let me just interrupt you here.

Of the 30 reported

cases of adolescents and youth that have acquired the disease, do we know what it's
been attributed to, if it's sexual behavior, HIV -- I mean IV drug use?
MS. DAVIS:

some of it -- the numbers are low, but some of it has been due to

same sex between men, homosexual, bisexual contact, and heterosexual contact, and
IV drug use.

You can get that information from the AIDS Program Office, the

Department of Epidemiology.

Unfortunately, in their monthly report that comes out,

they do not break it down by gender.
of males to females.

so we don't know the number of males, ratio

And they don't break it down again by transmission category

for the adolescent population; and you have to go and make further inquiries on
your own to get that information.
I think other co-factors that have to be considered in implementing effective
programs have to do with the fact that we're dealing with a population that has low
literacy, a population unemployed, the incarcerated population, and again the drug
use that is going on, and early sexual experimentation.
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paet 20 years that in major inner-cities annually that the rates of early sexual
activity are just decreasing in where in a lot of major inner-cities you have
children who are young as 10-, 11-, 12-years-old initiating sexual activity.
I wanted to briefly, to talk about some of the barriers in terms of funding.
I don't think none of the previous speakers really talked in depth about the Ryan
White CARE Act and the fact that with this money being available for the next four
years, how that is going to impact people-of-color communities.
I serve as a board member of the AIDS Regional Board which is responsible for
allocating Title II funding, and I serve as an alternate, recently identified as an
alternate for the CARE Council, Title I funding.

And I also chair the Minority

AIDS Consortium which is a group of service providers primarily targeting medically
underserved communities in L.A. County.

And we have been meeting for three years,

and we try to network and share information and resources and problem solve around
the issue of AIDS in people-of-color communities.
For the last several months, the consortium has made an attempt to access some
of that money, and it has been a constant battle to "get our fair share" of this
money aa it becomes available.

And ao that's one major barrier that we feel that,

in our communities, that we still are underserved in terms of getting our fair
share of the resources.

Again, the Ryan White monies was primarily for primary

care, not primary prevention or education.
intervention, et cetera.

The money was for treatment, early

And ao there's a need to do more lobbying and advocacy

for money for education to prevent HIV infection, in the first place.
going to be more coat-effective in the long-run.

It's just

Both at a local and a statewide

level, we feel that again that there has been insufficient funds coming to minority
communities to target women, adolescents, homeless populations, incarcerated
populations.

And we would hope that you can support us in our efforts to get more

funding for those populations.
I talk a little bit about strategies.

But what I would like to do is, to save

time, is to go over my list of recommendations.

In February of this year, I

participated in the first public hearing on women in AIDS in Loa Angeles County
that was sponsored by the L.A. Commission on the Status of Women and Councilman
Robert Farrell.
true today.

And the recommendations that I presented at that time still hold

And I will not go through all of them, but I just wanted to indicate

that there ia a need for more early intervention programs, for women and youth;
there's a need to expand the AIDS Clinic at Martin Luther King Hospital, the Oasis
Clinic.

Dr. Jordan now is having specialized services for women, adolescents.

And

we would like to see that the services for adolescents be expanded at that clinic
and services for women.
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There is a need to develop a mobile unit to target street youth in South
Central.

There is not a lot of providers targeting kids who are on the street,
And we

which could be former parolees, kids on probation, as well as gang members.

would like to have a mobile unit where we could send street outreach teams into the
community and South Central, do testing and counseling, and referral to the clinic
at Martin Luther King Hospital.

And that is a concept that we would like to see

Lmplemented as soon as possible.
We feel that, still, that there's a lot of denial going on in our community, a
lot of fear, ignorance, and homophobia.

And it wasn't until Magic Johnson again

made his disclosure that people really began to take ownership of the issue and
really personalize it, that it could happen to them.

And again, we were all

inundated with requests for people wanting testing and counseling in our community,
and there were not enough providers out there to meet that need.

There was one

local high school that called the clinic and wanted to know would they be able to
provide free testing to their high school students because the kids were so
concerned, they wanted to be tested.

And this clinic was just inundated with,

again, people wanting to come and be tested.

Even if you test positive, where are

you going to be referred if there are no, if there's no infrastructure in your
community?

So bottom line is what we feel that a infrastructure needs to be built

in our community so that we who have the expertise in the community can be given
the resources to meet the needs of that community.
Thank you.
CHAIRPERSON WATSON:

I appreciate your comments, and certainly throughout the

morning and afternoon we have been trying to zero in on the fact that it looks like
the minority communities -- specifically the African American community has been
somewhat set aside as we approach the distribution of resources.
I'm interested in the packet that you've given me.
out.

I just flipped through

But almost every item in here talks about women and AIDS and so on.

Were we

mistaken when we said there haven't been a lot of studies on women with AIDS?
MS. DAVIS:

No, you were right on track.

me has to do with the aero-prevalence.

Again

And one issue that really concerns
and you mentioned it and you

seemed very well aware of what's going on -- but for women of childbearing age
that's 14 to 44 -- I've been following that data for the last couple of years and
trying to make more people aware of what's happening.
these core-blood

But with the testing of

samples, doing random samples, last year I got the information

that from the pool of women tested in Alameda County, they were projecting that 1
out of every 100 Black women in that test group was HIV-positive.
County, it was 1 out of every 300.

And for L.A.

Well, the most recent data, L.A. county now is
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at the top of the list in that it has increased by SO percent, meaning that now
they're projecting that 1 out of every 174 Black women of childbearing age, out of
that population that were tested, came out HIV-positive.
give people cause for alarm.

And that really should

If you have your childbearing population in that gene

pool infected with HIV, you're really looking at genocide down the line because
there will be no future generations if everybody's infected and if all the women
are infected.
CHAIRPERSON WATSON:

I was just going over the titles that the audience might

be interested in knowing what some of the titles are:
AIDS in the

"Epidemiology of Women With

u.s., 81-90"; "Researchers Waking Up to the Needs of Women With HIV".

And then there is a report put out by Act out, "Women's Treatment and Research
Agenda, Women With HIV".
So it looks like there's been a wake-up call and that it was called before
Magic called it, but I'm going to have to look at this information very closely.
see there's some analytical reviews that have been done and so on.

I

So maybe there

is more attention being paid now at the current time to women with AIDS.

We

certainly will follow up, and I appreciate you supplying us with this information.
MS. DAVIS:

Well, we have a window of opportunity ••• gap in tape ••• at least

the incidence and the prevalence to get like it is in New York ••.• (gap in tape) •••
in '87 in New York and New Jersey.
CHAIRPERSON WATSON:

If you don't mind, I would like to request of you that

you do this, and that is, that you send us a letter to Sacramento outlining what
you think the needs are in terms of research for women with AIDS or research on
women as a whole.
MS. DAVIS:

Can you do that •••
Sure, sure.

CHAIRPERSON WATSON:
MS. DAVIS:

Thank you.

CHAIRPERSON WATSON:
All right.

We'd appreciate that.
Thank you so very much.

We're going to go down our agenda here.

MS. SUZI RODRIQUEZ:

Yes.

Good afternoon.

Suzi Rodriquez.

And I want to start by thanking

you for inviting me here today and to tell you a little bit about what I do.

I am

currently the co-chairperson of the Title I Care council in Loa Angelea County.
I'm a member of the AIDS Regional Board.

And along with Cynthia and Mario at the

other end of the table, we're also members of the Mayor's City AIDS Advisory
Committee.
I work for a community-based organization in East Los Angeles called AltaMed
Health Services.

We've been providing services, predominantly primary care

services, to a largely Latino population, for over 20 years in that same community.
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Like Cynthia, I'm not going to go word-by-word of my testimony becau .. I've
given you copies.

But I'd like to talk a little bit about some of the problems

that we're finding in the Latino community.

We also feel that as people of color,

we are underfunded and under-represented in terms of programming.
One of the problems that we have currently within the Latino population that
doesn't seem to be the same kind of problem that is occuring in the
African-American community is that we don't have an overwhelming number of
providers who are willing to get into the arena and provide HIV services.

We still

have a lot of denial in our community also, and the denial spreads not just within
the realm of sexual preference and sexuality but also in terms of drug use.
The community that I represent has, by conservative estimates, the largest
number of injecting drug users in Los Angeles County.

And yet, when we attempted

to open a Methadone Maintenance and Detoxification program, it took us three years
to be able to overcome the NIMBY syndrome because the people in our community were
just absolutely convinced that there was no drug problem in the community.
As I said, our agency is a primary care agency; we're a community health care
center.

And we've always done what is considered to be relatively safe

programming.

We have a teen pregnancy program.

We do a number of programs for the

Latino elderly, and we provide primary health care services.

But when the AIDS

epidemic, especially the way that we heard it being reported from back East in New
York specifically, and how it was affecting the Latino populations, our agency made
a concerted effort to get into the AIDS arena to be able to address the problems
that would be facing our community.

And again, there are not an overwhelming

number of providers who are willing to get into the arena.
We're pretty new in the direct-service arena.

We've been given many -- most

our money comes -- our Drug Services money comes from the Los Angeles County Drug
Abuse Program office.

And we receive federal funds from the Bureau of Health Care

Delivery and Assistance, from the Office for Treatment Improvement, which for those
of us that are involved in the drug arena, it's been like a blessing that there was
a new entity developed for treatment.
I dislike the fact that we're often, as treatment providers, pitted against
prevention and education programs about which should take a priority and which is
more cost-effective.

I'm having -- I'm a recovering person and I know that

treatment works, and so I'm always going to advocate for more treatment dollars;
and I feel really fortunate that the Office for Treatment Improvement was
established on a federal level.

And then we were able to access dollars through

the Ryan White CARE Act to provide community-based early intervention services.

So

I'd like to talk just a little bit about what we've learned in this short time that
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we've been delivering services to our population.
We find that most of our patients are of Mexican origin.
are undocumented.
schooling.

Many, many of them

Most have a relatively low level of formal education in

So I agree with what Paul Davis was talking about earlier in terms of

appropriateness with written and printed materials.

We put a lot of money into

those kinds of things without taking into consideration that people may not always
have the literacy level to read what we're spending the dollars to put out.

And

some people, AIDS Project Los Angeles, for instance, there's been some very
creative ways to reach into communities of color that I think need to be expanded
on; and I hope they'll talk about some of their projects.
Most of the people that we're dealing with are alone in the United States;
they're not here with the support system.

And all were infected, either by sharing

needles or by having sex with men who are infected.

We find that there's a

definite gap in culturally appropriate services for gay and bisexual Latinos,
especially those with drug problems and treatment needs.
And I'm going to take a sidestep for a second to tell you that I used to work
for the Loa Angeles County Drug Abuse Office.

And my job at that time was to go

into facilities of incarceration and speak to people who had been arrested on
drug-related charges and make arrangements for them to go to treatment.

What would

happen in those cases was when I had clients that were gay or bisexual, there were
no appropriate drug-treatment programs to service that population.

And

unfortunately, most drug treatment providers believe that changing your image is
directly tied to rehabilitating yourself.

And so if you're a gay or bisexual man

and you have long hair or you're a transvestite, most times you'll go into a drug
treatment program; and the first thing they'll do is tell you to cut your hair and
to change the way you look.

If you're a lesbian, you go into drug treatment

programs, they make you wear dresses and send you to charm school.
some real problems going on here.

So we've got

And there's a gap in the service base.

There's

not people that are doing outreach into the gay and bisexual community of drug
users, and that's a real problem.
attention to that.

And I would hope that people would pay some

We also feel that it's imperative that the clinic staff be

culturally appropriate to the population that they're serving.
I

Recently, my agency went down to Olvera Street, and many of the people here
know about the transient Latino population that's in Olvera Street.

We had been

told time and time again that there was no way to do follow-up testing with these
folks.

We tested 140 people at the Health Fair at Olvera Street.

We had 120 come

back for results, and we know that that is because the staff wa9 reflective of the
target population.

The majority of our staff are Latino.
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bilingual, and we're well staffed with representation of gay and bisexual men.
Some of the recommendations that I would like to put forth today is that we
also believe that linkages must be made with historically gay HIV/AIDS programs in
order to provide appropriate staffing, training, and service provision for gay and
bisexual clients.

In the case specifically of my agency, when we looked at where

the gaps were in service and we recognized that there was a gap for Latino, gay,
and bisexual men, we knew that we did not have the infrastructure to take care of
the needs of that specific population.

we were very fortunate to be able to link

up with AIDS Project Los Angeles and develop a whole, entire innovative program
that includes cross-training and for them to be able to give us the needs that we,
to fill the needs that we had to find appropriate staff and that -- I just can't
even tell you how valuable that was for us.

But it's very difficult to get

community-based agencies that primarily deal with people of color to look at those
gay and bisexual agencies as being valid and there as a resource.

And I think that

we, those of us that are doing those kinds of things, need to help break through
the stigma and role model for that kind of linkage.
We believe that there must be continuous and on-going education for and to the
community.

In the Latino community, we've got to access the church on a much

greater and broader basis.

We have found that there are many people within the

church who are willing to look at what their role should be, but it needs to be
vastly expanded.
We believe that there should be intensive training and pre- and post-test
counseling required for all case managers and that again clinic personnel should be
reflective of the population that they are serving.
We believe that HIV-testing should be encouraged to all program participants,
and we believe that a system of comprehensive care should be instituted that
includes pre-test counseling, HIV testing, post-test counseling when delivering any
results.

Too often we find that if someone tests negative, they don•t get any

post-test counseling; and that's really a shortcoming.

If the client is found to

be positive, there should be an expeditious way to admit that patient into a
medically managed program where one case manager will follow the patient during the
course of the disease.
We believe that there should be increased outreach done to the injecting
drug-using population.

My agency feels very strongly that the sero-positivity

rates remain low for this population only because the data being collected is
gathered, is reflective only of those people who are accessing treatment.
also like to ask that consideration be given to the legalization

of

programs that are tied directly to increased treatment availability.
-72-

We would

needle exchange
I know it's a

086

really hot issue, but it's something that definitely needs looking at.
DR. TATE:

But Senator Watson is introducing that next session.

MS. RODRIQUEZ:

Well, again, I would like you to know that there is many of us

that will do whatever we can to help you support that form of legislation.
CHAIRPERSON WATSON:
MS. RODRIQUEZ:

You missed my discussion about my bill early on.

Yes, I did.

I'm really sorry because we have a whole network

of people that would be willing to support that.
We also believe that staffing and programs should include a financial analyst
to assist patients with accessing appropriate programs, such as Medi-Cal and
Medi-Cal -- Medi-Cal and Medicare.

And that's about all that I have to talk about

today.
CHAIRPERSON WATSON:

We certainly appreciate your testimony.

Is there someone down there that wanted to say something?

Okay.

Because it

zeroes right into the ethnic community and its treatment that is specific to the
culture; and that's what we need to hear more about.

This is a very valuable piece

for us as we try to reform the system so that it will address those specific needs.
Thank you.
MS. RODRIQUEZ:

Thank you.

CHAIRPERSON WATSON:

May I ask the indulgence of the other members that I have

seated at the table here, if you will.

Dr. Reed Tuckson has come into the room,

and he was scheduled to speak at 3 o'clock.

He's a little early.

indulge him now, if I may, because I know he has a heavy schedule.

I'd like to
He is from Drew

University, and he was scheduled with the Hospital and Physicians and Clinics
panel.

So if you'll allow us to do that, we'll take you up now, Dr. Tuckson.

Welcome.
DR. REED TUCKSON:

Well, thank you very much.

And I very much appreciate your

indulgence, as well as the other members of the panel for allowing me to go
forward.
I will make some very brief comments.

First, let me just say that I am, I've

enjoyed my three months as President of Drew University of Medicine and Science.

I

emphasize the three months to say that my comments have to be tinged with a little
humility.

This community of Los Angeles, I'm still new to and I'm learning.

And I

have learned enough in my career, Senator, to know that it is very important to
spend time in a community before you become arrogant enough to make too specific
recommendations.

However, please consider my testimony as part of a team at Drew.

I think that Cynthia Davis Callahan, and also Wilbert Jordan, are certainly
experienced and competent to be able to make very specific recommendations, all of
which I endorse.
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I would say this, though, that as a person who's been fortunate to be a leader
in the national fight on this issue, and a number of national commissions and still
active, there are some important principles I would hope that you keep in mind as
you go forward and consider these issues.
First is that, as you are well aware, the HIV disease exists in the context of
a series of other very dramatic and contributory health problems, naturally the
tragedy of it.

As we think about funding for HIV disease, I think we always have

to remember the context in which it occurs for people of color and people who are
poor and the relative relationships between them.

As you've just heard in the last

speaker, HIV disease and the clear relationship to IV drug abuse is, of course,
important.

HIV disease is related ultimately in many ways to violence.

I've been

very concerned with the number of women who become addicted to drugs because of the
violence in their community and thereby find their way to HIV disease.
We find that the issues of self-esteem that lead to behavioral choices that
are incompatible to survival are common throughout; and so that as we look at how
we approach HIV disease, I only remind us that we have to look at the total health
package and the total health set of challenges that confront people of color, and
that is very important.

Similarly, to do the education that we need to do to try

to change behavior, to be able to support behavior, I think we have to face square
ahead the issue of being realistic about learning the knowledge, the attitudes, and
the behaviors of the people that live in our community.
I am very concerned by the recent decision by the Secretary of Health and
Human Services to cancel a study designed just to elicit such information about the
knowledge, the attitudes, and the behaviors, of the sexual behaviors of our
children.

I would hope that as we go forward that we would be courageous enough,

insightful enough, and thoughtful enough to really make sure we understand exactly
where our young people are so that we can in fact tailor health education messages
that will reach them where they are and not make assumptions and not burden this
process with politics.
I have been a health commissioner for a major urban metropolis for four years.
I have had my hands tied all during my tenure and have been unable because of
politics or because of all matter of competing interest, been restricted or limited
in our belief to teach our young people in a way that we can reach them and save
their lives.

And I would hope that as we go forward we would not be bound by some

of that.
Similarly, the techniques that we use, I would hope that a comprehensive
curriculum could be developed, a curriculum that was culturally specific and
sensitive but was creative and dynamic and that could be incorporated into the
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educational system not as a burden for the teacher to have to teach, in addition to
many other problems, but could be incorporated into a curriculum in a constructive
and positive and useful way, a partnership, a true partnership, between health and
the educational system.

I would hope that we would be able to be creative about

some of the ways in which we do public service announcements.

I would hope that

funding wouldn't go just for another commercial that just does and repeats some of
the, with the same technology but utilizes perhaps ways of empowering people.
Example, I had a chance to participate not long ago in an experiment that I
thought was fabulous where a live radio docu-drama was conducted on the radio that
dealt with real-life issues of a woman who was a single parent whose man in her
life was an IV drug abuser but she didn't know it.

And she was reminded of the

Lmportance of using a condom, given that he was also not faithful to her; and she
had to have a conversation with that man.

And they did it on the radio as part of

the docu-drama, and then he was very good and convinced her that perhaps that
wasn't necessary and was very smooth and very persuasive.

And then we stopped the

docu-drama at that moment and opened up the phone lines and allowed the women to
call in and be the star.
It's very fascinating to hear those women.

What would you say to that man and

what would you do and then put the man back on the radio and then have him argue
with the woman.

The women didn't always win.

What happened was, that night, there

were a lot of women who had been in the gymnasium practicing on their techniques,
practicing on arguments. And they were very empowered that evening, in that
particular city, and they knew exactly what to say.

And so there are ways which I

think we need to be a little more creative, a little more dynamic, as we think
about those kinds of interventions that will empower people, not only that gives
them information, Senator, but things that give you information in a way that
facilitates the changing of behavior, acting on information, not just giving it
out.
I would say that I really am excited by Cynthia Davis Callahan's suggestion to
you in education for mobile units.

We need to reach out.

I've spent many, many

evenings and many different cities in this country walking the streets.

And I will

tell you that the people who are prostitutes or IV drug abusers don't listen well
to health educators.

They listen well to people who are from their constituency.

I remember walking the street and having an addict on the street say to my
coworker, another addict, "I remember when you overdosed right there on that spot.•
And here that addict is now back to talk about the need to change behavior.

So I

think those kinds of mobile outreaches, efforts are important.
And I would say to you also that what you know well, Senator, is the
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Lmportance of community-based infrastructure and organization that will make a
difference.

I am very concerned that funding is about to run out from the federal

government anyway, funding community-based institutions in the fight against AIDS,
particularly our churches.

And the reason why that it is in jeopardy is because

they have been unable to prove effectiveness.

They've been unable to do the kinds

of studies that are required to show that in fact the money's been

w~ll

spent.

Drew University has, I think, a responsibility as one player in this community
to support in an intellectual and research capacity our community-baaed
institutions that are on the front linea, to prove the point of what works.

And

when things don't work, to be able to make those suggestions to how to enhance that
work.

That's a research agenda that is not being addressed.

University doesn't have any money to do that sort of thing.
commercial for Drew.

I know Drew
This is not a

It is a commercial for being more intelligent about how we

conduct community-based programs and not continue to give lip service to community
infrastructure but in fact to do it well.
In the one minute that I'm sure is all I have left, let me just very quickly
say that -- and again, my comments are a companion to my team's comments of Cynthia
as well as Wilbert Jordan, so they'll cover things that I won't cover.

But I would

say to you that I am particularly concerned about the, as we move forward to
develop the clinical trials for women and children and other people of color, men
and women who are, the clinical trials to give us more information, there is a
strange paradox.
To get access to comprehensive health care now, you almost have to be
HIV-positive for those women.

And I'm very concerned about the ethics of that.

Across the country now, what we find is the clinical trials are being developed to
take care of people that are HIV-positiveJ yet they're the same women, if they were
one week before diagnosis, wouldn't be able to get access to care.

And so I remind

you that this issue is, of HIV disease, again exists in the larger context.

And,

of course, once the study is over, then those comprehensive support services for
the HIV-positive women go away.

And so what we have to continually address is a

lasting health care infrastructure for people of color, as we deal simultaneously
with the overwhelming and extraordinary urgency.
Lastly, I would just say to you that even as we work through these problema,
the health care professionals who are going to be in our communities, they're
unavailable to take care of the comprehensive and multiple needs of persona who are
living with this disease.

We have to be very, very attentive to that.

I'a not

sure where those practitioners are going to come from, and I think that we're going
to need to be very supportive of those institutions that are dedicated to training
-76-

090

those professionals who will remain in our communities and be there to manage with
compassion and care versus living with this disease.
I've taken up my full allotment.

And so I will stop there.

I appreciate your indulgence as well as the rest

of the members of my panel.
CHAIRPERSON WATSON:

Thank you, Dr. Tuckson.

much of what has been said earlier today.
of what's needed.

I think you have pointed out

And so you do have a handle on the gap

What you will find as you try to learn this community in more

depth is that we have some political problems, and we have attitudes that have
prevailed.

California is really a very conservative state, and one of the problema

we face is trying to open up a debate in sacramento, large enough so we can put
into that debate the resources that are necessary to do the kind of innovative
things you've just described.
attitudes that prevail.

We get stumped and stymied because of these

And the more conservative the administration is, the more

stymied we become because once those bills get to the desk, they can be vetoed.
And once that belt comes out, and beats us up with it, then they die in committee.
So as you are going about trying to learn the community, you will be learning the
politics of AIDS.

And I think in some way the question has to be raised:

racism in the way we relate to AIDS?

Is there

And I think as you go about doing your

research and becoming oriented and acquainted, you'll find that maybe the answer
will be yes.

And there certainly is an attitudinal problem; there certainly is a

cultural problem that we're dealing with.

And so it goes to the social dynamics of

this particular disease.
DR. TUCKSON:

Well, Senator, I would just quickly say that in my three months

here in this State of California, it doesn't take much work to get a sense of what
you're saying.

I am amazed that the number of people that I have already

encountered with this disease is quite extraordinary.

And the degree of apathy

relatively and the degree of urgency in addressing the Hispanic and the African
American with this disease somewhat concerns me.
three-month sojourn here to reach that conclusion.

And it doesn't take but a
And so I hope that we're all

able to work together.
CHAIRPERSON WATSON:
to me.

Well, you said something that is of tremendous interest

You said Drew University ought to take on some of this.

We don't have the

budget, but we ought to be looking at some of these aspects of AIDS.

And I would

think that with your innovativeness that you would look at Drew as being a center
to give some guidance and leadership.
county.

South Central is really all over L.A.

But coming from South· central, I think you could be a beacon light.

And

you, coming from the nerve center from Washington, D.c., certainly have the
national perspective on this.

And when it comes down to the local area in which
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your university is located, you can really be that light to give guidance to the
county, to have a place where the researchers might come to do some research on
this issue.
DR. TUCKSON:

Well, I appreciate the challenge, and I would say to you that

you can fully expect us to reach that challenge.
other.

We will do it one way or the

But I will tell you, Senator, that it is very, very hard when all of your

resources are going towards just trying to maintain, seeing the patients that we're
seeing now.
not told.

And I will tell you that this is the tragedy that, the story that is
It's why I began my presentation very specifically by saying that HIV

disease exists in a larger context.
All of the resources in the health care system are devoted now towards meeting
the needs that have long been there before HIV disease became prevalent.

And to be

honest, we're doing an inadequate job of meeting hypertension, cardiovascular
disease, cancer, and so forth and so on.

Now this new phenomenon drops in the

middle of a system that is as weak as wet tissue paper.

It is inevitable that you

will have a disaster, and that is the disaster that we are now experiencing and
will continue to experience.

And so as we look to our smart people at Drew, I must

tell them to be thoughtful and to develop new research ideas and new interventions,
for HIV disease means that you cannot then be with your patient who has another
disease.

You must stop that work and do this other work.

That is immoral set of

choices to place on any health care provider or any institution.
talking about.
this.

That's what we're

And that's the picture that I think that is so often lost in all of

We don't have enough resources to do the work we have to do now.

Now we

have to find some other way to add more hours of the day, find more people to be
able to address these new needs; and we're not doing a good enough job of it, but
we will continue to try.
CHAIRPERSON WATSON:

We look for others to give us some help.
You have Drew/UCLA.

Now there's an arm for you.

And

I've been trying to, for quite a while now, talking to the chancellor, to take a
look at this sociological research that he says is not scholarly enough to start
looking.
You know, we've been talking about tenure of minority professors out at UCLA
for a long time because they focus in on the sociological research.
not scholarly enough though to grant tenure.

They find it

We've had this debate over a number

of years.
DR. TUCKSON:

Senator, can you indulge me with one more comment then.

CHAIRPERSON WATSON:
DR. TUCKSON:

Yeah.

This is a critical issue.

American Public Health Association.

Everywhere --'I'm on the Board of the

I serve on several committees of the Institute
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of Medicine.

Everywhere we go, we hear lip service to the rhetoric of how

important it is to have a community-based infrastructure with which to solve
problems.

Yet, when we look at the way in which we spend our money in the health

care research community, we spend lots of money to study the latest drug which will
solve just a very small part of it.

But to prevent the illness, to prevent the

problem, which is an ultimately community-based initiative, we spend very little
time and energy; and we don't respect that.
important.

But we give rhetoric to it as being

And I am just amazed that anyone could be that short-sighted in this

day and age to think that this is not worthy of scholarly pursuit.
this is what's going to save our community.

Ultimately,

And I think that if we don't put that

kind of intellectual attention and effort into it, we play games with people's
lives and we do ourselves a disservice.
The funding -- the last comment -- I promise will be the last comment.

The

issue that is of great concern is, when we fund community-based organizations to do
this vital work, we fund the disease of the month.

And if it's this month a

certain disease, and the next month, it will be HIV disease and then it will be
something else, the money runs out; the community institution goes away; then a new
one springs up.

What's not left is a viable, connected, stable, self-sustaining

community infrastructure.

And so this business, if we continue to approach this

casually, intellectually, and financially, we wind up never having in place the
mechanism and the tools and the resources and the intellectual brain power which
will sustain us year after year after year.
CHAIRPERSON WATSON:

You might want to take advantage of your relationship

with your parent organization, UCLA, the Department of Health Services, the Office
of AIDS, and my office, and see what we can do through Drew to address the issue
that you're mentioning.

You know, the disease-of-the-month concept is very rea1

and, you know, we put our resources where there is a great amount of political
pressure.

And so I think you're putting your finger right on the problem.

think you have a broad enough base to call on to get something moving.

But I

So I will

have Dr. Tate follow-up with you, and maybe we can put something like this
together.
DR. TUCKSON:

I appreciate that, and I would never, ever find myself modifying

anything that you might say.

I would just half suggest a different choice of words

other than UCLA being a parent.

They are associated with us, but we have a

tremendous pride at Drew, as you well know and share.
and of ourselves.

And we are an institution in

But I think the point you make is an important one, and that is,

UCLA has a responsibility.

I go over there -- I was just there yesterday, and I

couldn't believe -- I looked at those -- all those giant buildings with all those
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people and all that money and they're solving, working on some problems of
Lmportance; but they're not working on the problems of importance •••
CHAIRPERSON WATSON:

My words were not coincidental.

I chose them very

carefully because UCLA, being part of the UC system, gets its funding from the
state.
DR. TUCKSON:

Oh, in that context, yes.

CHAIRPERSON WATSON:

And we can move on the state university system to do

certain things with Drew.
DR. TUCKSON:

I appreciate that.

CHAIRPERSON WATSON:

And therefore, you see, in the funds you don't have, and

this is something we've been dealing with over the years
history of how Drew came about.

and you know the

And we've been pushing and pushing and pushing.

As I said, this debate started many years ago.

And so that organization can see,

if they prioritize correctly, that you at Drew had the resources to do what needs
to be done.
DR. TUCKSON:

I continue to learn from you.

CHAIRPERSON WATSON:

I'll leave it there without exposing too much of my

intentions.
DR. TUCKSON:

I continue to learn from you.

CHAIRPERSON WATSON:

Thank you, my dear, for being here.

We'll continue this

conversation later on.
DR. TUCKSON:

Thank you so very much.

CHAIRPERSON WATSON:

All right.

I appreciate it.

Let's move on.

Thank you very much.

Mario Solis-Marich, AIDS

Project Los Angeles.
MR. MARIO SOLIS-MARICH:

Hi.

Calvin Williams is going to start our

presentation.
CHAIRPERSON WATSON:
MR. CALVIN WILLIAMS:
Committee, good afternoon.

All right.

Very good.

Senator Watson, Members of the Health and Human Services
My name is Calvin Williams, and I'm a public policy

specialist for AIDS Project Los Angeles.

While it would be difficult to diseuse

during thi• brief session all the issues relevant to bisexual and gay men of color,
I would like to discuss one issue that I believe is of paramount concern.
When the question of AIDS education is discussed, the general misperception is
to focus on a limited segment of the population.

However, AIDS is not specific to

whom it will attack; and unfortunately, too many bisexual and gay men of color have
become infected with HIV and/or have died from AIDS due to the lack of sensitive
and tailored information regarding HIV and the AIDS epidemic.
Presently, the number of people of color who have contracted AIDS continues to

-so-

rise.

The National Commission on AIDS in its recent report declared, and I quotes

Gay and bisexual men are the largest segment of people with AIDS among Black and
Hispanics, 36 percent and 40 percent of cumulative cases respectively as of June
1991.

A total of 28 percent of gay and bisexual men with AIDS are Black and

Hispanics nationally.
Within the county, the numbers are even more staggering.

Within the Hispanic

community, the gay or bisexual men constitutes 73 percent of reported cases.

In

the Black community, gay and bisexual men constitute 65 percent of reported cases.
And within the Asian and Pacific Islander community, gay and bisexual men
constitute 80 percent of reported cases.
Despite these realities, epidemiologic and behavior studies and HIV disease
have virtually ignored gay and bisexual men of color.

In addition, there is yet to

be specific target programs funded either from the federal or state governments

that address issues specific to bisexual and gay men of color.

Those education

campaigns that have been initiated by private social services agencies have been
sporadic or limited at best.

Leadership is needed from the top.

State and local

agencies must begin the process of addressing funding priorities if we are going to
stem the growing numbers of people of color contracting HIV or dying because of an
AIDS-related illness.

The lack of leadership and the limited revenues available to

social service agencies that are dealing on the front lines of the AIDS epidemic
for this population must be addressed.
The feasibility of servicing the needs of the growing HIV and AIDS population
cannot be achieved through the work of only a few agencies, nor can a handful of
agencies reasonably educate the public on ways to prevent the spread of this deadly
disease.

However, through joint efforts between social service agencies and the

active participation of the state and local governments, our collective ability to
save lives and bring about more coordination and the delivery of services for
persons who are HIV-positive or who have AIDS can be realized.
But before coordination between state and local agencies can occur, and before
unity can be achieved, the state must take a leadership role in appropriating
additional resources that will provide a meaningful base in which to provide
services to gay and bisexual men of color who are impacted by HIV or AIDS.
Moreover, the proliferation of the AIDS epidemic demands that sensitivity be
required of all public and private entities that receive public funds.
Since many gay and bisexual men of color are presenting themselves to
community health centers throughout the state, specific contract language must be
required for those agencies to ensure that gay and bisexual men of color receive
sensitive, adequate, and professional medical services.
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forward in the war on AIDS.

Let ua drop the meaningleaa rhetoric and dedicate

ouraelvea to improve in the quality of life for all thoae afflicted.
Time that is spent debating question& of policy can be more appropriately used
by designing program& that benefit thoae who are ill and dying and preventing the
further spread of this diseaae.

Let us move forward.

A large and a much maligned

segment of our population is depending on us for their very lives.
CHAIRPERSON WATSON:

There i• a feeling that prevails that the AIDS project in

Los Angelea is the recipient of the resources and that some of the community-baaed
programs that really reach out to the grass-roots community received lese because
that money goes through the AIDS Project of Loa Angelea.
Would you comment on that.

There aeema to be kind of a tug between thoae

grass-roots organizations and AIDS Project.
MR. SOLIS-MARICH:

senator Watson, if I may, my name is Mario Solis-Marich,

and I'm the Director of the Public Policy Department of AIDS Project Loa Angelea.
I also sit on the executive management team of the agency.
They are definitely our intentions within the community around funding isauea,
and there will be continued pressures because there's not enough money for the
growing epidemic and the intense crisis that we face, especially on the
community-baaed level.
currently APLA provides case management and psycho-social services to over 70
percent of the people with AIDS in Loa Angeles county.

We have the only dental

clinic for our people with AIDS in Loa Angeles county.

We have the largest Food

Bank program and the Necessities of Life Program which provides food to 650 people
with AIDS a week from all over Loa Angeles County.
our client load, the demographic& of our client load, reflect or mirror the
demographics of people with AIDS in Loa Angeles County.

And eo, in fact, we do

75 percent of our funding, we raise privately; 25 percent comes from government
sources; and we do have a large budget; we do a big job; and there does need to be
more money to go around to all community-baaed organizations.
One of the things that we've attempted to do to address that need ia we've
established massive public policy efforts, both in Sacramento -- excuse me -- in
all areas -- the county, Sacramento, and in the federal government.

We aupport the

largest AIDS activist -- AIDS lobby in Washington, the AIDS Action Council.
provide them with a third of their budget.

We

It was through their lobbying and their

direct efforts in Washington, D.C., that Loa Angeles received over $7 million
through the Ryan White Act.
We've been able to therefore use some of our private donor dollars to effect
public policy and to get more dollars for AIDS from the federal government
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diatributed here in Los Angeles County, and that's one way that we've been, you
know, trying to expand our resources and have an impact with other community-based
organizations.

We do realize we cannot be all things to all people, and we tried

to establish cooperative efforts with those community-based organizations that are
willing to work with us.

And that kind of leads me, if I may, to the point that I

wanted to talk about this afternoon, and that is, earlier, Suzi Rodriquez from
AltaMed Health Services spoke.

And when I heard AltaMed Health Services, their

representative here speaking about gay Latinos, it made me feel really, really
wonderful because in fact I am a gay Latino.

And that institution is the largest

Latino community-based clinic in the United States.

And it makes me feel good to

see them doing what they see as necessary, basing the issues that confront a
community-based organization as they address issues surrounding homophobia and
access to all members of their community.
The particular project that we're jointly working on, we believe, will have a
major impact on gay Latinos and especially gay Latinos who are injection drug users
or have other substance abuse problems.

Currently, 80 percent of Latinos in L.A.

COunty that have HIV are gay and bisexual men.

Two-thirds of gay and bisexual

Latinos are actually gay and bisexual men, period, have some addictive behavior
problem.

Unfortunately, there has been no leadership from the administration here

at the state or federal government with the Bush-, you know, Reagan-Deukmejian
machine, to address the needs of substance-abusing, lesbian, and gay people.
HIV, this is a crucial, crucial issue.

With

And it's not only the direct transmission

of injection drug use, but it's also the correlation between being high and being
able to maintain safe, sexual behavior.
The program that Dr. Rodriquez alluded to was a program that was in fact
inspired by a person with AIDS.

And currently, we have the 3,200 clients at APLA;

but this particular person with AIDS was a staff person.

His name was Jose Perez.

And he was a gay Latino who was a recovering injection drug user.

Jose Perez

worked constantly with me -- I should say constantly on me -- before he came to
AIDS Project Los Angeles to serve as a policy specialist to get me to work more
closely with, you know, pull together HIV services, substance abuse services, in a
Latino cultural context.

He worked very, very diligently to create a joint medical

advisory committee where AltaMed had cultural sensitivity.

And through APLA, we

have access to some of the finest, you know, AIDS outreach in Los Angeles COunty
pulling those resources together to create treatment protocols and to make sure
that all people in East L.A. receive a very high degree of service.

This is a

long-term project that's been very, very difficult to pull both agencies together;
and unfortunately, it still has a ways to go.

But we believe that these are the
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type of efforts throughout the county with other agencies joining together that
really should be funded.
Jose Perez died on November 11 of this last year.
sorely missed.

His efforts are sorely,

But this next year, as we move forward to completing this project,

we constantly hear his voice, and we constantly feel his presence as he's pushing
this and other projects throughout the country along.
CHAIRPERSON WATSON:
Okay.

Thank you for that insight.

Thank you.
We appreciate everything.

Mike Neely.

MR. MIKE NEELY:

Good afternoon.

CHAIRPERSON WATSON:
MR. NEELY:

Good afternoon.

Before I begin my testimony, I'd like to say something before you

go charging off to the Department of corrections on the problem of HIV transmission
within the prison system.
Sexual contact is a very important means of transmission.

However, there is

another very, very prevalent means of transmission within the prison system that
nobody's looked at, and that is, through the tattoo machines.

And I think that

unless we look at all of those aspects, we're going to miss a part of the problem.
Now to get on with my testimony, and in the interest of time, I'm not going to
do all the reading like everybody else.
I'm Mike Neely.

We'll just hit on some of the high points.

I'm the Director of the Homeless OUtreach Program.

What I

want to talk about basically is HIV and the AIDS epidemic and how it impacts the
homeless community.
One of the things I want us to understand is that by definition, the homeless
individual has no resources except for public resources.

However, as we begin to

look at the public resources, those resources are definitely going into other
communities which are not necessarily poor, which are not necessarily
undereducated, or not necessarily under-represented.
Homeless people have a very serious and unique kind of problem in terms of HIV
infection and dealing with the care system.

A person who is infected and who is

homeless in Los Angeles, in the State of California, is without care.
mean very simply that the system is designed on an either/or basis.

By that, I
Either they

deal with the medical problems of the individual or they deal with the survival
problems of the individual.
The best way to illustrate this, I would imagine, would be by a small example
that I've come up with, and that is an individual who goes to the clinic, gets
their medication; they come pack to the shelter.

The shelter then either takes the

medication away from that individual or allows that individual to take the
medication on the time schedule of the shelter.
-84-

098

Then the person -- let's say that person has night sweats or diarrhea or some
other things where that individual just can't sleep that evening, one of the
problems that eventually that person runs into is the next morning, they've got to
get up because the shelter rules say you have to be up at 7 o'clock and you have to
be out of the bed.

Now if the individual takes medication and that individual has side effects,
one of the things that happens is that now you have to leave the shelter and the
clinic, or wherever he may have been getting hie medication, and says, well, that's
just normal and there's nothing we can do with you.
So then the individual says, well, wait a minute.
my life more difficult.

This medication is making

And in that situation, the individual may then elect to

not take the medication.

And in not taking their medication, then that individual

then has to make a real life-and-death kind of choice.
individuals.

This isn't the fault of any

This is just the way the system is set up.

This is real life.

This

is what happens every day.
We have a very serious situation in terms of -- I'll probably be the only
peraon up here that says that we don't need any more money.

What we do need is a

better allocation of the money, and that allocation of the money -- I just heard
someone talk about the efforts of getting $7.8 million into the county or the City
of Los Angeles, the County of Los Angeles, wherever it went to.

For the homeless

population, I think that the total allocation was like $120,000 or $140,000.

At

any rate, that was less than 2 percent.
So we are totally and completely ignored.

We don't have the ability to have

the largest lobby in the country; we don't have the largest lobby in any place.
One of the things that the Senator made very, very clear just a minute ago, one of
the ways that Sacramento does business is who provides the most political pressure,
gets the most results.

Homeless people do not have that ability.

Homeless people

do not have the ability to even get to Sacramento Street, let alone to get to
Sacramento, California.
Those kinds of issues are issues that we have a real problem with.

You take

this and you couple it with just the normal problems of day-to-day existence, and
then you infect us with a disease, a very serious disease, and then somehow or
another, people ask us to compete, to compete for funds, to compete for attention,
to compete for any kinds of services.

We're not even in a position to compete for

public health services aa they currently exist today.

And this was our only source

of public health services.
And I want to make it very clear, that the population that I'm talking about
is the population that was on the streets that is affected after they are on the
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streets.

A lot of times, people will try and confuse the issue by throwing in the

sympathy factor, and that is, individuals who contracted the disease and then
become homeless.
my population.

I understand that that's a very serious problem, but that's not
Those are not the individuals that I have to deal with.

I have to

deal with the individuals who, according to our records and all of the stuff that
I

we see, about one in five of those individuals are infected.

In the tuberculosis clinic, which is located right in the middle of skid row,
25 percent of their patients are HIV-positive.

This is the kind of problem that we

have to deal with, and this is the kind of situation that we have to try and
compete.

And as it stands right now, the playing field is not very level.

Dr. Tate can tell you, I'm a very big advocate for categorical funding.
that the homeless population does need to be culled out.

And as

I think

I think that some very

serious, serious monies have to be devoted to that because when we look at it in
the long-run, the basis of homeless service providers is to get people back into
the mainstream as quickly as possible.

If we're getting people back into the

mainstream as quickly as possible and those individuals are undiagnosed, carriers
of the HIV virus, then what we are doing is getting the HIV virus back into your
community as quickly as possible.
act in some way or another.
CHAIRPERSON WATSON:

And that, we have to look at and that we have to

Thank you.

Thank you for that insight on the homeless.

I think it's

very necessary to keep in mind that we've got a lot of people out there on the
streets with needs as well as in institutions.

We appreciate your comments.

Kazue Shibata, Executive Director for Asian Pacific (Health) Care Ventures.
Okay.

Helen Fitzgerald.

MS. HELEN FITZGERALD:
Prototypes-WARN.
testimony.

Thank you.

I'm Helen Fitzgerald.

I'm with

And we'd like to thank you for inviting us to take part in this

I'm honored to be in the presence of Senator Watson.

I had the

opportunity to hear her speak at the Black Women's Conference held in Compton
several months ago, and I was really empowered by your speaking.

And I'd also like

to thank Ruth Slaughter (?), the Director of Prototypes-WARN for feeling that I can
come here and present our agency and the problems that we encounter on a daily
basis while doing straight outreach.
WARN is misspelled on the agenda.
for Women and Aids Risk Network.

WARN is an acronym itself, and it stands

Okay.

We were one of the first projects in the nation to provide AIDS prevention and
education specifically for women of color.

I wrote a piece describing many of the

women of our targeted population, and I would like to share that with you in hopes
that you can better understand the women that we work with.
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It ia unanimous that all women are at risk for HIV and AIDS.

However, the

women of our targeted population are injection drug uaera, sex workers, and
partners of injection drug users.

They are considered by society to be hard-core,

low-claas, and socially unacceptable.

Our women come from broken homes, broken

marriages, and they have children in the system or may have been of that very
system themselves.

They are mothers with and without children, teens without

Many of our women are homeless.

f~ilies.

unemployable.

Some are undereducated and moat are

In their lives, they have experienced child abuse, sexual abuse, and

sexual assault.

They have been the victima of phyaical violence as adolescents or

as adults.
Our women suffer the loss of hopes and dreams, and they have become accustomed
to broken promises.

They have been set up to believe that they cannot truat anyone

and that no one can be unconditionally interested in their welfare.

As a result,

these women have adapted behaviors that may be labeled pathological and
psychological.

But we realize that for them, these are probably the only means to

cope with life.
As an outreach worker with Prototypes-WARN, a senior outreach worker, and team
leader for the South Central area, we are very familiar with HIV and with
addiction.

And we know that for our women in our target population of HIV and

addiction is only a symptom of a much deeper, emotional, and psychological problem.
Our staff of outreach workers have been trained in HIV pre- and post-test
counseling.

We have been trained to do outreach to partners of injection drug

users as well as injection drug uaers.

And we have been trained by the Foundation

to offer emotional support for women or for people who are living with
life-threatening diseases.
The problema that we encounter on a daily basis while doing outreach ia that
it gets very frustrating to do outreach for a community or to provide services to
the women when there are no servicea to refer them to.
We have -- I want to backtrack for a minute.

We did, back in the summer, in

one of the parte in South Central -- I'm very nervous

I need to say that.

One

of the parte in South Central where we do AIDS outreach, AIDS prevention education,
we had encouraged our women and men of that population to be tested.
with another AIDS agency to have these people tested.

And we worked

We had 25 men and women to

be tested for the HIV virus, and three of those were staff members, including

myself.
were

So it was 22 people to be tested.

HIV~positive;

Out of those 22 people who tested, 12

and only one showed up for the test results.

And we feel that

that was because of the fact that it took a very long time for them to get their
reaults.

Many of the people were homeless.
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And when we asked them

and we knew
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who they were, that they go to get their teat results -- they would say that they
lost their paper so that there was no way of keeping track with them.
Another thing ia that when, if you're BIV-poaitive and you're a woman, there'•
no services for you; there are virtually none.
addicted, there are no services for you.

And if you're BIV-positive and

So basically, it gets really frustrating

in trying to do our job and trying to provide the AIDS prevention education and
trying to promote the behavior change.
woman as where she ia at the moment.

And so we find some relief in meeting a
If her problem may be that she need• food or

shelter, this is what we would try to provide for her.

We try to build a trust

because we know that our women have been set up to believe that they can't trust
the system.

So our outreach workers are, including myself, were indigenous to our

target population.
I don't know.

I'm a recovering addict, and I know what it was like for me to

go into drug treatment.

And I thank God that I had insurance, that I didn't have

to deal with the county facilities.
with the county.

My understanding, there's 36 beds available

And of those 36 beds, there are only a certain number for women;

and our agency works specifically with women.

So it gets to be very discouraging.

There's only three of ua under the contract that I've worked for, so we have
to work with the other projects within our agency to do our outreach, and we work
with a state-funded outreach worker and are funded by the Children's Hospital to do
teen outreach.
So there's not enough outreach workers because if one of them -- our outreach
worker, she does routine outreach work.

When she's at the juvenile hall doing teen

outreach there, then one of our aitea may go unvisited that day.
able to provide education to a certain area.
workers.

We may not be

So we see the need for more outreach

We also see a need for more BIV test sites.

We had an agreement -- not agreement -- but we did work with one of the
testing facilities or clinics in East L.A.; and it worked very well for us because
they would let us come in and we would bring our women in, and we had priority
testing.

But what happened was, as a result of our testing -- and they only had

one phlebotomist.

So she was not able to accommodate the clinic's need aa well as

our needs for the women in the street.
is on a Wednesday after 5 o'clock.

So they limited us to one day a week, which

And some of the areas that we do outreach in,

because we're in South central -- were in Figueroa; and were in the Avalon Heights
areas.

So some of those areas that we're in during the day that we would want to

be in after 5 o'clock, so it makes it difficult for our women to get tested.

We also would like to see a receiving center, something like out, like a
receiving center in the South Central area and in other areas that women or men who
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are HIV-positive and are waiting for a slot in the drug treatment center can come
in.

They could start getting treatment; they could start getting detoxed while

waiting for these drug treatment facilities.

Like I said, when I went into drug

treatment, I was really fortunate to have insurance.

And what happened as a

result, when I first went there, they couldn't find my insurance.

So at home,

feeling hopeless and helpless, feeling like there was no hope for me -- and what I
did was continued to use more.
hospital called for me.

But then they found my insurance record and their

And it took me from the day I went to go into the

hospital, and from the time they accepted me, it took me at least a month to get
back on my own and I had insurance.
are dependent upon the county.
I

don't know.

So I know what it's like for women and men who

our staff is multi-cultured and language sensitive.

There is a need for more Latino outreach workers.

One of our women today had to -- our staff was -- we had to go to another
facility because they needed someone to talk to, a person who's HIV-positive and
who only spoke Spanish.
but she got here late.
team.

So she was supposed to be here to support me this morning,
And like I said, there's only three of us who's on this

And I feel that we are really overworked; we're underpaid; and our job is

very dangerous.

I mean when I put on my tennis shoes and my sweatshirts and my

Levi's and become color-conscious of the neighborhood that I'm in, I'm also
sometimes afraid for my life.

I put my life on the line on a daily basis.

Thank

you.
CHAIRPERSON WATSON:
said that's an acronym.
MS. FITZGERALD:
DR.

TATE:

What does it stand for?

Women and AIDS Risk Network.
Women and AIDS.

I have brochures here about our project.

Did you speak earlier about how you're funded?

MS. FITZGERALD:
Program Office.

Prototypes-WARN -- you

Women and AIDS?

MS. FITZGERALD:
DR. TATE:

Thank you for that testimony.

We are -- the project -- I'm funded through the Drug Abuse

We also receive funds from the Los Angeles Children's Hospital.

We're state funded.

And there are projects that are funded by NIDA and NOVA, award

the one project.
DR. TATE:

Which are these funds?

MS. FITZGERALD:

I wouldn't know.

CHAIRPERSON WATSON:
MS. FITZGERALD:

Thank you so very much.

Thank you.

CHAIRPERSON WATSON:
MR. JOEL TAN:

I'm not sure.

All right.

Joel Tan, United -- Colors United.

.£..,I.u.n_ra:..&ia.li&.P~~::;i,...nwo.:....------·

CHAIRPERSON WATSON:

)

Good afternoon.

Good afternoon.
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MR. TAN:

My name is Joel Tan.

I'm the founder and co-facilitator for COlore

United Action Coalition of Los Angeles.

I'm also an HIV educator for the Filipino

Americans working on an Immigration and AIDS project that works specifically with
immigrant families and Asian Pacific Islander youth gangs.
I would like to acknowledge and thank Senator Diane Watson and the Senate
COmmittee on Health and Human Services for giving me the opportunity to speak on
behalf of the Colors collective and the issue that faces us in the community.
COlors is fairly new to the lesbian and gay bisexual community, and so I'm
going to give a little bit of a history; and it's somewhat of an activist culture
of Act Up, Queer Nation, as well as other groups, colored groups also.

COlors

United Action Coalition is a co-gender, multi-racial collective that includes
lesbians, bisexuals, transgenders, gays, heterosexuals, men who have sex with men,
women who have sex with women, men who love men, and women who love women.

We are

dedicated to empowering and educating communities that have been marginalized by
the Euro-centric-patriarchial establishment, through voter registrations, HIV/AIDS,
prevention, education, and outreach, grass-roots political lobbying, and community
educational forums.

The group was founded shortly after the AB 101 veto marches in

the lesbian, gay, bisexual, people-of-color communities, to confront the
segregation that exists between the white establshment and people of color in the
lesbian and gay community.

our membership consists of women and men, lesbian, gay,

bisexual, transgender, and heterosexual from the African American, Asian/Pacific
Islander, Native, LatinajLatino, and Caucasian communities.

Diversity is our

ideal, and we believe that we can make positive changes by learning from and
celebrating each other's diversity.
We confront and process difficult issues, such as racism, AIDS phobia,
lesbophobia, homophobia, heterophobia, and other social disorders that plague our
society and keeps us separated as people.
COlors United Action coalition is a rich stew of human resources that has
members and supporters from the AIDS Health care Foundation, Black Men's Exchange,
United Lesbians of African Heritage, Gays and Lesbian Latinos or Hidos, VIVA, Gay
Asian Pacific Support Network, as well as many other groups that are committed and
connected to their home communities.
Since there is such segregation in the lesbian and gay community, people of
color have different needs.

I believe that the community still has more work ahead

of them and education when confronting HIV disease and AIDS in the lesbian and gay,
bisexual, transgender, people-of-color communities.
CUltural-sensitivity policies must evolve into racial and ethnic competence
and accountability.

My experience has been that the sensitivity has only provided
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translated materials that was written for the Euro-centric-patriarchial experience.
Open-door policies are ineffective to people of color, since we need more than
an open door to guarantee us a safety that everyone needs to access AIDS services.
More facilities must be built in South central, Monterey Park, Lakeview Terrace,
Montebello, Rosemead, Bast L.A., and Carson, just to name a few.

These facilities

ahould be staffed by locals of that neighborhood who are dedicated to the
~provement

of their communities.

limitations.

Cultural sensitivity and open doors has its

It's now time for us as a world collective to renew our commitment to

take a step beyond just being sensitive and to being competent.

It is time to walk

through these open doors and invite people into our agency through a needs base and
effective outreach.
People of color are dying, and sensitivity will not save our lives.
competency, effectiveness, and our accountability will.

There are smaller groups

that are established in the heart of the people-of-color communities that have
little to no access to local, state, and county resources.

Much of the funding and

attention that goes into the larger, well-known establishments are not often shared
with these little-known, smaller organizations that are at the primary contacts and
representatives of people in their community.
Also, from my experience with the lesbian and gay community, I'm aware that
people know very little about the subcultures that are neglected in lesbian and gay
culture.

These are bisexuals, transgenders, MSMs, men who have sex with men, women

who have sex with women, who do not identify as lesbian, gay, or bisexual.

These

are people who may have been incarcerated, as it's been mentioned over and over.
MSMs and WSWs are a recognized population -- the Asian and Pacific Islander
communities, Latino/Latina, Native, and African American cultures, and they have
been for a long time.

These are also people of color who identify

they're also

people who identify, people of color who are identified, as MLMs, men who love
other men, and WLW, women who love other women, do not identify with the Western
Buro-centric label of lesbian or gay.
These populations thrive in the Bcho Park area where many MSMs, who have wives
and families at home, search for anonymous sex around the lake with other men.

Men

who love men and women who love women congregate in small private clans, in
restaurants, in tight communities in the San Fernando Valley and Hollywood areas.
They often don't participate in the lesbian, the white lesbian and gay community.
There's a large population of gay men in the skid row area.

There are MSMs,

men who have sex with men, and WSWs in the low-income housing projects where there
are women and men who may have adopted this sexual culture while they were
incarcerated.

Many downtown bars feature African American, Asian Pacific Islander,
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and Latino drag queens and gender benders as their star performers.

Many of the

Hollywood streets are littered with drag queens who pose on the corner as working
girls.
Who reaches out to them?
populations?

How many even know how to begin to understand these

Does HIV education reach them in a language they know and understand?

These are the questions and challenges that we face.

These smaller, hard-to-find

populations do exist, and we must reward them with the same education, access to
treatment and prevention that the mainstream community has been given.

We must

give more to people of color and women, women's communities, who are at least five
years behind in the struggle against AIDS.
In closing, I'd like to lay some challenges before this committee.

I

challenge everyone to recognize lesbian, gay, bisexual, transgender, KLK, WLW, MSM,
WSW peoples as belonging to a sexual culture that dictates the specific needs.

We

can no longer settle with the narrow confines of sexual preference or orientation.
We are a thriving, growing culture that has family systems, spirituality,
traditions, language, herstory, history, and leqends.

Investigate and be aware of

populations that have been neglected by the Euro-centric-patriarchial
establishment.
Racism and classism is alive and well in all communities, even in the lesbian
and gay community.

Challenge yourselves on how we may all be able to service the

marginalized within the marginalized within the marginalized.

Keep challenging

yourselves to access the wealth of knowledge that belong to organic intellectuals.
These are people who may not have academic standings, but these are the true
experts that live, work, and speak from the community's needs, issues, and
integrity.

Challenge education materials and program designs and see if they are

effective, accountable, and competent to the communities they are assigned to.
Challenge to advocate for hiring policies that will hire from within the community
and promote peer education.

Challenge outreach strategies and make sure that they

come from a needs-base assessment.

Let us make sure that these strategies will

enhance and become part of a community's ecology rather than disturbing it with
alien ideas and outsiders.
We all have got a lot of work ahead of us, and I'm looking forward to the day
that we'll have to look for other jobs, not because our AIDS contract was not
refunded.

And, you know, the one thing that I'd like to say is the other syndrome

that I keep hearing here -- and coming from an Asian Pacific Islander perspective
as a man who loves other men, I'm still a little discouraged about how Natives and
Asian/Pacific Islanders are put in the "other" category because we haven't shown
enough dead bodies.

There are dead bodies.
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They're decomposing in homes where
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there's a great deal of fear in the Asian/Pacific Islander cultures -- or they're
being sent home to the Philippines, to Thailand, where they are made to pray 24
hours a day to get rid of this disease.

So I hope we could break out to this other

syndrome because in lesbian and gay cultures, these transgenders, MSMs, are also
broken into that.
There's a great deal of profit, monetary profit, to be made with
marginalizing, but that is unethical and immoral.
Cin Filipino

,)

CHAIRPERSON WATSON:

Thank you very much.

You certainly have placed in front of us a great

challenge because you described structures and substructures and sub-substructures
that most people are not even aware of in terms of a breakdown.
become educated.

And we have to

I think the need is so great, we treat those with AIDS.

But when

you start looking at the sub-sub-substructures, we don't even know how to move into
those categories.
I think this very new group that has come up around the veto of AB 101 could
be very instructive to society because you just broke it down.
pretty sophisticated.

I thought I was

You know, you talk about homosexuality and lesbianism.

Then

you broke out a category called men who love men and women who love women who don't
consider themselves in that category.

And I guess that's one of the reasons why

the information we have doesn't reach, because when we say this is targeted towards
the gay male or the lesbian female, we miss some who don't consider themselves in
that category.
MR. TAN:

These are -- men who love men and women who love women -- these are

categories that are alive and well in a lot of tribal cultures, in the Philipines.
I hear also that's in African American culture.

And when you come up to somebody

and say are you gay or lesbian, what they see on TV, because TV is very racist,
they see white lesbians and gays and they don't associate that with that because
they can't break away from their community as easily and they have another system
that they work under.
CHAIRPERSON WATSON:

Now I heard you mention "Queer Nation".

Is that not a

derogatory reference?
MR. TAN:

Oh, that whole thing with Queer Nation is -- I'm not going to speak

about Queer national.
CHAIRPERSON WATSON:

I think that, I don't know why Queer Nation, unless it's

kind of satirical thing they're doing, because Queer Nation conotates that it
deviates from what I hear you saying, brings people together and saying this is,
for some people, a very normal way of life.

I think "queer" does not connotate

that particular •••
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MR. TAN:

Well, I mean, as far as I hear from other Queer nationals -- Colors

United is its own autonomous body.

Queers, it's also all-encompassing, they feel.

By not putting the negative power back into the word, they feel like they would,
that's their opinion.

And like I said, right now we use people of color, and I

hear a lot of sisters and brothers saying, "They're colored", with pride.
CHAIRPERSON WATSON:

Well, I don't think the definition as we all understand,

"queer", like "weird", does what you want it to do.
and my standpoint.

I don't think -- these other breakdowns make sense to me.

that one does not, and I just throw that out.
MR. TAN:

That's coming from my opinion
But

You don't even have to respond.

Okay.

CHAIRPERSON WATSON:
DR. TATE:

Thank you very much.

We appreciate your testimony.

Joel, can we get a copy of your testimony, either now; or could you

send me a copy.
MR. TAN:

I'll send you a copy.

DR. TATE:

Okay.

CHAIRPERSON WATSON:

Corinne Tanon, Health Educator, with the American Indian

Free Clinic, I understand has been here since about 9:15 this morning.
MS. CORINNE TANON:
CHAIRPERSON WATSON:

Right.
We want to commend you for your tenacity and your ability

to sustain all this information thrown at you and still be here willing to testify.
So we'll call

on~you

MS. TANON:

right now.

Okay.

CHAIRPERSON WATSON:

Great.
And give you your opportunity to do what others have been

doing all day.
MS. TANON:

First of all, I want to thank you for inviting me to come and

share this information which is so important to all of us here.

I'm kind of

nervous, so I want to -- first of all, I want to talk about the demographics,
community demographics.

And then I'm going to go into health issues and then gaps

in health care and AIDS and how that's affecting us as Indian people.
According to the 1980 Census -- I'm referring to the 1980 Census because the
1990 Census, we feel, are not a good count of our population.
1980 Census, California has the largest Indian population.
225 American Indians from 200 different tribal affiliations.

According to the

There are approximately
In L.A. County alone,

there are 90,000 urban American Indians and is the largest urban community in the
nation.

out of the 90,000 American Indians in L.A., 54,000 are below the poverty

level, and there is approximately 45 percent unemployment.
The Indian population is a young population; and the nationwide average age is
20.4.

In L.A. County, the average age is 17.3 years of age; 67 percent of the
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Indian population are 25 years or younger.
Indians are three times more likely to die young, between the ages of 24 and
40, the Nunn

Indians.

Average life expectancy is 44 years of age.

This is

lower than the migrant farm worker.
According to the L.A. Unified School District, the Indian High School dropout
rate is 23 percent.

This figure increases when you include those that never

attended, enrolled into high school.

The average age of Indians living in Los

Angeles is 17.31 67 percent of our urban Indian adolescents are drunk -- or use
drugs moderately to heavy.
Health issues, Indian suicide rate is seven times that of the national rate.
Indians have the highest rates of heart disease and diabetes.

Twenty to 25 percent

of all American Indian children suffer from mental illness, just as alcoholism
rates is 41.3 deaths per 100,000 versus 17.4 deaths for African Americans.

In the

white population, it is 6.4 deaths per 100,000.
Gaps in health care:

Health care is expensive to nearly all segments of

society but especially to many Indian people.

They may not be able to afford

health care due to the lack of insurance or other needs that are more pressing.
They will go to a health care facility only when a need is acute.
will not hear about the message of AIDS prevention.

Therefore, they

And that's why it is so

pressing to have outreach at those places where they congregate -- sport events,
pow wows, community functions.

But the high rates of sexually transmitted diseases

and alcohol and IV drug use among American Indians, hopefully the State of
California, may understand the importance of funding as a preventative measure.
The source of continued funding is always contingent upon the outcome of
census demographics and socioeconomic and political strategies.

Because we are a

small population of 90,000 American Indiana in Loa Angeles County, we are sometimes
mistaken for Hispanics, Filipino, white, African Americana.

The community is well

dispersed, and this may contribute to the political under-representation and social
misrepresentation in the communities.
of society.

We are poorly represented in every segment

I can only speak for myself.

voices aren't being heard.

We have no political clout, and our

The theme is reflected in the decision-making of our

city fathers and government.
According to the HIV/AIDS and American Indiana' Handbook for Tribal Leaders,
stated the following:

Since September 1991, the center for Disease Control has

approximated 305 American Indiana diagnosed with AIDS.

Dr. Emmett Chase, AIDS

coordinator for Indian Health Service, estimates that there are 12 to 13 new Indian
AIDS cases identified each month.

The fact is the annual rate of increase of new

AIDS diagnosis is greater for Indian people than for any other racial group.
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number of Indians diagnosed with AIDS grew by 91 percent from (19)89 to (19)90.
While other racial groups have a higher number of individuals with AIDS, the number
of Indians with AIDS is rising at a rate proportionately faster than for other
groups.
Percentage increase in AIDS cases from '89 to '90a

whites, 8 percent; African

Americans, 13 percent; Hispanics, 5 percent; Asian/Pacific Islanders, 17 percent;
and Indian/Alaska Natives, 91 percent.
The time of prevention is now.

Indian people can benefit from the experiences

of other populations which have dealt with the AIDS virus for the past eight years.
we must act now before the virus wipes us out like the smallpox epidemic of the
early 1800s.
According to the center for Disease Control, found that Indians and Alaska
Natives have experienced a higher rate of gonorrhea and syphilis.
indicates that we are at risk.

This study

The transmission categories for these cases are 54

percent, were homosexual/bisexual transmission, and the rest by blood product
transmission.

This contrasts with white transmission which is 76 percent

homosexual/bisexual; 15 percent shared needle; and 2 percent heterosexual.
The percentage of Alaska Native and American Indian women with AIDS is 13
percent of the total number of American Indian and Alaska Native cases, in contrast
to 4 percent of the white women.

According to CDC, has been working with Indian

Health Service to evaluate the HIV in the American Indian population.

It is

estimated that for every 1 million American Indians and Alaska Natives,
approximately 1,000 individuals are currently HIV-infected.

Then it could be

estimated that for over 85 percent of these individuals do not know that they are
HIV infected.
The time of prevention is now.

We must act now before the virus wipes us out

like the smallpox epidemic of the early 1800s.
I have quote here from Chief Funnycoups (?) -- he's Crow, or was Crow:
the white man's education, you are his equal.

"With

Without it, you are his victim.

Please stop us from being the victims of the disease of AIDS by funding our
communities."
T~ank

you.

CHAIRPERSON WATSON:

Thank you very much.

Something that we picked up when we

had other hearings and we listened to representatives of the various ethnic groups,
is that among Indians -- and correct me if I'm not correct -- is that there is a
higher propensity towards addiction?
MS. TANON:

Right.

CHAIRPERSON WATSON:

That's true.

That's correct.

And having that higher propensity, and I don't know if
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it's genetic or what it is, there necessarily would come along with it an increase
in the risk of AIDS?
MS. TANON:

Bxactly, because we have a high rate of alcoholism.

And with

that, you have the high-risk behaviors involved with that which leads to sexually
transmitted diseases.

So at this point right now, we have a high rate of STDa,

sexually transmitted diseases -- gonorrhea, syphilis.

So that means, yea, we have

a high risk of contracting AIDS right now.
CHAIRPERSON WATSON:

I think if we look at addiction itself, we might be able

to learn something about the increase among American Indians.

It's startling to

see that you've gone up 91 percent in a two- to three-year period.

And I guess

that's because you have fewer cases.
MS. TANON:

Right.

CHAIRPERSON WATSON:
MS. TANON:

And now more cases are being detected.

Exactly.

CHAIRPERSON WATSON:

That's true.
But I think, and one of the things that keeps coming back

to your theme, is that we don't know that much about addictive behavior.
I, you know, if I can just look at it historically because the purity of the
system of the Native Americans; therefore, once the toxins gets into the body of
the addictive substance, it's a quick reaction.

And that's off

th~

top of my head.

But we need to look at it, and I don't think we know enough about addictive
patterns among the various ethnic groups and why do some become addicted much
quicker than others and why is the high-risk behavior then increased with that
addiction.

so I think these are some of the things that we need to learn more

about as we look at the various cultures and how we deal with them, particularly
with this disease.
MS. TANON:

Exactly.

CHAIRPERSON WATSON:

Thank you so very much.

We appreciate your long wait and

your testimony.
I'd like to now go back to Cleant Stain, the Director of South Los Angeles
AIDS Program at the Watts Health Foundation.
MS. CLEANT STAIN:
CHAIRPERSON WATSON:
MS. STAIN:

Okay.

Welcome.

Thank you.
We did call on you earlier.
I'd like to thank you for the opportunity for being present

here today, and I'd also like to concur with my other colleagues and echo some of
the same

~oncerns,

and that is, that HIV/AIDS does not occur in a vacuum.

There's

still many other health and social problems that exist within our community, which
is South Central.
Oftentimes while my staff and myself are involved with people infected with
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HIV or AIDS, we find ourselves overwhelmed with the number of problema that exist
within their situation.

And oftentimes, prior to working with AIDS-related issues,

we must first assist with other social problems.
when we were going into an individual's home.

For example, there was one case

We thought we were going to assist

the pereon with AIDS with housing issues, which ie a social concern.

When my etaff

and I arrived to the individual's home, we walked into a 3-bedroom home with 18
people living in that home, massive overcrowdedneaa.

There was battery going on.

The lady we were talking to had, you know, bruises under her face.

And eo when you

go into a home or many times when you're working with people with HIV, you want to
know will the real issue please stand up or will the real client please stand up
and everyone stands up.

So before we can even begin to deal with many AIDS-related

issues, we have to deal with other issue& first.
As you know, south central Los Angeles is geographically dispersed and
ethnically diverse, and many of the people living in that community are
economically depressed.

Within this community, there's only one anonymous test

site, and that's at the Minority AIDS Project; and they're open two days a week.
So anonymous testing is a big concern in our community.

There's only one drug

reimbursement program for people to access clinical trial drugs within the
community.
There's also a lack of coordination between the federal, state, and county
government.

For example, we've just received funding from the Ryan White Title

III-B which came directly from the federal government.

And one of the goals or

objections of this program is to provide primary care to people infected with HIV
and also to increase the number of people who get tested within the Watts Health
Foundation system so we can identify what our aero-prevalence rate is.
When we -- and prior to doing any testing, we have to first do pre- and
post-test counseling.

So as I was on the telephone trying to access this service

through the State Office of AIDS and with our local AIDS Program Office, we were
unable to get anyone to come out and actually do training for our staff so that we
could follow the guidelines of our contract, which is, you know, testing.

And

ethically, there is no way that we should be drawing blood for HIV without doing
the pre- and post-test.
DR. TATE:

Why weren't you able to get someone from the Office of AIDS to come

MS. STAIN:

We were told that their priority, the priority for training, was

out?
for people who, for contractors who were state funded under the early-intervention
program.
DR. TATE:

And yours came straight from CDC?
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MS. STAIN:

No, it came from the federal government.

funds, Emergency Act funding.

So we're all Ryan White

But because we got ours diverted from another

direction and we were not able to access some of the same services, and that was
About a month-and-a-half ago, so what we had to do is look within the community;
and we were very fortunate that Martin Luther King Hospital had people who were
trained and certified for pre- and post-test counseling.

And they came out and

gave, took time away from their caseload and from what their regular job was, to
come and train staff so that we could go out and perform our contract.

That's a

big problem.
The drug reimbursement program is another problem.

As we start identifying

more cases who are HIV-positive within our system and within the community, people
who are coming in, not only from within our system but from outside of our system
who are coming in for services, we're finding that, you know, drug reimbursement is
going to be a problem to have the clinical drugs on site for our program.

When the

telephone calls were made to the county, and hopefully that will be worked out that
we will be able to disperse the medication.

But what ends up happening with the

Drug Reimbursement Program as it stands now, is you can have the drugs on hand; but
then the eligibility paperwork is very time consuming, so there's no funding to pay
for a staff person to actually do the eligibility screening, which is very
~portant

to see who actually qualifies for the drugs.

I guess within our system it may not be too terribly bad of a problem.

But if

we have people who come from outside of our system who present a voucher, then we
can be overloaded, because when you look at the geography of South Central, we are
at the southern end of South Central.

And if we are distributing drugs, and the

next place that's distributing drugs is at Hubert Humphrey, which is like maybe ten
miles away, so that can present a problem.
CUrrently, at Watts Health Foundation, we have six funded AIDS programs.
We've just been funded with three new programs that we're very excited about.
I'd like to just list the programs briefly.

And

We're funded by the Los Angeles county

AIDS Program Office to •••
CHAIRPERSON WATSON:
MS. STAIN:

Okay.

CHAIRPERSON WATSON:
MS. STAIN:

Can you kind of bypass that.

Okay.

And just hand us that in print.
Well, basically although the programs that we have funded

meets some of the HIV needs, the funding is very

l~ited;

and we're unable to hire

enough staff to actually make an impact within the community.

For example, with

the education grant, we're only funded for three staff people.

When you look at

not only Watts Health Foundation, but you look at South central, the number of
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agencies who are actually funded to do education, there are very few.

So we've got

maybe four or five programs in South central that have two to three staff people,
you know, to do the education; and the area is very large, so that's another
problem.

So we would like to see within the funding mechanism that when funds come

down for agencies, not only for our agency, that enough funding is allocated to the
agencies to actually hire staff people to do the work.
CHAIRPERSON WATSON:

That's about it.

We appreciate your comments also.

I've heard you testify

before, and that's been several years and the need is even larger now than before.
What would you say the percentage of increase in the area where you work has
been, say, in the last five years, the increase in HIV-positive?
MS. STAIN:

Well, as you know, with HIV-poaitive, many of the clients are not

coming in for testing.
actual AIDS cases.

So, you know, I can only apeak to what we know which is the

I think with the education that's going on right now, I know

for us right now, we've just started confidential testing.
backed up two weeks, so we need more staff people.

And we're already

I was reviewing budgets this

morning prior to coming here to see how we can, you know, what can we do with the
money to bring more staff people in so we can actually meet the need of the people.
We're starting to see families who are coming in.

We're seeing young women, young

pregnant women, who are coming in with risk factors of having sex with men who are
incarcerated.
So, you know, from what I'm seeing right now, the cases are increasing; but I
don't see the whole picture for South Central.

And we don't -- the demoqraphic

profile or the profile information on people who are actually HIV-positive is not
really showing up.

I think that outreach -- we need to have outreach, and the

outreach that we need to have is to educate about testing.

You know, people have

information about AIDS, what is AIDS, and how to contract it.
internalizing their own risk factors.

People are not

So we need to have some targeted outreach or

targeted education with specific risk-assessment questionnaires, you know, toward
specific populations like for women.

If you ask a woman to look at her risk

factors and, say, if you had multiple sex partners, well, for that woman, you're
asking her if she's a slut.
sex partners.

So she may say in her mind, no, I don't have multiple

But if you ask a woman have you, have you aver exchanged sex for

money or have you exchanged sex for drugs or if you, you know, just really
specifically asking about sexual behaviors that they may have been involved in, a
ride home.

I mean, you now, they may not be honest in answering the questions when

you're asking them, but it's something that will provoke a thought for them that
may motivate them to get tested.
I think what we need to do is increase the number of people who get tested, to
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identify who they are, because with the early intervention treatment that's
available, there's no reason for anyone to, in the old days, which was four years
ago, to •••
CHAIRPERSON WATSON:

When you say "identify who they are", you mean in the

population identify who is a carrier.
MS. STAIN:

Right.

Identify who the carriers are.

Not for me to identify but

for them to know who they are, for them to know for their own sake so that they can
be referred or go into some early intervention programs, because when I spoke four

years ago, what we were seeing was people falling into the emergency room with
chest pain thinking they had a bad cold, only to find out that they had
pneumocystis pneumonia which gave them an AIDS diagnosis.

Do you understand what

I'm saying?
CHAIRPERSON WATSON:

Yeah.

Do you think we ought to require blood testing

before one gets a marriage license?
MS. STAIN:

I don't know.

partner to be tested.

I think if I were getting married, I would want my

But that's a personal thing.

I can't speak for the

general •••
CHAIRPERSON WATSON:
MS. STAIN:

I think so.

some of the transmission.
CHAIRPERSON WATSON:
MS. STAIN:

I think that if it was, that maybe one way to stop

It's something to consider.
All right.

Thank you very much.

Okay.

CHAIRPERSON WATSON:
Paula Starr.
Okay.

You think that's an idea we ought to pursue?

We appreciate you coming and testifying for us.

Is Paula here?

Let me go back over.

Maisonnet, Doctor.

Kazue Shibata.

Phil Wilson, I don't think is here.

Germaine

And Paula Starr was the last one we had.

Is there anyone with new information that feels that he or she needs to come
to the mike?

And if you can give us some new information, I think we've heard

almost everything.
MR. CLEO MANAGO:

I'll attempt -- I mean what happens usually at these type of

testimonies, people who are invited are the ones that you usually see.

The ones

that you usually see are there for sometimes for political reasons or various
reasons.

What happens a lot is that -- I think it's been reiterated here that

language and geography has a lot to do with the barriers.
The reason that AIDS has increased in the Black community is because of
barriers.

And I want to introduce who I am so you can know that I'm not just

somebody who sells toys, but I work in this field.
My name is Cleo Manago, and I'm the founder of the Black Men's Exchange.
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is a national organization that primarily provides support servicea, empowerment
services, and general education about health with AIDS emphasis to African American
men.

Usually these African American men are the ones who are referred to aa hard

to reach -- men who love men, men who love men and women, men who don't identify
with the mainstream populations in the so-called gay and lesbian community.
I think it's important to understand that, when it comes to the African
American community, the majority of the people who are so-called homosexual are not
in those places that are called lesbian and gay.
places.

They don't identify with those

And because of the lack of support of services for so-called gay men or

men who love men in the African American community, some choose to go to the white
lesbian and gay community, be empowered, for their sexuality and who they are.
Often some of them just totally separate from the community because they feel a
sense of ownership and acceptance there, and they are the ones who you see usually.
At these hearings, you don't hear from people who are in the community all the time
and often.
BMX was developed in 1989.
Wilbert Jordan.

I've done work with him, with the Watts Health Foundation, with

Dr. Maisonnet, and Cynthia Davis.
1985.

My work history has been in collaboration with Dr.
I've been working with these people since early

The primary location for the Black Men's Exchange is in Oakland, California.

That's where our headquarters are located.

Oakland has a major epidemic going on

there that's been hardly addressed at all.
One of the problems has been homophobia because San Francisco is right across
the bridge, and the city government in Oakland doesn't want to identify itself with
that homosexual reputation that San Francisco has; so it doesn't deal with the
issues that talk about AIDS at all because we cannot identify with that kind of
population.

You understand what I'm saying?

Is that clear?

So there's a lot of

political things going on.
In South Central Los Angeles, BMX is ran through Faith United Methodist Church
which is in South Central Los Angeles.

And in San Francisco, it's ran through the

Bayview Hunter Point Foundation. In Sacramento, it's ran through the Project
Survival Foundation which is part of Women's Civic Improvement Center.

In Oakland,

it's ran through an Institute, which is the African American AIDS Support Services
Institute in Oakland, California.
per year statewide.

The Black Men's Exchange serves up to 2,000 men

And again, there's a national addendum, so an organization in

Denver, Minneapolis, and in Atlanta.
We have found it difficult to acquire funds due to racism, due to politics,
and due to hidden agendas.

Again, a lot of people who do this work who are men who

love men, for example, tend to identify with the mainstream community, trying to
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get their foot in the door to get funds so they call themselves lesbians and gay.
And some of these programs are, such as the.Minority AIDS project, and AIDS Project

Loa Angeles.
I think it's important to understand that, and I wish the guy from the AIDS
Project Los Angeles was stil\ here.
services.

AIDS Project Los Angeles provides fine

They provide very good services.

But Black folks are not going to go to

APLA and get services, until they're on their last leg and they're so desperate to
go anyplace.

It's kind of like what we do when we don't take care of our teeth and

we wait till it becomes a toothache, and then we don't care if the doctor's a
Martian.

We just want the tooth out of our head.

in South Central are dealing with AIDS.

Well, that's how a lot of people

And one thing that keeps being said, you

see, if we don't look at the barriers, we will not resolve this.

The reason we

have not resolved this problem is because we keep saying the same thing over and
over and over again, and no innovation is implemented.
There's been one thing that keeps being said that disturbs me because it's not
true, from my experience.

A lot of people keep saying that a lot of people in the

Black community think AIDS is a white gay disease.

That's not true.

A lot of

Black people in the community know that AIDS is not a white gay disease.

The

problem with internalizing these messages is the fact that people.in our community
are distracted.

Like the doctor from Drew said, there's other issues going on.

There's other issues such as guilt around being a good Christian, guilt around not
being good enough, not making enough money, guilt around not being a good enough
wife, not being a good enough man, especially if you're a bisexual or a man who
loves men who feels like you failed the Black male litmus test of being man enough.
All these issues have a lot to do with why men do not come forward and why people
in our community do not come forward.
One thing that might sound overwhelming -- I know you mentioned being cynical,
potentially cynical, earlier, Senator Watson, is that -- oh, gosh, so much going on
with me; it's hard to concentrate -- is that people of color are set up for
distractions and failure from a very young age by not having their culture and
anything that validates them in the curriculum of their education.
In collaboration with the distraction such as gang violence, such as
institutional racism, all these things together set us up for being distracted from
self preservation.

So the issue from my point of view, which is going on a

ten-year point of view, is not that the Black community thinks that it's a white
gay issue.

That's not true.

It's just that we need excuses not to take care of

ourselves because we're so distracted.

A lot of women in our community are being

served through AIDS programs that are part of WICK clinics, but they go home to men
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who are not educated.

so they come home with all this knowledge, and the man is

offended by being challenged on anything because he has not been educated and he's
distracted.
There was a comment made earlier that a lot of the men who go to prison who
come out having homosexual behaviors, don't identify with the community, the
so-called gay community, please don't think that everybody who doesn't identify as
gay, who are men who have sex with men, are people who have been incarcerated.
Some people just don't like the terminology.
very inclusive

excuse me -- exclusive.

The white gay community tends to be

And just as racist is the mainstream

community, and so there's not a real attraction to that community, no matter what
it offers.

I mean if there's a million dollars available to Black people at APLA,

many of them won't get that money because they don't want to go to APLA.

Though

service providership is not the issue, they provide a high quality of service.

But

a lot of Black people would not wind up there, not unless they're so desperate that
they're almost dying anyway.

And there's minimal things that can be done to keep

them healthy.
I think it's important to understand that a lot of the people who do not come
to you in our communities, obviously because you don't see them, they're not being
well funded.

The Minority AIDS Project is way on the other

si~e

of town.

And

also, I don't want to say anything bad about them because they're doing some
excellent work, but they're geographically inaccessible to a large segment of the
population in the Black community.
The United Fellowship Church is right on 109th and Western.
located.

It's centrally

But because of politics, hidden agendas, and personalities, it's very

difficult for this program to get the monies that it needs.

And also somebody made

reference to language that's needed to properly create an RFP or a proposal or a
grant.

Some of that language is very stymie; it stymies people; it's very limited.

It's hard to express ourselves fully with the language that the RFPs require
because they don't -- they're not appropriate in our community.

So again, if a dot

is not, you know, dotted, and the "t" is not tied, or whatever the terminology is,
many times those RFPa are put aside.

And many times agencies would have a larger

name, such as APLA and others, will get that money just because they have a big
name.

But listen to me, the fact they have a big name does not mean they're

providing adequate services.

Most of these services, including APLA and others

which will not be mentioned, are providing a Band-Aid approach to AIDS that does
not cause any prevention at all because by the time they get there, as you know,
they're already dying.

These are not preventive efforts.

These are multi-million

dollar, crisis-dying institutes for Black people and other people to get their
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hands held until they die, until they die.
There needs to be innovative and culturally competent programs funded, that
are already working in South Central, such as the Black Ken's Exchange, to be
advocated for and supported.

Again, the over thousand plus men that we deal with

in Southern California alone, the work that we do is hardly ever recognized because
we're not part of the lesbian and gay clique.

We're not part of the high-profile

clique because frankly those cliques have turned off a lot of people and don't
invite a lot of people who are in the Black community.
So if we really want to do something about the AIDS issue, we have to stop
being impressed by glamour and glitz of the million-dollar agencies and find out
who's doing things in South Central.

And I have some recommendations, believe it

or not, or after all this talking.
CHAIRPERSON WATSON:
MR. MANAGO:

Yeah.

Can you get to the •••

Yes, I will get •••

CHAIRPERSON WATSON:

I'm going to give you just a few more minutes because

we're over our time limit.
MR. MANAGO:

Okay.

I'm sorry.

Okay.

I recommend that there be some advocacy

and support provided to programs that are in South Central Los Angeles and that are
not necesarily connected to the high-profile agencies but who are individually and
independently and innovatively providing some great services in South Central Los
Angeles.

I think we should include persons who are from the grass-roots and who

have ongoing contact with hard-to-reach populations in research and data collection
projects.
It was mentioned earlier -- you asked about IV drug use in the Black community
and were there any documentation that assess what is going on.

Most of the people

doing the research do not have a cultural understanding of the community, and they
can't even get adequate information because they're not from the community.

And

people tell -- either they don't see the people at all, or people don't trust them
enough to tell the truth.

So there's a lot of IV drug users out here who are not

even part of the statistics, as well as people with AIDS who die and get other
diagnosis because the family doesn't want anybody to know about it, and they do not
trust these agencies who have all this glamour.
Also, I think it's important to include persons identified by the community as
representing the community to be involved in the consortiums and city-wide and
county task force and involved in the language that's developed for RFPs and
grants.

People from those communities should be in that system to tell you this

language is not appropriate; this language is a barrier; it's going to get in the
way.
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Again, innovative programs that are holistic and effective, like the doctor
from Drew said, you cannot go to someone and say AIDS 101 and give them an AIDS 101
education and expect them to take care of themselves.
the psycho-social issues; they need to have support.
tested before marriage.

They need to be dealing with
You asked should people be

No one should be tested if there's not any appropriate

counseling or a psycho-social support system there to help them deal with whatever
their diagnosis might be after the test results.
I think, and this is essential.
recommendation.

This is my most favorite and important

Existing services, existing service to a provider should document

and prove their ability to attract and serve, underserved, and unserved populations
by some kind of tool that must be developed to prove that.

And the goal of this

recommendation is to not fund or to provide technical assistance to existing
organizations who have been incompetent as it relates to minimizing this epidemic
in our community, because as you said many times, it has not been minimized; it's
getting worse.

And it's because of these barriers that I'm addressing.

I probably

could go on with others, but we don't have time.
I also think that holistic, culturally sensitive health care and AIDS 101
program should be institutionalized in public and civil servant populations, people
who serve people who are in public service.

I'm a former deputy sheriff.

And

inside the prison, you were talking about asking the people who work in prisons and
in jails to assess homosexuality in the prisons.
saying this.

Now I may get in trouble for

But what's difficult about that is that there's a morale problem

going on with law enforcement.

You've heard about Rodney King and the dog bites,

and I can go on and on and on.

Everybody who's in the positions of "power" in

legislation are not necessarily culturally sensitive or concerned about the life
and death or comfort of people of color.

That's why they let dogs bite them and

beat them up with canes and stuff.
Inside of the jails, there are people who work for law enforcement who are
bringing in IV drug needles who work, who have on a badge.

There are people who

make sexuality in the prison a joke -- well, let's see who's going to get who
tonight.

It's like they bet, you know.

It's a game, because if you don't respect

faggots and homosexual and faggot behavior -- you know how we treat -- you now how
there's racial jokes and there's homophobic jokes and there's jokes made on how
many Black people get killed.

You heard about how the police use the KKK over the

radio station to talk about what they're going to do somebody Black.
that.

You've heard

That's been made publicly -- that's been public knowledge based on reports

from the news.
CHAIRPERSON WATSON:

You said they don't respect faggots.
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Do you want to
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refer to that group as faggots?
MR. MANAGO:

Not at alL

I'm putting that in -- I'm, paraphrasing.

I mean

when you're being disrespectful, you don't go, oh, I don't have any respect for
homosexuals.

You don't have no interest of being respectful.

disrespectful.

That's why I used the language that's disrespectful, just like when

the KKK it's going to kill niggers.
Americans.

The whole thing is

They don't say I'm going to kill African

It's a disrespectful process, so the language is disrespectful.

I'm

just trying to give it to you the way it is so you can see what I'm talking about
so we can get rid of these barriers and save lives because people are dying from a
disease that's preventable.
cliques.

And there's all of these barriers and all these

Some of these agencies are serving cliques, friends.

A lot of the AIDS

work for the past ten years, even among so-called people-of-color agencies are
serving a clique of people, not the whole community.
CHAIRPERSON WATSON:
MR. MANAGO:

Right.

And that has to be addressed or else we're not going to publicly

serve everyone.
CHAIRPERSON WATSON:

Can you finish your recommendations in just another

second.
MR. MANAGO:

Okay.

I really infer with the young man or the man who talked

about a mobile unit in the community.

What we did when I went down to Atlanta as a

consultant was came with an ice-cream truck with the music and everything where
people would run out to it, and they would get AIDS information and AIDS education.
And, of course, kids were very young.

We asked, was your mother home, could she

come out here, before we gave them information, because we need parental consent.
But, you know, using the social behavior of a community as an educational apparatus
works.

Try to bring white gay devises and approaches to our work in our community

does not work.

And that's another reason why the epidemic has increased.

We've

got to use organic skill and social behavior that's already organic to our
community as part of the educational format.

And that has not been done.

Again, all these labels and stuff are a barrier -- gay and lesbian and all
those other kind of stuff.
CHAIRPERSON WATSON:

I believe I'm finished.
Now we just heard from a speaker who broke it down into

sub-sub-sub-sub-sections, and it gets a little confusing because who on the outside
really knows that this is a subset that hasn't been served when you say people who
are at high risk?
KR. MANAGO:

Well, see, what people tend to do is follow trends.

make this real quick because I know I don't have a lot of time.

But the white gay

community are the ones who are empowered to do a lot of this work.
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And I'll

Then people who
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identify with that community as gays and the people-of-color community jump on that
bandwagon to do work.

So we became this vacuum of lesbians and gays, white, people

of color, who are doing all this work and •erving each other.

And the language now

waa promoted politically and through the media was lesbian and gay.
required in the grant.

So that waa

When people from south central who referred to themaelves

by the grant and talked about the fact that our language is not appropriate because
the people who provide the funds are not familiar with men who love men, that
language, women who love women, that language, the grant is put aside.

The Black

Men's Exchange has been using that language for several years; it's not new.
just that we have not been invited.

It's

Again, the Black Men's Exchange was not on the

list.
CHAIRPERSON WATSON:

Well, what you could do to help us is clarify for us how

we can identify all these different groups who don't get served because they don't
fit the definitions.

I mean every time we hold one of these hearings, we get an

education.
MR. MANAGO:

Right.

CHAIRPERSON WATSON:

Because unless you are in the streets every day working

with these programs, you know, the vernacular changes.

The descriptions change.

It's trendy.
MR. MANAGO:

Well, you know what?

Let me tell you something.

The vernacular

has not changed, just like someone keeps saying in these meetings that the epidemic
has a second wave.

That's a misnomer.

The epidemic was always in the Black

community, always, from the very beginning.
CHAIRPERSON WATSON:

Well, what I'm trying to get you to focus on is how can

we identify who needs to be served.
MR. MANAGO:

Okay.

CHAIRPERSON WATSON:
MR. MANAGO:

The way you can identify •••
And I don't want you to tell me now.

Okay.

CHAIRPERSON WATSON:

I want you to put it in writing because we really have to

bring the hearing to a conclusion.

We're way over time for the use of thia room.

So if you could send it to us, if you just want to send us a memo or a letter
describing what the problem is in terms of the way the request for applications and
so on goes out, it would help us if we want to broaden the impact -MR. MANAGO:

Right.

CHAIRPERSON WATSON:

of the funding.

And you've got to be sure we know how

you're going to ask for it.
MR. MANAGO:

Okay.

CHAIRPERSON WATSON:

Just one last thing.
And conclude because •••
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MR. MANAGO:

I sure will.

People tend to use language as a way to get funded

too, once they learn the the political terminology.
CHAIRPERSON WATSON:
MR. MANAGO:

You're going to help us with that by --

Okay.

CHAIRPERSON WATSON:

-- broadening out our understanding.

MR. MANAGO:

And that's why it's important to target and understand

Right.

and locate •••
CHAIRPERSON WATSON:

Well, we can only target if we know what's being used

today.
MR. MANAGO:

Right.

CHAIRPERSON WATSON:

And I'll help all I can with that.

Thank you so much.

Thank you very much, and I want to thank all of you.

appreciate your attendance; we appreciate you staying with us.

We

And as we -- our

attempt was to learn more about what's happening in the streets as it relates to
AIDS.

And we held a hearing years back.

And every time we hold these hearings, we

get updated.
our intention is to go back and put together a package of legislative measures
that will address some of the issues that were raised here today.

I thank the

people from the department and the Office of AIDS for staying with us.
learned a lot.

I think you

And in learning, we're able then better to address the needs out

there in the streets.
I thank all of you for coming, and this concludes our hearing.

---ooo---

-109-

12:1

B A C K G R 0 U ND
I N F 0 R MA T I 0 N

124

FACT

SHEET

ETHNIC MINORITIES AND AIDS

*

A HIGHER PROPORTION OF AFRICAN-AMERICAN AND HISPANIC AIDS
PATIENTS ARE WOMEN, CHILDREN, AND HETEROSEXUAL MEN, DUE TO
DRUG-RELATED TRANSMISSION.

*

AFRICAN-AMERICANS ARE THREE TIMES MORE LIKELY TO HAVE
CONTRACTED AIDS THAN WHITES.

*

NEARLY

90% OF AMERICAN BABIES BORN WITH AIDS ARE AFRICAN-

AMERICAN OR HISPANIC.

* 57%

OF PEDIATRIC CASES WITH AIDS ARE AFRICAN-AMERICAN OR

HISPANIC.

*

AFRICAN-AMERICANS REPRESENT

24% OF THOSE WHO HAVE BEEN

DIAGNOSED WITH AIDS, AND HISPANICS REPRESENT

14%, WHICH IS

GREATER THAN THEIR OVERALL PROPORTION IN THE COMMUNITY

(12% AND

6% RESPECTIVELY).

*

INTRAVENOUS DRUG USE IS THE SOLE RISK FACTOR FOR
AFRICAN-AMERICANS AND
ACCOUNT FOR

* 60%

34% OF

35% OF HISPANICS WITH AIDS, BUT ONLY

5% OF WHITES WITH AIDS.

OF ALL WOMEN WITH AIDS ARE AFRICAN-AMERICANS.
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THE CHANGING COMPOSITION OF AIDS CASES
1991

1990

RACE
WHITE
BLACK
HISPANIC
ASIAN
OTHER

3030
536
579
64
22

*

PATIENT
GROUP
GAv/BI
IDU
GAv/BI IOU
HEMO
HETERO
TRANS
NIR

*

*

mb_

PERCENT

2830
627
774
76
39

65.1
14.4
17.8
1.8
0.9

PERCENT

mb_

71.6
12.7
13.7
1.5
0.5
*

*

*

*

*

*

*

*

mb_

PERCENT

t«l.

PERCENT

3351
280
288
21
80
70
115

79.7
6.7
6.8
0.5
1.9
1.7
2.7

3223
392
326
17
99
71
189

74.7
9.1
7.5
0.4
2.3
1.6
4.4

SOURCE:

OFFICE OF AIDS

AUTHOR:

Jim creeqer, Chief, IDS case Reqistry
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AIDS BY ETHNICITY AND TARGET GROUP IN CALIFORNIA
ETHNICITY

PERCENTAGE

WHITE. . . • • • • • • • • • .72%
HISPANIC . . . . . . . . . . . 14%
AFRICAN-AMERICAN . . . . . . . 12%
ASIAN. . . . . . . . . . . . . 2%
NATIVE AMERICAN . . . . . . . 80 CASES

RISK GROUPS

PERCENTAGE

HOMOSEXUALS. . . . . . . . . .82%
I.V. DRUG USERS . . . . . . . . 6%
HOMOSEXUAL I.V. DRUG USERS .. 9%
HEMOPHILIACS . . . . . • • • 1 ~
HETEROSEXUALS. . . . . . . . . 2%
TRANSFUSIONS . . . . . • • • 2 ~
NONE OF THE ABOVE. . . • • • 3i•

0

•

0

•

0
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CALIFORNIA'S

ACCOMPLISHMENTS IN AIDS

1. A COMPUTERIZED AIDS REGISTRY

2.

AN AIDS ADVISORY COMMITTEE

3.

UNIVERSAL BLOOD-DONOR SCREENING

4.

ESTABLISHMENT OF THE ALTERNATIVE TEST-SITE PROGRAM
FOR VOLUNTARY, ANONYMOUS HIV TESTING

5.

AN AIDS VACCINE RESEARCH AND DEVELOPMENT PROGRAM
COMPLETE WITH CLINICAL TRIALS

6.

VARIOUS PILOT PROJECTS FOR HOSPICE, HOME HEALTH,
AND ATTENDANT CARE FOR PEOPLE WITH AIDS

1~8

....hand W.lfar!t ~ \

·~ s. Gould,~<
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AIDS AMONG CALIFORNIA ASIAN
AND PACIFIC ISLANDER SUBGROUPS
INTRODUCTION
!111ft.::::.: (

he number of new acquired immunodeficiency syndrome (AIDS) cases
among Asians and Pacific Islanders in
California has been steadily increasing. However,
little is known about the impact of the AIDS
epidemic among the more than forty ethnic groups
within this population. Refinement of AIDS reporting practices can provide valuable new data about
Asians and Pacific Islanders who have or may be
at risk of developing human immunodeficiency
virus (HIV) infection.

.I .)\:[:I

Diagnoses of persons with AIDS are reported by
physicians and other health professionals to the
State Department of Health Services through local
health departments. AIDS case information is
ascertained using the confidential report form
developed by the Centers for Disease Control,
which includes data on demographics, risk
behaviors, diseases indicative of AIDS, and
laboratory results. Currently, the form allows for

the reporting of Asians and Pacific Islanders only
as a combined racial/ethnic group, making it
difficult to plan prevention and treatment services
targeted to specific ethnic subgroups within this
population. To address this concern, Assembly
Member Roos drafted Assembly Bill 3815 which
passed during the 1990 legislative session, requiring enumeration of specific population
subgroups among Asians and Pacific Islanders
with AIDS reported in California. The Office of
AIDS designed and administered a survey to
obtain this information. Analyses of AIDS case
trends among Asian and Pacific Islander
subgroups based on the survey are presented in
this report.
METHODS
As of February 14, 1991, 24 counties in California·
had reported a cumulative total of 476 Asian and
Pacific Islander AIDS cases. These counties were
requested, by a survey, to identify the specific
ethnic groups of those cases. A data collection

. 12D
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form listing identifiers for the reported Asian and
Pacific Islander cases from each county was
developed and tested. The form was mailed to
each of the 24 counties on February 22, 1991. All
24 counties responded to the request for Information. Survey results were merged with the
demographic and risk factor information for each
case already collected and stored in the computerized AIDS database, the AIDS Reporting
System (ARS). Trends in AIDS cases reported
among Asian and Pacific Islander ethnic
subgroups were then analyzed. Detailed analyses
were not completed for some subgroups due to
the small number of reported cases.
RESULTS

Of the 476 reported cases, the specific ethnicity of
22 (4.6%) could not be identified. An additional
four newly reported Asian and Pacific Islander
cases were included, and 11 cases were coded as
Asian and Pacific Islander in error, reducing the
- actual number of cases to 469. Table 1 shovvs the
cumulative number of Asian and Pacific Islander
AIDS cases reported by county. Due to the
miscoding of racejethnicity information, only 22
counties reported Asian and Pacific Islander AIDS
cases out of the original 24. Statewide, AIDS
incidence among Asians and Pacific Islanders is
lower than among other racial/ethnic groups.
However, the AIDS incidence rate is much higher
in San Francisco than in other counties, among
Asians and Pacific Islanders as well as for other
racial/ethnic groups.
Table 2 shows the number of cases, deaths,
mortality and incidence rates of the 22 identified
subgroups in California. Cumulative AIDS incidence rates indicate the impact of the epidemic
relative to population size and varied substantially
among subgroups. However, these rates should
be interpreted cautiously because of the
somewhat small numbers of both Asian and
Pacific Islander AIDS cases and populations.
Also, large population increases occurred in
California for some Asian and Pacific Islander
subgroups since 1980, so that substantially different rates would be generated using 1980 versus
1990 census data.
Trends in AIDS incidence for Asian and Pacific
Islander subgroups are shown in Table 3. The
differenc
., in the average number of AIDS cases

.. lr'}
0
t...J-
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for three year intervals, which was used to compensate for fluctuations in small numbers of
annual diagnosed cases, shows recent increases
in Incidence for most subgroups. The large
Increases seen among some subgroups may be
due to the small number of AIDS cases within
these subgroups. This is most notable among the
Southeast Asian ethnic populations.
Exposure Categories
As with all racial/ethnic ;roups,
homosexual/bisexual men constitut~ .---.a highest
proportion of AIDS cases among Asians and
Pacific Islanders, making up more than three
fourths of the reported cases (Table 4). The
second most common mode of transmission
among Asian and Pacific Islander men is
transfusion with HIV infected blood, which involve
almost 8% of the reported Asian and Pacific
Islander AIDS cases compared to 1% among other
racial/ethnic groups in California. Conversely, the
proportion of Asian and Pacific Islander AIDS
cases attributed to injection drug use is lower than
the proportion among other racial/ethnic groups.
Among Asian and Pacific Islander women, the
largest proportion of cases (41%) are associated
with heterosexual contact. Of these 14 cases, 6
(43%) reported sexual contact with bisexual men
while 3 (21%) reported sexual contact with men
who injected drugs, 4 reported sexual contact with
an HIV infected person, and 1 reported sexual
contact with a hemophiliac. Injection drug use,
which is the most common exposure category
among female AIDS cases in other racial/ethnic
groups, is less prevalent among Asian and Pacific
Islander women with AIDS.
Age Categories
Among Asian and Pacific Islander subgroups, as
well as other racialjethnic groups, the most frequently occurring category of age at AIDS diagnosis was 30 to 39 years (Table 5). A higher
proportion of AIDS cases among Chinese and
Japanese were over age 59, reflecting the higher
proportion of transfusion cases in these
subgroups. The proportion of AIDS cases diagnosed at 20 to 29 years of age was highest
among the 'Other A/PI' subgroup (20.3%), compared to the Chinese (5.9%), Filipino (13.8%),
Japanese (13.9%), and racesjethnicities other than
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Asians and Pacific Islanders (16.7%).
Regional Trends
Table 6 shows the distribution of AIDS cases
among subgroups throughout five regions of the
state·. More than one third of all Asian and Pacific
Islander AIDS cases are found in San Francisco,
which has the highest proportion of cases among
the Chinese (50.6%), Filipino (40.2%) and
Japanese (41.7%) subgroups. Nearly 40% of the
Asian and Pacific Islander AIDS cases from the
'Other A/PI' subgroup were from Los Angeles,
with 12 out of those 54 cases (22%) of Thai des·
cent. Half the 40 Asian and Pacific Islander cases
from the Southern Metropolitan region were 'Other
A/PI' cases, with 11 of the 20 (55%) of Southeast
Asian descent. Filipinos make up the largest
proportion of Asian and Pacific Islander AIDS
cases in the San Francisco, Bay Area, and
Remaining regions.
The number of AIDS cases among Asians and
Pacific Islanders increased through 1989 in all
regions, with a possible plateau or decline in 1990
(Figures 1-4). AIDS incidence increased in San
Francisco after 1985 primarily among Chinese and
Asians and Pacific Islanders who are other than
Chinese, Japanese, or Filipino ('Other A/PI'); in
Los Angeles among 'Other A/PI'; and in rest of
the state among Filipinos and 'Other A/PI'. Of
recently diagnosed (from 1988 through 1990)
Asian and Pacific Islander AIDS cases, 34% were
from Los Angeles, 31% from San Francisco, and
35% from the remainder of the State.

* Bay Area region (Alameda, Contra Costa, Marin,
Napa, San Mateo, Santa Clara, Solano, and
Sonoma counties); Los Angeles county; San
Francisco county; Southern Metropolitan region
(Orange, Riverside, San Bernardino, and San
Diego counties); Remaining region (remaining
counties in the State).
DISCUSSION
As of March 1, 1991, 469 Asian Pacific Islander
AIDS cases were reported in California, comprising
less than 2% of the total AIDS cases in the State.
Completeness of reporting is thought to be about
85% statewide for all race/ethnic groups and is
not known to be different among Asians and
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Pacific Islanders. Although comprising a small
proportion of ttle total AIDS cases in California,
45% of the nation's Asian and Pacific Islander
cases are from California1 • The detailed breakdown of racial/ ethnic subgroup information indicates that the AIDS epidemic has affected nearly
all Asian and Pacific Islander populations. This
information can be used by health care providers
in the development of culturally sensitive treatment
and support services for Asian and Pacific Islander
AIDS patients.
The number of Asian and Pacific Islander AIDS
cases increased through 1989 throughout the
State with specific subgroups increasing at higher
rates than others. An increase in incidence of
AIDS among Asians and Pacific Islanders in San
Francisco was noted by Woo, et al2 in 1988. In
Los Angeles and San Francisco counties, the
increases are seen predominately in subgroups
other than Filipinos, Chinese and Japanese. The
apparent plateau or decline in incidence seen in
1990 may be due to inadequate reporting delay
adjustments, random variation, or the effect of
early drug treatment strategies similar to that seen
among white homosexual/bisexual men in San
Francisco and Los Angeles. 3
Currently, there are too few cases to determine
accurately trends for each specific subgroup in
each region. To continue to monitor these trends,
the AIDS Case Registry is implementing methods
to collect the subgroup information as each AIDS
case is reported. This information can be placed
in the comment area of the AIDS Case Report
form. Also a local field variable for subgroup
information has been created so that the 23 local
health jurisdictions which have the AIDS Reporting
System (ARS) can then enter specific ethnic
information directly into the computer when a new
Asian and Pacific Islander AIDS case is added.
In addition to those with AIDS, an estimated 3,000
Asians and Pacific Islanders may be HIV positive4
and many more are likely to be at risk of HIV
infection. To effectively target and plan education
and preventiOJl strategies for Asians and Pacific
Islanders, AIOS case data must be incorporated
with HIV seroprevalence data, behavioral risk data,
knowledge, attitude and beliefs data, and the
wisdom of the community service providers.
Homosexual/bisexual

men,

the

predominate

'

1" 1
1

l

:'1
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patient group among all Asian and Pacific Islander
men with AIDS, would benefit from culturally
appropriate AIDS intervention programs. Although
several studies have found Asian and Pacific
Islanders to have the lowest HIV seroprevalence
rate compared to other racial/ethnic groups s.s, the
San Francisco Young Men's Study found that 40%
of the young Filipino men surveyed engaged in
high risk sexual behavior7 •
Since 60% of
homosexual/bisexual Asian and Pacific Islander
men with AIDS were diagnosed before age 40 and
the median incubation period for AIDS diagnosis
is approximately ten years8 , programs for preventing HIV transmission targeted to younger men are
needed.
HIV seroprevalence among Asian and Pacific
Islander childbearing women was found to be two
to six times lower than for childbearing women of
Nevertheless,
all other racesjethnicities 9 •
HIVI AIDS education and prevention programs
stressing safe sex and the risks of injection drug
use are needed for all women of childbearing age.
Among the Asian and Pacific Islander subgroups
significant differences exist which relate not only to
their diverse cultures, but also to their knONiedge,
attitudes, beliefs, and behaviors concerning
AIDS 10• Cultural taboos result in the denial of the
existence of the disease in their communities.
Finding appropriate methods to present information regarding the disease and disseminating
the messages must be specific for each subgroup.
Multicultural, multilingual service providers are
needed to earn the trust of the clients.
Further AIDS case analyses among Asians and
Pacific Islanders can examine country of birth to
see how the degree of acculturation may be
related to the risk of HIV infection. Also, the
diseases indicative of AIDS can be examined to
determine which diseases occur most frequently
among Asians and Pacific Islanders. Additionally,
further analyses of several statewide knowledge,
attitudes, beliefs, and behavioral surveys can be
conducted. These analyses and the additional
subgroup information gathered on "Asian and
Pacific Islander AIDS cases can be used to assist
in the development of culturally sensitive services
and prevention strategies.
By Sally Jew, Research Analyst I, Office of AIDS
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TABLE 1. C&a.llative AIDS Cases Mong AsiMS and Pacific Islanders (A/PI) in Cali fomi a, as of March 1, 1991,
by CCUlty of Residence when AIDS Diagnosed
Cli1Ulative
C1.111.1lative
Cli1Ulative
Incidence
Incidence
AIDS Cases
Cli1Ulative
per 100,000
A/PI
per 100,000
all Races/
~
population***
AIDS Cases
A£PI POoulation* Ethnicities***
Alameda
Contra Costa
Fresno
Los Angeles
Marin
Merced
Monterey
Napa
Orange
Riverside
Sacramento
San Bernardino
San Diego
San Francisco
San Joaquin
San Mateo
Santa Barbara
Santa Clara
Solano
Sonoma
Stanislaus
Ventura
TOTAL

30
7
**
148
**
**
4
**
10
5
**
**
23
170
6
17
**
20
8
**
**
**

16.23
9.48
**
16.30
**
**
15.77
**
4.15
13.04
**
**
12.42
82.65
10.76
16.10
**
7.95
19.76
**
**
**

1,559
579
202
11,416
390
29
164
52
1,442
594
600
559
2,500
9,110
156
577
194
783
248
546
107

121.87
72.04
30.26
128.80
169.49
16.26
46.11
46.95
59.82
50.75
57.62
39.41
100.08
1,258.36
32.46
88.82
52.49
52.28
72.85
140.64
28.88

__jM

~

469

17.91

31,971

120.57

* Based on Census of Population and Housing, 1990: S~.~m~ary Tape File 1
** Counties have three or less Asian and Pacific Islander cases
*** Based on California HIV/AIDS Update, February 1991
Cl.allative AIDS Cases Mong Asian and Pacific Islander (A/PI)
as of March 1, 1991

TABLE 2.

CI.J!lUlative
Number of Total
AIDS Cases

Percent
of Total

Deaths
SJ!2.:l

37
18
15
5
4
4
3
3
2
1

~roups

Mortality
Rate <X>

in Cal ifomia,

Cumulative.AIDS Incidence
per 100,000 A/PI
SY2gr2Ye ooculation*

SUBGROUP
Filipino
Chinese
Japanese
Unknown
Thai
Vietnamese
Hawaiian
Samoan
Guamanian
Korean
Indonesian
Cambodian
Laotian
Fijian
Other**
TOTAL

..

***

174
85
72
22
21
18
15
12
10
7
6
5
5
4
13

1
1
1

118
59
54
8
11
10
10
8
8
4
3
4
4
2

.2

469

****100

,

1.1

69
75
36
52
56
67
67
80
57
50
80
80
50
85

23.80
12.10
23.00
***
66.50
6.40
43.50
37.60
39.90
2. 70
***
7.30
8.60
***
***

314

67

16.48

68

Based on Census of Population and Housing, 1990: Summary Tape File 1
Includes 7 other subgroups each with three or fewer AIDS cases
Census information not available
Totals do not add up to 100% due to rounding
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TABLE 3. Percent Change in AIDS Incidence Mona Asian and Pacific Islander Scbgrot..,s in cal Homia
SUBGROUP

Average Amual
Incidence
1985·1987

Average Amual
Incidence
1988·1990**

22.0
8.0
12.3
2.0
1.0
2.0
2.3
1.7
1.0
0.7
0.3
0.3
0.0
1.0
1.3

33.0
18.7
11.0
5.3
6.3
4.0
2.7
2.3
1.0
1.7
1.7
1.3
1.3
0.3
2.7

Filipino
Chinese
Japanese
Unknown
Thai
Vietnamese
Hawaiian
Samoan
Guamanian
Korean
Indonesian
Cambodian
Laotian
Fiji
Other*

Percent
Chanse

sox
134X
·11X
165X
530%
100X
17X
35X
OX
142X
467X
333X
·70%
108X

* Includes 7 subgroups each with 3 or fewer AIDS cases
** Data not adjusted for reporting delay; includes cases reported as of March 1, 1991
TABLE 4.

Cta~lative AIDS Cases by
Stbgr~ in California,

Exposure category and Sex for Major Asian and Pacific Islander (A/PI)
as of March 1, 1991
RACE/ETHNICITY

Filipino
No. <X>

Other A/PI
No. (X)

All Not A/PI
No. (%)

Chinese
No. (X)

Japanese
No. <X>

88)
1)
3)
1)
0)
5)
_.!!. ( 2)

70
0
0
0
0
10

(
(
(
(
(
(

85)
0)
0)
0)
0)
12)
f._( 2)

52
0
3
2
0
6

(
(
{
(
(
(

79)
0)
5)
3)
0)
9)
.2< 5)

(
(
(
(
(
{

85)
2>
4)
2)
2)
2)
_.2 ( 5)

( 82)
( 4)
( 9)
( 1)
( 1)
( 1)
___2§Q ( 2>

164 (100)

82(100*)

66 ( 100*)

118( 100*)

30,921 (100)

2 ( 25)
4 ( 50)
2 { 25)
Q ( 0)

0 ( 0)
0 ( 0)
2 { 67)
1 ( 33)

0 ( 0)
3 ( 67)
2 ( 33)
Q ( 0)

4 ( 22)
7 ( 39)
4 ( 22)

2 (

17)

358 ( 34)
338 ( 32)
273 ( 26)
_.E ( 9)

TOTAL WOMEN

8 (100)

3 (100)

5 ( 100)

18 (100)

1,061 (100*)

PEDIATRIC

2 (100)

0 (

( 100)

3 (100)

215 (100)

TOTAL CASES

174

85

EXPOSURE CATEGORY
MEN
Homosexual/Bisexual Men
Injection Drug Users (IOU)
Homosexual/Bisexual IOU
Hemophiliac
Heterosexual Contact
Transfusion
Other
TOTAL MEN

144
2
5
1
0
8

{
(
(
(
(
(

99
2
5
2
2
2

25,359
1,304
2,816
165
198
399

WOMEN
Injection Drug Users (IOU)
Heterosexual Contact
Transfusion/Blood Prod
Other

*

Totals do not add up to 100% due to rounding

0)

72

139

32,197
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Qallatfve AIDS Cases by Age Groups for Major Asian end Pec:ifiC Islander (A/PI) SU:lgroups in
california, as of March 1, 1991

RACE/ETHNICITY

AGE

Fit ipino
No.
lX!

GROOP

<13 Yrs
13·19 Yrs
20·29 Yrs
30·39 Yrs
40·49 Yrs
50·59 Yrs
OVer 59 Yrs
TOTAL

2
,
24
74
53
14
6

( 1.1)
( 0.6)
(13.8)
(42.5)
(30.5)
( 8.1)
( 3.5)

174 (100*)

* Totals do not add up to 100X

TABLE 6.

due

Chinese
No.
<X>

Japanese
No.
<X>

Other A/PI
No. ~X}

0 )
0 )
( 5.9)
(42.3)
<28.2)
(13.0)
9 (10.6>

1
0
10
24
22
6

( 1.4)
( 0 )
(13.9)
(33.3)
(30.6)
( 8.3)
9 (12.5>

2
1
28
60
38
7
2

85 (100)

n

138(100*)

0
0
5
36
24
11

(

(100)

( 1.5)
( 0.7)
(20.3)
(43.5)
(27.5)
( 5.1)
{ 1.5)

All Not A/PI
No.
~Xl

215
59
5,377
14,493
8,127
2,831
1.095

( 0.7)
( 0.2)
(16.7)
(45.0)
(25.2)
( 8.8)
{ 3.4)

32,197 (100)

to rOU'Iding

Qallative AIDS Cases A.:x1g Major Asian
california, es of March 1, 1991

~

Pec:ific Islander (A/PI) SU:lgroups by Regions of

RACE/ETHNICITY
~

Filipino
No.
~Xl

Chinese
No.
lXl

Japanese
No. {Xl

Other A/PI
No.
{Xl

Bay Area
San Francisco
Los Angeles
Southern Metro
Remaining
Unknown

33
70
44
15
12

13
43
24
3
2

10
30
26
2
4
0

(13.9)
(41.7)
(36.1)
( 2.8)
( 5.6)
{ 0 !

30
27
54
20
7
0

n

c100*>

138 (100)

TOTAL

(19.0)
(40.2)
(25.3)
( 8.6)
( 6.9)
0 l
0 '
174 (100)

(15.3)
(50.6)
(28.2)
( 3.5)
( 2.3)
0 l
0 '
85 (100*)

(21.7)
(19.6)
(39.1)
(14.5)
( 5.1)
~ 0 1

All Other

,xl

No.

4,550
8,944
11,286
5,042
2,367

(
(
(
(
(

14.1)
27.8)
35.1)
15. 7)
7.3)
0 l
8 '
32,197 (100)

* Bay Area region (Alameda, Contra Costa, Marin, Napa, San Mateo, Santa Clara, Solano, and Sonoma
counties); San Francisco county; Los Angeles county; Southern Metropolitan region (Orange, Riverside,
San Bernardino, and San Diego counties); Remaining region (remaining counties in the State).

,.,:1 l..J~

I
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Figure 1. Annual AIDS Incidence Among Asians & Pacific Islanders,
San Francisco County, March 1, 1991
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Figure 2. Annual AIDS Incidence Among Asians & Pacific Islanders,
Los Angeles County, March 1, 1991
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Figure 3. Annual AIDS Incidence Among Asians & Pacific Islanders,
Rest of State, March 1, 1991
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Figure 4. Annual AIDS Incidence Among Asians & Pacific Islanders,
All of California, March 1, 1991
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INFLUENZA IMMUNIZATION OF HIV-INFECTED PERSONS AND OF
CARE-GIVERS TO PERSONS WITH CUNICAL AIDS

California Department of Health Services
Immunization Unit
August, 1991
The U.S. Public Health Service Immunization Practices Advisory Committee (ACIP) recommends
influenza immunization eacn fall (ideally in November) for certain groups of high-risk persons, as
well as for care-givers to these persons.
Reproduced below are selected sections from the
ACIP's influenza immunization recommendations
for the 1991-92 season (MMWR 1991; 40:No.
RR-6, 1-15).
Persons Infected With HIV

1.

Physicians, nurses, and other personnel in
both hospital and outpatient-care settings
who have contact with high-risk persons in
all age groups, including infants.

2.

Employees of nursing homes and
chronic-care facilities who have contact
with patients or residents.

3.

Providers of home care to high-risk persons (e.g., visiting nurses, volunteer
workers).

4.

Household members (including children) of
high-risk persons.

Little information exists regarding the frequency and severity
Influenza Vaccine Dosage
of influenza illness in human
immunodeficiency virus (HIV)
Influenza vaccine' dosage, by age of patient - 1991-92 season
infected persons, but recent
reports suggest that symptoms
may be prolonged and the risk
Nunber of
Route•
Product'
Age Group
Doses
Dosage'
of complications increased for
this high-risk group. Because
1 or 2"
IM
Split virus only
6 - 35 mos
0.25 ml
1 or 2'
IM
Split virus only
3 - 8 yrs
0.50 mL
influenza may result in serious
Split virus only
0.50 mL
1
IM
9 - 12 yrs
illness and complications, vac1
1M
2:: 13 yrs
Whole or split virus 0.50 ml
cination is a prudent precaution
and will result . in protective
antibody levels in many
recipients. However, the antibody response to vaccine may be low in persons
Contains 15 1-Lg each of A/Taiwan/1/86
with advanced HIV related illnesses; a booster
(H1 N 1), A/Beijing/353/89 (H3N2), and
dose of vaccine has not improved the immune
B/Panama/45/90 hemagglutinin antigens in each
0.5 mL.
Manufacturers include Connaught
response of these individuals.
(Fiuzone• whole or split, distributed by E.R.
Squibb & Sons);
Evans Medical Ud.-Lederle
Groups That Can Transmit Influenza to
Laboratories (Flu-Immune•, distributed by Lederle
High-Risk Persons
Laboratories); Parke-Davis (Fiuogen• split); and
Persons who are clinically or subclinically infected
Wyeth-Ayerst Laboratories (Influenza Virus Vaccine, Trivalent• split). For further product inforand who attend or live with high-risk persons can
transmit influenza virus to them. Some high-risk
mation, call Connaught (BOO) 822-2463,
persons (e.g., the elderly, transplant recipients, or
Parke-Davis (800) 223-0432, Wyeth (800)
persons with AIDS) can have low antibody respon950-5099, and Lederle (800) 522-3753.
ses to influenza vaccine. Efforts to protect these
2
high-risk persons against influenza may be
Because of the lower potential for causing
improved by reducing the chances of exposure to
febrile reactions, only split virus (subvirion) vaccine
should be used in children age 12 years and
influenza from their care providers. Therefore, the
younger. lmmunogenicity and side effects of split
following groups should be vaccinated:
and
whole virus vaccines are similar in adults
:~OQ
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AIDS CLINICAL TRIALS
INFORMATION SERVICE

3

It may be desirable to administer influenza
vaccine to high-risk children when they receive
routine pediatric vaccines, but in a different site.
Although studies have not been conducted,
simultaneous administration should not lessen
immunogenicity or enhance adverse reactions.
Some avoid giving influenza vaccine within 3 days
of giving pertussis (DTP) vaccine since both
vaccines commonly produce mild local reactions
and fever in children.
4

The recommended site of vaccination is the
deltoid muscle for adults and older children. The
preferred site for infants and young children (under
age 18 months) is the anterolateral aspect of the
thigh.
5

Two doses are recommended for children
8 years old who are receiving influenza vaccine
for the first time.
~

Sources of Influenza Immunizations
Besides the private medical sector, local health
departments in California conduct clinics offering
low cost influenza immunizations each fall (late
October through November) to persons at
increased risk from influenza. Locations and times
of these clinics can be determined by calling the
local health department (c.f. county or city
government listings in the telephone book).

The AIDS Clinical Trials Information Service
(ACTIS) provides current information on federally
and privately sponsored clinical trails being conducted to evaluate drugs and therapies to treat all
stages of human immunodeficiency virus (HIV)
infection in adults and children and to treat related
opportunistic infections. ACTIS is a Public Health
Service project provided collaboratively by CDC,
the Food and Drug Administration (FDA), the
National Institute of Allergy and Infectious
Diseases, and the National Library of Medicine
(NLM).
The ACTIS database includes information on more
than 300 clinical trails and more than 100 drugs
being tested. Information is available on the
purpose of the study protocol, t~e Jo~ati~n, the
eligibility requirements, the exclus1on cntena, and
the names and telephone numbers of contact
persons. ACTIS provides information on all AIDS
clinical trails sponsored by the National Institutes
of Health and on studies of all treatments undergoing clinical testing for effectiveness in privately
sponsored trials approved by FDA.

The AIDS Clinical Trials Information
Service can be reached by calling:
1-80o-TRIALS-A (1·800-874-2572)
FAX: 1-300-738-6616
1TY/TDD: 1-800-243-7012
International Une: 1-301-217-0023

I
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AIDS News
NATIONAL CASE SUMMARY:
DC announced that the cumulative number of individuals diagnosed with AIDS
in the United States totaled 191,601 and
122,905 persons have died at the end of August,
1991.

CAUFORNIA CASE SUMMARY:

period (September 1989 - August 1990) for both
racejethnicity and mode of transmission in the
tables that follow.
PREVIOUS 12 MONTHS
l of Total

LATEST 12 MONTHS
#Reported l of Total
Race

# Reported

66.0
14.6
17.0
1.5
0.9

5,171
955
1,027
131
26

70.7
13.0
14.1
1.8
0.4

76.3
8.3
7.1
0.4
2.4
1.6
3.9

5,741
469
516
32
151
137
216

79.1
6.4
7.1
0.4
2.1
1.9
3.0

361

4.7

261

3.6

45

0.6

48

0.7

White
Black
Hisp
Asian
Other

5,037
1,113
1,301
. 116
72

Patient Gry

uring August 1991, 784 new AIDS cases
and 614 AIDS related deaths were
reported to the AIDS Case Regist{y.
However, 154 cases were deleted from the registry
leaving a net case increase of 630. From the start
of the epidemic through August of 1991, the
cumulative case total is 36,620 with 24,938 AIDS
related deaths. One year ago, there were 854 new
AIDS cases reported with 452 AIDS related deaths.
Cases rE~ported in the latest twelve month period
(September 1990 - August 1991) are compared
with cases reported in the previous twelve month

AIDS cases and ArnJal Incidence Rates per 100,000
Population by ~etropol itan area with 500,0000 or .ore
population, reported Septenber 1989 through August
1990, Septf!llt)er 1990 through August 1991; and
cumulative through August 1991
METROPOLITAN

9/89-8/90

9/90-8/91

Area of Res idence

llo.

llo.

San Francisco 1,782
San Diego
699
Los Angeles
2,231
Oakland
538
Anaheim
345
Riverside/
San Bernardino 243
San Jose
160
Fresno
56
Sacramento
145
Bakersfield
33
Oxnard/
Ventura
37
From the CDC's
September 1991.

Rate

Oa.tlative

Rate Total

111.1 2,361 146.2 10,845
28.0
523 20.4 2,657
25.2 2, 731 30.3 12,714
501 23.7 2,328
25.8
14.3
321 13.1
1,520
9.4
10.7
8.4
9.8
6.,
5.5

HIV/AIDS

326 12.1
176 11.6
8.9
61
210 13.8
50 9.0
42

6. 1

Surveillance

1,241
833
234
796
149
175
Report,

Gay/Bi 5, 793
IVDU
629
Gay/I VDU 539
Heme
27
Hetero
185
Trans
123
NIR
298
Women

Children

The more significant changes include the
increased reporting of black and Hispanic cases,
and the higher number of women reported. While
fewer cases among homosexual or bisexual men
are being received, more IV Drug User,
heterosexual transmission, and No Identified Risk
(NIR) cases are being reported. Of the 185
heterosexual cases reported in the most recent
twelve months, 69 occurred among men and 116
among women.
Overall, the net increase in reported cases for the
epidemic was 7,639, in the past twelve months as
compared to 7,310 in the previous twelve months.
However, 850 cases were deleted during the past
year. There were 6,121 AIDS related deaths
reported in the most recent period as compared to
5,269 in the previous twelve month period.

By Jim Creeger, Chief, AIDS Case Registry
Office of AIDS
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Acquired Immune Deficiency Syndrome (AIDS)
AIDS Reporting System
Sunreillance Report · 08/31/91
1.

Disease Category *

Adult/Adolescent
Cases ( X>
Deaths ( X>

PCP
Other Disease w/o PCP
KS Alone
No 0 i seases Listed

20583
12108
3683
0

----------------

--------------Total

2.

Age
...

--- ....... .

3~74

Total

........................

246
78
6074
16418
9305
4499
0

( 33)
( 10)
( 0)

-- .. -..
----- (100)

Cases ( X>

Under 13
13-19
20-29
30-39
40-49
Over 49
Unknown

4.

----------( 57)

(
(
(
(
(
(
(

1)
0)
17)
45)
25)
12)
0)

----- ...........

3.

..........................

14766
7865
2166
0

-----

( 72)
( 65)
( 59)
)
(

.

.............

24797 (

68)

Race/Ethnicity

67
74
0
0

138 ( 56)
0 ( 0)
0 ( 0)

----- -----

----------( 57)

( 62)
( 54)
)
(
)
(

20691
12246
3683
0

.
.

............

141 ( 57)

246 (100)

Pediatric
Cases ( X>

..........................

...............................

..

26164
4477
4996
540
76
121

(
(
(
(
(
(

72

)
)
)
)
)
)

12
14
1
0
0

----- ----36374 (100)

( 33)
( 10)
( 0)

-----

36620 (100)

Adult/Adolescent
Cases ( X>

..................................

Total

............................

----------108 ( 44)

White, Not Hispanic
Bleck, Not Hispanic
Hispanic
Asian
Native American
Unknown
...................................

Total
Deaths ( X)
Cases ( X)

Pediatric
Cases < X>
Deaths < X>

87 ( 35)
72 ( 29)
80 ( 33)
6 ( 2)
1 ( 0)
0 ( 0)

---- ...

.. ....... -

.............................

14833
7939
2166
0

( 72)
( 65)
( 59)
)
(

.

----- -----

24938 (

68)

Total
Cases ( X)

26251
4549
5076
546
77
121

( 72)
( 12)
( 14)
( 1)
( 0)
( 0)

246 (100)

36620 (100)

Adult/Adolescent
Females < %)

Total < X)

36620 (100)

Patient Groups **
Males ( X>

28691
2005
3136
194
639
765
944

( 79)
( 6)
( 9)
( 1)
( 2)
( 2)
( 3)

or bisexual Men
Intravenous (IV) drug User
H~/Bi IV drug User
Hemophi l iec
Heterosexual contact
Transfusion with blood/products
None of the above/Other

28691
1567
3136
185
240

832 ( 2)

399 ( 32)
299 ( 24)
112 ( 9)

Total

35117 (100)

1257 (100)

36374 (100)

Males < %)

Pediatric
Females < %)

Total ( %)

H~sexual

Hemophiliac
Parent at risk/has AIDS/HIV
Transfusion with blood/products
None of the above/Other
Total

( 82)
( 4)
( 9)
( 1)
( 1)

466 {

1)

0 (

17 { 12)
64 { 47)
54 ( 39)

0 (

0)

9 (

1)

1)

85 { 78)
21 ( 19)
2 ( 2)

18 { 7)
149 ( 61)
75 ( 30)
4 ( 2)

137 (100)

109 (100)

246 (100)

2 (

1 {

*Disease categories are ordered hierarchically. Cases with more than one disease are
tabulated only in the disease category listed first.
**Cases with more than one risk factor other than the combinations listed in the tables
are tabulated only in the category listed first.
Case count reflects the deletion of 154 cases.

0)

438 ( 35)

1)

I
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Acquired Immune Deficiency Syndrome (AIDS)
AIDS Reporting System
Surveillance Report - 08/31/91

5.

Reported Cases of AIDS and Case-Fatality Rates by Half-Year of Diagnosis:
Half-Year
of Diagnosis

NU'Iber of
Cases

------------

...................

NU'Iber of
Deaths

Case-Fatality
Rate

---------

..........................

Before 1980

1

0

ox

1980 Jan ·June
July-Dec

3
7

2
5

67X
71%

1981 Jan ·June
July-Dec

16
44

15
40

94%
91%

1982 Jan -June
July-Dec

70
146

63
135

90%
92%

1983 Jan -June
July-Dec

295
402

276
376

94%
94%

1984 Jan ·June
July-Dec

573
799

543
746

95%
93%

1985 Jan ·June
July--Dec

1118
1370

1058
1278

95%
93%

1986 Jan ·June
July-Dec

1783
2157

1658
1946

93%
90%

1987 Jan ·June
July-Dec

2654
2no

2331
2317

88%
84%

1988 Jan ·June
July-Dec

3072
3120

2398
2282

78%
73%

1989 Jan -June
July-Dec

3525
3241

2308
1892

65%
58%

1990 Jan -June
July· Dec

3453
3086

1630
1084

47%
35%

1991 Jan -June
July· Aug 31

2597
318

539
16

21%
5%

............................

Totals

.. ...................

... ..................

36620

24938

.. ...........................
68%
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CUMULATIVE AIDS CASES and INCIDENCE
1980 through 08/31/91
AIDS Deaths
Cases
Alameda
Berkeley
Alpine
Amador
Butte
Calaveras
Colusa
Contra Costa
Del Norte
El Dorado
Fresno
Glenn
Hllli:x> l d t
!~rial

Inyo
Kern
Kings
Lake
Lassen
Los Angeles
Long Beach
Pasadena
Madera
Marin
Mariposa
Mendocino
Merced
Modoc
Mono
Monterey
Napa
Nevada

1, 725
200

Mortality INCIDENCE
Rate per 100,000

1,054
115

61.1X
57.5X

134.85
188.15

6

4

62

36

2

1

4

3

643
1

390

34
245

26
170

66.7'%
58.1%
50.0%
75.0%
60.7%
0.0%
76.5X
69.4%
71.4X
60.8%
70.8%
75.0%
52. 9"-'
44.0%
81.5%
40.0%
70.1%
68.4%
66.5%
33.3X
50.1X
0.0%
65.6%
54.5%
100.0%

19.97
34.04
6.25
24.58
80.00
4.26
26.99
36.70
28.23
42.81
21.96
21.88
28.52

7

5

51
24

31
17

4

3

155
25
27

82
11
22

5

2

13,147
1,080

9,217
739
113

170

12

4

441
1

221
0
42

64
33

18

1

1

1,605
27

Orange
Placer
Plunas
Riverside
Sacramento
San Benito
San Bernardino
San Diego
San Francisco
San Joaquin
San Luis Obispo
San Mateo
Santa Barbara
Santa Clara
Santa Cruz
Shasta
Sierra
Siskiyou
Solano
Sonoma
Stanislaus
Sutter
Tehama
Trinity
Tulare
Tuolume
Ventura
Yolo

0

0

AIDS Deaths
cases

CtlJNTY

24.64

53.33
18.12
148.33
257.33
126.96
13.62
191.66
6.99
79.66
18.50
10.33

0

217
69
16

145

66.8%
75.4%
87.5%

52
14

61.01
62.29
20.38

1

495

4

3
422

472

2,647

1, 750

9,889
1n
81
625
230
851
157
38
2

6,965
101
42
382
152
592
94
25

6

2
5

253
555
111
12

148
358
68
10

5
3

2
2
. 32
8

50
18
174
42
14
17

Unknown
Total

1

678
707
620

Yuba

1,055
13

36,620

123

24,938

68.1%

Oct 90

Nov 90
Dec 90
Jan 91
Feb 91

Mar 91

Apr 91
May 91
Jun 91
Jul 91
Aug 91
400

200

0

200

400

600

800

Reported Deaths

61.3%
83.3X
40.0%
66.7'%
64.0%
44.4X
70. 7'%
54.8%
76.5%

Sep 90

600

64.5X

64.3%

Sep 1990 - Aug 1991

Reported Cases

75.0%

68.1%
66.1%
70.4%
57. 1%
51.9%
61.1%
66.1%
69.6%
59.9%
65.8%
100.0X
83.3X
58.5X

13

Reported AIDS Cases and Deaths

800

65. 7'%
48.1%
100.0X
73.0X
66.8%

23
9

* Incidence Based on 1990 Census, California De rtment of Finance, Population Unit.

1000

Mortality INCIDENCE
Rate per 100,000

1000

66.58
15.63
5.07
57.93
67.90
10.90
43.71
105.96
1365.96
36.83
37.30
96.21
62.23
56.83
68.34
25.84
60.28
13.78
74.32
142.96
29.96
18.63
10.08
22.97
16.03
37.15
26.01
29.n
24.04
123.05
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California AIDS Cases
Cumulative Cases
as of August 31, 1991
Department of Health Services

Office of AIDS
Epidemiologic Research &
Statistics Section
Uorin 441
Son Francisco 9889 -Son Uoteo 625 -Sonto Cruz 157 4

620

13147

678

2647

24
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MEETINGS/ANNOUNCEMENTS
• November 7: "HIV Disease in Women and Children", a conference at Chico
Community Hospital which will provide current medical information on HIV
disease symptoms, diagnosis, treatment and care for women and children living
with HIV disease. For more information call: (916) 265-1450.
• November 14-16: ·raking Charge: Communities of Color in Solidarity Against
the HIV/AIDS Epidemic", a conference sponsored by the U. S. Public Health
Service, Regions IX and X. It will be coordinated by the Office of Minority Health
and held in Seattle. For more information, call (206) 728-8911.
• November 19-22: "Planning and Evaluating HIV Prevention Programs". The
conference will be held in San Francisco. For information contact the STD
Prevention/Training Center, 1372 Mission Street, S.F. 94103 or call (415) 5549620.
• December 3: "HIV Disease and the Social Security System·. For information
on this conference, contact: AIDS Project Los Angeles, 6721 Romaine St., L.A.
90038 or call (213) 962-1600, ext 355.
• December 9-10: "Clinical Care of the AIDS Patient•.
Presented by the
University of California, San Francisco. Please write UCSF Postgraduate
Programs, 521 Parnassus Avenue, C405, S.F. 94143-0656, or call (415) 4765808.

California HIV1AIDS Update is published on a monthly basis by the California
Department of Health Services, Office of AIDS, 714/744 P Street, Sacramento,
CA 94234-7320, Phone: (916) 445-0553, FAX Phone: (916) 323-4642.
Editor: Aleck B. Darr, M.A., M.P.A. Circulation Manager: James Creeger.
Editorial Advisory Board: Robert Benjamin, MD, MPH, Alameda County; Michele
M. Ginsberg, MD, San Diego County; George W. Rutherford, MD, Department
of Health Services, Infectious Diseases Branch; Peter Kerndt, MD, MPH, Los
Angeles AIDS Epidemiology Program.
Departmental Advisor: Betsy Hite, Chief, Office of Information and Public Affairs,
Department of Health Services.
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Epidemiology of acquired immunodeficiency
syndrome and human immunodeficiency
virus infection in adolescents
HELENE D. GAYLE, MD, MPH AND LAWRENCE J. D'ANGELO, MD, MPH

...

Attention baa increasingly been focused on human
immunodeficiency virus (HM infection and acquired
immunodeficiency syndrome (AIDS) among adoles·
cems. In the early years of the HIVI AIDS epidemic.
adolescents received leu attention than younger chil·
dren and adulta. This was due at least in part to the
fact that most of the early knowiedp of the AIDS
epidemic came from AIDS case reporting. Since ado1-=ents 13 to 19 yean old comprise leu than 1% of
all people with AIDS, the risk of HIV infection in this
group appeared mjnjmeJ relative to the pediatric (leu
than 13 years) and adult populations. However, for
purposes of prevention and care, adoletcents are a
unique and important group to higldight. Adoletcence
ia a time when semal behavior and drug use patterns
are developing: clearly it is a critic:al time to have an
impact on those behavior patterns. Also, there is a
growing recognition that adolescents may be a group
at considerable risk for HIV infection. 1... However.
information about this group is still limited. Many
gaps in our knowledge remain. limiting our ability to
provide appropriate health and social services and
prevention efforts for the adolescent population. We
will review the epidemiology of HIV infection and
AIDS among adolescents and examine factors that
place adolescents at risk and the current research
needs related to these areas.

total reported AIDS cases. Another 6472 cases (4.3%)
have been reported among young adults 20 to 24 years
of age, many of whom were presumably infected with
HIV as adolescents. Since 1982. the number of cases
of AIDS among adolescents has increased steadily, at
a rate of increase similar to that for adults and children (Fig.l). This sugpsta that, as with the other age
groups, AIDS in adolescents will be an increasingly
important cause of morbidity and mortality.
AIDS cases in adolescents have been reported from
4latates. Puerto Rico, and the District of Columbia.
F"dt;y-three percent of all adolescent cases have been
reported from New York. Florida. California. Texas.
Puerto Rico, and New Jersey, with 14% from New
York alone. Thia geographic distribution has remained
fairly stable over time with 46 to 59% of the cases
being reported from these areas each year since 1984.
Additionally, most (72%) ofthose for whom residence
information was available were from Metropolitan
Statiatic:al Areas with populations of 1 million or more.
By contrast. only 42% of the total1980 United States
population lived in metropolitan areas of this size.
The proportion of cases reported from these large
metropolitan areas has dec:reaaed. from 78% in 1986 to
69% in 1988. Since the number of adolescent AIDS
cues reported per year is still small. interpreting these
trends is difficult. These data suggest, however. that
HIV infection among adolescents is an issue for concern regardless of place of residence.
Overall. older adolescents, males, and racial and
ethnic minorities predominate among adolescents
with AIDS. Reported cases steadily increase with patient's age. Relatively few cases have been reported
among adolescents younger than 17 years, with 75%
of the reported cases occurring in those 17 to 19 years
old.
Eighty percent of the total number of adolescents
with AIDS are male. The cumulative male to female
ratio is 4:1 compared with a male to female ratio of
10:1 among adults 20 years of age and. older. The male
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As of October 31, 1990, 604 cases of AIDS among
adolescents 13 to 19 years of age had been reported to
the Centers for Disease Control (CDC) AIDS surveillance system. This represents 0.4% of the 152 231
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to female ratio remained stable from 1985 to 1987
(4.5:1 to 5:1), but in 1988, it dropped to 3:1. reflecting
an 80% increase in the number of female cases reported between 1987 and 1988.
·: -: · As for AIDS cases overall. minoritv adolescents are
·· ' disproportionately represented amo~ persons with
AIDS. African-Americans and Hispanics make up 36
and 18% of adolescents with AIDS. respectively, but
represent only 14 and 8%. respectively, of the 1980
U.S. population 13 to 19 years old. The cumulative
incidence is highest for all other racial and ethnic
groups compared with whites.
MODES OF TRANSMISSION

To date all reported AIDS cases among adolescents
have resulted from transmission of HIV infection by
the same routes as for adults, although in somewhat
different proportions. By individual transmission category, the largest proportion of reported adolescent
AIDS cases were those resulting from transfusion of
blood products for coagulation disorders. The second
largest category is transmission by homosexual or
bisexual contact, comprising approzimately 30% of
cases. However, when behavior-related exposures are
combined. sexual contact and intravenous drug use
account for the majority (57%) of cases.
Within the adolescent age group, there are distinct
differences in modes of transmission by age, sex, and
race or ethnicity. Among young adolescents 13 to 14
years old. exposure to HIV through the transfusion of
blood products for hemophilia accounts for 70% of
cases. and blood transfusions another 21%. Understandably, in this age subset. 87% of AIDS cases are
mong males. The proportion of cases attributable to
exposure to blood or blood produets decreases markedly with age to 72% of cases among 15- and 16-yearolds and 25% in older adolescents 17 to 19 years old.
Correspondingly, the proportion of cases due to behavior-related exposure increases with age from 9%

·1 :.:.s

among 13- and 14-year-otds to 24% among 15- and
16-year-oids and 69% of cases among oider adolescents
17 to 19 years oid. The largest single exposure category
for older adolescents is sexual contact between maies.
accounting for 36% of cases in this group. The importance of this progression is emphasized by the fact
that over 90% of all cases among young adults 20 to
24 years old are attributed to behavior-related exposures.
Modes of transmission· also differ by gender. Overall
among males, blood product exposure accounts for the
larpst proportion (38%) of cases. closely followed.-Dy
sema1 contact between males (37% ). However. by
adding tb.e overlapping categories of male homosexual
or bisexual contact and IV drug use. up to 43% of
caaea among males could be due to male-to-male sexual contact. Among females. the most frequent exposure category was heterosexual contact. accounting for
44% of cases. followed. by IV drug use (28%). Male IV
drug users were reported as partners in 60% of female
heterosexual-acquired cases or 28% of all female cases.
Therefore, in total. 56% of reported female cases were
related to IV drug use. The male to female ratio is
highest for cases due to blood product exposure and
lowest for heterosexual contact.
The mode of acquiring HIV infection among adolescents also vary by race and ethnicity. More than
half (53%) of cases among white adolescents are attributed to transfusion of blood products for hemophilia; another 23% are due to homosexual or bisexual
contact. By contrast. the two largest transmission
categories are homosexual or bisexual contact (39%)
and heterosexual contact (24%) for African-Americana. and IV drug use (29%) and homosexual or bisexual contact (28%) for Hispanics. The higher proportion of cases due to heterosexual contact and IV drug
use among the African-American and Hispanic cases
account for the higher proportion of females and lower
male to female ratios in these groups compared with
whites.
INDICATOR DISEASES AND MORTALITY

Clinically, adolescents with AIDS are more similar
to adults than to children. Adolescents with AIDS
have been diagnosed with a wide spectrum of opportunistic diseases. conditions. and cancers. Pneumocystil carinii pneumonia was the most frequently diagnosed infectious disease, reported in 43.5% of cases.
Wasting was the next most common condition ( 15% ),
followed by Candida esophagitis (7% ), cryptococcosis
(6.5% ), and toxoplasmosis (5% ). Kaposi's sarcoma was
not diagnosed frequently among adolescents.
Fifty-seven percent of adolescents with AIDS reported to the CDC surveillance system are known to
have died. Additionally, AIDS mortality data are
available from the National Center for Health Statis-
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tics. Based on these data. AIDS accounts for less than
1% of deaths among adolescents 13 to 19 years old.
However. for young adults 20 to 24 years of age, AIDS

accounts for 2% of all deaths and is now the fourth
leading cause of death.5
HlV SEROPREVALENCE DATA

Although AIDS case reporting is very useful for
asaessing serious morbidity and mortality due to HIV
infection. it does not provide as much information on
the current, ongoing situation. Given the long incubation period between HIV infection and the development of AIDS, the number of AIDS cases alone is
probably much too low to serve as an estimate of the
prevalence of HIV infection among adolescents.
Adults aged 20 to 29 yean represent 209'0 (N • 21834)
of the total reported AIDS cases. Many of these adults
were most likely infected as adolescents. Back-calculation is one method of estimating the number of
persons previously infected with HIV by using reported AIDS cases and the estimated incubation
period between infection and development of AIDS. 6
Applying this method, the probability of being infected
with HIV as adolescents for people 13 to 29 years old
can be calculated.7 Based on these probabilities, it is
estimated that from 1981 througb.1987, approximately
17 000 persona aged 13 to 19 years were infected with
HIV.7 Current knowledge about the incubation period
and natural history of H1V infection is limited. however, and the number of adolescents with AIDS is
small. These factors can affect the precision of estimates derived from back-calculation. However, this
estimate serves as a more useful indicator of the
probable impact of HIV infection among adolescents
than can be provided by AIDS cases alone.
Estimates of HIV aeroprevalence in adolescents and
young adults exist from multiple sources. As part of
the CDC Comprehensive Family of Serosurveya, seroprevalence data have been collected for adolescents
in different health-care settings.11 All of these surveys
were conducted in a blinded manner by testing discarded blood specimens that were collected for other
routine medical purposes. Test results are linked only
to limited. nonidentifying demographic information.
This method is used to provide an unbiased estimation
of aeroprevalence while preserving anonymity.• Seraprevalence data are also available to CDC from HIV
screening of applicants for military service (U.S. Department of Defense) and from applicants for residen·
tial Job Corps programs tU.S. Department of Labor).
Since all applicants for both of these programs are
screened for HIV, seroprevalence data are available
for the entire applicant pool.
From 1988 to 1989. more than 108 000 specimens
and demographic data from adolescents (15 to 19 years
old) and young adults (20 to 24 years old) attending
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sexually transmitted disease (STD) clinics and women's health centers across the country were collected
(9). In these surveys, the median seroprevalence was
highest in the STD clinics for adolescents (0.5%, range
0 to 4.6%) and young adults (1.8%, range 0 to 30.4%).
Median seroprevalence in the women· s health centers
was 0% (range 0 to 1~7%) for adolescents and 0%
(range 0 to 3.1%) for young adults. The median rates
for adolescent males and females in STD clinics were
1.3 and 0.69'0, respectively.9
From October 1985 to September 1989, the overall
HIV aeroprevalence for applicants for military service
wu 0.039'0 (range 0 to 0.69'0) among adolescents aged
17 to 19 years and 0.19% (range 0 to 1.19'0) for adults
aged 20 to 24 years.10 Among 17• to 19-year-olda. the
seroprevalence wu equal for men and women (0.039'0 );
among 20· to 24-year-olda. the proportion of HIV•
infected males (0.199'0) wu approximately twice as
high as that for females (0.099'0). The aeroprevaiences
for 17- to 19-year-old African-Americans and Hispanics were 5 and 1.5 times that of white recruits of this
age, respectively. A similar trend was seen in the 20to 24-year-old age group. These data are an important
source of national seroprevalence estim•._ for the,
adolescent population but may underestimate the severity of the problem in this age group since homosexual and bisexual males. IV drug users. and persons
with coagulation disorders are discouraged from applying for military service.
The Job Corps, the major federal job training program for socioeconomically and educationally disadvantaged youth, began screening all applicants to their
residential training program for HIV infection in
1987. 11 Almost all (97%) of Job Corps entrants are
aged 16 to 21 years. The overall seroprevalence in this
group is 0.39%. The seroprevalence varied by age, sex.
race or ethnicity, and geography. The highest aeroprevalence occurred in African-Americana and Hispanic males (0.99 and 0.83%, respectively) and Afri·
can-American females 19 to 21 years old (0.66% ). The
male to female ratio wu 1:1 for 16· to 18-year-olda
and approximately 2:1 for 19· to 21-year olda. Seraprevalence wu highest in the Northeast (0.639'0) and
the South (0.42%). These data indicate that this population is at higher risk for HIV infection than those
applying for military service. Since the Job Corps does
not accept known IV drug users. this population may
not neceuarily represent the total spectrUm of adolescents at high risk for HIV infection.
Other blinded seroprevalence surveys have been
done in adolescent populations in several areas between 1987 and 1989. In a study of runaway homeless
youth 16 to 20 years old, a aeroprevalence rate of 7%
waa found. 12 Data from an STD clinic in Baltimore
showed a 2.2% aeroprevalence among 15- to 19-yearold adoleacents. 13 In a study conducted among adoles-

cents aged 13 to 19 years attendin~ an adolescent
outpatient clinic in Washington. DC, the seroprevalence was 0.37%, with the highest prevalences occurring in females W.47%) and in patients 18 to 19 years
old (0.56% ). 14 Another study was done among individuals who had blood drawn ior syphilis screening in the
general medical or pediatric clinic or emergency room
of a municipal hospital in the Bronx, New York. 15 The
seroprevalence was 1.2% among adolescents and
young adults aged 15 to 24 years. Also in the Bronx. a
seroprevalence survey among young women attending
a family planning clinic for first-trimester abortions
revealed a seroprevalence of 2.5% among young
women aged 20 to 24 years. 16 Although methods for
these different surveys vary, they indicate that there
is a heterogeneity in the seroprevalence among the
adolescent and young adult population and that certain adolescents are at very high risk of HIV infection.
These data suggest that adolescent females may be at
higher risk for HIV infection than males of the same
age and that African-American and Hispanic adolescents also appeared to be at an increased risk relative
to white adolescents.
RISK OF HIV TRANSMISSION IN
ADOLESCENTS

Data from AIDS case reports and selected seroprevalence surveys indicate that behavior is a major factor
for placing adolescents at risk for HIV infection. Since
the risk of transmission of HIV through exposure to
infected blood or blood products has been drastically
reduced with the advent of blood screening, blood
donor self-deferral. and heat treatment of clotting
factors, virtually all new infections among adolescents
will result from semal or drug-use exposures. Information on risk behavior among adolescents will be
important for developing prevention efforts in this
population.
Studies indicate that many adolescents may be at
risk for HIV infection through semal exposure. There
has been an increase in adolescent semal activity over
the last 2 to 3 decades with both a declining age at
fust intercourse and increasing number of partners
over time. 11-2o The median age at first intercourse is
16 years old in this country, but it varies substantially
by gender. race or ethnicity, and geographic location.19· 21 In a 1982 study of never-married females
living in metropolitan areas. the proportion reporting
ever having had intercourse ranged from 17% for 15·
year-olds to 70% for 19-year-olds reporting having
had intercourse. ~z The impact of the increasing proportion of males and females who have had intercourse
during adolescence is heightened by the relatively
small number who constantly use contraceptive methods that could also prevent HIV infection and other
STDs. 17• 18• 23 The presence of STDs indicates behavior

l

that places one at risk for exposure to HIV infection.
STD rates in adolescents are high and have increased
over time. Since the early 1960s. the annual numi>er
of reported cases of gonorrhea in teenagers taged 10
to 19 vears 1 has increased dramatlcallv from a total of
4
56 907 cases reported in 1960 to 25S 112 in 1980. "
Females had higher rates of gonorrhea and a faster
rate increase than same-aged males. From 1960
through 1970. 15- to 19-year-old males had a higher
rate of infection than same-aged females. By 1973, the
gonorrhea rate among females in this age group exceeded that of males and has remained conaiaten.UY
higher. In 1987, gonorrhea was reported in 43 of
100 000 persons 10 to 14 years old. in 1028 of 100 000
persons 15 to 19 years old, and in 1527 of 100 000
persons 20 to 24 years old, compared with s749 of
100 000 persons aged 25 years or older.25 However.
when adjusting for rates of semal activity among the
different age groups, 15- to 19-year-olds actually have
the highest gonorrhea rates of any age group.26
Other features of adolescent semal behavior may
influence the risk of HIV transmission in this population. Receptive anal intercourse has been demonstrated to be an important risk factor for transmission
of HIV infection. Anecdotal evidence suggests that
anal intercourse may be practiced frequently among
some groups of adolescents as a method of avoiding
pregnancy and of "maintaining virginity." In a recent
study among African-American and Hispanic innercity adolescent females. 25% acknowledged having had
anal intercourse.27 Because homosemal and bisexual
activity has been the major mode of HIV transmission.
adolescent males engaging in sex with other males
may place themselves at considerable risk of exposure
to HIV infection. This may be particularly true since
homosexual adolescent males who have intercourse
tend to have older male partners.26 Based on the
Kinsey data from the 1970s, approximately 10% of the
male population is predominantly homosemaL '.19 However, studies have described 17 to 35% of males having
bad homosemal experiences during their lifetimes.
Regardless of eventual sexual orientation, the earliest
semal experiences of many adolescent males are homosexual in nature. 1a. 30
Leu information is available about IV drug use
among adolescents; however, this is clearly an important risk factor. In a national survey conducted in
1986 of approximately 15 200 high school seniors attending 129 schools, 1% reported ever having used
heroin and 16.9% reported ever having used cocaine.
The proportion of students injecting these drugs is
not known. Drug use can begin very early. Of eventual
users of these drugs, 10% reported first using heroin
and 1% reported first using cocaine in the sixth
grade.J 1 A 1987 national survey of HIV -related knowledge, beliefs. and behavior provided information on
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drug use from four of the participating sites. The
proportion of students reporting ever having injected
cocain, heroin, or other illegal drugs ranged from 2.8
to 6.3%.a2 Since only students enrolled in school were
included in these surveys, these figures probably underestimate drug use among adolescents. The crack
epidemic will very likely have an effect on HIV transmission. Although crack use by itself has not been
directly linked to the spread of HIV, increased highrisk semal behavior that often accompanies crack use
has been associated with an increase in STD rates and
will undoubtedly have a similar effect on HIV transmission. 33. 34 Additionally, injectable forma of cocaine
and heroin may accompany crack use and increase the
mk of HIV transmiuion.3$ It is also important to keep
in mind that alcohol and marijuana use, which are
more prevalent than use of opiates among adolescents,
can lead to impaired judgment about sexual choices
· ., · and increased risky se:r:ual behavior.3a. 31

.. ,

KNOWLEDGE. ATTITUDES. BELIEFS AND
BEHAVIOR

Although adolescents are at risk of becoming in·
fected. with and tranam.itting HIV, many of them are
misinformed about their risk of tran.smiuion. Information on adolescents' HIV-related knowledge. attitude, beliefs, and behavior is available from several
studies.37-43 Although these studies vary considerably
in their methodologies and populations surveyed, cer·
tain common results were found. Overall, most ado·
lescents knew that se:r:ual intercourse and sharing
needles for IV drug use are the main modes of HIV
transmission. Adolescents were somewhat more likely
to associate HIV transmission with homosexual as
opposed to heterosexual contact. The most common
misconceptions were about acquisition of HIV through
caaual contact and blood donation and believing that
one could tell if a person was infected with HIV. Even
with adequate knowledge, many adolescents fail to
translate this knowledp into appropriate behavior.~7· 37-40 Although some adolescents report changing
their behavior because of fear of AIDS. few reported
changes in kinds of behavior that would decrease the
risk of exposure to HIV (i.e., abstinence or condom
use •· Perceived risk was found to be associated with
decrease in risky behavior. Most adolescents expressed
an interest in learning more about HIV infection and
AIDS: schools and health professionals were preferred
sources of information for many.n •2. 44
RESEARCH NEEDS

Knowledge related to AIDS and HIV infection in
adolescents has definitely grown rapidly. Our knowledge in this area. however, still lags behind what is
known about the disease and infection in young children and adults. Further information is needed about
the clinical. epidemiologic, behavioral. and prevention
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aspectS of HIV infection among adolescents. For example, very little is known about the natural history
of HIV infection in adolescents. Evidence from studies
of HIV infection in people with hemophilia suggests
that infected adolescents may have a lower rate of
progression to AIDS or a longer incubation period and
may tolerate severe immunodeficiency better than
adults. 45 More data from a wider range of patients are
needed to better understand the natural history and
to determine whether factors unique to adolescence,
such as the hormonal changes accompanying puberty,
influence the clinical course of infection and progression to AIDS. 1
Further work should be done to evaluate healthcare models for adolescents, particularly since many
of those at highest risk may have limited access to
health-care facilities. For many adolescents. their status as legal minors may act as a barrier to obtaining
needed services, such as drug treatment. HIV testing,
and. in some states, STD treatment. 44 HIV-infected
adolescents have had very limited access to clinical
trial&. since research protocols for adults often exclude
minors and pediatric protocols are generally designed
for children younger than 13 years of age.
Epidemiologically more data are needed about distribution of risky behavior among all adoleecenta and
about which subpopulations of adolescents are at highest risk. Of particular interest is the impact of the
crack cocaine epidemic on HIV transmission through
increaaing semal and other risk-taking behavior. As
more data are gathered from seroprevalence surveys
and AIDS case reporting, models are needed to provide
better estimates of the number of HIV-infected adolescents and to monitor the trends. Data on the antecedents of high-risk behavior in adolescents are
critically needed to prevent these kinds of behavior
from developing. Evaluation of ongoing intervention
efforts will provide information to improve our ability
to prevent HIV infection.
PREVENTION

Preventing HIV infection among adolescents will
require new, creative approaches. AIDS education
combined with appropriate HIV counseling and
testing" are critical elements for preventing new HIV
infections in adolescents. AIDS case data indicate that
educational messages should cover all risky behavior,
be targeted to males and females of all racial and
ethnic groups and sexual orientation, and begin as
early as the preteen years. Public and private schools
have a strategic role in educating young people about
AIDS and specific actions they can take to prevent
infection. CDC recently published guidelines for comprehensive school health education to prevent the
spread of HIV infection. 44 However, many adolescents
will not be reached by school-based education programs. In 1984, about 615 000 adolescents ages 14 to
-4 , • ..f

17 years and 1.1 million 18- and 19-year-olds were not
enrolled in school and had not comoleted high
school. 1 ~ These adolescents wiil need to ~eceive th~ir
educational messages from other sources.
Additionally, prevention efforts must go beyond
imparting information and must help adolescents develop the motivation, attitudes. and skills to avoid
behavior that places them at risk for HIV infection.
Clearly, adequate knowledge alone does not always
translate into behavior change. Innovative prevention
models that reach adolescents in an acceptable and
appropriate way must be developed.
Preventing further transmission of HIV infection
and AIDS in adolescents will depend on the combined
efforts of persons who have contact with adolescents.
Pediatricians and other l!e,..lth profesaionala who understand and deliver care to adolescents can play a
critical role by providing appropriate counseling and
prevention messages. Counseling and ascertainment
of potential risks for HIV infection should be approached in a straightforward. nonjudgm.ental manner
(see Chapter 38). Undemanding the epidemiology of
AIDS in adolescents may help identify those adolescents at highest risk for HIV infection. However,
clinicians should remember that any adolescent. particularly one who is sexually active, can be at risk now
or in the near future. Counseling should include information about risk reduction and waya of protecting
oneself from HIV infection and, if infected, of reducing
the risk of posaible transmisaion to one's sexual or
needle-sharing partners. This second component of
counseling is often overlooked and may be particularly
important for adolescents who acquired HIV infection
from blood or blood products.;;o These adolescents
were not infected as a result of their behavior but may
place current or future sexual or needle-sharing partners at risk of exposure to HIV.
Targeting adolescents whose behavior places them
at high risk of ·iiV infection is important. However.
providing infor .ltion and helping to build skills that
will prevent otner adolescents from beginning such
behavior is also crucial. Information about appropriate
prevention education and approaches for youth is
emerging but still limited. " 1 ~ Helping preadolescents
and adolescents to develop safe sexual behavior and
to avoid drug use will have a major impact on the
future of the HIV-AIDS epidemic. Hopefully, efforts
to decrease the transmission of HIV will also have a
major impact on other important problems in this age
group, including teenage pregnancy, sexually trans·
mitted diseases. and drug use.
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:pidemiology of Women With AIDS in
.1e United States, 1981 Through 1990
. Comparison With Heterosexual Men With AIDS
jd V. Ellerbrock. MD; Timothy J. Bush; Mary E. Chamoerland. MO. MPH: Margaret J. Oxtoby, MD

the United States, women account for an increasing number and percentage
adults with the acquired immunodeficiency syndrome (AIDS). Overall. 51% of
>men with AIDS were infected through intravenous drug use and 29% through
!terosexual contact; the proportion of intravenous drug users decreased, while
e proportion attributed to heterosexual contact increased, between 1986 and
190. Most women with AIDS were black or Hispanic (72%); residents of large
etropolitan areas (73%), especially cities along the Atlantic coast; and of
productive age (15 to 44 years} (85%). However, the proportion of women with
DS reported by smaller cities and rural areas has increased from 22% in 1986
28% in '1990. The male-to-female ratio of heterosexuals with AIDS has
mained about 2.4:1 since 1987. A comparison of women with AIDS to hetero~xual men with AIDS showed that these two groups were similar by age, race,
1d geographic distribution. Also, survival times from AIDS diagnosis to death for
omen and heterosexual men with AIDS were not significantly different.
<JA.\IA. 1991:265:29il-2975l

I~CE 1981, when the first cases of the
cquired irrununodeficiency syndrome
~IDS) in women were reported in the
;nited States, the number of women

.. \.. ' - · - - - - :--·---.J-1! ... ! ... - -.... ·-=·-·'..::........
............. ¥·-·-·"'·"'-'""'•"'-""-'•• ... J • - .....,
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~IV) infection has increased rapidly.

n 1988-more than 1800 (0.7%) women
rho gave birth in New York State were
IIV seropositive, and in some areas of
~ew York City more than 2% of child.earing women were infected with the
irus.= As a result of this increase. HIV
Las had a major impact on morbidity and
nortality among young women. By
.987, AIDS had become the eighth leadF'Om !r.e Oovosoon ot HIV/AIDS. Center tor 1nrec:10us
:oseases Center$ lor Otsease Control. Attanta. Ga Or
:hamoenano os tv:11t Wltl'l !l'le Hosootal lnfecuons P:olram. Center tor lntecuous 01seases. Centers tor D•s·
tase Control.
Reonnt reauests to Centers tor Disease Control 1&::C
::,tton Ro NE. Mailstoo E-45. Atlanta. GA 3C333 :Cr

ing cause of death in women of reproductive age (15 to 44 years) in the
united States and the leading cause of
death in black women of the same age
g':"~~;. :.;: ~: ~,,.. ~·v~·!: :.ud :\' c-;,~.! ~~. ~~::. !~
addition, since HIV-infected women
tran-<>!'l'tit the virus to about 259C to 35%
of their children during pregnancy or at
delivery, increasing HIV seropre>-a·
lence rates in childbearing women has
resulted in a gro\\ing number of children \\ith HIV infection and AIDS ... , In
1989, an estimated 6000 infants were
born to HIV-infected women in\ the
united States. and probably about 1500
to 2000 of these infants were infected
perinatally.'
understanding the epidemiology of
HIV infection and AIDS in women is
essential for developing better public
health strategies and allocating re3

<:nnrrP" mnrP pffpctivelv to ore\·ent the

spread of HIV to women and children.
National AIDS surveillance provides
information on current HIV-related
morbidity and mortality and continues
to be essential in accurately predicting
national trends and patterns of HIV inf.:ctior. in the l:nited S~at.:s! In this
article, we analyze surveillance data for
women \\ith AIDS in the United States
and compare the epidemiology of AIDS
in women \\ith that in heterosexual
men.
METHODS

This descriptive analysis reviews
AIDS cases in women reported to the
Centers for Disease Control (CDC)
through December 31, 1990. The CDC
AIDS surveillance system includes all
50 states. uS territories, and the District of Columbia. Cases of AIDS are
initially reported to local and state
health departments. which in turn for;;·OJ.·.::! r.:pvi.·~s ;;-ithou:. f.terson.:.l idt::n~if.
ers to the CDC. '"I! Reports are updated
to record date of death for persons who
have died. The CDC defines a case of
AIDS as an instance of a disease, a:
least moderately predictive of a defect
in cell-mediated immunity, occurring
\\ith HIV infection or no known cause
for diminished resistance to that disease.13 Increased use of the HIV an•ibody test and greater understanding of
the spectrum of HIV-related diseases
led to a re\ision of the case definition in
1987 that expanded the list of diseases
indicative of AIDS and included some
diseases diagnosed presumptively (ie.
\1.;thout histologicai or laboratory confirmation). Each c~e of AIDS reported

.!V ·it.

in women and heterosexual men was
placed in only one exposure category.
by using the follO\\ing hierarchical order: (1) intravenous drug use, t2l hemophilia or other coagulation disorder,
(3) heterosexual contact \\ith a person
at risk for AIDS, (4) transfusion \\ith
blood or blood products, and (5) undetermined risk. Women \.\ith more than
one reported mode oi exposure to HIV
are classified in the exposure category
listed first in the hierarchy. Women
~lith AIDS were compared v.ith heterosexual men \\ith AIDS, who were defined for this analvsis as men whose reported risk behavior did not include
sexual contact with other men. Adult
AIDS natients were 13 vears of ae-e and
older, -and pediatric ~>\IDS patients
were less than 13 years of age.
Data were analyzed by year of report.
Since only 1020 AIDS cases in women
were reported during 1981 through
1985, trend anah·s~s of exoosure categories were perf;r:-:-t~d on cases reported prior to 1986 and then for each subsequent year.
Geographic analyses were based on
place of residence at the time of AIDS
diagnosis. The denominators for rates
were calculated from 1989 population
estimates by age, sex, and race. The
1989 estimates are an extension and
modification of white/nonwhite age estimates for 1982 and 1984 produced by the
US Bureau of the Census from 1980 census data. The denominators for rates of
heterosexual men are estimates of the
adult male population, including homosexual and bisexual men. :Metropolitan
areas are defined as the .Metropolitan
Statistical Areas for all areas except the
six New England states. For these
states, the New England County )!etropolitan Areas are used. )letropolitan
areas are named for a central citv in the
:.letropolitan Statistical A.rea ~r New
England County flletropolitan Area.
and they may include several counties
and cross state boundaries. Kaplan:.Ieyer survival analysis was calculated
by using AIDS cases and deaths report. ed through December 31, 1989. Persons
V~-ith no date of death on the report as of
December 31, 1989, were presttrned to
be alive. Statistical testing included
analysis by X2 tests for associations and
linear trends. Unless othernise stated,
all trends or comparisons were significant at P<.OOL
RESULTS

As of December 31. 1990, a total of
15 493 (10%) of the 158 279 adults reported V~-ith AIDS in the United States
were women. Between 1985 and 1990,
the percentage of adult AIDS cases that
occurred in women increased from 6. 6%
2972
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Taole 1.- Numoer and Percentage ot Reported Cases ano Mate-to-Female Ratto tor Women anc
Heterosexual Men With AIDS tn the Umted States.
No.
Year

198J

ot Casest

Women

1981t
1982

(~·.1

Oy Year. 1981 Througn 1990'

Heterosexual Men

Ratto ot
tieteroscxual
'-len to women

6 !3 2\

24 (12 7\

~7.4)

151 (23.6\

3.2

14-1!70\

4.35 !21.01

30

47

1984

285 !6 4\

·866 (19 41

30

1985

538 (6 6\

1553 (1901

2.9

1986

960 (7.5\

2523 {19 3\

26

1987§

1701 (8.11

4127 (19.7)

24

1988

3263 (10.41

7956 (25.3)

24

1989

3639 (10.5\

8836 !25.61
11 632 (27 .3\
38 103 (24.1)

24

1990
Total

4890 (11 5)

15 493 (9.8)

24
25

• AIDS ondocates the acQuored ommunodelielency synorome.

tThe oenomtnator for the percentaoe ot cases os au reoonea AIDS cases. including l<.>nY..seJ:ual anc '"sexuat
men. for tne resoectJve year.
iReoorung began on mo0-1981.
§The case oehnrtoon changed in Septemoer 1987

"AIDS indicates the acQUifed immunodefiCiency synorome.
tPer 100 000 women (1989 inteteen.SaJ populaliOO estimate).
iPer 100 000 men. tneluOing hOmOsexuals and bosexuaiS (1989 imereensal populatiOn estimate).
§Women vs heterosexual men. P<.OOt.
!!Women vs heterosexual men. P< .OS.
~Percentages have been rounded to the nearest whOle numbers.

to 11.5% <Tabie 1). During the same
period. the percentage of cases in heterosexual men also increased. Since
1985. the largest percent increase of
AIDS cases in both women and heterosexual men occurred between 1987 and
1988. Of the AIDS cases reoorted in
1988. 1322 (41 Lj() cases in women and
3269 (41%) cases in heterosexual men
met only the 1987 case definition. suggesting that at least part of the increase
in AIDS cases in these two groups in
1988 was due to the change of the AIDS
case definition. Thus, while the proportion of cases in heterosexuals increased
from 28% in 1987 to 39% in 1990, the
male-to-female ratio for heterosexuals
with AIDS remained relatively constant at about 2.4:1.
Overall. sliszhtlv more than half of the
women \\ith -AIDS were black, whiie
about one fourth were white and one
fifth Hispanic (Table 2). As a result,
Hispanic and black women had cumulati\·e incidence rates 8 and 13 times. respectively, that for whites. Between
1986 and 1990. the absolute number of
women \\;th AIDS increased in all racial

1[j5

and/or ethnic groups; however. the proportion of women with AIDS who wen
black did not change s;rruficg,nrly, whi !
the proportion who were hispanic tr.
creased from 18% to 229C and the pro
portion who were white decreased fror.
28'i'c to 25/!c. Although women w::.
AIDS had a larger prspor:ion oi biac~:
and a smailer proportion of Hispar.1c
than heterosexual men v.ith AID~
overall these t\vo gr0ur- had simi' :u- n
cial distributions. Heterosexual me
who were Hispani~ or black had ..:u:1;;,:_
tive incidence ratr.:; 9 F··d 12 times. :-•
spectively, that for wh!:es.
At the time of diagnosis of AIDS. ::
mean and median ages for women we.
36 vears and 34 T.'L'S, re:e-;:>ectivei
compared with 38 y~ars and 36. years !~
heterose:cual men. About 1C1c of bo
women and heterosexual men \\i
AIDS were 13 to 19 Y""L.-s of age ar t
time of diagnosis tTable 3). A .....-g
proportion of women compared "'~
heterosexual men were in their ~
when diagnosed (27% vs 16%). a
many of these women were likely infe
ed as adolescents. Overau, 85% of we
Women With AIDS-E!lerorocK

rith AIDS were of reproductive age
.o 44 years) at the time oi diagnosis.
ases of AIDS in women have been
:nosed in residents of all 50 states.
10 reporting areas v.ith the highest
1ulative incidence rates of AIDS
~s in women included Puerto Rico,
.1t states located on the Atlantic
st, and the District of Columbia (Fig). These 10 areas reported almost
ee fourths (12%) of the AIDS cases in
men. The geographic distribution of
cerosexual men with AIDS by numr of cases and cumulative incidence
te was similar to that in women. As of
~cember 31, 1990, 26 657 (70%) of
103 heterosexual men v.rith AIDS
ere reported from the same 10 reportg areas. Puerto Rico had the highest
1muiative incidence rate of AIDS
ISes in heterosexual men (224 per
)() 000 adult male population), followed
y New York (179 per 100 000), New
ersey (158 per 100 000), Washington,
>C (154 per 100 000), and Florida (75
1er 100 000). New York had the largest
1umber of both women (4830) and het!rosexual men (12 427) with AIDS. In
Lddition, New Jersey had the second
argest nwnber of AIDS cases for these
:wo groups (2120 women and 4782 heterosexual men), followed by Florida
fl923 women and 3802 heterosexual
men).
At the time of diagnosis, about 73% of
women with AIDS were residents of
large metropolitan areas v;ith populations over 1 million. Another 21% were
from small-to-medium metropolitan areas (population 50 000 to 1 million), and
the remaining 5% were from nonmetropolitan areas (population <50 000).
Large metropolitan areas also had the
highest cwnulative incidence rate of
women with AIDS (25 per 100 000 women), followed by small-to-medium metropolitan areas (nine per 100 000) and
nonmetropolitan areas (four per
100 000). However. between 1986 and
1990, the proportion of women with

Table 3.- Number and Percentage of Reported Cases lor Women and Heterosexual Mef! With AIDS tn the
Untted States, by Age and Rtsk Groups. as of December 31, 1990•
No. <~•) of ~ses
Women

Group
Age group. y
13·19

157 {1)

280 (1\

20-29

4171 (27)

6090 (16)

1.5

30·39

7245 j47)

18541 (49)

2.6

40-49

2298 115)

8536 122\

3.7

;;;50

1622 f11)

4656 (12)

2.9

Ai$1< group
IVDU

18

7858 (51)

26 537 (70\t

3.4

Sex partner of IVDU

3\llJ (21)

1287 (3\t

0.4

High·nsk. non·IVDU sex partner

1337

i?lt

0.4

Transfusion~

(9)~

597

553 (4)

1483 (4):'

27

1466 (9)

3604 (9)

2.5

Born in panern II counlty§

1096 (7)

Undetermoned

15 493 (100)#

Total

4595 (12\t

42

38 103 (100)

2.5

• AIDS ondiClltes 11\e ac:Quored tmmunodehoency synorome: and IVDU. ontravenous dl\lg user.
tWomen vs heterosexual men. P< .001.
;The sex pat111ers ot tnese women •nctuded 498137">) bisexual men. 175 (13%)...,.., wllo ~eeeweo transtusiOfls
s.nce t9n. 53 (4"'•\ men wllO _,. born on a panern II country. and 611 (46"1.) men infected wrth human
immunodeficiency vorus with no ,.ported ns1< factor.
§In these countnes. most of ll'le reported AIDS cases occur on heterosexuals. and lhe male·to-lemale raoo iS
lll)pr'Ox~~T~;~tely 1:1.
1\Women vs heterosexual men. P < .0 1.
,Includes adutt nemopl'uttacs.
#Percentages nave been rounded to lhe nearest wllofe numDerS.
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tan and nonmetropolitan areas increased from 22% to 28%. For heterosexual men with AIDS, both the
percentage of cases and the cumulative
incidence rate v.-ere highest (71% and 62
per 100 000 men, respectively) in large
metropolitan areas and lowest (79C and
12 per 100000) in nonmetropolitan
areas. Since 1986, the proportion of heterosexual men 'lhith AIDS reported by
small-to-medium metropolitan and nonmetropolitan areas increased from 249C
to 299C.
Slightly more than half of women 'lhith
AIDS were intravenous drug users fTa., r- ~,;~;~;"!1 a!mo~t one third

Heterosexual Men .

Ratio of
Heterosexual
Mento Women

Cumulative in<:tdence rates of cases of the acauored ommunodeficoency synorome 1n women oy state of
19stdence per 100 000 women. Uhlled Stales. through December 31. 1990.

were sex partners of intravenous (IV)
drug users and 99C were sex partners of
men with other risk factors. lri comparison, heterosexual men \\ith AIDS had a
larger proportion of IV drug users than
women with AIDS (70lic vs 51%}. while
a smaller proportion of heterosexual
men with AIDS reported sexual contact
\\ith high-risk partners (517c vs 29%).
:.\lore than two times as many women
, .. --. ..

,.

-· .. ...: .. ;...

-o ....

~,.:.\..

AIDS. reported heterosexual contac:
high-risk partners. The proportions of both groups were not sigrjficantly different for those who received
transfusions of blood or blood components or were born in a countr: \\ith a
high rate of heterosexual trans~ssion ..
From 1986 to 1990, the number of
women with AIDS who were I\' dru~r
users increased. but the proportion
'''""'1"!1 v:i'~ .l_ IDS who were IV drJI!
\~ith

oi

15G

Table 4.-Percentage of Reoorted Cases tor Women and Heterosexual Men With AIDS in the Un.ted States. by R•sk Group and Year. as ot De<:embe• 31. 1990'
A1sk Group
IVDU
Women

:51985

1986

1987

1988

1989

1990

56

50

50

Sol

52

.!.C

Heterosexual men

72

7'2

68

7J

70

66

Sex panner ot IVDU
Women

14

20

20

21

21

22

3

3

4

.:

9

7

9

10

2

2

4

2

Heterosexual men
H.gn-nsk. non-IVDU sex partner
Women
Heterosexual men
Born 1n pattern II country
Women

8
<

1

Heterosexual men

,,7

Transfusion reop1ent
Women

10

Heterosexual men

9

e

Undetermmeo
Women
Meterosexual men

6

4

6

5

3
3

,

13

10

13

15

10

5

4

~

6

;,

;

·~

0

-··--·

--:1

~

9

8

---·
-

'AIDS indiCates tne acquoreo 1mmunoclehC1ency synorome; and IVDU. Intravenous orug user.

users decreased (P = .01) (Table ~).
During the same period, the proportions of women with both IV dru11:-usin~r
and other high-risk sex partners in:
creased ( P =. 05 and P = . 02, respectively). Similarly, the proportion of heterosexual men v.ith AIDS who were IV
drug users decreased from 72'} in 1986
to 66% in 1990, while the proportion
\~ith high-risk sex partners increased
from 3% to 6%. In addition. during the
same period the proportions of both
women and heterosexua: men \\ith
AIDS who were transfusion recipients
or who were born in countries \\ith high
rates of heterosexual transmission
decreased.
Survival times from AIDS diagnosis
to death for 10 558 women and 26 362
heterosexual men. reported to the CDC
as of December :31, 1989. were not statisticallv different. The median survival
time from AIDS diagnosis to death for
women was 9.8 months. comoared with
9.:3 months for heterosexual men. After
a diagnosis of AIDS. the 3-year sun·h·al
rate was 20% for women and 19</c for
heterosexual men.
COMMENT

In the 'C'nited States. \Vomen account
for an increasing number and ~rcent
age of adults with AIDS. About 51% of
women with AIDS were infected
through IV drug use and 29% through
heterosexual contact. )lost women with
AIDS were young, black or Hispanic,
and residents of urban areas on the Atlantic coast. Although most women with
AIDS were reported as residents of
large metropolitan areas. the proportion reported by smaller cities and rural
areas has increased since 1986. Additionally, a comparison of \vomen v.ith
AIDS to heterosexual men v.ith AIDS
2974
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showed that these two groups were similar by age, race, geographic distribution. and sun-ivai time from AIDS diagnosis to death.
Since severe, clinical manifestations
of HIV disease are required for the diagnosis of AIDS and the median time for
progression from HIV infection to
AIDS may be as long as 10 years, patients with AIDS represent only part of
the HIV epidemic." Persons infected
v.ith HIV who are asymptomatic or
have HIV-related symptoms not included in the AIDS case definition represent
the other, much larger part of the epidemic. In 1989, an estimated 1 million
persons were i~fected v.ith HIV in the
Cnited States.' Although the number of
HIV-infected women at present is not
known, HIV seroprevalence surveys
and studies suggest that the epidemioiogy of women who are HIV-infected but
do not ha,·e AIDS is similar to that of
women v.ith AIDS. For example. the
highest rates of HIV infection in women
have been found in IV drug users. \\ith
rates greater than 10% reported primariiy from states in the i'ortheast. ·'"
State\\ide screening programs of neonate:: for passively acquired maternai
HI\" antibody found much higher rates
in states located along the Atlantic
coast, where seroprevalence was highest in inner-city areas and lowest in rural areas.:.::.:, Routine HIV antibodv
testing of female applicants for militar:.·
service found the hi~rhest rates in ~ ew
Jersev, Puerto Rico:~ew York. Washingto~. DC, and :>Iaryland: the rates in
Hispanic and black women, respectivelv. were four and se,·en times that of
~-hite women in this group."
:\lale IV drug users \\ith AIDS accounted for about 80% of the absolute
difference between the number of AIDS
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cases in women and ~he numoer o~ caH:-5
in heterosexual men. This difference i;:
probably not the r~sult of distincti\'e
drug-use behaviors by either group. because HIV seroprevalence rates among
heterosexual IV drug users do not differ
significantly by gender."' Thus, the
greater number of AIDS cases in heterosexual men, as compared with women, is most likely the result of the larger
number of men who are estimated to use
IV drugs.:'
The hi11:her number of women \\itr
heterosexuallv transmitted AIDS w~
probably the -result of several iactor~
Since most IV drug users and virtual!;
all hemophiliacs are men and some me1
with HIV infection acquired througi
sexual contact v.ith other men are bisex
ual. women in the United States ar
currently at hig!1er ru:~ than men c
encountering an HIV-infected hete;c
sexual partner. In addition. ::eve!'l
studies of couples v.ith one infec:e
partnPr :uggest tL:.:. :;he rel~:1ve e:f
ciencv of sexual transmission of HI'
from· male to female may be greatE
than from female to male. ::..:1
Several case histories of possible f·
maie-tr female sext•'ll transmi:::sion
HIV rave heen renorted. "·.:.; Womt
v.i .. n AID:: .-.-ho reJ._,ned sex~<.i rei
tions only v.ith a female partner sir,
19i7 represented about 0.8% of Ali
case.: r women repor~ "d to the Cr::
through September 30, 1989.-'' ~inei
five percent of these women with Ali
were IV drug users. while the rema
ing 5% were recipients of blood or bic
prone: ·ts. · · J ca:::- ·in ·:!'leA If'~ 51·r;E
lance uat.aus.se i1ave du::ur•. -::.h€.~
male-to-female transmission.
)lore knowledge about the nat-.:
historv of HIV infection in womer:
needed. A previous study sugge::
.v'omcn Witr. f.J .05-E'Ier::lrcc~. ·

he median sur.
" from
diagnosis to deac ..
· -'norter
men than in rr;~_
·ays for
nand 357 days l<..
~owev
.s study of 5&'3:~ __
- ·n AIDS
osed in New ·:. _.
')nor to
compared me~:
· -~ homoi!.ls and bisexu.,..
. women.
ivai in hornost.·..
· ~ bisexual
is longer than .
·r.her risk
tps. In part, tr, ..
·~d to the
ter percentage •:
···<>xual and
~xual men witr:
sarcoma,
ch has a longer
:ime than
er opportunist;.
· ·~ Survival
llyses based 0.
ance data
mid be interJ.n
· ·n caution,
•Ce the report1r:;.
--~for AIDS
ses is known tu .
"')iete.
Also,
·th the proport:·•·• diagnosed
death and u.,
--: reporting
~aths may vary ;.. ..
-·«groups."
In the Uniteo •.
'{tlOnal AIDS
u.rveillance is at.
":stem. Local
.nd state healtr.
~~nts identify
UOS cases pnn.~
·
---,ugh
frequent
:ontact v.;th hu., .....
-rj other health
:are provider::;:
• other methods, such as rev ..
: ''>spital admissions and deat.
used. Overall, '-~ . ·'~ates, are also
rt, to 90% of lifethreatening ~:·,
~-.lc HIV infec-

tions have been ascertained throug-h
AIDS surveillance."' At present, few
data are available that quantify underdiagnosis or underreporting m different
groups, including women and heterosexual men IIlith AIDS. Differential
completeness of AIDS case reporting
for women and heterosexual men 'll.ith
different demographic characteristics
and risk beha\iors could potentially bias
data obtained through AIDS surveillance, thus affecting the validity and
generalizability of the conclusions of
this report.
To improve surveillance. the AIDS
case definition was revised in September 19Si to include several additional
AIDS-indicative diseases, such as HIV
encephalopathy and HIV wasting syndrome. and some presumptively diagnosed diseases. such as Pneumocyst1s
carinii pneumonia. A higher proportion
of persons who met only the 1987 case
definition were female, black or Hispan·
ic, or IV drug users compared Y.ith
those meeting the earlier case definition."' However, many of these persons
probably would have developed conditions included in the pre-1987 case definition and been reported at a later date.
Although additional AIDS cases were
reported because the case definition

was revised in 1987. the ~pidemiologic
trends for AIDS cases in women and
heterosexual men that were significant
prior to the revision continued after the
revision.
Mortality statistics, AIDS case surveillance, and HIV seropre~-alence surveys all document the increasing impact
of HIV on the health of women in the
United States. Through education and
counseling, uninfected women can learn
to protect themselves from HIV infection, and those with high risk behaviors
can be referred for treatment of drug
addiction and/or sexuallv transmitted
diseases that contribute to transmission
of HIV. For women alreadv infected
with HIV. recent advances i~ therapy,
including zidovudine and other antiretroviral agents, as well as prophylactic
measures such as pentamidine isethionate to prevent P carinii pneumonia.
suggest that early recognition of HIV
infection with medical interventions for
persons showing evidence of immunodeficiency can delay HIV-related morbidity. Clearly, providing all persons at
risk for HIV infection readv access to
education, counseling, and HIV testing
and appropriate medical follow-up must
be health care priorities.
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Researchers waking up
to needs of women with HIV

Women and HN: Feeing the
Epidemic, a conference on
women and HIV, will be held
from 8:30 a.m. to 6:30 p.m. on
Saturday, Nov. t, at the
Faculty Center of UCLA.

By STEPHAN KORSIA
with AIDS
are finally beginning to be heard.
At this year's
7th International

The conference, cosponsored by AIDS ProJect
Los Angeles, Ia designed for
women with HIV and anyone
Interested or Involved with
the Issue. Morning
presentatlona on toplca auch
as epidemiology, medical
Issues and prevention will be
followed by an afternoon of
workshops on topics auch aa
actlvlam, safer sex , living
healthy, legallssuea,
pregnancy and aubstanca
uae. Guest apeakera will
Include Eunice Dlaz, M.S.,
M.P.H., of the National
Commission on AIDS and
Mark Katz, M.D. of Kalaar
Permanent• Medical Center.
Presentations will be made
In English and Spanish.
Donations of $15 or more
will be appreciated but not
required.
For Information, call
Lori Levine at Being Alive/
People with HIV/AIDS Action'
Coalition, (213) 667-3262 or
Jeffrey Fricke at (213) 8253596. Callers who want
Information In Spanish may
call Angle Martinez at
AIDS ProJect Loa Angeles,
(213) 962-1600, Ext. 198.

in Florence, Italy, several
studies focused on health
issues specifically encountered
by women with HIV disease.
These studies confirm what
AIDS activists have been
insisting for years: Women
with HIV suffer from frequent
gynecological manifestations
with symptoms that are often
worse than those observed in
HIV -negative women.
Common symptoms
The two most common
manifestations seem to be
genital warts, due to the
infection by the Human
Papilloma Virus (HPV) and
cervical cancers. Both these
infections benefit from
patient's diminished immune
status, and seem to help each
other's development.
A study presented in
Florence by Dr. Katherine
LaGuardia from New York
Hospital shows that 61 percent
of female patients with no
AIDS symptoms and fewer
than 200 T4 cells per mm3
(cubic millimeters) suffer from
cervical cancer, versus 38
percent of patients with more
than 200 T4 cells per mm3. In
92 percent of the patients
studied, these cancers are
associated with genital warts.
An analysis of21 studies
shows that HIV -positive
women are five times more at
risk to develop cervical
cancers. These results clearly
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indicate the need for Pap
Smears and gynecological
examinations every six months
for women with no AIDS
symptoms and every three
months for women who
experience symptoms.
Genital warts seem to
appear mainly in women with
fewer than 250 T4 cells per
mm3, and cervical cancers are
more frequent in patients with
fewer than 150 T4 cells per
mm3.
HIV-positive women also
seem to suffer from a higher
susceptibility to sexually
transmittable disease, especially genital ulcers and Pelvic
Inflammatory Disease (PID).
The cervical inflammation that
develops during these infections is responsible for an
increase in the secretion of
HIV particles in vaginal
fluids.

wasting syndrome as well as
urinary and neurological infec-

tions. Irregularities in the
menstrual cycle, as well as
loss of sexual drive, have also
been reported.
Despite earlier diagnosis
and antiviral therapy, women
with AIDS still have a shorter
survival time. A study
conducted in San Francisco,
reported that an average of 11
months passes from diagnosis
to death in women AIDS
patients, versus an average of
15 months for male patients.
Impact of pregnancy
The effects of pregnancy
on the progression of HIV
disease are better known.
In patients with no AIDS
symptoms, pregnancy does not
seem to have any negative
consequences, except for a
possible increased susceptibility to bacterial lung infections,
which disappear a few months
after delivery.
nterestingly, no study
For women with HIV
was presented in Florence
regarding the incidence of symptoms, consequences seem
to vary greatly, depending on
recurrent yeast infections
the T4 cell counts and plasma
in women with mv.
levels of p24 antigen, a viral
This topic is particularly important because clotri- protein. Women with HIV
symptoms seem to give birth
mazole vaginal creams, the
standard treatment for vaginal to a larger percentage of
yeast infections, are now
infected children.
Research on the manifestabeing sold over the counter. If
vaginal yeast infections are an tions of HIV disease on
women remains limited.
early symptom of HIV
disease, repeated use by the
Especially needed is a prevenpatient would delay diagnosis
tive treatment plan against
and initiation of helpful
opportunistic infections geared
toward women. In terms of
therapy.
A study conducted in
new HIV infection, women are
Georgia shows that women
the fastest-growing group. But
with HIV are prone to develop still very little is known about
oesophageal thrush, Mycothe natural history of HIV
bacterium Avium infection,
infection in female patients.
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Women's Treatment and Research Agenda
The U.S. government's negligence towards women in the AIDS crisis has prompted this attempt to
aeate a Women's Treatment Agenda. For the past four years, AIDS activists in different countries
have been raising issues about women's exclusion from research, treatment and educational programs
engaged in by various government agencies. This past year the focus intensified. In May 1990, ACT
UP and other AIDS activists "Stormed the NIH• to demand changes in the way drugs were being
researched by :be federal government. There were many affinity groups at that action, all with
different foci, hopi'Bg to bring attention to the many levels of bureauaatic blundering, blatant
discrimination and unnecessary deaths in the AIDS crisis. One affmity group took over the office of
Dr. Daniel Hoth, Director of AIDS at NIAID. They demanded that the ACfG (AIDS Clinical
Trials Group) form a Women's Committee. One month later Hoth was confronted by AIDS
activists at the VI International Conference on AIDS where, again, the same message was repeated
in the form of a banner reading •NIAID: FORM A WOMEN'S COMMITTEE NOW: Under
continued pressure and with the threat of another sit-in, Dr. Hoth and Dr. Tony Fauci agreed to
meet with women from ACT UP /NY and ACf UP /DC to discuss women's issues. At that meeting
we were met with a great deal of professed ignorance about women's health and HJV as well :.::. with
sexist belligerence. We demanded that NlAID have a Women and HIV conference within 6 weeks.
ACf UP initially participated in planning that conference and in submitting names of women with
HIV and women working with HIV + women in clinics and other settings on a day-to-day basis to be
on the Steering Committee and to be presenters at that conference. ACf UP's representative on the
Steering Commiuee formed to plan the conference, had to resign rather than have ACf UP's name
attached to a process in which the government wrenched control of the conference from the planning
group. In short, NlAID revised the initial structure and content for the conference. Meanwhile,
meetings at the Centers for Disease Control (CDC) with Drs. Noble, Berkelman et aJ, revealed their
intransigence towards changing the CDC definition to include women specific oppommistic
infections, despite available research evidence. We heard no one solid scientific reason for their
refusal. Their perspective was sexist and revealed the double standard pervasive in this pandemic.

rU'St

The first draft of this document was handed out at the
National Conference on Women and
HIV Infection (December 13-14, 1990) in Washington D.C. However limited, we believe it provided
more information than the government bureauaats who were given the opportunity to address the
1500 participants during plenary sessions. Instead of hearing from women with HJV about their
symptoms and issues or from practitioners seeing hundreds of HIV + women daily in their clinics, we
were subjected to an ·AIDs lOr lecture from Dr. Fauci, a presentation on clinical treatments by Dr.
Daniel Hoth who began by saying he had no information about possible clinical treatments for
women since NlAID had not researched any, and a presentation by Dr. James Curan of the CDC in
which he once again refused to admit any problems with the CDC AIDS surveillance definition,
although it does not contain one single woman specific O?pommistic infection.
Since the conference NlAID has formed a Women's Health Committee, but it remains to be seen
what will be accomplished for women through that system.
In December 1990 we did another action at the CDC and have begun a campaign to obtain 1,000
endorsements for a call to change the CDC defmition of AIDS. We have also continued to work on
this agenda.
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W-! still consider it a work in progress though it certainly presents far more directions for research,
education and treatment than what has come out of government agencies in the past ten and a half
years. This agenda is part of our commitment to pressure the U.S. government until there is a
concerted effort to actu.ally save the lives of women with HIVI AIDS.

ACf UP!
F1GHT BACK!
F1GHT AIDS!
The Acr UP Network Women's Issues Committee
May 1991
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HIV/AIDS: AD International Crisis For Women
The global AIDS crisis has had a devastating impact on women. While this research and treatment
agenda focuses primarily on issues specific to the United States, we recognize the international
dimensions of the AIDS pandemic and are committed to advocating for expanded resources and
treatmeut options for women worldwide.
Globally, according to the most conservative estimates, eight to ten million adults are HIV positive.
Three million, or one-third. are women. The fastest growing number of cases is among women. The
World Health Organization predicts that by the year 2000 the number of HIV positive women will
exceed the number of H1V positive men. Already in sub-Saharan Africa, H1V positive women
outnumber H1V positive men.2 In some countries of Central and East Africa. women and men have
been affected by H1VI AIDS in roughly equal numbers since the beginning of the epidemic. The
number or women expected to be diagnosed with AIDS worldwide during the next two years will
exceed the cumulative total or all the AIDS cases reponed to the Worid Health Organization during
the first decade of the paademic.3

Unfonunat:ely, the response of economically powerful Western nations to the international scope of
the crisis has been deplorable. The United States has scapegoated Third World countries, partic-Jlariy
Haiti and the countries of central Africa, rather than providing adequate medical resources and
financial assistance. By the mid 1980's. many Western scientists and researchers were claiming that
the HIV virus originated in Africa. None of these claims have ever been scientifically substantiated.
Fueled by racism and ignorance of local cultural practices, arguments promoting either the Afric:m or
Haitian "origins" of AIDS were printed in widely read newsmagazines such as Newsweek. .lim, JDd
U.S. News & World Report. In shon. the presence or h.ip rates or HIV inCecdon in certain Third
Worid nations was not treated as a va:ing in&ernatioaal health issue. Instead. :Ureaed cities and
counaies were blamed by the U.S. for •spreading disease• through prostitution and semaJ
promiscuity.-' Thus. women in u.ese nations have been a-ealed as vectors of disease rather than as
individuaJ.s with legitimate health concerns.

In fact, the rapid spread of HIVI AIDS in many of the poorer nations of the world can be directly
linked to lack of aa:ess to basic healthca.re. culturally relevant edue1tional information. JDd sterile
medical supplies. All of which can. in turn, be linked to the extraction and exploitation of IOCll
resources by politically powerful Western nations. The deteriorating economic sicuation in many Thirci
World countries has adversely affected the health status of entire populations. The b.igh prevalence of
HIVI AIDS in many nations is only one life-thre:nening epidemic 3.Dlong many others such as malaria.
malnutrition. and dehydration. All of these life-threatening conditions disproportionately impact
women and their children.

1

"WHO Notes & News." World Hellth Forum. Volume 11. 1990. p. 3-'1.

2 The Futurist. November-December, 1990.
3 Netter, Thomas. ·world AIDS Day 1990; World Health. November-December, 1990.

" Sabatier. Renee. Blaming Others: Prejudice. R~c;. ilnd Worldwide AIDS. P::mos, 1988.
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In every known society worldwide, women are the primary caregivers to children and the elderly.
Women with HIVI AIDS typically tend to the needs of partners, children, and dependent elderly
family members before addressing their own healthcare needs. As the epidemic continues, more and
more women in every country will find themselves caring for sick children and partners and neglecting
their own needs. The burden of care-giving must be more effectively shared throughout families and
communities in order to allow women with HIVI AIDS the time, energy, and resources to care for
themselves.

IDa:nlatioaal Scope or mv1AIDS Crisis
The impact of AIDS varies tremendously from one country to the next. It would be impossible in this
short piece to dOCUIIlent the impact of the pandemic in every country in the world.
Because there has been so much mythology and misinformation about African AIDS promoted by the
mainstream media in the United States, it is necessary to present a more accurate account of the
pandemic on the African continent.
ID Nigeria, for example, there have been relatively few cases thus far. More recently, however, testing
in urban areas suggests that approximately 4% of urban dwellers in Nigeria may be HIV positive.
ID Uganda, on the other hand, approximately 23% of the population has tested positive for the human
immunodeficiency virus (HIV). 5 Some villages in Uganda are comprised of only small children and
the elderly; the vast majority of people between the ages of 20 and 50 have died of AIDS. There are
200,000 orphans in Uganda, and the number is rapidly growing.
The hardest hit African countries thusfar have been, in descending order, Uganda, Kenya, Malawi,
.·
Congo, Ivory Coast, Zaire, Burundi, Rwanda, Zimbabwe, and Zambia.6
The following countries on the African continent have reported a case rate of less than one case per
one hundred thousand residents: Algeria, Angola, Cameroon, Cape Verde, Central African Republic,
Comors, Equatorial Guinea, Ethiopia, Guinea, Lesotho, Lberia, Madagascar, Mauritania, Mauritius,
Mozambique, Nager, Nigeria, Sao Tome & Principe, Seychelles, Sierra Leone, South Africa, Swaziland,
and Togo.
Every region and every continent has reported AIDS cases to the World Health Organization. Less
than 15 countries worldwide have reported zero cases of HIV I AIDS thusfar. Countries reporting high
case rates in Latin America and the Caribbean include: Bahamas, Barbados, Bermuda, Brazil,
Dominican Republic, Haiti, Mexico, and Trinidad & Tobago. In Southeast Asia, India and Thailand
arc experiencing small but growing caseloads which should be of concern to the international AIDS
community. In Europe, Romania, the United Kingdom, Italy, the Netherlands, Spain, and Switzerland
are coping with relatively large and growing caseloads.
There is some evidence to suggest that many countries are underreporting AIDS cases. The CDC in
the U.S. admits to a 40% undercount. U nderreporting can be the combined result of three factors.
FU'St, there may be a reluctance on the part of government officials to acknowledge the growing
epidemic. Second, many countries still have neither adequate resources to provide accurate testing
nor health professionals trained to diagnose and treat people with HIVI AIDS. Fmally, because of the
5
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approximation of the international statistics.

1.65

stigma of AIDS internationally, many people are naturally reluctant to be tested. This is particularly
true for women.

Currently, there are approximately 600 AIDS-related studies under way in Africa. Over half of them
are being directed by researclaers from outside the continent.7 The reality is that the vast majority
or Africans will not benefit from most Western medical advances for two primary reasons. First,
there is no profit in the African market for Western drug companies (and these companies are not
known for their generosity to the poor). Secondly, many drug treatments and trials are designed to
8
address opportunistic infections and HIV-reiated conditions more common in the industrial world.
It is no secret that the clinical manifestations of HIVI AIDS in women and people of color have been
inadequately addressed in the Western industrialized nations. Therefore, many of the research models
being implemented by Western researchers in Africa reflect the same narrow understanding of the
parameters of HIV infection that bas plagued research in the West.
Unfortunately, there bas been very little debate concerning the ethics of research in Africa. Many
Western researchers see cenain countries in Africa and other parts of the Third World, with their
large AIDS caseloads and high rates of transmission, as ideal "laboratory settings" for biomedical
research. A draft repon of the World Health Organization indicates that many AIDS-related research
activities "have been directed solely by the sponsoring country, with little or no input from local
investigators."9 In fact, only about half the AIDS-related studies now being undenaken in Africa
were ever lenown to national AIDS officials when they were begun! Moreover, local investigators are
often exploited by Western researchers wbo use them to gain access to a population group and then
never make the research results available to the host investigator.
Regardless or societal and cultural differences, no researcher should ever be excused from the ethical
obligation to provide dear, accurate, and culturally relevant informed consent. However, some U.S.
researchers have argued that "it makes no cultural sense to have somebody give informed consent the
way we often go about informed consent.• Warren Johnson, a tropical disease researcher at Cornell
Medical Center claims "it's a little naive for us to expect the same procedures we utilize in Manhattan
in an urban, educated population to be meaningful and relevant to a rural, largely illiterate
population...it's not very meaningful to have a thousand sheets of paper with an 'X' on them." 10 This
type of view speaks volumes as to the dangers of Western researchers conducting HIVI AIDS research
in Third World countries.
Unfortunately, few researchers have educated themselves regarding the cultural values, customs, and
languages of the populations from which they are drawing their research subjects. Too many Western
researchers have naively "confused illiteracy with lack of intelligence and even education. You can
always translate technical terms to levels that people will understand and encourage potential subjects
to make an informed choice." 11
7
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Fmally, there is the issue of compensation for participation in research studies. In.one study of
maternal HIV infection they offered a fhotograph of a child to women who participated in their study,
and in another it was a bottle of milk. 1 The rationale used to justify this exploitation of women and
their communities is that "cash compensation would prove too tempting." 13 More needs to be done
to insure that women are adequately compensated for their participation in trials which, after all, are
more likely to benefit the researchers than the actual trial participants in the long run.
The growing international research interest in Africa finally prompted the World Health Organization
and the U.S. Public Health Service to convene a group of researchers and health officials to discuss
the ethical issues. This process began in Annapolis, Maryland in 1990. The idea behind the
discussion was to take a "first step" towards drafting rules that will apply to all PHS-funded research in
Africa and other regions in the Third World. 14
These discussions, not surprisingly, have failed to be inclusive or Third World researchers, health
officials, and people Uving with HIVI AIDS. As activists we must demand that any agenda setting or
ethical guidelines for Western research in the Third World be open to the participation or
researchers, social workers, and people with HIVI AIDS from the countries in question.

There are many actions those of us in the U.S. can take to support and advance the efforts of women
with HIVI AIDS in the Third World.
o Interrogate the research of North American scientists who rely primarily on African women, men
and children as research subjects. What measures are they taking to insure the safer:y.and well-being
of the populations being researched? Are they working collectively with local doctors and social
workers? What cultural assumptions are they making about their research population?
o We often confront researchers here in tlie U.S. with ethical concerns about HIVI AIDS trials
designed for U.S. based populations of women. When doing so, we must malce it clear that our
ethical concerns are internationally focused--they extend to all women with HIVI AIDS. Let them
know that our objections should Jlmi be constrUed as an invitation to pack up their trial and "export"
it to another country.
o Demand that local researchers and people with HIVI AIDS be involved in every stage of U.S.
sponsored research projects in Third World countries, from concept through design and
implementation.
o Researchers, government officials, and drug companies~ iYarantee that any beneficial
treatments resulting from U.S. sponsored trials in the Third World be made available and realistic:Uly
affordable to ALL people with HIVI AIDS regardless of gender, race, or country of residence.
Demand worldwide access to treatment for women with HIVI AIDS!
o Demand that the U.S. Congress increase the amount of humanitarian aid provided to countries
with high infection rates. Demand a shift from military aid to humanitarian aid.
o V~gorously challenge any individual who claims that AIDS ..,riginated on the African continent or in
12
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Haiti. Demand that they present scientific and sociological evidence to support their misinformed
claim.
o Demand that the United Nations/World Health Organization convene and fully fund an
international conference on women and HIV1AIDS. Demand that conference participation accurately
represent the demographics of the global pandemic. The majority of women attending such a
conference should be women with HIVI AIDS from countries where women are disproportionately
impacted. Other participants should include activists, educators, and healthcare providers from around
the world whose work is focused on women.

mvI AIDS ia tbe Ua.ited States:
IDtrodlldioa ud Ova view

Womea ud

It is estimated that over 1 million 15 people in the United States are infected 'With mv16 and that
at least 100,000 of these persons are women. Because of the long incubation .period of the disease,
the number of CDC defmed AIDS cases is expected to rise dramatically over the next few years 17•
From 1980 through 1990, there have been 100,000 AIDS deaths in the United States. In 1
991 alone, there will be over 50,000 AIDS deaths in the US. In New York City and other major US
cities, AIDS is the leading cause of death for women ages 15-44. Nationwide, AIDS is among the top
five leading causes of death in women of "childbearing" age.
Epidemiologists have been charting the demographic shift of the pandemic toward women, Hispanics
and blacks for several years. Women are among the fastest growing groups of newly infected
persons with HIV. There has been a 31% increase in the number of new AIDS cases in women in
1990, versus a 22% increase in AIDS cases among men. 18
Women are the most misdiagnosed, underdiagnosed, and underserved population in the AIDS
pandemic. Statistics on life expectancy evidences the shortcomings of the health care delivery system
in respect to women, especially minority women, who are most effected by AIDS. The life
expectancy for men, from day of diagnosis, currently ranges from between 24 to 36 months. Life
expectancy for women from day of diagnosis averages between 15 weeks and 6 months. The average
life expectancy for a black woman in New York City, is approximately 15 days. In San Francisco,
survival time for women after diagnosis is less than 8 weeks19•
The reasons for the vast discrepancy in survival statistics are varied. Issues of access to proper
medical care, treatment, information on early diagnosis and intervention, insufficient funding for
women and the programs that assist women 'With HIV disease, the Department of Health and Human
Services' criteria for disability insurance and the Center for Disease Control's classification system,
are some co-factors for low survival rates for women with AIDS. Access to health care, treatment,
and education for women is a broad social problem that is not limited to the AIDS pandemic.
When these problems meet the AIDS pandemic however, the result is fatal.
Recent seroprevalance data from New York indicate that in younger age groups (13-19; 20-24) an

15

All of these figures come from the Centers for Disease Control (CDC) and other government
agencies which admit at least a 40% undercount. We believe the undercounting of women is even greater
since neither the CDC surveillance defmition of AlDS nor their classification system include a single
woman specific opportunistic infection.
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equal or higher percentage of women, compared to heterosexual men, are seropositive20• And, for
reported AIDS cases, the second highest percentage· of cases of women within an age grou~ are
women 65 years of age and older ·23% of the cases at this age are reported among women 1. Of
the women diagnosed with AIDS, 52% are black, Z7% are white, 20% are Latina, and Asians and
Native Americans comprise a little less than 1%, though their numbers are increasing dramatically.
Currently, the majority of women with HIV illness are low-income and rely.on Medicaid and public
health care facilities for their primary health care needs. The AIDS pandemic has exposed the
serious failures of the public health care system in meeting the needs of women.

New York City Department of Health, Division of AIDS Program Se~ces, HIV Serosurvey Unit.
AIDS and HIV Infection in New York City-Men and Women. Vol 1, #3, 1990.
20
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AIDS is a Crisis

ror Womea..

What is tbe

u.s. GoftrameDt''

Respoa.se?

Edac::atioa

The government has cut $30,000,000 out of the AIDS budget which would have gone for education
and prevention specifically for women and children with HIV. Women are among the fastest
growing groups of newly infected persons with HIV and therefore are among the most needy in terms
of materials for education and prevention. It is not me: ely government inaction which is respons1ble
for the spread of AIDS, the government it would seem is actually taking steps to insure the spread
of AIDS among women by cutting back on preventative and educational services.

The Center for Disease Control's (CDC) classification of AIDS does not recognize HIV-related
opportUnistic infections which are specific to women. Pelvic Inflammatory Disease (PID), chronic
vaginal candidiasis, chlamydia and Human Papillomavirus (HPV) are a few of the manifestations of
HIV which are specific to women. Because the CDC does not recognize women specific
opportUnistic infections, women are not accurately represented in national statistics on AIDS. If a
woman dies of PID or HPV, even though she is HIV positive, her death is not registered as an AIDS
death.
The CDC is a government agency and other government agencies, such as the AIDS Clinical Trial
Group (AcrG) and the Social Security Administration, use the CDC's information to form policies
and set agenda:; for research. The CDC is not malcing responsible decisions in terms of women with
HIV infection and their bias in policy malcing is responsible for the deaths of hundreds of women
with HIV. In a study of the death certificates of women for whom HIV /AIDS was listed anywhere,
recently conducted by the CDC, it was found that 48% of women died of conditions not listed in the
CDC definition for AIDS 22 • This clearly illustrates that the CDC is not accurately representing
how HIV is impacting women. Other institutions which in turn base decision making on the
information provided by the CDC are excluding women's interest in their policy-making process.
Funhermore, the CDC must make an all out effort to conduct responsible studies which establish the
natural history of HIV in women. Physicians who treat women must be provided with materials
which outline early symptoms and strategies for care. Physicians, especially in rural areas, rely on
CDC guidelines for diagnostic information. Researchers set priorities based on natural history
studies. Effective treatment for women with AIDS cannot be fully established until the CDC
acknowledges and reports on how women are being affected by HIV.

It comes as no surprise that opportunistic infections and indicator diseases related to HIV will be and
are different in women. Possibly, the power of this document lies in its departure from continuously
establishing that gynecological infections, for example, or metabolic consumption of pharmaceuticals
are different in women. In this document, we auempt to begin to suggest a treatment agenda that
gives direction to research, both in terms of drugs/treatments and basic science for women with HIV
infection.
Very little research has been done on women with HIV infection. Women are both technically and
functionally excluded from AIDS clinical research. Because there are very few FDA approved
22 Chu, Setal. •Impact of the Human Immunodeficiency Vtrus Epidemic on Mortality in Women
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drugs/therapies to treat AIDS and its associated opportunistic infections, clinical trials are for many
the only m :·:tanism for access to therapeutics.
Many AIDS Clinical Trial Group (ACTG) trials require a CDC defined AIDS diagnosis as entry
criteria. As women are not represented in the CDC's definition, they are barred entry into these
trials. Most clinical trial participants fmd out about trials through primary Ca.re physicians. The
majority of women affected by the AIDS pandemic are low-income and depend on public health
facilities for their primary health care needs and often are not provided with information on bow to
gain access to experi::uental therapeutics. Whlle the institution of parallel track programs are
commendable, because of the vast amount of paper work required for these protocols, public health
physicians are reluctant to enroll patients. The ACTG bas been negligent in the recruitment of
women into trials.
Women are often excluded from clinical trials because of their "child-bearing potential". Almost all
ACTG trials require women to be on some type of contraceptive rather than having trial arms for
pregnant women. Those with a contraceptive requirement do not offer specific criteria for
acceptable forms of birth control, some of which could be dangerous for women with HIV (for
example pills or IUDs). Researchers interpret the requirement as stringently as they see fit.
Adequate birth control for some researchers may be word of mouth confirmation, others require
measures as drastic as sterilization. Women's "reproductive potential" should not be held as trade
for access to poSSible life-saving therapies. This is immoral.
There are no women specific questions in protocol guidelines for case reports. Women experience
many gynecological manifestations of HIV, yet pap smears and pelvic examinations are not part of
standard research protocols. Routine pap smears and pelvic exams as a standard of practice in
clinical research could provide a mechanism for gathering data on the progression of HIV in women.
Women specific case questions would also provide a mechanism for more thorough and accurate
drug evaluation. What effea, for instance, does ddl have on menstruation, pregnancy, or the
development of cervical cancer? A drug's toxicity is not adequately established until these questions
are answered. Toxicity is supposedly established in phase I clinical trials and therefore women mus~
be included from day one of phase one testing of drugs to treat life-threatening illnesses.
The scope of AIDS in women is unknown because accurate means of tracking the pandemic in
women do not exist. Statistics are showing a rapid rise of AIDS cases in women. despite poor
diagnostic measures. Transmission risks and education are severely under-researched. Vutually
nothing is known about woman to woman transmission of the virus, although there are increasing
numbers of documented cases. Risk assessment procedures do not address or represent the real
world of the AIDS pandemic.
The government bas not responded to the AIDS crisis in women, therefore we, women with AIDS,
their lovers and advocates are. In this document we will outline a strategy for a treatment and
research agenda for women with HIV. We will address the following:

o De.scripdoa ol Oiaic:al Manif'esaatioas
o Standard ol Care Recommendations
0 Critique ol Rtsearda
o Tra·•smissioa
o Centers for Disease CoaD'ol's (CDC's) Policy
0 Additional Refen:na:s

Description or Some Clinical Manifestations or mv in Women

o Pelvic Inflammatory Disease

o Bacterial Pneumonias
o Menstrual Irregularities

o Tuben:ulosis
o SemaJJy Transmitted Diseases
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Pelvic Inflammatory Disease or PID is probably the most under-researched and life-threatening
gynecological complication of HIV infection. Little is known about the pathogen most commonly
causing this infection in HIV positive women. In fact, most of the scant AIDS literature published
on PID still remains in the realm of epidemiology. Nonetheless, infectious disease spec::ialists and
gynecologists seeing women with HIV infection anecdotally report an alarming rate of PID that is
resistant to traditional t.-eatment resulting in tuba-ovarian abscesses and radical hysterectomy.
On October lOth, Phillip J. Illits' article, "Growing Concern Over Pelvic Infection in Women• was
published in the New York Tunes. According to the article, PID "must be counted as the most
important sexually transmitted disease affecting women, excepting only AIDS: Probably it is
unnecessary to sever the tie between the two seemingly separate illnesses. And the rates of PID have
alarmingly sky-rocketed in the past twenty years, especially among young women. If we look at the
increase in the number of cases of ectopic pregnancies (half of which are caused by PID) we see
something more than a ripple effect. In 1970 there were 18,000 tubal pregnancies. Alarmingly, 16
years later, the new number of cases hovers at 84,000. Dr. Patricia Kloser, director of the AIDS
Program at the University of Medicine and Dentistry of New Jersey, reports that "seven percent (of
her patients) have PID that is often so severe it is more likely to require hospitalization than some
AIDS-defined infections.•23
Although much anecdotal information abounds, and epidemiologically few studies have been
completed, Dr. Howard Minkoff at SUNY Downstate Medical Center in Brooklyn suggests that
further investigation of PID and HIV is needed24 • In New York Ciry-in 1989-1990-there were two
reported deaths due to PID. A single death from this disease was reported to the New York City
Department of Health in the ten years prior. Could these women have died from a refractory PID
complicated by HIV-infection?
Unfortunately, PID diagnosis is difficult. According to Illits' article, "It takes ploce in a part of the
body that is inaccessible to doctors: Furthermore, while PID diagnosis can be made by examining
the abdomen with a surgically inserted instrument called a laparoscope, Mary Beth Caschella writes
that, "HIV-infected women may be unable to mount an immune response, causing the inflammation
and pain by which professionals are able to make a diagnosis.•25 This means that traditional modes
of PID diagnosis must be re-evaluated for women with HIV-infection, as is the case with cervical
neoplasia and HIV.
Some clinicians have suggested that PID can present itself as a form of disseminated tuberculosis.
This comes as no surprise. According to Dr. Kloser, chlamydia and gonorrhea, common cause
pathogens in PID, are easily treatable in the HIV infected woman26 • Thus, the cause of PID
infection is quite possibly not related to GC or Chlamydia. If there were that relationship,
presumably more traditional modes of treatment for PID would be effective in the HIV -infected
23
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woman, but they are not. Lab analysis of pathogens responsible for PID is crucial if we are to begin
to research treatment modalities for HIV-infected women. Also, to unravel the mystery as to why so
many HIV-infected women regularly experience amenorrhea we might look to PID and its resultant
tubo-ovarian abscess as a cause.
There are many unanswered questions about the relationship between HIV and PID. In the
immediate future, certain pieces of information must be ascertained if treatments for
HIV-complicated PID are to be further researched. What follows is a list of recommendations for
research in thiJ area:
o

0-

o

Determine the pathogem responsible for refractory PID.
It comes as no surprise that HIV-related PID appears to be untreatable if the assumed
pathogen is, for example, C. trichomatous, when in fact it is Tuberculosis.
Develop new methods for diagnosis. Make laparoscopy more readily available.
When PID is suspected in the HIV-infected client, immediate referrals for accurate diagnosis
and pOSSible hospitalization should be made.

Primary respiratory illnesses account for the largest proportion of life-threatening opportunistic
infections occurring in people with HIV disease, AIDS and AIDS-Related Complex (ARq 27•
Pneumocystis Carinii Pneumonia (PCP) is still the leading cause of death ~ people with Acquired
Immune Deficiency Syndrome (AIDS), despite the availability of prophylaxis such as aerosolized
pentamidine, Bactrim and Dapsone. Moreover, PCP is the most common AIDS defining
opportunistic infection reponed to the CDC. Currently, reponed incidences of PCP presenting as an
in..tial AIDS defining opportunistic infection are higher for women than men28 • Similarly, of the
major AIDS defming opponunistic infections, women present more frequently with Mycobacterium
avium-intrac:cllulare (MAl) than do men29• The respiratory tract is the most common ponal of
entry, though edlty through the gastrointestinal tract may OccurJO. Vutually no research has been
done to examine why women present more frequently with PCP and MAl. Clearly there is a lack of
research on the affects of therapeutic agents for these opportunistic infections in relation to women's
physiologies. That women with HIV infection present more frequently with PCP and MAl begs the
question: Do women have a greater suscepubility to pulmonary incidence of HIV related
complications than do men?

In the last ten years in the U.S. there has been an increase in the death rate of women from bacterial
pneumonias31 . Whether these women presented with HIV infection is unknown. Clearly it is
possible as HIV infected persons are more suscepuble to bacterial pneumonia and other
non-pneumocystis carinii pneumonias, including fungal pneumonias, than the general population32 .
Additionally, in a CDC study of the death certificates of women who had HIV /AIDS listed
anywhere, pneumonias other than PCP were listed as the cause of death for 14% of the C3Ses33 • It
is estimated that 10-20% of pneumonias manifesting in people with HIV are community-acquired
bacterial pneumonias, Hemophilus influenzae, Streptococcus pneumoniae and Branhamella
catarrhalis being among the most common. When examining the non-AIDS fatal outcomes of HIV
infection in women, bacterial pneumonias warrant much further study.
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The true scope of bacterial pneumonias presenting in people with HIV infection has not been
adequately researched. It is clear, however, that pyogenic bacteria are the cause of a substantial
number of respiratory infections in patients infected with HIV. This is not as surprising as HIV
infects macrop~s, B Lymphocytes and alters B lymphocyte function- -increasing a patients risk for
bacterial infection . Incidences of H. Influenzae, S. Pneumoniae and Branhamella catarrhalis
seem to be associated with underlying B-cell defects described in people with AIDS 35 • Incidences
of serious pneumococcal infection are inversely relational to CD4 counts and in persons with HIV
there is a high rate of recurrence, evidencing the need for ongoing therapy after initial presentation.
Neutropenia seems to be related to increased suscepubility to bacterial infection. Neutropenia is
not, at present, considered to be a symptom of HIV disease but has been seen directly associated
with drugs used for the treatment of HIV infection such as ZDV, gancyclovir, and pentamidine.
Absolute neutropenia is associated with bacterial infections in patients with HIV disease 36 •
Epidemiology

Bacterial infections have been recognized as a cause of pulmonary disease in AIDS patients since
early in the pandemic. Health workers have been reponing increases in the rates of
community-acquired pneumonias in patients with HIV disease, AIDS and ARc37• Similarly the
incidence of nosocomial or hospital-related pneumonias are increasing in patients with HIV disease.
In some sites, Methicillin-resistant Staphylococcus aureus (MRSA) is presenting in epidemic
proportions. MRSA strains often spread quickly among the most seriously ill, antibiotic-treated
patients38 • MRSA strains are, of course, very serious as they are resistant to most therapies.
Injection drug users (IDUs) are at increased risk for bacterial pneumonias39 This is ememely
imponant to acknowledge when giving women information on treatment options as over 50% of
women with reported AIDS are reported with injection drug use as a risk factor.w.

Oinical Feata.n:s
Signs and symptoms of bacterial pneumonias in seropositive individuals are similar to the typical
.clinical finding of community-acquired pneumonias in non-HIV infected patients, though infections
are often more severe and occur more frequently. Fever, a productive cough, dyspnea, chest pain,
and focal consolidation are typical manifestations. HIV seropositive adults usually present with
encapsulated H. In.fluenzae. Typically, though not always, patients presenting with bacterial
34
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pneumonias have a higher white blood count (WBC) than baseline WBCs for patients presenting
with PCP. The majority of patients with respiratory illness will have abnormal chest radiographs.

Chest Radiograph. The chest radiograph (chest x-ray) is considered the best initial screening tests.
HIV + patients with bacterial pncumonias most often have focal infiltrates characteristic of
community-acquired organisms. Many patients have single segmental or patchy lobar infiltrates.
Acute diffuse infiltrates arc reponed common in patients with H. Intluenzac. Dense lobar
consolidation is seen frequently in patients with S. Pncumoniac41 •
Gram.Stain. Patients with abnormal radiographs should have sputum collected for gram-stain and
culture. The presence of polymorphonuclear leukocytes (PMN) is not common in patients with PCP
or mycobacterial pneumonias and is commonly seen with bacterial pneumonia. A predominance of
gram-positive diplococci or pleomorphic gram-negative coccobacilli may be seen with pneumococcal
and H. Influcnzae pncumonias, respectively. Cultures of sputum and blood offer more dcftnitivc
diagnosis of a bacterial infection. Bacteria causing pneumonias in patients with HIV infection are,
gram-positive: Streptococcus pneumoniae, Group B Streptococci, Staphylococcus aureus and
gram-negative: Hemophilus in.fiucnzae, Hem~hilus sp, Branhamella catarrhalis, entcrobactcriaceac
and, less frequently, Legionclla pncumophilia . Gram-stain is not conclusive in determining PCP
infection.
Open Lung Biopsy is not recommended as pan of routine evaluation. Though it may be the most
complete diagnostic technique, it is very painful and costly. Other diagnostic methods, such as
bronchoscopic procedures should precede open lung biopsy43 • II sputum does not provide a
diagnosis, bronchoscopy has been highly successful in detecting pathogens. Needle aspiration should
be used as a last resort as pneumothorax can easily occur. Less invasive techniques should be
employed first.

Because of the large number of potential pathogens, an aggressive diagnostic approach to establish
etiologic diagnosis and to help direct therapy is warranter. Antibiotic therapy should be carefully
monitored because of possible kidney and hearing problems resulting from toxicities. Women
beginning antibiotic regimens should be made aware of posstble side effects. If a yeast infection
appears or worsens, it could be indicative of overly high dosages. Antibiotic therapy, if managed
properly, does not cause yeast infections. Antifungal regimens to prophylax against yeast infections
could only further disrupt the bodies natural flora.
Empirical treatment of patients with strong clinical indications of bacterial pneumonias with
cefuroxime or ampicillin may be warranted. H. Influenzac seems to be highly responsive to
41
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ampicillin. In areas where beta-lactamase-producing H. Influenzae is high, amoxacillin-clavulanic
acid should be used instead of penicillin. Penicillin resistant stains of Hemophilus are not
uncommon. Antimicrobial treatments should be employed to see what the bacteria is sensitive to.
Injection drug users who may have bacterial endocarditis or pneumonia should be treated with an
anti-staphylococcal agent such as nafcillin, as well. Specific therapy for bacterial pneumonias should
be tailored to the in vitro susceptibility of the organism. Resistant strains of H. Influenzae have
been detected in western Europe, indicating the necessity for geographical monitoring for resistant
strains.
Response is prompt in patients with HIV infection. Improvement of symptoms and clearing of
infiltrates usuallv occur in several days in adult patients. Patients with gram negative pneumonias
other than H. Inftu110Zae, the most common bacterial pneumonia presenting in people with HIV
infection, have a poor prognosis of short term survival time. Patients with HIV-related bacterial
infections have a 25-50% rate of recurrence. Continued antibiotic therapy is recommended.
Prnaatioa

Because of the high incidence of bacterial pneumonias, bacteremia and recurrence of HIV-related
pulmonary complications. prophylaxis and prevention methods should be utilized. Both prophylactic
antibiotics and immunotherapy are proving to be useful in controlling and preventing bacterial
cOmplications.
Trimethoprim-sulfamethoxazole (TMP-SMX) has been used for prophylaxis against encapsulated
bacteria and is advantageous as a PCP prophylaxis as well. It is not recommended, however,
because of the increasing incidences of adverse reactions in people with AIDS to sulfa drugs.
Adding ampicillin to pentamidine may be effective in prophylaxing against both PCP and bacterial
infections. Bactrim may be useful in prophylaxing against bacterial lung infections as well.
Immunotherapy such as PATH or HIVIG, to prevent bacterial pneumonias has been recommended
in some settings. The efficacy of vaccines in patients with HIV infection is doubtful a.s protective
antibody responses do no: typically occur45 •
Preventative therapies should be examined and considered in light of the context of each woman's
life. Women should be informed of their risk for bacterial infection and their treatment options and
then be let to make an informed choice on the specific course of prophylaxis. For instance, a
woman who is an injection drug user should be informed that HIV seropositive IVUs experience a
seven-fold increase in the rate of bacterial complications compared to seronegative IVUs,
community-acquired bacterial pneumonias and hospital-acquired pneumonias should be adequately
addressed and treatment options and risks should be outlined.46

Tbe followiag is a list ol guideli.aes
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As women seem to be disproportionately affected by PCP than are men, women need to be
actively recruited into BW566 trials. While PCP is presumably caused by a protozoan, it is
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essential to address PCP when coosidering pulmonary incidences of HIV infection in women.
Abbott Laboratories must lmmedlately establish a compassionate use protocol for
Clarithromycin for the prophylaxis of MAI. Women, who are disproportionately affected by
MAI, should be actively reauited into existing trials.
Trials must be conducted to examine the efficacy and toxicity of Clarithromycin in combination
with drug detox therapies such as Methadone, a similar approach musfbe employed with
BW566. Additionally, arms of these trials must be designed to examine the efficacy and toxicity
of these pharmaceuticals in combination with street drugs. This information is essential towards
obtaining a clear profile of these therapies in the real world of the AIDS pandemic.
Gender relational research must be done to examine the suscepttbility of pulmonary incidences in
people with HIV infection.
Research must be conducted to determine gender relational respooscs to current therapies for
bacterial pneumonias.
Clinical trials of pneumococcal and other vaccines in patients with HIV infection must
begin immediately. Women specific questions must appear on all case reports for all trials
and pap smears, colposcopy and cervical examines must be conducted routinely. Women should
be actively reauited into these trials. All trials should be located in centers that serve large
numbers of women and child care must be provided during visits.

MEDLINE searches reveal that the handful of studies which mention women with HIV do not
address women's reproductive health-specifically menstrual irregularities. As this Treatment
Agenda desaibes in other sections, the few medical reports which do exist largely treat women in
terms of their capacity to transmit HIV to men and children.
The lack of attention to women's health results in many unanswered questions. How does HIV affect
women's menstrual cycles? How do HIV and drug treatments like AZr and ddl affect levels of
progesterone and estrogen? When HIV infected women suffer from secondary amenorrhea
(cessation of menstrual periods) or dysmenorrhea (difficulty with menstrual periods) what are the
causative factor(s)? The laclc of gynecological care at clinical trials means that it is unknown which,
if any, sexually transmitted diseases (STD's) or gynecological infections are present.
Women's complaints about amenorrhea or dysmenorrhea are generally not recorded in medical
records of HIV clinical trials. Because of this and because women are not usually asked about
menstrual difficulties, it is difficult to draw conclusions. It is also impossible to conduct retrospective
studies.

HIV infected women frequently complain about painful periods and bleeding which lasts for weeks,
as well as a laclc of bleeding.

Women suffering from all chronic fatigue syndromes report an inaease in pre-menstrual syndrome
(PMS) problems (breast tenderness, bloating, more aamps, longer periods, mood changes). It is
also known that sub-acute, chronic Pelvic Inflammatory Disease (PID) and bacterial infections can
cause longer periods, which are exacerbated for immunocompromised women.
Some H!V infected women report that it is common knowledge among themselves that AZT is
connected to worsening aamps, painful blood clotting, and menstrual periods which last 10 to 15
days. Many women take themselves off AZr because of dysmenorrhea. Women on ddl and in other
experimental trials often report common knowledge about similar menstrual problems.
During which part of the menstrual cycle is the extended bleeding taking place? Is it related to
ovulation bleeding?
Do AZT or other drugs inaease estrogen? Do they inaease progesterone (which causes glands in
the endometrium to seaete nourishing substances and which increases uterine blood supply)?
Would these cause longer and heavier periods? Or are the arteries and veins in the uterus pinched
off too slowly? later than they should be?
Dysmenorrhea researcher Katherina Dalton theorizes that one type of dysmenorrhea (spasmodic)
results from too much progesterone in relation to estrogen, and the other (congestive) as well as
PMS result from too much estrogen for the amount of progesterone-from a progesterone deficiency.

Amenorrhea is associated with stress, weight loss, and street drugs, particularly heroin. How does
HIV-related wasting fit in? Or poor intake of food because of poverty or drug use? At a New York
Community Health Project or Bronx-Lebanon Medical Center, where women frequently complain of
amenorrhea. roughly 60% of the women are present or former drug users.
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It is imperative that researchers and care providers begin to record women's complaints and begin to
ask women about their reproductive health. Women who do complain of dysmenorrhea or
amenorrhea should be taken seriously and diagnosed-menstrual problems should not be merely
taken for granted. Women should receive a pelvic exam, pap smear, ultra sound, etc. Anemia
should also be monitored in women who suffer extended bleeding.
If HIV infected women share common knowledge about how AZr, ddl, or infections affect their
reproductive health, why do researchers and care providers remain ignorant and unwilling to record
women's complaints? Until clinicians become involved in the health of women they are treating, HIV
infected women are likely to continue prescnbing their own relief from menstrual pain (such as
taking themselves off AZT - sometimes without informing their clinicians) Clearly this benefits no
one.

Vaginal candidiasis also known as vaginal thrush or yeast infection, is a fungal infection generally
caused by Candida a]bicans. Its most common symptoms are severe vaginal itching and a thick, often
white discharge with the consistency of cottage cheese. It is a common probl~m which most women
will develop at least once. It is often caused by antibiotic therapy, use of corticosteroids, birth control
pills or immune suppression associated with pregnancy. Vaginal candidiasis is usually treatable by the
use of common antifungal agents such as Gyne-Lotrimin (a trade name for the generic drug
clotrimazole).
When a woman with mvI AIDS develops vaginal candidiasis however, much of this picture is altered.
Although the initial symptoms remain the same, the infection is no longer easily resolved, is painful
and sometimes results in lesions. Women with HIV /AIDS fmd that their vaginal candidiasis recurs
within a short period of time after they stop using their medication. Frequently they will have this
infection almost nonstop for a year or more. Some HIV positive women have reported that although
they have symptoms of Candida albicans and initial microscopic evidence of such, confirmatory
cultures fail to grow the organism-possibly indicating another organism as a cause of these symptoms.
The infection is usually seen in conjunction with a decre3Sed CD4 cell count, often below 200, and a
decreased T4/T8 cell ratio. Vaginal candidiasis will often predate the appearance of esophageal
and/or oral thrush (also caused by Candida a]bicans) by at least a year. Resistance to treatment also
develops with the persistent, recurring infection; which often leads to the use of more potent drugs
such as AmphOlericin B. Drugs such as these present their own problems for women with
HIV/AIDS.
Researchers at Walter Reed Hospital believe that at least 24% of women with AIDS will have
recurrent vaginal candidiasis as their presenting symptom. They also believe that it is often the only
clinical indication of the severe underlying immunodeficiency and may present a serious risk for the
onset of other AIDS-defining illnesses.

Does this mean that the appearance or vaginal candidiasis may be an indication or advanced
disease in women? Unronunately, the research bas not been done to answer this question.
The persistent, recurrent vaginal candidiasis that women with HIVI AIDS contract may be a form of
Candidiasis Hypersensitivity Syndrome (CHS). However, the medical profession has not been able to
agree whether this type of syndrome really exists, and if it does exist, how it should be defmed. As a
result, there are no studies being done on the best ways to treat it. What knowledge we do have,
derives from the problems with oral thrush that cancer patients have been faced with, especially since
the advent of chemotherapy. Common antifungal agents such as clotrimazole (now available over the
counter as Gyne-Lotrimin) or Nystatin are most frequently used. If these drugs are not effective,
usually a drug such as Amphotericin B will be used. Amphotericin B is usually given through an IV
and has many side effects. It is an antibiotic, and antibiotics can increase yeast production unless
acidophilus is taken with it. It can cause anemia, which often is caused by other medications taken by
women with HIV I AIDS. It is also dangerous to the kidneys, creates sensitivity to light and also often
causes high fevers and chills. Fluconazole is a new drug approved last year for the treatment of oral
candidiasis, can be taken as a pill or through IV, and may be a safer and more effective treatment.
However, it has never been tested for vaginal thrush.
Vaginal candidiasis complicates the treatment of women with HIV /AIDS. It is known that it can be
caused in healthy women by taking antibiotics; women with AIDS frequently have to take antibiotics
due to other opportunistic infections. It can also be caused by taking birth control pills; women with
AIDS who want to participate in ACfG trials are often required to use contraception as defmed by
the researchers, and birth control pills are often the method required. It often appears during
pregnancy; most of these drugs will have an unknown effect on pregnant women and fetuses.

Since a drug such as Amphotericin B can cause anemia, does this mean that it can't be used by a
woman taking AZT, which also causes anemia? Will the development of recurrent vaginal candidiasis
inevitably lead to the development of esophageal or oral thrush? Do women develop this infection
more frequently when their CD4 cell count falls below 200, or are we just not seeing these women
sooner because they can't afford the medical costs? Will recurrent vaginal candidiasis which is
resistant to treatment cause a more rapid progression of immunosuppression and therefore death?
Since women in general, and HIV positive women in particular, are more likely to get a variety of
fungal infections, can some type of broad spectrum anti-fungal prophylaxis be developed which is
similar in treatment regimen to Bactrim or Pentamidine (for PCP)? W'ill taking such a regimen allow
women to remain healthy for longer periods of time?
Why is it that the CDC recognizes Candida albic:ans as an AIDS defining illness in esophageal thrush,
but not in vaginal thrush? Why can't the medical profession decide whether Candidiasis
Hypersensitivity Syndrome really exists and define it, so that research will begin on effective
treatments? Why is the medical profession ignoring an illness that is believed to be the presenting
symptom in one quarter of all women with HIVI AIDS?
These questions remain unanswered more than ten years into the epidemic. Researchers need to
establish priorities to examine these issues immediately~ order to save women's lives.
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Cytolytic Vaginosis
.Cytolytic Vaginosis, previously known as Doderlein Cytolysis, is an easily diagnosed and treated
condition that is frequently missed since symptoms are often similar to those associated with vaginal
candici.iasis. Cytolytic Vaginosis should be ruled out, especially in women with apprent chronic or
recurrent candici.iasis. A wet smear (m.iaoscopic examination) negative for trichomona.s, Gardnerel.la.
or Candida with fewer white blood cells (than normally associated with infection), ina-eased evidence
of lactobacilli, and evidence of destruction of living cells (cytolysis) are all indications of Cytolytic
Vaginosis. A hallmark of this condition is low vaginal pa usually between 3.5 and 4.5. Discomfort is
usually most severe during a phase of the menstrual cycle knowu as the luteal phase. Suggested
treatment is sodium bicarbonate douches, which inaeasc vaginal pH.
·
Practitioners who see women. especially HIV positive women. with vaginal yeast infections that do not
respond to usual treatment should be alert to the possibility of Cytolytic Vaginosis. Although there is
no evidence to suggest that HIV positive women have an inaeased likelihood of developing Cytolytic
Vaginosis, the difficulty in treating some vaginal infections in HIV positive women makes it imperative
that this condition be investigated and that an accurale diagnosis be made.·

• Source: International Society for the Study of Vulvar Disease (ISSVD Tutorial Reporter. March.
1991). Leonard J. Cibley, :MD, Harvard Medical School, Clinical Professor. OB/GYN. ISSVD
Tutorial Reporter, Gardiner-Caldwell SynerMed, PO Box 458, Califon. NJ 07830
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More than 20 organisms have been identified as causing sexually transmitted diseases (STD)
Here
we will focus only on those which at this time appear to have a panicular impact on women who are
seropositive or have been diagnosed with AIDS. These include syphilis, chancroid and herpes simplex
virus (HSV)48• Others, such as gonorrhea, chlamydia and trichomonas will be mentioned briefly.
Human papilloma virus will be discussed in a later version of this treatment and research agenda.
Syphilis, HSV and chancroid are the most common <:auses of genital ulcer disease. Since 1980 the
U.S. bas seen rates of primary and secondary syphilis increase by more than 200%.49 The incidence
of genital herpes in the U.S. is up 16 fold as reflected by visits to practitione~. Five thousand and
one (5001) cases of chancroid were reponed in 1988 in the U.S. Approximately 2/3 of these cases
were loc:ali:zed in New York Ciry51.
Lymphogranuloma venereum (a disorder of the lymph tissues caused by chlamydia) and granuloma

inguinale (a chronic bacterial infection of the genitals) are comparatively rare. Other causes of genital
ulcer disease include cuts or open skin surfaces, gonorrhea and infectious mononucleosis.52
Genital ulcer disease is important in discussions of HIV infection in women for a number of reasons.
Genital ulcers and some cervical infections, notably chlamydia and trichomoniasis, are suspected of
increasing the risk of HIV transmission (see Transmission Issues section). Whether HIV actually
increases a woman's risk of genital ulcer disease is a question which remains unanswered by current
research.
Reports from healthcare providers treating HIV positive persons for syphilis. HSV and chancroid
suggests that the typical course of illness and/or treatment may be different than for HIV negative
individuals. For example, some studies indicate that treatment failure for chancroid can be an
important predictor of HIV seropositiviryS3•
HSV infection is more common and recurs with more frequency in HIV positive women than in
seronegative women54• HSV 1 and HSV 2 gene products in a laboratory test (in vicro) may increase
the replication of HIV. Further study is needed to determine whether HSV actually accelerates the
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progression of disease in

mv positive women55 .

Secondary syphilis in HIV seropositive individuals is frequently undetectable by standard testing.
Whether mv positive women are more affected in this way is a question which should be answered,
especi~ since research indicates that primary syphilis in women is more like~y to be undetected that
in men . In HIV positive individuals infected with secondary syphilis, tests for syphilis have been
negative. Failure of standard treatments for syphilis and rapid progression to neurosyphilis have been
demonstratecf 7•
Although little research exists about the relationship between gonorrhea and mv and, in fact, what
does exist describes gonorrhea as easily treatable in women who are mv positive, some questions
remain. We know that the gram stain test still used in some places is useless for detecting gonorrhea
in women. Cultures, though more accurate, must be taken from appropriate sites. Yet we also know
that gonorrhea can show up as endocarditis, pneumonias and adult respiratory distress, unusual or
abnormal sites for the infection (disseminated gonorrhea)58 • Though these symptoms of
disseminated gonorrhea are rare in people who are not HIV positive, women who are HIV positive
(as well as intravenous drug users) have a high incidence of bacterial pneumonias, endocarditis and
other respiratory diseases. Is it possible that the relationship between HIV and gonorrhea
(undiagnosed or seemingly treatable but really not cured) is at the base of this symptom picture?
Early and accurate diagnosis and treatment of STDs is important for all women, but especially for
women who are HIV positive since some infections may be more difficult to treat. Additionally
clinical evidence exists to suggest that pelvic inflammatory disease (PID) is not only more common
among seropositive women but also more severe and refractory to treatmenr5 9 . In fact, investigators
Moss and Kreiss report that, •... HIV infection itself appears to increase the severity of certain STDs
once they are acquired60: Educational materials. clearly describing symptoms, must be developed
since knowledge about the course of illness is an important source of information for diagnosis.
Clinical misdiagnosis of genital ulcers occurs as often as 40% of the time. Inappropriate use of
testing, unavailability of tests, advanced condition of ulcers, and patient self treatments can all
contribute to making diagnosis difficult. False negative results of cultures and blood tests ~ay account
for many of the high number of cases (25-50%) where no cause for symptoms is identified01 • More
sensitive diagnostic testing should be a research priority.
The demographic and geographic distribution of panicular infections such as syphilis, HSV and
chancroid, as well as the distribution of drug resistant strains, may be useful tools in diagnosing and
treating illness. These should, however, never be used as a substitute for thorough examination,
history taking and diagnostic testing.
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Generalizations about disease prevalence are subject to socioeconomic factors. For example, it may
be that African-Americans living in urban areas in the U.S. have a higher recorded incidence of
syphilis because many rely on public clinics for treatment where case reporting is more likely to occur
than with private physicians62 • Consequently, women suspected of having any STD should be tested
for a full range of possible pathogens.
Practitioners should also bear in mind that secondary infections and coinfections are always possible.
It is imponant that clinicians understand and be able to use blood (serologic) and other diagnostic
tests appropriately. The critical .1eed for timely diagnosis and treatment for HIV positive women
justifies any added expense of direct testing for pathogens using the latest and most accurate
technology.
It is of major imponant that the practitioner be able to discuss sexual histories and practices in a
frank, culturally sensitive and non-judgmental manner. Assuming that all women sleep with men and
self-identify as heterosexual renders lesbians invisible and provides inaccurate information which may
impact on treatment decisions. Clinicians must not rely on assumptions and concepts such as risk
group categories which are impediments to assessment, treatment and patient education.
Since there is evidence of standard therapy failure for women with some STDs (syphilis, chancroid)
and HIV coinfection, it is imperative for there to be close follow-up after treatment. Routine initial
culture and sensitivity testing to detect drug resistant organisms may reduce treatment failure.
Clinicians will do well to •think• HIV coinfection when treating genital ulcer disease, especially when
confronted with treatment failure, virulent and/or refractory PID or test results inconsistent with
clinical evidence.

o Improved diagnostic testing for Sexually Transmitted Diseases and access to necessary tests should
be a priority.
o Questions regarding the rate of false negative diagnostic tests among HIV positive women should
be researched.
o Research should be conducted on the course of STDs in seropositive women. These should
include, but not be limited to syphilis, chancroid, HSV, HPV, trichomoniasis, chlamydia, gonorrhea,
granuloma inguinale and lymphogranuloma venereum. Special attention should be paid to all
questions regarding the spread of these infections beyond their original sites (disseminated disease).
o Questions regarding the relationship c: HIV infection to genital ulcer disease need to be addressed.
as do questions remaining about the increased risk of HIV transmission in the presence of genital
ulcer disease.
o The possible link between HSV 2 and genital cancer as well as questions about a possible
partnership between HSV 2 and HPV in causing cancer must be researched with special attention
paid to the potential consequences to HIV seropositive women.
o HIV positive women should be intentionally included in all AIDS research and drug trials.
o Researchers and practitioners must acknowledge the existence of lesbians and address the reality
that lesbians can and do become infected with STDs and HIV through sex with one another.
62 Lichtman
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It is estimated that half of the world's population is infected with the tuberculin bacilli (a rod shaped
organism identified as causing tuberculosis). TB prevalence worldwide has doubled in the last decade;
it is the world's major infectious killer. Half of the 6-8 million people in the world believed to be
infected with HIV actually have TB, and TB is the most prevalent opportunistic infection to be
reported in conjunction with HIV worldwide.

In subSaharan Africa TB has doubled in the past 5 years; 40-70% of people with TB are HIV
antibody positive-yet many have a negative test for TB on analysis of sputum samples63•
From 1984 to 1986, the incidence of TB increased in the U.S. by 2%, and by 36% in New York City.
In New York City today, active TB occurs at a rate 10 times that which was reported in 1980. When
cases of TB increased during this period, a public health correlation with HIV should have been
made.

In 1987, the CDC added extrapulmonary TB to the list of AIDS-defining opportunistic infections even
though it was only in 1988 that systematic information regarding the presence of extrapulmonary TB
among HIV antibody positive individuals was collected. Pulmonary TB has yet to be added to the
CDCs list of AIDS defining infections64•
In 1989 and 1990, in the U.S., the incidence of TB rose 5% and 8% respectively. The largest
increases were seen in children under the age of 5 (15% in 1989) and in individuals between the ages
of 25 and 44. Since 4-5% of cases are not diagnosed until death, this would indicate approximately 10
million people who are infected with tuberculosis without a diagnosis of infection65 • .
Prior to World Warn, TB was the major killer of all African Americans; black women were 4-5 times
more likely to be infected than were white women. In the U.S., it is predicted that the downward
trend in TB in whites will continue. Today, the incidence of TB in persons of color is twice that of
whites 66 •
TB occurs at a rate 30% higher in people who are institutionalized (nursing homes, prisons, shelters
and refugee encampments) than in people in more ventilated noncongregate housing. For people
without any housing. there is a greater danger of exposure to drug resistant strains, the prevalence of
these strains being 300% higher than in all other populations.

As of May, 1991, 84% of newly diagnosed cases ofTB in New York state were reported in New York
City; with reactivation infection highest in older men and new infection highest in younger women67 •
Deaths due to TB in HIV positive women are double that reported in AIDS case surveillance, and the
presence of HIV and TB together is almost entirely due to IV drug use, the largest transmission
ategory for women in the U.S. (It is estimated that in IVDUs and women AIDS is underestimated
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by 100%.) There are virtually no repons of TB in women who are HIV antibody negative.
TniND"issioa ud Preselltatioa ol TB

TB is a chronic bacterial infection which usually goes unrecognized, even though some bacilli remain
alive in the systems of individuals infected who have healthy immune systems. TB is spread from
person to person via particles which can be airborne and which contain TB. These particles can be
coughed or sneezed by a person with clinically active pulmonary TB.
In immune competent individuals the TB bacillus remains dormant, contained in an envelope called a
granuloma. In immune compromised individuals, the envelope is lost. Immune suppression increases
the likelihood fpr dormant TB to become activated, resulting in clinical symptoms. HIV infection
appears to be one of the highest risk factors associated with the progression from inactive to active TB
infection; in HIV antibody positive individuals, the risk of activation of dormant TB is almost
100%68. In addition to HIV as an agent of immune compromise, lack of proper nutrition, absence
of specific nutrients, inadequate ventilation, incomplete health care provision and injection of immune
suppressive drugs all contribute to decreasing immune competence.
Pulmonary TB usually shows up in the upper portion of the lungs, however, in HIV antibody positive
individuals, the involvement is in the middle or lower portion of the lung. TB emphysema involves
infection throughout and around the lungs and has been misdiagnosed as lymphoma.
Exuapulmonary and atypical TB are often not recognized as TB, and other diagnoses are fust
reported. In the U.S., 5-10% of people with TB have both pulmonary and extrapulmonary
manifestations. Extrapulmonary TB can involve any organ or system, including sites not observed in
people who are HIV antibody negative. These include the gastrointestinal tract, brain, blood, genitals,
pericardium, wrists, lymphatic and other presentations. Unrecognized TB diagnoses include oral or
vaa;inal candidiasis. meningitis, peritonitis and lymphoma69 • Central nervous system mass lesions
caused by TB are relatively common in IVDUs with AIDS and precede other Ols by months.
Symptoms of active TB include fever, night sweats, weight loss and sputum production-symptoms
which are often overlooked in institutionalized and older individuals. In the absence of specific
treatment, death occurs from chronic wasting. respiratory failure and meningitis.
Both MAl (Mycobacterium avium intracellulare) and TB are of the same family of mycobacterial
species. MAl is the most common species seen in persons with AIDS in general, while in IVDUs TB
is more common. In the U.S., where greater than 50% of women with CDC-defmed AIDS are
reported to have been infected through IVDU, ::vw shows up more frequently than in men70 •
However, TB is not being reported unless enrapulmonary in nature. Since both MAl and TB can
present with the same clinical picture the current CDC statistics are questionable. While TB is
infectious, it is also generally curable if treatment is begun early in the infectious process. At present
there is no treatment for MAl and it could be the progression of untreated tuberculosis.

TestiDc
Initial screening for TB is based on skin test reactions. However, when someone is immune
suppressed, these types of tests are meaningless, often nonreactive in the face of active infection. In a
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r~ceive a dose too high to be effective as an immune modulator. Some practitioners have raised the
concern that these high doses of naltrexone might be immunosuppressive, and should be avoided in
drug users with HIV disease.

The question of interactions of AZr with other drugs has been a major concern since the drug's
approval. Drugs that share the same mechanism of elimination as AZr (hepatic ghu:uronidation)
are likely to increase AZr toxicity, as well as to see their own toxicity increased. In addition, drug
users tend to have abnormal hepatic functions, due to the lasting toxic effects of opioids on their
liver. Some of the drugs that increase AZr toxicity have been identified. Non-steroidal
anti-inflammatory drugs such as paracetemol and acetaminophen (Tylenol) have been suspected to
increase toxic effects of AZr, i.e., to be respoosible for an increased incidence of anemia92; aspirin
and ibuprofen do not seem to produce similar effects.
Anti-infectious drugs such as sulfadoxine and sulfamethoxazole (a component of Bactrim/Septra)
also compete with AZr for glucuronidation and might increase AZr toxicity. In addition, these two
drugs, as well as pyrimethamine, gancyclovir (DHPG) and Amphotericin B, may potentiate AZr
toxicity on the bone marrow.

AZr has been used in individuals receiving methadone, as well as in individuals injecting opioids,
with satisfying results93• However, opioids such as morphine or codeine compete with AZr for
hepatic glucuronidation, and might increase AZr toxicity.
Unofficial reports have mentioned that AZr treatment might interfere with lithium administration in
drug use treatment. i.e., that patients taking AZr might be more likely to become addicted to
lithium. This information has not been confirmed since.
Probencid is a drug used to treat gout, but also to increase the duration of action of antibiotics by
competing for glucuronidation. Proper use of probenecid with AZr could reduce the amount of
AZr needed every day, thus dramatically cutting the cost of AZr treatment.
The question of interaction of AZr with sexual hormones is still an open one. A
Burroughs-Wellcome study of female mice chronically receiving large doses of AZr showed an
increased incidence of cancers of the reproductive organs. To this date, no data collection has been
made on the effects of chronic administration of AZr in women. Interactions of AZr with birth
control pills and use of steroids by transsexuals have been completely ignored. Since female drug
users often suffer from reproductive dysfunction, and hormonal cycle seems to have an influence on
the effects of drugs on women's physiology,94 the safety of AZr and other antiretrovirals on the
health of women with HIV who are drug users should be investigated in priority.

AZf use in pregnant women is under studied, and there does not seem to be any incompatibility so
far. However, more studies are needed regarding the specific toxicity of AZr in pregnant drug users
with HIV disease.
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study done by Selwyn and coworkers, 3% of people who were not mv antibody positive were anergic
(unable to produce a skin test reaction because of immune suppression). Z7% of mv antibody
positive patients were anergic to multiple antigen skin testing.
Tests used to establish a definitive diagnosis of extrapulmonary TB include collection of a variety of
specimens for culture including respiratory secretions, bronchial washings, gastric lavage, lung tissue,
71
pleural .fluid, lymph node tissue, bone marrow, blood, urine, stoo~ brain and cerebrospinal .fluid .
The current microbiological lab procedure to culture TB takes 6 weeks to grow. There is a need for
the development of tests for the rapid diagnosis of both exttapulmonary and pulmonary TB.
While skin tests (used to detect TB infection regardless of its site) are often uninformative, samples
collected for diagnosis are invasive and often do not provide results. Given the incidence of
nonreactive skin tests, there is a need for the development of more sensitive tests for both
exttapulmonary and pulmonary TB. Less invasive tests, and research into appropriate body fluids
from which to collect samples in .cases of exttapulmonary TB, which will yield accurate and definitive
results must be developed.

In New York state doctors are currently being denied Medicaid reimbursement for TB (and syphilis)
testing. In the absence of signs or symptoms on an individual chart, payment is denied. This applies
to screening tests of any kind, includin~ blood chemistry profiles where appropriateness of tests
ordered must be specifically indicated . Community health physicians are being audited and some
are being required to subject themselves to administrative hearings. According to Peter Wyer, M.D.,
there is "no precedent in the history of medicine" for this type of scrutiny in patient care 73 .

According to the World Health Organization (WHO) people who are IDV antibody positive have an
almost 100% risk of reactivating dormant TB. TB is one of the first Ols presenting, and once
diagnosed is treatable74• Untreated it is fatal to HIV positive individuals. Standard treatment is
chemotherapy over a course of 6-18 months. However, poor nutritional status, malnutrition and
famine threaten complete healing and the stability of healed lesions. In the US., 95% of primary TB
lesions completely heal with treatment.
Inadequate treatment is as fatal as lack of treatment-a poorly implemented program may worsen the
condition. Underdosing can lead to drug resistant disease. There are estimates that 25% of infected
individuals in California and 15% in New York are drug resistant to one of the 3-5 drugs which are
part of a treatment regimen. People who stop treatment on their own prior to the completion of a
regimen, can also develop drug resistance. If the strain of TB was originally drug susceptible, the
bacteria mutate and a secondary resistance is created. For people who do not respond to prescribed
treatment, a more difficult and extended course is administered.

If someone is resistant to TB chemotherapy, the resistant strain of TB can be spread. More than 30%
of adults with TB at Kings County Hospital, a public hospital in Brooklyn, were resistant to at least
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one drug75 • In a study at Grady Memorial Hospital (a public hospital in Atlanta. GA.), gay men
76
who were mv antibody positive had contracted drug resistant TB within the hospital setting •
Isoniazid is inappropriate for people who are active alcoholics or in those with clinically significant
liver disease. Resistance to this therapy is widespread in industrialized countries.

If on methadone, and given rifampin, individuals may require increased methadone dosage to avoid
withdrawal symptoms caused by the interaction between methadone and rifampin11• While this data
was published in 1976 and therefore certainly not a new finding, individuals continue to have these
drugs prescribed at inappropriate levels. This results in methadone failure leading to •noncompliance"
for the rifampia regimen.
The Following Is a Ust Of Guidelines For Research:
o Develop rapid, predictable diagnostic tests for the presence of TB which are unaffected by an
individual's immune status and which include testing appropriate for infection in women.
o Develop acute and prophylactic treatment regimens which are more efficacious and unaffected by
compliance (which often results in the development of resistant strains).
o Study was to boost defense mechanisms prior to infection as well as risk factors (such as living
conditions) and their effect on TB infection.
o Develop treatment regimens which do not contribute to immune suppression. Some examples may
be: diet, beta blockers, air, rest and phototherapy.
o Investigate the usefulness of vaccines which are CUITently in use in non-industrialized countries.
o Fully investigate the clinical and pathological course of extrapulmonary TB in women.
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Standard of Care Recommendations

o Alternative Therapies
o Drug Detoxification

o Prison Issues
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A recent survey by the Physicians Association for AIDS Care found that over half of PWAs use an
"alternative• or ·complementary" therapy and feel that it is beneficial. Despite this opinion -from
people living with HIV -the traditional medical establishment, the FDA, NIH, and health insurance
industry (among others) are actively antagonistic towards non-traditional, non-pharmaceutical,
nontoxic treatments for HIV infection and opportunistic infections (Ois). Physicians aiticize
alternative and holistic treatments, the Nnl refuses to research them through its ACI'G system, the
FDA won't license them, and the health insurance industry refuses to pay for them-even when they
are widely used in other countries. Their resistance is aU the more outrageous when we remember
that the distinction between "traditional" and "alternative" therapies is largely artificial. since today's
alternative treatment may be tomorrow's conservative medical approach. After aU, where would you
put Compound Q or NAC? Both started out in the AIDS underground and are now being
investigated by government- and AmFAR-backed trials.
We must demand that people with life-threatening illnesses have the freedom to make informed
choices about the full r:tnge of treatment options. The right to choose an alternative course of
therapy is especially needed by those segments of the AIDS-affected community to whom the
traditional medical establishment offers the least-notably, women and people of color. We demand
that panicipants in the health care delivery system in this country recognize and support this right
and respond accordingly.
The reason:-, for the exclusion of alternative and holistic AIDS treatments are many, but essentially it
comes down to the same problems we face in other areas of AIDS policy--professional chauvinism,
careerism, :inancial interest, racism, sexism, and xenophobia. Because of this exclusion, numerous
barriers exist to use of iilternative treatments by the communities that need them most. Generally,
information Jbout alternatives is available only to people who are well-educated, English-speaking,
and motivated to seek out that information. It is not available at the agencies that provide healthcare
services to lower-income people. Second, because of lack of research, alternative therapies are not
approved by the FDA. Non-FDA-approved therapies are not covered by public or private health
insurance; they are excluded from the Medicaid formally, and not available to low-income women
who comprise a big chunk of the HIV + female population. Consequently, all cost for alternative or
holistic therapies must be paid by the user. There is no such thing as insurance reimbursement for
Vitamin C.

In addi£ion to offering greater potential access, alternative treatment regimens may also offer effective
therapies for women-specific Ols or Ols that occur with greater frequency in women.
Anal and cervical cancer. As more becomes known about women and HIV, it is dear that various
forms of cancer are more common in HIV + women. Research by Chinese scientists suggests that
garlic may have an anti-tumoral effect, by killing cancerous cells and protecting against carcinogens.
Pelvic Inflammatory Disease. A potential treatment for PID may be ozone, which many believe to
be helpful against various bacterial and viral infections, including hepatitis-B and abscesses. Ozone
needs more research in the United States, since it is currently available only in Germany.

Vaginal and cervical candidiasis. This is one 01 that may be entirely treatable with natural
therapies. One of the most effective ways of controlling many kinds of yeast infections is by altering
one's diet. Most nutritionists tell candida-sensitive people to stay away from reftned sugar, fruit,
dairy, and foods like beer that contain yeast. Chinese herbs, such as astragalus, have shown
anti-candida ability in addition to inhibiting HIV and Epstein-Barr virus. Ascorbate may slow the
growth of yeast and acidophilus may prevent areas from becoming colonized. Some physicians
prescribe pau d'arco tea or tablets for candidiasis. Most holistic practitioners try to avoid using the
allopathic standard-nystatin-because a long term program may be necessary. The objectives of
treatment should be to restrain the growth of yeast long enough for sensitivities to lessen and to
restore the ability of the immune system to suppress the yeast on its own.
Chlamydia. This parasitic infection may be treatable by a number of natural substances. Hypericin
(St. John's wort extract), for example, has been found to be a broad-spectrum antimicrobial. Other
supplements, such as alkylglycerols, may increase white blood cell counts, enabling the body to defend
itself better.
Human papilloma virus infection. Once again, hypericin may be a possible treatment since we know
it is effective against herpes viruses. Chinese studies of garlic showed anti-CMV, anti-herpes effect;
it should be investigated for HPV infection, too. We could also beneftt from additional research on
the use of bioflavinoids such as Quercitin as an antiviral.
Pneumoeystis pneumonia. This 01 is the highest reported killer of women with AIDS; in fact, HIV +
women generally have more pneumonias and respiratory problems than men. Garlic should be
researched further for its anti-protozoal effect, especially since standard treatment with a
broader-spectrum drug like Bacuim can cause yeast growth-a bad idea in a population that is
already disproportionately affected by candidiasis. Vitamin C may also offer some promise.

Nutritional supplements can help PWAs deal better with the side effects of traditional therapies. For
example, metabolization of many standard HIV treatments depletes the body of nutrients necessary
for proper immune functioning. In addition to causing anemia. AZr depletes B vitamins, and B- U
deficiency may be responsible for some of the CFlDS symptoms associated with AIDS. ddl and ddC
can decrease trace minerals, and vitamin therapy may reduce these side effects. Therapies like
acupuncture and colonies may help the body to detoxify from overuse of pharmaceuticals or illegal
drugs. Acupuncture could be part of a treatment program for injection drug users, to help them
reduce the risk of re-infection by sharing needles. Acupuncture is covered by Medi-Cal in California
but not by Medicaid or Medicare. Many states do not even have a mechanism for licensing
practitioners of acupuncture.
Strategies for tbe futnre

In addition to overall reform of the drug development, testing, and approval process. and the current
medical research paradigm, there are a few steps the activists can take to make the benefits of
alternative therapies available to more women.
Activists mUst stress the importance of enrolling women in community-based trials. These studies,
run by physicians in their offices, constitute the only access to some non-pharmaceutical
experimental drugs. Community-based research organizations must have community advisory boards,
just like ACfG trials, and these boards must include women. All barriers to participation by women
and people of color-including financial barriers-must be removed.
Women need to contribute to the development of a master protocol for alternative and holistic
therapies. The way that clinical trials are designed, they automatically disqualify many

non-pharmaceutical treatments, since these therapies may have their effect through different
mechanisms from mainstream drugs. We must design a trial model that evaluates alternative
therapies for efficacy on their own terms.
We need to continue to alter the power relationships between doctor and patient. Without an open,
comfortable, and supportive relationship with her physician, many women will be hesitant to ask
about alternatives. Without discussion, some women will choose not use many substances that could
improve their health; others will use treatments but not tell their physician, and thereby be deprived
of medical input on the therapy or its interactions with other medications. (For more on this topic,
see Michelle Roland's article in AIDS Treatment News or Project Inform's Discussion Paper, "Doctor
and Patient: Building a Cooperative Relationship).

A long tradition of limited research on women's health issues has resulted in a lack of information
regarding substance abuse treatment in female drug users, and especially in those infected with HIV.
Female drug users with HIV have to deal with a double stigma. Society rejects them as persons
addicted to alcohol or drugs, and as persons infected by HIV. Sexist attitudes stigmatize them
further, especially as inadequate, irresponsible childbearers. Such bigotry places female drug users
with HIV disease among the most disenfranchised populations.
In addition, female drug users have access to far fewer resources than their male counterparts. They
are underrepresented in treatment programs, and consequently, these programs are often not geared
to their specific needs. Because these treatment centers do not want to take medical responsibilities,
pregnant women are not accepted. There are only 4 or 5 centers in the United States which accept
pregnant women; there are none in New York City. Child care is usually not offered. and children
uuder 12 are not allowed to visit. Pre and post-natal care, training for single parents (up to 40% of
female drug users are single parents), and women support groups are rarely providedi'8.
Moreover, drug use is high in the lesbian community although it is rarely acknowledged nor are
support groups provided.
All these factors, as well as the burden associated with HIV disease, are responsible for the major
psychological problems experienced by female drug users with HIV. To the usual low self-esteem,
shame and guilt associated with drug use, these women grieve what they perceive as the loss of
health. body image, sexuality and childbearing potential. They experience denial and tend to neglect
their health. leading to anger at being incapacitated. Depression is widespread and often results in
cocaine use. Fmally, drug users with HIV disease are often rejected by their peers, and feel
extremely isolated.
Although women are less likely to become dependent upon illicit drugs than men, they are more
likely to become addicted to prescription drugs and to use them with alcohol. They also tend to
frequently use cocaine and other psychostimulants, as a way to offset depression, to induce weight
loss, or simply to keep going in demanding conditions. How~ver, female drug users with HIV are
often intravenous drug users, and in addition to traditional substance abuse treatment, may be
offered to participate in a methadone maintenance program.
Women's health is more vulnerable to substance use.
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to develop cirrhosis of the liver, as well as damages to the central nervous, cardiovascular and
reproductive systems. Drug-dependent women often have problems with menstruation., such as lack
of periods, and a wide variety of medical problems (poor nutritional state, hypertension., hepatitis, ... )
that motivate them to look for medical attention., often the first step toward drug treatment.

Issues CoDcenU.og Medical Care for Female Dnlc Ula"S
with HIV Disease
Little is known of the natural history of HIV disease in women, and other articles in this document
are discussing factors that might have an influence on the way HIV disease progresses in women
specifically. Of concern in this article is the influence of drug use on the rate of progression of the
disease. A short discussion concerning the effects of pregnancy on disease follows, mainly as an
introduction to the issue of drug interactions.
Numerous studies have shown that chronic use of drugs has a deleterious effect on the immune
system of users, whether infected by HIV or not. Intravenous drug users have abnormally low levels
of beta-endorphin (a natural ~ain killer secreted by the body) in their blood. and their body tends
to stop producing endorphins . It is because opioids act on the same sites as endorphins that drug
users' brains stop producing endorphins, since they do not seem needed anymore. When users stop
drug administration., it is the lack of endorphin production that is responsible for withdrawal
symptoms.
Interestingly, some white blood cells involved in immunity have receptor sites that attract endorphins.
Thus, endorphins appear to regulate some immune functions. Persons with AIDS have low levels of
endorphins in their blood. probably in relation to abnormally high levels of alpha-interferon (which
might signal the brain to decrease endorphin production). Whether this decrease in endorphin levels
plays a role in the progression cf HIV disease remains unclear. Thus, drug use and HIV infection
act together to dramatically decrease the blood levels of a substance involved in immune regulation.
In addition., drug users have high levels of cortisol (an hormone produced in the body to deal with
stressful conditions) in their blood, and cortisol acts as an immunosuppressor, thus further
diminishing the body's ability to react against HIV. Alcohol, heavy marijuana use and cocaine have
been shown to have similar effects on the immune system80, and cocaine use has been shown to
increase the rate of progression of HIV disease.
In addition, it seems that the mere act of injecting a substance intravenously can be deleterious for
CD4 lymphocytes. Reports indicate that drug users with HIV who stop injecting drugs and start
receiving methadone experience an immediate increase in the absolute number of CD4 lymphocytes,
even in the absence of any other treatmenc81.
The effects of pregnancy on the progression of HIV disease have been reported in several studies in
this country and abroad. In asymptomatic women with HIV, there is no evidence that pregnancy
accelerates disease progression. However, pregnant female drug users with HIV are more likely to
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develop bacterial pneumonia, and breech presentation is slightly more frequenr:!2 .. The effect of a
second or third pregnancy during HIV infection have not been studied. Pregnancy, with its
accompanying deaease in immunity, may mask non-specific symptoms of infection, and delay
diagnosis of HIV-related symptoms.
In female drug users, drug use often produces amenorrhea (absence of periods), and pregnancy is
often diagnosed late, thus making difficult the assessment of fetal growth problems.
Treatment for HIV infection in drug users relies on the same bases than for tne rest of patients.
AZT is taken with a high compliance level, especially in methadone maintenance programs. Dosage
is similar to the one used in non- drug using population. There is a lack of data regarding the
pharmacokinetics of AZf in male or female drug users. Chronic drug use induces lasting damages of
the liver, and the usual AZf dosage might be either toxic or insufficient for drug users.
Tuberculosis is becoming inaeasingly common in drug users with HIV disease, and intradermal
tuberculin skin testing should be done yearly. In addition, some practitioners use isoniazid as a
chemoprophylaxis to be given daily along with methadone83• Diagnosed tuberculosis must be treated
immediately with a multidrug combination.
Stress reduction is part of rehabilitation programs, and is likely to have positive effectS on the
immune system as well.
Clinical trials of experimental drugs are often excluding female drug users with HIV disease, because
they are designed in ways that disqualify drug users and women. Drug users have a reputation of
bad compliance, which is not true. They often show elevated liver enzymes that exclude them from
most trials. Exclusion from trials on the basis of elevated liver enzymes is arbitrarily imposed by
protocols in most cases. Absence of drug treatment programs and child care at the study sites also
excludes female drug users.
With drug users, and especially with female drug users, the problem of drug interactions is a crucial
one. Women with HIV in methadone programs often take AZf, as well as other HIV-related
substances. What are the effects of these substances on the HIV-infectcd immune system, and what
are the effectS of drugs interacting with each other? In addition, pregnant female drug users with
HlV face the possible consequences of drug effect on their developing child.

Metbadoae Tratmeat
The effects of methadone on immunity seem to be extremely positive. Long-term methadone
treatment seems to regularize the levels and release of endorphins84, by allowing the brain to
regain progressively control of endorphin production. Individuals that have received methadone
treatment for more than 11 years show recovered activity of their Natural-Killer lymphocytes85 •
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~rug users with HIV disease who receive methadone usually observe a lasting increase in their
number of CD4 lymphocytes, likely to be also caused by the cessation of the deleterious effects of
intravenous injections of opioids. Thus, it appears that methadone has a positive effect on the
immune system through normalization of immune function. as it has been observed for the
neuroendocrine system.

The effects of methadone during pregnancy are extremely imponant to identify since it is often the
case that female drug users enter a methadone program during their pregnancy, and relapse after
giving birth. Women in methadone programs are more likely to wow :/ for prenatal visits. receive
better prenatal care (although still not optimal), and have less anemia . Babies born from
mothers receiving methadone have normal binh weights.
Evidence of methadone withdrawal symptoms in babies born from women receiving methadone lead
to a reduction in methadone dosage during the third trimester of pregnanc{7. However, such a
reduced dosage is not sufficient to offset drug withdrawal, and women tend to use substitute drugs
such as Valium to alleviate withdrawal. Valium abuse complicates narcotic withdrawal in newborns,
and some practitioners recommend an increase in methadone dosage during the third trimester of
pregnancy to avoid this type of complication88• In addition. there does not seem to be a direct
correlation between maternal methadone dosage and the severity of withdrawal in neonates89•
Interactions of methadone with other drugs are minimal, it does not interact with alcohol or Antabuse.
However, rifampin, a drug used to treat tuberculosis and MAC (Mycobacterium Avium Complex),
increases elimination of methadone by the liver, and requires an increase in the dosage of
methadone (as well as other opioid analogs, such as morphine or codeine) 90•
Interactions of methadone with AZr have not been extensively investigated. Unofficial reports at an
ACI'G conference stated that AZr and methadone compete for the same elimination mechanism,
and that individuals receiving methadone should reduce their AZr dosage, possibly by half.
However, no official guideline has ever been given.

Naltrexone is used in drug users to stimulate the production of endorphins and, at high doses, to
block the site of action of opioids. Recently, some researchers have tried to use naltrexone to
regularize the immune system in people with HIV disease. Using very small doses of naltrexone, a
study identified patients that responded positively to the treatment, and tended to develop less
opponunistic infections91 • However, drug users wbo receive naltrexone as pan of their treatment,
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In summary, research regarding standard of care for female drug users with HIV .disease suffers from
the same neglect that most issues regarding women and HIV. It is time for government and
researchers you realize that drug abuse treatment is AIDS prevention, and drug users must be
offered the same treatment options as other persons with HIV disease. Drug treatment programs
must be expanded and made more available and acceptable to women. Admission barriers to these
programs must be lowered, and programs must be able to offer primary care, pre- and post-natal
care, child care during and after hospitalization, and parental training on site. In addition, increased
support and resources services are needed for female drug users with HIV disease.
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The number of women prisoners who are HIV infected is not known. However, in states (such as
NY) voluntary testing among all inmates9S (male and female) has shown an approximate 20% rate
of infection. Women specific studies in Massachusetts have shown an approximate 35% rate of
infection in the inmate population96• Women in jail face an inequity of
as compared to their
male counterparts, a reflection of gender bias in their "outside" society. Since the 1970's, the female
prison population has increased steadily and at a faster rate than the male population. The number
of women in prison was approximalely 40,000 as of 199fi"'. Most of these are drug related
convictions. Due to the stiffer penalties for drug charges and nationwide "Drug-Free Society" fervor,
women (and men) are receiving stiffer penalties now prior to 1970. The influx of female prisoners
bas resulted in vastly overcrowded jail conditions. For example, at CJ.W. Frontera., 2,500 inmates
are housed in a structure originally intended for 800 prisoners. Although CJ.W. (California Institute
for Women) Frontera is a worst-case scenario, the problems of overcrowding and the resultant
negligent care is a nationwide problem. Female prisoners who are HIV infected are particularly
vulnerable to inadequate and inhumane prison conditions. The primary areas of focus to improve
conditions for HIV infected women are as follows:

care

1) Health Care
A

B.
C.
D.

E.
F.

Lack of access to appropriate and time medical care
1. Lack of AIDS knowledgeable medical staff
2. Understaffmg of nurse/guards
3. VISiting doctors rather than on-staff
4. Transponation difficulties for access to outside hospitals
5. Lack of state licensing for infirmaries resulting in inferior medical care
6. Lack of state bureaucratic supervision and specific HIVI AIDS policies which lead to
prison officials deciding these policies for themselves
Lack of access to outside opinions
Poor housing conditions
Lack of adequate nutrition
L Prison food
2. Lack of access to vitamins and nutritive supplements
Lack of access to clinical drug trail participation
Lack of access to experimental HIV/AIDS drugs

2) AIDS Education
A.
B.
C.

D.

Lack of implementation of Safe Sex/Safe Works education for inmates and staff
Lack of AIDS education for prison health care providers
Lack of prisoners support and education networks inside prisons for HIV infected and
the general population, including safe sex materials such as dental dams and condoms
(A unique example of this is A.C.E.S. in NY)
Lack of drug rehabilitation programs inside prisons ("A large percentage of women
prisoners have histories of IV drug use, a significant source of HIV transmission for
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E.
F.

women98
Lack of outside suppon systems for H1V infected female prisoners
Lack of voluntary and confidential H1V antibody testing inside prison with pre and post
test counseling

3) Discriminatory Practices
A.
B.

C.
D.
E.

F.
G.

Quarantine of HIV infected inmates due to ignorance of HIV transmission routes
Lack of ac..:ess to educational, job training programs and other rehabilitative programs
for HIV infected inmates
Disparity between conditions of female vs. male HIV infected inmates
Lack of confidentiality for prisoners HIV status
Unnecessary use of face masks, rubbers gloves, etc. for dealing with HIV infected
prisoners (For example, in California there is a non-official policy of making HIV
infected inmates wear face masks while being transponed to other facilities or going
before the parole board presumably due to ignorance of HIV transmission routes.)
Blatant medical neglect due to the lack of AIDS/HIV education on the part of the
prison staff
Inability to participate in overnight family visits and general discrimination in visitation
rights

4) Compassionate Releases
A.

Difficulty in obtaining due to the lengthy bureaucratic procedures out of sync with the
sometime sudden and severe onset of full blown AIDS

The situation varies according to Federal, State and local policies. However, one major concern is
the lack of outside monitoring of prison conditions. In most state and local prisons nationwide,
prison officials create their own policies. This lead to wide discrepancies in HIV testing, quarantine,
medical care and discriminatory practices.
For example, there is a law in California that inmates are not allowed to take care of other inmates
making the implementation of a program such as A.C.E.S.99 (NY) impossible to implement.
Additionally, the lack of AIDS education and drug rehabilitation inside prisons (for staff and
inmates) is a primary cause of many legal and human rights violations, and a primary contnbutor to
the spread of HIV infection among the prison population and to their families on the outside. Lack
of access to outside medical consultation and treatment and the inability to participate in clinical
drug trails and other experimental treatments are also blatant areas of discrimination which
contribute to the untimely illnesses and deaths of HIV infected inmates. Overcrowding in and
limited budgets for correctional facilities nationwide is at the root of many of the inhumane
conditions which HIV infected women prisoners experience. Understaffed infumaries with illtrained
and uneducated health care providers is the rule rather than the exception, nationwide.
The most effective advocacy for H1V infected women prisoners must come from the prisoners
themselves. A non-intrusive stance based on individual reports from prisoners and constant
communication with them will outline specific local areas of concern and action. What type of action
is taken on behalf of prisoners must be outlined by the prisoners themselves in order to protect
prisoners from further violations and abuses as a result of intrusive methods. Given the violent,
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uneducated and irrational attitudes found within the prison system on every leve~.the utmost
sensitivity is required. The most effective method of changing prison conditions is in determining
specific local and state policies (or lack of polici~s), working with inmates to determine actual (vs.
officially stated) conditions, applying public pressure (letter writing, phone zaps. media focus,
coalition with other groups. legislative advocacy) to the prison bureauaacy to change specific
conditions, and applying pressure for massive implementation of AIDS/HIV educational campaigns
for staff and prisoners.
In conclusion, a 3-pronged approach is suggested at this time in advocating for:
1) Local activism re: HIVI AIDS education in the prison system
2) Local and State activism re: Cohesive local and state policies and outside monitoring of
medi~ ~reatment and conditions inside the prison system
3) Nationwide activism re: Clinical drug trial participation and access to outside medical care
and alternative drug treatments and therapies.

WOIDal PrisoDers Mast Haft Aa:1ess to IDV/AIDS OiaicaJ
Compassioaate Use Dnlp

Draa

~

'l"reatmaat INDs aad

Women have historically and systematically been left out of or underrepresented in HIV /AIDS
clinical drug trials. They have had limited access to treatment INDs and compassionate use drugs.
However, women prisoners (and men prisoners) have never been allowed to participate in these drug
trials and have had no access to experimental HIV I AIDS drugs.
The inclusion of HIV positive women prisoners is an essential pan of the "'Women's Treatment
Agenda:: Women in prison have access to substandard medical and nutritional care. Prison doctors
and health care workers are for the most part not knowledgeable about HIV I AIDS. In New York
State, over 1/3 of the cases of prisoners with AIDS were diagnosed after death. Also in New York
State, prisoners with AIDS were found to live one-half as long as IV drug users with AIDS living in
New York City. Given the lack of understanding in the medical profession about women with AIDS,
these figures are probably much higher for women prisoners.
A joint report issued by the New York State AIDS Advisory Council, Ad hoc Committee on AIDS in
Correctional Facilities, AIDS Institute and the New York State Department of Health concurred that
it was essential that prisoners have access to clinical drug trials:
Because of the speed and potential benefits of research, access to experimental
produa.s could be a choice for inmates as it is for others with HIV infection.
New drugs become approved and available through clinical trials, many of which
have often excluded women and IV drug users. The burdens and benefits of
testing should be shared equitably within the populations infected or at high risk
of infection. It is extremely difficult to conduct long-term clinical trials involving
IV drug users in the community. If the prison population can be permitted access
to these trials, while remaining protected from coercion and abuse, not only
individuals but also society may benefit. An altruistic motive for behavior, which
is permitted to non-incarcerated populations and which may ennoble suffering,
should not be denied to inmates. Of course, particular attention must be paid, in
this instance as in all others. to the process of and protection for informed
consent.
Access to HIVI AIDS clinical drug trials, treatment INDs and compassionate use drugs could help
prolong the life of women prisoners with AIDS, many of whom are poor African-American and
Latina women. In New York City, women prisoners have an estimated seroprevalence rate of 25

percent and in New York State, almost 19 pcrcent. 100
Women prisoners cannot rely on prison health care to treat HIV/AIDS. Federal regulations require
that prisoners who desire to be included in clinical trials make that decision for themselves.
Participation must be non-coerced and voluntary and only during the Phase n and m of non-placebo
drug trials so as to avoid any abusive research or experimentation. Confidentiality of medical records
must be respected and upheld as much as possible. All drug trials and expanded compassionate
drug use should be conducted outside of the prison environment by the trained staff of an
A ~S-designated hospital or the equivalent. Prison medical staff should not administer these drug
trials. Fmally, any clinical trials in prison must be reviewed by an IRB with at least one prisoner
representative on the paneL The active participation of AIDS activists, women's advocates and
community-based AIDS service organizations is essential to the successful monitoring of this process.

Women prisoners have already taken the lead in fighting this epidemic in the prisons by establishing
peer education and counseling projects like the AIDS, Counseling and Education (ACE) program at
Bedford Hills Correctional Facility in New York State.
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W0111m, AIDS, &Del tbe AIDS Ciaic:al Trial Groap S,SU. .

The AIDS Clinical Trials Group (ACI'G), funded and managed by the National Institute of Allergy
and Infectious Diseases (NIAID), was aeated in 1987. The ACI'G is the largest federally funded
program of clinical trials to evaluate potentially effective agents for treatment .of HIV infection.
There are 47 institutions which are funded through this system to establish research priorities,
develop protocols and implement clinical trials.
NIAID developed the following as goals for the ACI'G system:
o Study the full range of HIV-related disease, including primary HIV infection, opportunistic
infectiorb, snalignancies, and neurologic disorders,
o Evaluate a wide array of potentially promising agents,
o Perform both pilot/phase I innovative trials and large comparative trials.
NIAID lists among the accomplishments of this system the development of 152 protocols and a total
accrual of more than 11.000 patients. Their conclusion from these accomplishments is that •the
ACI'G has contributed substantially to the current status of therapy of HIV disease. •
An analysis of this ACI'G system of clinical trials from the perspective of women with HIV, however,

falls dramatically short of any contributions toward the health and longevity of women with
HIV/AIDS.
WOIDCil Witb BlV/AIDS: Who's Afl'ected aad Who's EaroiJed

Women account for 9.1% of the adult AIDS diagnoses in the U.S. Their numbers increased by 45%
over the past 12 months. Of the women affected, 73% are women of color: African-American,
Latina, Native American, and Asian c~ Pacific Islander. Most of these women are poor, most have
children, and most have been affronted by a system of health care which has inadequately met their
needs over the course of a lifetime.
Although women now account for an alarmingly inaeasing number of cases, only 5% of all ACI'G
clinical trial participants are women. Only !75 of the symptomatic women in the U.S. are in
ACI'G-sponsored trials. Further, only 9 pregnant women have been enrolled in ACI'G trials.
NIAID, however, continues to report inflated and inaccurate statistics for the participation of
-women• in AIDS clinical trials. Their statistics combine into a single number-women, female
children, and female infants.
'111e ACI'G S)'Staa: Where are tbe Sites aad Who Raas tbe Trials

The 47 ACI'G trial sites were selected based on the perceived ability of a particular institute to
conduct scientifically sound research. It has long been the perception that such research can take
place only in the context of medical school/teaching institution-affiliated hospitals-tertiary care
centers. Institutions such as Duke University, UCLA, Johns Hopkins, Columbia University and Ohio
State University are part of the ACI'G system.
The reality of the lives of women affected by HIVI AIDS is reflected in the places where women seek
health care. Primary care (when available at all) is provided at city and county hospitals or in local
or state .!unded clinics. The linkage between these primary care settings for women and the tertiary
centers where ACfU sites are located is poor. The result-women with HIVI AIDS either do not
know that these trial sites exist or do not have the financial or logistical means to access them. A
1989 National Institutes of Health SUI'\'eY of women giving birth at 46 medical centers where
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Federally-sponsored AIDSfHIV clinical trials are underway revealed that women.do not receive
sufficient referral either to clinical trials or to AIDS-trained physicians.
ACfG trials are proposed and directed by a network of principal investigators (Pis) located at the.
various ACI"U trial sites. Of the 47 Pis, only 8 are women. None of the 47 Pis spedalize in
gynecology, even though the reality of HIV disease in women often manifests in specific
gynecological diseases.
ACI"U sites are funded under contracts, called cooperative agreements, between N1AID and the
specific site. These conttac:ts request and fund particular resources which are available at the ACI'U
site. If an immunologist is needed, it is specified in the conttact. If the ability to perform CD4
counts in the site's immunology laboratory is needed, it is specified in the contract. None of the 47
cooperative agreements request, specify or fund a gynecologist or an oncologist whose specialty is
gynecology. Under the present contracts, if gynecological assessment is to be done, it must be
funded through a mechanism outside the ACfG system.

Bow ACI'G Trials are Desiped to Elrdude Womea
Before enrolling in a trial, a woman must provide evidence of adequate birth control. While the
concept of •adequate• is subjective, the interpretations of this requirement at various trial sites are
diverse. Most site coordinators apply rigid criteria to the interpretation of this question, even if the
woman bas no plans to become pregnant. The requirement for birth control focuses on women as
incubators and potential vectors of disease transmission, trades the advantage of access to
experimental therapy in an HIV infected woman for the risks to a •theoretical" fetus and renders
HIV infected lesbians invisible.
Although not a requirement for entry into an ACfG trial. a large number of trial sites refuse to
admit individuals who are injection drug users (IDUs) and are not enrolled in a drug treatment
program. Since 52% of HIV infected women, according to Centers for Disease Control (CDC)
statistics, have a history of injection drug use, a majority of these women are excluded. This
philosophy presumes two things: first, that there are enough treatment programs to go around, and
second, that IDUs are irrespoDSlble. Neither of these assumptions are true.
Baseline levels for liver function enzymes are used as entry criteria for clinical trials. Normal
acceptable ranges for these enzyme levels are established arbiuarily and may not be scientifically
necessary. These baseline levels are exclusionary to IDUs, since in individuals with a history of drug
use, liver function may be impaired (and reflected in elevated liver enzyme).
Other serum markers such as baseline CD4 levels and p24 antigen have not been analyzed in women
for correlation to clinical AIDS and may express at lower levels, if at all. in non-white individuals
with HIV disease.
Timing for blood collections during the pharmacokinetics phase of trials may be unnecessarily rigid.
Specifications for collection increments may not reflect the reality of the half-life of a specific drug
and may have been established simply because ·thars the way it bas always been done: Requiring a
48 hour sample when children must be picked up from school or cared for in the hospital, often
results in missed pharmacokinetic appointments and arbitrary removal from protocols.
Individuals who are enrolled in the ACfG-sponsored trials are required to provide their own primary
health care and regular physiological assessment. Women as a group are less likely to have access to
health care for economic reasons, particularly women with HIV disease who are often poor.
Women also make conscious decisions not to access a system which recommends invasive procedures
such as total hysterectomies; or where coercive counselling, rather than informed choice is the
norm. If primary health care is a requirement for enrollment in an ACfG-sponsored trial, NlAID

must make the funds available for access to that health care.
Since ACTG trial sites are often inaccessible to IDV-infected women., and since many mY-infected
women are single heads of households and may have mv-infected children., it is imperative that
NIAID fund transportation to the site and provide childcare during a woman's visit. Operating
hours must be adjusted to reflect reality of women who work. In addition., various sites have not even
recognized that by simply seeing pediatric patients and women at the same time and on the same day
and time, women could have the opportuDity to take care of the healthcare needs of themselves as
well as their children.
Most cliuical trials which enroll women require urinary testing for controlled substances prior to
enrollmenL This requirement arbitrarily assumes that most mv infected women are using drugs.
More importantly, results of drug screening are not confidential and may by used by states in child
custody decisions or in the case of child abuse (particularly for pregnant women). This requirement
puts women in jeopardy and is not disclosed in the informed consent required for trial enrollmenL
If cooperative agreement proposals can require institutional assets such as libraries and computers to
receive funding, why can't they require the provision of primary care physicians. routine
gynecological assessments, child care and transportation? These services should not only be
provided during the time that a woman is on a study, but also during the years after the study is
complete.

What's Beiag Studied Vs. What Disases BJV IDiected Womea Get
Of the 152 protocols developed under the ACTG system, 63 involve the study of zidovudine (AZT or
ZDV). The ACTG system has not evaluated the efficacy or safety of zidovudine for AIDS and its
related illnesses in women.
There are 10 ACTG trials which study the effects of various treatment on Kaposi's Sarcoma, 17
which study varous treatments on Pneumocystis Carinii Pneumonia (PCP), U which study
cytomegalovirus (CMV) retinitis, 4 which study cryptococcus, 4 for toxoplasmosis, 1 for histoplasmosis
and 19 trials which assess various compounds for dllc:acy and safety in treating pediatric AIDS.
There are no trials specifically designed to evaluate the efficacy and safety of treatments for AIDS
and related opportunistic infections in women. In addition., there are currently no trials, nor are
trials being planned, to study treatments for AIDS manifestations specific to women -pelvic
inflammatory disease (PID ), human papilloma virus (HPV), cervical cancer or prophylaxis for vaginal
thrush (Candida albicans). Most of the trials for opportunistic infections (Ois) target ·end-stage• or
lifethreatening Ois. This concept ignores the reality that women often do not live long enough to
get these particular Ois. In addition, woman-specific Ois exist which are life-threatening and are
currently not being studied.
ACTG 126, a trial designed to assess impediments to initial and continued enrollment of IDUs in
ACTG clinical trials has been deferred.
Tbe Pl:diatric Committee ol the AcrG System: A Model ol Semm

The Pediatric Committee of the ACTG exists as a fully operational core committee within the ACTG
committee structure. A subcommittee of the Pediatric Committee, the OB/GYN subcommittee, is
where NlAID officials direct inquiries regarding enrollment of HIV-infected women into the
ACTO-sponsored trials.
The reality of the OB/GYN subcommittee is that members are either pediatricians or obstetricians.
None are gynecologists and none are interested in the health of women. Members of this
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subcommittee speak openly about their interest solely in pediatric AIDS and research into
interrupting "vertical transmission".
Out of this committee came ACI'G 076, a protocol to assess the efficacy of escalating doses of
zidovudine for interruption of fetal transmission. Protocol 076 targets enrollment of 700 pregnant
women. The numbers are large to account for the fact that two-thirds of the infants born to these
mothers will not be HIV positive. This is the largest ACI'G-sponsored trial currently being planned
and will use an abundance of constrained financial resources.
The trial requires that these women receive escalating doses of zidovudine, doses which may render
them zidovudine-refractory when the course of their own disease may require zidovudine therapy.
Maternal laboratory assessments are minimum -assessments designed solely to detect zidovudine
toxicity so that doses may continue to be increased.
Although a recently revised draft of the protocol for this trial incorporates a gynecological assessment
on entry, the six week follow-up evaluation does not include a gyn exam. It is unethical to use
women as "animal models"; i.e. vectors of transmis.aon. The protocol is an example of rampant
sexism on the part of the investigators; there are no plans to assess the effect of zidovudine on the
women in this trial.
There is substantial evidence for the use of high titer neutralizing gp120 serum antibodies as a
screening indicator for fetal outcome. Women whose serum does not contain these antibodies are
most likely to give birth to an HIV infected child. Investigators involved in 076 refuse to include this
marker as a criterion for enrollment. It is unethical to give AZr to fetuses not likely to be
HIV-infected.
In December 1989, Burroughs Wellcome Co. released data on zidovudine indicating that it may be
carcinogenic. The ACI'G temporarily suspended its studies in pregnant HIV-infected women and
their newborns until the carcinogenicity data could be thoroughly reviewed. In the Burroughs study
in m~ce and rats receiving oral zidovudine, histological examination revealed vaginal carcinomas in
10% of the animals tested. The panel which reviewed this alarming data was comprised of
Burroughs employees and Pis involved in the 076 trial.
The panel concluded that the potential benefits to newborns outweighed the risk to mothers. These
results, the composition of the review panel, and their conclusions raise additional ethical questions
regarding the safety and the health of women who enroll in ACI'G 076.
There are numerous additional problems with the 076 trial. These were offered simply as an example
of the ways in which ACI'G trials display a wanton disregard for the health and well being of
women.
Why the emphasis on continuing ACI'G 076? If any compound can be shown to interrupt fetal
transmission of HIV, the next step will be mandatory testing for all high risk pregnant women.

ACI'Gs: 1990 aad BeJoacl
As a result of activist pressure, the Executive Commiuee of the ACI'G system voted at its last
meeting in November 1990, to form a Women's Health Committee, a full core committee with in the
ACI'G system. There is danger, however, that members of the old OB/GYN subcommittee will
simply become the newly formed Women's Health Committee. This must not happen.
The Women's Health Committee must:
o Include a gynecologist, an infectious disease specialist, a GYN oncologist, an HIV positive
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woman and a women's health activist. There is no reason to include either an obstetrician
or a pediatrician. Individuals with this expertise can be consulted through the Pediatric
Committee.
o Receive full fmding commitments immediately
o Develop standards for gynecological assessments which are routine for every ACTG
protocol
o Immediately write protocols to assess the efficacy of fluconazole as a treatment for vaginal
thrush and work with the Oncology Committee to develop treatments for preventing
HPV-related CIN and AIN.
Core Committee appointments follow the same incestuous reasoning that is exhibited in concept sheet
approvals and drug company consultative agreements with principal investigators. The chair of the
newly formed Women's Health Committee has been selected by the Executive Committee, and the
appointed chair will select the additional members. Not exactly the ideal of demoaacy, especially
given the lack of commitment to women's lives which bas already been exJubited by members of the
Executive Committee.
Activists must watch carefully the implementation of ACTG recompetition scheduled for next year.
This recompetition is supposed to correct problems of trial accrual, specifically for women and HIV

infected people of color. However, NlAID proposals for research initiatives being submitted to
various trial sites include the following requests for resources:
o Support for expansions of the pediatric AIDS clinical trial effort through the establishment
of new pediatric clinical trial units.
o Development of reliable methods for early diagnosis of HIV infection in newborn and
infants and establishment of timing of perinatal transmission of HIV.
o Research into development and use of animal and in vitro models for pediatric metabolism.
Research into the mechanisms of transplacental infection.
o Development of strategies for preventing transmission of HIV from mother to infant.
Where are the requests for proposals to save the lives of women?

Other NlAID lssues/EII'orts Whida lpon BIV ill Womc:a
The community based trial efforts of NIAID, Communir:y Programs for Clinical Research on AIDS
(CPCRA) are following in the footsteps of the ACTG system. A major effort of CPCRA in the
upcoming year is a community based version of ACTG 076. In addition, the committee (CPCRA
working group) which presumably focuses on women-specific issues is the •Minorir:y; Women's and
Children's Issues Working Group: Obviously, CPCRA operates under the same sexist principles as
the ACTG system: women don't exist outside the context of children and their abilir:y to reproduce.
The National Cooperative Drug Discovery Groups (NCDDG), funded by NIAID, were developed to
encourage collaborations among scientists from academia, industry, and government on research to
discover and develop new AIDS therapies. The NCDDG-HIV was established in 1986. The
NCDDG-01 (Opportunistic Infections) is a part of this effort. In August, 1990, funding awards were
given for the development of six new NCDDG-Ois. The six new awards will focus on:
1)

Mycobacterium avium

2)
3)
4)
5)
6)

Fungi- cell wall inhibitors
Toxop~a

Fungi- enzyme inhibitors
Pneumocystis, cytomegalovirus and Toxoplasma and
Cryptosporidium.

None of the new NCDDG-OI grants were awarded for Women-specific research.
NlAID also funds epidemiological studies. In 1983, two pr~pective cohort studies designed to follow
the natural history of HIV infection in men were begun. The Multicenter AIDS Cohort Study
(MACS) and the San Francisco Men's Health Study (SFMHS) continue to be funded with limited
dollars to answer questions such as how treatment affects the natural history of the epidemic, why
some people with high risk behavior never become infected with HIV, and how often and for how
long HIV infection can occur before it is identified by seroeonversion. These issues are duplicative to
efforts by the CDC in the Spectrum of Disease study. Limited resources need to be used wisely.
Two other NIAID-funded epidemiology studies are the Heterosexual AIDS Transmission Study
(HATS) and the Women/Infants Transmission Study (WITS). The HATS study, as a result of
activist pressure, recently included a question which reads, "Have you ever had sex with another
woman?" Prior to inclusion of the question, all women interviewed were presumed to be
heterosexual. The addition of this question only serves to allow NIAID to obtain ·clean heterosexual
·data"; it does nothing to provide information on woman-to-woman transmission.
NlAID bas a long way to go to direct their research agenda in a way that will allow women access to
trials and that will provide for the development of treatments which will prolong the lives of women
with HIV. Activists will continue to watch, collect information, and demand that NIAID-funded
research be directed in a way that will address the changing reality of those who are affected by HIV.

Safety ud Elfic:acy: The FDA'S Role For W()lllell?

The Food and Drug Administration (FDA) is responsible for regulating the entire process of testing
experimental drugs in humans. It follows a drug through each phase of testing, and examines data
submitted by the trial sponsor after completion of a trial. to determine if the drug meets standards
legislated by Congress, and conferred by Congress onto the FDA.
·
The FDA's mission is to review data and determine that all drugs are both safe and ei1icacious
prior to their approval for sale on the open mark.et. As a part of this effon, the FDA must also
approve all experimental drugs trials as reasonably safe, in relation to the possible benefits of
research and risks to trial participants. How has this mission impaded the lives and health of women
in the U.S.? Certainly not to the substantial good.
During the late fifties and early sixties a sleeping pill, thalidomide, was in widespread use abroad.
Thalidomide was an efficacious sleeping pill, but it was also a drug which caused severe birth defedS
in children born to pregnant women who bad taken it. Dr. Frances Kelsey, an FDA official, had
serious questions about the safety of thalidomide and single handedly prevented thalidomide from
being approved for use in the U.S.

The thalidomide incident brought the FDA to a devastating conclusion regarding the testing, safety
and efficacy,of drugs for women; don't test experimental drugs on women of child-bearing age. The
one single exception to this rule, of course, is in drugs which deal with reproductive choices.
Contraceptives have been developed, tested and released with such a frenzy that women have been
forced to use such unsafe methods of birth control as oral contraceptives (the pill) and the Dalcon
Shield. Unfortunately, the side affedS of these drugs and devices, and drugs such as DES are all too

well known.
Meanwhile, drugs which may be equally devastating for women in general, and particularly for
women with HIV, are being released to the public with no information on their particular adverse
affedS in women. The disregard for the differences in women's bodies, the rejection of medical
documentation of particular opportunistic infections in women with HIV (particularly gynecological
infections and cancers), and the focus on the importance of a fetus as opposed to a woman, have
resulted in deadly serious consequences for women with HIV. This sexist obsession with protecting
a fetus also ignores the fad that 22% of women with HIV are over 40, and could enroll in trials
potentially without the risk of becoming pregnant.
Zidovudine (ZD V), the only licensed antiretroviral therapy, was approved for widespread use despite
evidence of its sex- and site- specific carcinogenicity in female animals, and despite alarmingly small
numbers of women with HIV in its clinical trials. The few women who participated in the trials,
were followed for male-defined complications associated with its use. The trials were not designed to
assess the impad of ZDV on gynecological problems.
ZDV is now in widespread use for the treatment of HIV in women. The risk of vaginal carcinoma
associated with its use, coupled with the increased incidence of cervical neoplasias in women with
HIV is alarming. There is also evidence that fatty liver associated with the use of ZDV may be
increased in women, and that individuals who are taking methadone and ZDV may be at increased
risk of seve. e anemia
The FDA must require immediately that Burroughs-Wellcome institute a Phase IV post-marketing
study to assess the safety and efficacy of RetrovirR (ZDV) in women with HIV. The study must be
designed to assess parameters such as anemia, interactions wim ocher drugs, pharmacokinetics, and
gynecological endpoints. Endpoints assessed must extend beyond CDC-defmed AIDS.
Even mough women were excluded from the clinical trials of ZDV, women are now being

e:1couraged to participate in the ACfG-sponsored trial, ACfG (176, designed to assess the efficacy
of ZDV in interrupting perinatal transmission of HIV. This protocol, which was reviewed and
approved by the FDA, has deadly serious consequences for women (see section on ACfG C176).
Data being collected on a second antiretroviral (which works in a similar fashion to ZDV), ddl,
presents a similar picture. Few women are enrolled in the NIAID-sponsored trials of ddl, and only
4% of compassionate use ddl is in women with HIV. None of the data being collected from this use
includes data collected from pap smears. Data aren't available to assess the impact of ddl on
gynecological problems, yet researcher; already make statements that imply no differences in the
adverse affects of ddl between women and men.
The FDA has direct regulatory responsibilities to demand appropriate, gender-specific research prior
to clinical trial development and drug approval Prior to initiating a clinical trial, a protocol must be
developed detailing the trial's design, procedures, methods of data collection, and exclusion and
inclusion criteria. The FDA must approve a clinical trial protocol before the trial can begin. The
FDA must begin requiring the inclusion of HIV infected women in trials and must require that data
be collected to assess the safety and efficacy of a drug on woman-specific endpoints which are not
limited to CDC-defined AIDS.
Every institution which conducts clinical trials must have an Institutional Review Board (IRB) which
initially approves research proposals and performs periodic reviews of such research. The IRB is
directly answerable to the FDA IRB reviews are primarily ethical, however, it is unethical for an
IRB to approve a protocol which does not consider the safety and health of female trial participants
or a trial which systematically and unnecessarily excludes women. Therefore, the !=DA must require
that IRB's review trial proposals for the inclusion of women and the provision of data collection
mechanism designed to assess the effects of such drugs on women-specific opportunistic infections.
Fmally, informed consent documents must be developed for every research protocol. This
information, given to trial participants prior to trial enrollment must provide accurate information on
the risks of a particular therapy or protocol. The informed consent is approved by the IRB. r'.ll
available information including information from literature searches must be included in the informed
consent, and must be written in language accessible to non-medical individuals.

In the absence of a commitment to research on the affects of HIV treatments in women, the FDA
must initiate efforts to provide information on such treatments which allow women the availability to
choose therapies with information which either presents what women-specific information is known,
or clearly states that no supporting scientific information is available.
On March 5, 1990, FDA announced in the Federal Repster the availability of a guideline entided,
"Guideline for the Study of Drugs Likely to be Used in the Elderly". The guideline provides detailed
advice on the evaluation of new drugs in older patients and is intended to encourage routine and
thorough evaluation of the effects of drugs in elderly populations so that physicians will have
sufficient information to use drugs properly in older patients. Such guidelines must be developed
immediately for studying drugs in HIV infected women.
The Federal Food. Drug, and Cosmetic act (Section 502(1)) states that a drug will be deemed to be
wisbranded unless its labeling bears "adequate directions for use•. These directions are defmed in
Section 201-5 of FDA's general labeling regulations which state "directions under which the layman
(or woman) can use a drug safely and for the purposes for which it is intended".
The FDA (Section 201..57) currendy requires that labeling information associated with prescription
drugs include information on the use of drugs in pregnant women (actually in a fetus) and in the
pediatric population. A proposed rule change by the FDA was outlined in the November 1, 1990,
Federa1 Rezjster requiring a labeling change to include similar information in the geriatric

population.
The FDA must immediately draft an additional proposed rule change to include similar information
on the use of drugs in women. All available information from the drug's sponsor relevant to its use
in women, including results of controlled studies, other pre- and post-marketing studies or
experience, or information obtained from a literature search must be disclosed in labeling. Included
in this information must be reports of adverse reactions, required by law to be documented and
reported to the FDA.

If clinical studies do not include sufficient numbers of women, a statement to that affect must be
included. In addition, a recommendation for starting a drug at the low end of the dosing range
should be made. For drugs that are .known to be carcinogenic (such as ZDV) or are .known to
increase the risk of gynecological infections (such as certain antibiotic agents) a statement should be
included. This is particularly important for women with HIV. Cautionary statements must not be
limited to risks associated with CDC-defined AIDS symptoms/infections.
The FDA must ensure the safety and efficacy of drugs for all populations. Their concern for "special
populations• has, to date, excluded women. This practice must stop. The FDA must immediately
address the regulatory issues which will ensure that women have access to information which enables
them to make an informed choice about their health.
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ZDV For W01111m: A Doable :SW.d Gamble

or Risks VL Beaefits

The ZDV years, the years when this drug was the treatment of choice for people with HIV, were a
time of hope for people with HIV and a time of fierce activist pressure to release a treatment that
could save the lives of millions. The politics of expeditious release of ZDV, the intense and
incestuous commitment of NlA1D to the development of this drug with Burroughs-Wellcome, the
subsequent information indicating that ZDV would not be the •cure for AIDS; and the economic
devastation associated with the cost of this therapy have been the subject of demonstrations, writings
and congression;'.i investigations. The unique and life-threatening problems of ZDV therapy in women
with HIV, however, are only beginning to be addressed.
Clinical trials supporting licensure of ZDV included an alarmingly low number of women. The
reasons for this exclusion included:
1)
2)
3)

a refusal to test experimental therapies in women of child-bearing age,
the rejection of the reality that women with HIV exhibit different symptoms than men, and
the refusal of NIAID to put into place AcrG trial sites which were both physically and
economically accessible to women with HIV.

It is a testament to the willingness of researchers and regulatory authorities to change the rules
according to their latest research interests, that each of these three exclusions has in some way been
either rejected or ignored in subsequent research on ZDV, or in recommendations for routine ZDV
therapy for women with HIV.
The refusal of researchers to test ZD V in women was a result of concerns for a theoretical fetus (see
section on FDA). This information was confirmed at a recent conference on women with HIV by a
Burroughs-Wellcome spokesperson. Women who enrolled in any of the original trials of ZDV had to
document either •appropriate• methods of birth control or commit to abstinence during the duration
of the trial. Women's ·compliance" with these unnecessary rigid demands were conf.umed with
routine, periodic pregnancy tests during trials enrollment.
AcrG (176, a trials in which ZDV will be given to HIV infected pregnant women has incorporated a
mechanism to circumvent this requirement. Pregnant women enrolled in this trial will be given
ZDV during the second and third trimester of pregnancy, since organogenesis (the developme::t of
f~tal body organs) is complete after the f1rst trimester. It seems that when research interests focus on
the theoretical benefits to a fetus, the •ruJes• no longer apply. Willingness to acknowledge the safety
of experimental therapies in this cohort of women should abrogate the arbitrary exclusion of
pregnant women or women of child-bearing age in future experimental protocols.
What are the clinical manifestations of HIV in women? Researchers and activists know that both the
early indicators of immune dysfunction, as well as the ongoing and end-stage manifestations include
gynecological infections and cancers. Refractory vaginal thrush, pelvic inflammatory disease (PID ),
treatment-resistant human papillomavirus (HPV), and cervical cancers are well-documented in the
literature, despite the Centers for Disease Control's (CDC) denial of their existence. However, the
small number of wor ::1 included in the ZD V trials supporting product licensure, ignored these
symptoms both from <.. .;:andpoint of assessing ZDV in interrupting or exacerbating their
progression. No gynecological assessments were incorporated into these trials; women were
evaluated using male-defmed endpoints.
Results of studies in female animals given ZDV reveal an increased incidence of carcinogei:Jcty
among these animals. In the Burrougbs-Wellcome study, oral ZDV was administered to m1ce and
rats for 18-20 months. Enminations revealed vaginal carcinomas in five female mice. Three female
mice had benign vaginal tumors. Literature searches reveal three other compounds which induce
vaginal tumors: DES (diethylstilbestrol) a synthetic estrogen, and two naturally-derived estrogen
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compounds. The devastating effects of DES are well-known. The increased incidence of vaginal
carcinomas in women with mv, coupled with the information provided in these animal studies, raise
serious questions about the long term effects of ZDV in women. Should ZDV be prescribed for
mv-infected women? The answer lies in a post-marketing study to assess the long-term
gynecological effects of ZDV in women. Given the available information, the FDA must require that
Burroughs-Wellcome fund and conduct just such a study, and until such information is available,
these questions should be discussed in the package inserts supplied to pharmacists and physicians
with Retrovir.
Additional concerns regarding the effects of ZDV in women include:
1)
2)
3)

the increased incidence of fatty livers in women on ZDV therapy,
the interaction between ZDV and other concomitant therapies (ie. methadone), and
the effects of ZDV on CD4 counts in mv-infected women (both symptomatic and
asymptomatic). The Burroughs post-marketing study must be designed to address these
issues as well.

Now that the interest in ZD V research lies in the investigations surrounding fetuses and newborns,
uial sites have been selected to target geographic locations with dense populations of women with
HIV. Although the intent of ACI'G (]76 is in no way designed to assess the impact of ZDV on any
relevant parameters in women, these very same researchers who rejected women, particularly
pregnant women, in the original ZDV uials, are actively seeking women, specifically pregnant
women, as an entre' to the study of the •innocent victims.· Indeed a woman can participate in this
study at centers other than NlAID trial sites; Harlem Hospital, for example, will enroll women since
Mount Sinai Medical Center has no access to qualified study subjects.
Where were the same concened efforts to seek out, enroll, and assess the effects of ZDV on women
in the original studies of this drug? If ACI'G (]76 targets the accrual of 748 pregnant mv-infected
women for this trial. why can't they seek out equally large numbers of women for trials of other
antiretrovirals and prophylactic therapies?
There is some data from the original ZDV studies which should be retrievable to begin to answer
some questions regarding the risks vs. benefits of ZDV therapy in women. NIAID must instruct the
researchers and data analysts to compile and analyze that data immediately. In addition, further
work must be done to assess ZDV's effect on women-specific parameters. The risks are too great and
the benefits too questionable to require any less.
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There are two pieces that make up the puzzle of women's lack of perceived risk. The first part has
to do with the way in which public health education campaigns have failed in this epidemic to do
little but scapegoat gay men. Most women can feel or have felt a false sense of security in knowing
that they are not gay men. In fact, the confusion of "risk groups• with routes of transmission has
practically guaranteed the spread of HIV to women. Every time a woman has sex with a man and
does not use a condom or has sex with a woman and does not use a latex barrier clearly denotes the
CDCs failure to adequately educate the public. As early as 1981, (this comes from the
epidemiological article in AIDS: The Burdens of History) cases of women with AIDS were known to
this agency. As we see with their refusal to change the definition of AIDS to include gyn-HIV
infection, fear of alarm in the white middle class has been at the forefront of the creation of policy
in this epidemic.
The second piece of the puzzle, fitting perfectly with the first has to do with practitioners of all
varieties not seeing women as posstbly HIV-infected. The lack of awareness that women can, do and
are becoming HIV-infected prevents them from receiving appropriate medical treatment.
Misdiagnosis of AIDS-related diseases in women occurs too often. For example, PCP is the number
one documented cause of death in women with AIDS. Interestingly, Chris Norwood in Ms.
Magazine in 1988 noted that the number of women in NYC dying of bacterial and other pneumonias
increased dramatically over time. Whether or not these women were HIV infected is unknown, but
most likely many of them were. Anecdotal reports from HIV positive women
chronicle events such as their being sent home from hospital emergency rooms with a prescription for
penicillin in hand only to get sicker. As women, they were not seen as possibly HIV-infected and
hence in need of particular medical treatment, Fmally, a woman need not know her HIV-starus in
order for her practitioner to begin to think "AIDS".
Fmally, a third element which secures the further HIV infection of women is the artificial deflation of
numbers in this epidemic. The recent fi:."'W'es are the only way in which people can, short of
knowing individuals infected with the virus, feel any proximity to their possible infection.
Unfonunately, reading that women account for only 9.1% of adult AIDS diagnoses reinforces the
notion of women's safety from infection. The manner in which these numbers are kept low run the
gamut from misdiagnosis and underd.iagnosis to a medically inappropriate definition of AIDS for
women to women's poverty and resultant lack of access to health care. It is sobering to remember
that the increase in AID diagnoses in women skyrocketed when this disease's definitions was
changed in 1987. One can only imagine how those numbers in women would again soar if cervical
cancer, pelvic inflammatory disease, endocarditis and pulmonary tuberculosis were to be included in
definition of AIDS. Of course, this is the most morbid of ways to make sure that people feel some
proximity to and take some precautions against becoming HIV-infected. It would be altogether
easier and less murderous to create safer-sex and safer-drug campaigns that work. In this epidemic,
the great educator has been either personal loss of a loved one or feeling overwhelmed at the
numbers of "your kind" that are infected. For many gay men, these two factor have been quite
persuasive. What does the CDC have in store for women?
CODdoms, Lesbians & Tbe Bat Study

Many people have been given the opportunity to feel liltle fear of HIV or AIDS while other people
(namely gay men and IVDU's) have had to shoulder the burden of being perceived as the absolute
embodiment of risk. This has far reaching implications for infection control as has been previously
discussed. However, it is worthwhile to take note of three ideas that predominate in a discussion of
women's perceived lack of risk.

"When the media refer to heterosexual AIDS as a myth, they seem to suggest that "heterosexual•
must not include women, because AIDS for heterosexual women is not only a myth, but is what, in
some cities, is most likely to kill them: (Women, AIDS and Activism, p. 187)
Condom use has failed because women have been targeted to •get• men to wear these prophylactics.
This idea comes from a very uninformed point of view about the real lack of power women have in
heterosexual sex. That the CDC has focused very little attention on encouraging condom use among
straight men has aeated a false sense of safety among heterosexuals Necessary to preventing further
infection in women, public art campaigns need to be aeated that address straight men and make
condoms appealing to them. For many women who have sex with men, the fear of becoming HlV
infected is insignificant in comparison to the fear of reprisal involved in even suggesting to their
lovers that they use condoms. (IBID, p. 188)
Heterosexual women are vulnerable to this virus through a lack of power in sex. Simply knowing
what prevents transmission is not a guarantee of behavior change in the least. However, not
knowing what prevents transmission of this disease places lesbians in a rather precarious position.
Of all the women who have a perceived lack of risk, lesbian's lack of information and overall denial
that they are at risk is overwhelming. This problem could be somewhat remedied if the CDC would
study the ways in which people become infected, and not who's infected them. Indeed, if this were
to take place, by necessity cunnilingus would come to be considered a risk behavior and all people,
including lesbians, could realistically assess their risk of infection by this and other modes of
transmission.

Bow tbe Gcm!namaat uad tbe Media Blallle Womea for the AIDS Crisis
"Vector Discussions•

The normal discourse about women in the HIV pandemic has focused on our. role as vectors of
transmission. The intent of this discussion, of course, is to continue the long and sexist tradition of
sending messages of guilt to women. On an examination of the science, however, the fact is that
women infrequently transmit HIV. Women are twelve times more likely to b .x:ome infected during
vaginal intercourse with a male sexual partner than the other way around. And, the incidence of
perinatal transmiuion has been estimated as approximately 33%. The occurrence of perinatal
transmission is rel'Qrted to be as low as 15% when women receive adequate prenatal health care.
Several factors may exacerbate the alarming rate of male to female transmission of HIV. Most of
these relate to circumstances causing erosions of the surface of the cervix or vagina. Note: It has
been postulated that the increased incidence of cervical carcinoma associated with ZDV therapy is
also a result of vaginal/cervical sloughing, resulting in increased contact of ZDV urinary by-products
with the vaginal/cervical subepithelium.
Cervical infections and genital ulcers -caused particularly by syphilis, gonorrhea, Herpes simplex-2,
trichomoniasis, and chlamydia! infection may increase HIV transmission by disrupting the integrity of
the cervical mucosa. An association has also been found between HIV transmission and the use of
oral contraceptives. When cervical erosion occurs, the columnar epithelial cells lining the cervical
canal extend to an area of the cervix ordinarily protected by squamous epithelium, appearing as a
friable, reddened area.
As cervical erosion is a natural consequence of puberty, this may account for the increased incidence

of young women of reproductive age who become HIV infected (as compared to older women).
Sexual activity during menses may be an additional risk factor.
V agina1 tightening agents and vaginal herbal medicines may increase the risk of female HIV
transmission. In addition, semen with increased numbers of lymphocytes may pose an additional
risk. Intercourse with men who have not been circumcised or who have penile ulcers have also been
implicated in increased transmission.
The lack of research into modes of transmission leaves the above questions unanswered. It is
imperative, however, that women be informed of these possible risk factors when making decisions
about their relative risks of infection.
Almost every current and available barrier to HIV transmission is fraught with problems, particularly
from the perspective of women. Relying on women to control the use of condoms with male sexual
partners is ridiculous.
Recent studies of spermicides as virucides raise serious concerns. A recent srudy by Joan Kreiss
(University of Washington), found that nonoxynol-9, on a vaginal sponge or as a suppository, was not
protective against HIV. Further, in the case of the vaginal sponge, it may have acrually been
associated with increased rates of trans~ion.

Lade of specific transmission research has led to a variety of ·home remedy" viral barriers. Fmger
cots (latex gloves and tips used on the fmger during vaginal and anal insertion) are used by some.
Research into the incidence of transmission via digital to oral/anal insertion may show that this type
of protection is unnecessary.
Dental dams or rubber barriers have been used for protection during oral/anal and oral/vaginal sex.

Tile Caters ror Diseale Coatrol's Policies

Until the Center's for Disease Control changes the definition of AIDS to include gynecological
infections, there is no reason to believe that NIAID will sponsor clinical trials to study HIV-related
gynecological infections. Government agencies have a responsibility to each other and to the public.
Scientists must use their authority to assert needed pressure on other government institutions when
they stand in the way of life-saving scientific and medical research. Clearly this is what is need to
stem the already overflowiDg epidemic of AIDS in women.
Womm.. The AIDS Crisis, aad the Ceaters for Disease Control
Basic to the prevention and spread of any disease, as well as to the care of people who are ill, is the
knowledge of its symptoms and routes of transmission. This information may eventUally lead to
understanding the cause of a disease but the most important part of epidemiological research is that
the information gathered can reduce the impact of a disease even before its exact nature is
understood.
Accurate information about symptoms and transmission routes is necessary, first and foremost, so
that people , themselves, can take preventative measures to avoid infection, can determine if they
might be infected, and can seek appropriate care (if it exists) and avoid further transmission.
Accurate information about symptoms and transmission routes is also important for health providers,
although they usually see people after they are already ill. However, if they know what symptoms to
look for they can be alert for signs of illness in people who may not know they are ill.
Accurate infonr. ...-on about syr;. ?toms and transmission routes is necessary to provide the basis for
focusing scientific research on appropriate treatments and for providing standards of care for people
who are ill.
Fmally in an epidemic.. accurate information about symptoms forms the basis for establishing the
extent of the epidemic. This information about symptoms is necessary in order to obtain an
adeqUate level of funding from Federal, State and Local governments. Without adeqUate funding for
education, prevention, social services, research aad treatment we cannot end this epidemic and
people will continue to die needlessly.
The Centers for Disease Control, which is part of the Public Health Service, is the agency charged
with doing the appropriate epidemiological research, with developing prevention and educatio::.. J
programs and with setting standards of care. Yet, wbea it comes to the AIDS crisis, the CDC is not
doing aa adequate job ill any or these respects. After 10 1/2 years into this epidemic.. the
information they have collected (and are still collecting) is minimal and misleading. It includes no
women-specific symptoms. The CDC knows very little about transmission routes for people and
their method of defining AIDS which excludes the symptoms women are getting keeps the extent of
this epidemic artifici.ally low and becomes a barrier to obtaining the funding necessary to end this
crisis. They have published few standards of care and the research they are now doing is inadequate
and will not provide useful information for several years.
Instead of collecting and disseminating aceurate information and doing appropriate research in an
efficient manner, the CDC has focused most of its energies and funding on mandatory and
confidential, rather than anonymous testing and is seeking to institute undemoaatic and unnecessary
control procedures -contact tracing. partner notification and •routine testing", espcci.ally for pregnant
women. These strategies bave been sbOWD not to work for sexually transmitted diseases or for TB.
They act to make people avoid seeking medical care, especially those people who have had a history
of negative treatment by the health system, including people of color, women, poor people,
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intravenous drug users and lesbians and gay men. These measures substitute ~ false sense of control
for effective programs and practices of prevention, education and treatment which would really save
lives.

In this section of our Women's Treatment and Research Agenda we will address:
o
o
o
o
o

the background and history of the current AIDS Surveillance definition;
the data currently being collected -what is missing and what is wrong;
why the CDC surveillanc.; definition is important;
other problems with CDC research and policy, especially in relation to women; and
what we believe the CDC must do to save lives.
B.c:qromad ud History ol tbe Clllftllt CDC Slll'ftillaDce Defiajtioa ol AIDS

AIDS is not a single disease -it is a syndrome -Acquired Immune Deficiency Syndrome. A syndrome
is medically defmed as a set of symptoms and diseases. This set changes and, therefore, the basis
for a diagnosis changes. It is not fixed like, for example, TB. The definition of a syndrome must be
continually changed as new symptoms are identified. In addition, not everyone gets symptoms. Some
symptoms will be unique to specific groups because of anatomical differences. For example, women
have vaginas, uteruses, fallopian tubes and ovaries. Men do not have these organs and opportunistic
infections associated with AIDS cannot affect them in these sites. Some other differences which
could produce different symptoms and severity of symptoms in different people might be their
general state of health, the mode of HIV transmission, endocrine differences, age, geographic
location, and so on.
There are at least three different systems the CDC refers to in relation to AIDS/HIV:
1)

2)

3)

The CDC has a classification system ror HIV disease. This
divides people, all of whom have tested positive for HIV, into groups starting with HIV,
asymptomatic. It is supposedly based on clinical manifestation of HIV ~~
although not one I)'Decological symptom is listed in any category. This means that a
woman who has tested positive for HIV would be considered asymptomatic even is she
had any number of gynecological symptoms known to be associated with HIV. This
system is supposedly not hierarchical in terms of severity, but it does range from
asymptomatic to a listing of conditions. It is not used for surveillance purposes.
There is also an international classification system (MMWR,
36, No 7), in which a person doing the reporting codes "associated conditions• under
categories of -wjth HIV-, "due to HIV", "with an AIDS-like disease•, ·due to an
AIDS-like disease•, "with AIDS" and "due to AIDS". AIDS, in this system, is defined
according to the CDC surveillance defmition. Although there are over 50 categories of
"associated conditions• on this list (and a larger number of specific infections), not one
I)'Decological symptom is Usted in any category.
The CDC has a sumillanc;e definition or AIDS. The
surveillance defmition of AIDS is the only one used for U.S. national reporting. It is
the most limited set of symptoms compared to the other two; it includes cases which
are diagnosed "presumptively", that is people who show cenain symptoms but whose
lab tests have not been done; it also includes people who have no laboratory evidence of
HIV but who show specific diseases/symptoms and for whom causes other than HIV
have been ruled ouL This classification system does not include any I)'Decological
symptoms. The figures from this system are the only ones used for determining the
extent of the epidemic and on which budget requests are based. For example, this was
the data used to determine the choice of sites for the CARE Bill Funds as well as for
the allocation of these funds aaoss sites.

The CDC surveillance definition was originally published iD 1982, based on a sm~ number of cases
among predominantly white gay men. The conditions then considered to constitute an AIDS ~e for
national reporting were limited (PCP, KS, cryptococcal meningitis, and certain lymphomas). This was
;>efore HIV was discovered. No research bad been done.
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Here is what officials at the Centers for Disease Control said about aeating that definition:
•yes, we asked clinicians.·

-yes, we went around the country looking for more cases -surveillance data
-opportunistic infections -it wasn't clear that is was an epidemic at first -an
epidemic of Kaposi's Sarcoma, an epidemic of pneumoc:ystis pneumonia -so
we looked for everything ...what we found got included in the definition.·
AIDS was so associated with gay men at that time that, initially, it was called GRID (Gay-Related
Immune Deficiency). That AIDS was associated with a •gay-male life style" can be viewed both
positively and negatively. Epidemiologically speaking, on the positive side, the fact that it was
discovered "Post-Stonewall" (after the Gay Liberation movement) meant that some gay men were out
enough to self-identify. Therefore, the reporting of PCP, even in a small number of cases (5) who
all self-identified as gay might be the only thing that led to its discovery at all. (It bas since become
clear that there were earlier cases, notably among intravenous drug users, which bad never been
identified). And, since the CDC bad just been involved with the Hepatitis B studies in the gay
community, they were familiar enough with gay male sexual behavior to look for posstble clues to
transmission. However, the negative pan was the immediate connection between a gay "life-style"
(including the use of "poppers") and the illness -a homophobic direction -which we have never
recovered from and which not only still affects the gay community but affects. everyone else as well.
Between 1983 and 1985, HIV was discovered (first by the French and called
Lymphadenopathy-Associated Vuus, lAV; then by the Americans and called Human T-cell
Lymphottopic Vuus m, HTI..V-m; and finally, after an international panel arbitrated the issue, it
became known as the Human Immunodeficiency Vuus, HIV). It is considered to be the cause of
AIDS (although there is still disagreement as to whether it is the sole cause of AIDS and, for some
people, whether it is the cause of AIDS at all).
NIAID (The National Institute for Allergy and Infectious Diseases), Ia 1983, instituted its only major
epidemiological study to date -The Multicenter AIDS Cohort Study (MACS). IDitial evaluations were
completed in April, 1985. 4.955 gay men were involved in this study; 1,835 were seropositive on
entry, the remainder were noL This is a natural history study. Every six months the men have
physical exams, answer questions, and provide lab specimens. According to NIAID, this study
identified unprotected "anal-receptive" intercourse as the primary route of transmission and also
showed the linlc between T -cell suppression and seropositivity. As it progressed it also provided
information for expanding the CDC surveillance defmition.
In 1985 the CDC made its first substantive revision of their surveillance definition. Some diseases
were added to their lisL The defmition made a distinction between opportunistic diseases present
with an HJV+ finding and those present with such a ftndlDg. Even so. the CDC estimated that its
1985 mjsions resulted in the m;lassificatlon of less thaq one pm;mt of pm;ously Rvoned qses
and added only 3-4% new cases. At this point there bad been 428 female AIDS cases reported and
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These quotes and others are from a meeting which took place at the CDC. Atlanta, Nov. 19, 1990.
Present were members of Acr UP and Lifeforce (a peer education project for HIV + women) and Gary
Noble, Ruth Berkelman, May Guinan, Jacob Gayle, Bert Petersen, Peter Drotman and Bill Para, all of
the CDC.
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1,785 intravenous drug users -1,511 male, 224 female -compared to 5,413 homose~/bisexual
males).

In 1987, the CDC once again revised its surveillance definition with changes in both adult and
pediatric definitions. In desaibing the process they used to change the pediatric definition, the CDC
stated that they gathered together clinicians and other experts who had been seeing cases of
pediatric AIDS (although the number was quite small at that time) and used their information on
which to defme Pediatric AIDS symptoms. For adults, additions included HIV encephalopathy
(dementia), PIV wasting syndrome and certain lymphomas. Fmally, the CDC added diagnosis made
presumptively (without having to do with laboratory tests) as long as a person was HIV+. In our
opinion the diseases which were added in 1987 were probably found because the gay men being
followed were staning to live longer due to medications for opportunistic infections including PCP
prophylaxis. As some diseases in this group started becoming less prevalent, others began to appear
at a more advanced state of illness (HIV Wasting Syndrome or HIV Dementia). This revision had
a significant impact on reported cases or AIDS:

a) Prior to the revision, of cases meeting the CDC defmition, 67% were homosexual/bisexual
men and 23% were intravenous drug users. In the fJrSt year following the revision, the
percent who were intravenous drug users, both homosexual and heterosexual. increased to
43%, Blacks increased from 24o/o-36%, Hispanics from 13%-16%, and women from
2.6%-3.6%.
b) As of 1989, nationally, approximately 30% of new cases fit only the 1987 defmition. In the
latest New York City Surveillance report, all cases diagnosed since January 1990, 30% of all
cases fit only the 1987 revision. Furthermore, 38% of IVDU cases fit only the 1987 definition
and 26% of heterosexual transmission cases fit only the 1987 definition.
c) In the August 1990 CDC National Surveillance Report, of reported cases fitting only the
1987 definition, approximately 56% were presumptively diagnosed and about 30% were people
diagnosed with HIV encephalopathy or HIV wasting syndrome.
d) According to the CDC itself, ·compared with patients who meet the pre-1987 definition, a
higher proportion of patients who meet only the 1987 definitiot~ were female, Black or
Hispanic or were intravenous drug users.· (HIVI AIDS Surveillance Report, August 1990).
Both locally in NYC and nationally these categories overlap. For e.g., nationally, 58% of
reported AIDS cases among Black females were listed under IVDU {August 1990).
Why was it that adding these few, new advanced diseases/symptoms and, especially presumptive
diagnoses, resulted in so many new cases among women, Blacks, Latino/as, and intravenous drug
users? This is the way we have pieced the story together:
o The majority of people who were not (and still are not) being counted are people who are
poor, have little access to health care (including drug rehabilitation), and do not have primary care
physicians or access to expensive testing. Some gay men who were not being counted had access to
private physicians who did not report them until they had to enter the hospital system -at a more
advanced· stage of the disease.
o Due to institutionalized racism and sexism in this country, both economic and otherwise, a
disproportionate number of women, Blacks and Latino/as are poor. They do not have access to
private health care and have to use public health care systems when necessary (and if they are
available). Women tend to come more into contact with these systems in their roles as caretakers of
others and because childbirth has been moved outside the home and into the hospitals. Many poor
people do not go for health care in these settings until they are very ill; women often go to emergency
rooms when they are about to give birth. In both cases this is due to the way poor people have been
treated, personally and medic:a.lly, in such systems. Even when it comes to intravenous drug use, it is
poor people who enter the public system since wealthier people can go to private physicians and avoid
becoming part of published statistics.
o There began to be enough cases reported in other than gay males so that health care
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providers could be alert to the possibility that AIDS was a poss1ble diagnosis.
.
o The earlier opportUnistic infections, in women especially, but also in intravenous drug users
(many of whom are women) are not listed in the CDC definition.
o The infections/symptoms which were added in 1987 occur later on in illness and these
people were probably diagnosed when they were close to death; many were not diagnosed until after
death. Fmally, presumptive diagnosis would allow low-funded public health care systems to diagnose
people without having to do expensive diagnostic testing.
Yet, despite these additional cases, recent studies indicate that 35-40% of the serious HIV related
disease treated in hospital in-patient settings do not fit the CDC definition of AIDS. (New York
City Department of Health Case Projections, 1989-1993). And, in one CDC study of the death
certificates for women which listed HIVJAIDS, 48% died from conditions not listed in the CDC
definition. 102
And, the CDC admits that "Diagnosed AIDS cases do not represent all cases of severe morbidity
associated with HIV infection. Many HIV + persons suffer from illnesses that are not reportable as
AIDS even under the current definition and some persons may not have access to medical or
diagnostic care. The number of persons with serve HIV related morbidity exceeds the number of
diagnosed AIDS cases:103

When somebody already fits the CDC definition, the health provider is supposed to report the case to
the CDC (or to their local surveillance unit). The CDC keeps these statistics by case number
(although the names exist). Other data include age, race, sex of the person, their geographic
location (by zip codes), the mode of transmission (ac:tually a •fisk group• in the way it is done) and
the •life-threatening illness• at the time of the AIDS diagnosis. The CDC collects no other
information about the use until the person dies. This is what the CDC has been collecting and
publishing for 10 years. They don't even know what diseases someone dies from (you don't •die from
AIDS•; a person dies from an AIDS-related cause). Many people become part of the CDC data only
after death when an autopsy reveals HIV.
Getting counted is a catch-22. You have to already have an identified disease in order to be counted
and they only identify that disease. How can a new disease be added as they should in the case of a
syndrome? They haven't been added since 1987. Those diseases now in the defmition come from a
very selected sample of people, predominantly gay men.
Much research now exists which shows and association between HIV and specific opportUnistic
infections or indicator diseases which have atypical outcomes in immunocompromised people (not
responsive to conventional therapies, much more rapid progression, and so on). These aa infections
or diseases which are showing up primarily in wgmen and intravenous drug uun. The aa
severe. disabling conditions which are life-thrptening. Why aren't they being included in the CDC
sui"'Veillanc;e definition?
When we met with officials from the CDC on November 19th, they could not provide a satisfactory
answer to this question. Here are some of the answers they gave (Although in quotes, the answers
are paraphrases of longer answers):
102 Chu S, et aL, "'mpact of the Human Immunodeficiency VU'US Epidemic on Mortality

in Women

of Reproductive Age, United States,• JAMA July ll, 1990, 254(4):225-229.
103

MMWR Supplement, S/12/89. AIDS and Human Immunodeficiency VU'US ID.fection in the
United States, l988 update.

"Some women who are HIV + show some of these symptoms while others don't•
(This is also true for the symptoms in the current CDC definition; some HIV +
men get them and others don't. In fact, this is the nature of a syndrome; it does not
have the same pattern in all people).
"So many women get these infections that we can't be sure they are caused by HIV".
(In fact, the CDC definition now in existence lists infections which gay men had
before the AIDS epidemic. One is Herpes Simplex VU"US. However, there is a
condition attached to its use as a definer of AIDS: •causing a mucocutaneous ulcer
that persists longer than one month•. Isn't it possible to do the same thing with
symptoms women show?
"So many women have pelvic inflammatory disease and vaginal thrush that it would
throw them into a panic if they believed they might be HIV + or have AIDS:
(Since the CDC wants to push "routine testing", their strategy would seen to raise
more panic since such testing would not be based on the appearance of symptoms
at all).
·How could a doctor tell the difference between severe, chronic pelvic inflammatory
disease that is not AIDS related and a case that is?" (The current international
classification system asks health care providers to do just that with over 50
diseases). Dr. Harold Minlcoff, at the National Conference on Women and HIV
Infection. December 1990, stated that clinically one could tell the difference
between PID in a severely immunocompromised woman and PID in a woman
·
without severe immunocompromise.
"The bottom line is immunosuppression -we look for immunosuppression as the
cause of the disease.• (There is research showing a relationship between
immunosuppression, HPV and Cervical Cancer -see section on opportunistic diseases
in women. PCP occurs in cases of imm~osuppression other than HIV).
"When you talk about less severe diseases they really aren't AIDS -they are not
life-threatening. • (People who have a bout of pneumocystis pneumonia -which is in
the current definition -can live for years. Cenainly cervical carcinoma is not less
severe than some diseases already listed in the CDC definition).
-we would be laughed out of the country for inflating the epidemic curve and simply
trying to bring more money into AIDS research: (This is not a reason for giving
up scientific integrity and for saaificing women's lives. We need more money for
AIDS research.)
-we need more research to show a casual relationship between the conditions
women get and HIV before we can include them in the defmition: (All the
surveillance defmitions so far have been based on clinical evidence and not on large
scale research srudies showing causality beyond a shadow of a doubt. There are
many doctors seeing hundreds of HIV + women and who know which symptoms
they are getting. There is also more research now in terms of relating cenain
symptoms to HIV in women than there ever was on which to base earlier
defmitions. The CDC is using a double standard for women.)
Given their stated concern with research and the lack of major epidemiological srudies of women,
one would thi.nk that the CDC would focus on that area. Yet, last year, the CDC instituted studies
designed, according to them, to finally get information on the spectrum of diseases shown by a
broader range of people with HIV infection (that is, people other than gay men). The SPECTRUM
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OF DISEASE STUDIES have been underway for about one year. The sites chosen were Atlant~.
Dallas, Seattle and Denver. (They did not choose Newark, Brooklyn, Miami, San Juan or other. oues
with the largest numbers of reported cases for women or intravenous drug users). How was this
study done and what type of information is being collected about whom?
o Each site was allowed to design their own study. In Atlanta,
representatives from ACf UP have panicipated in designing the study. We were told that
Atlanta will account for 60% of the data because they were the only location which used
multiple sites to gather cases. In the other locations. oae hospital or provider has been
selected as the source of information.
o In our meeting at the CDC we confirmed our earlier
information that although a total of 4,000 people are now involved in these studies onlv 7':'9
are womep. We were also told that there are few people of color and few intravenous
drug users. Is this another study of gay men? H the CDC so desperately needs a research
base for their changes in defmition, how could they design yet another study which excludes
women?
o We found out that when the Atlanta site presented their list of
opportunistic infections/indicator diseases for approval by the CDC they were told they
should not collect data on vaginal thrush because lots of women get it. Therefore, when
we wanted to access this data it had not been entered into the computer and we were told
that perhaps it we went through each form by hand it might be listed under "other
conditions.· CDC officials did not seem to know about this at all.
Clearly, the CDC is unwilling to change their surveillance definition to include infections/indicator
diseases specific to women, diseases which have been documented clinically and in scientific research
papers. The CDC is requiring a different procedure for adding these infections compared to the
procedures used for earlier revisions. The CDC is requiring a level and type of research it did not
require for earlier revisions. research will take years and years to complete. Their own research.
supposedly designed to include women, has only 7% women among 4,000 people after one year.
The CDCs willful use of such a doubl\! standard and their inadequate monitoring of their own
research (or willful concern for its adequacy) has no scientific justification, is unethical and will be
respoDSible for the deaths of thousands of women.

Wby tbe CDC SanaJiaace Ddlaitioa is haportut
Many social service benefits as well as access to experimental drug trials are based on having CDC
defmed AIDS. Obviously, these agencies do not have to use the CDC defmition. For example. the
HHS has an independent responsibility to decide what constitutes a disabling condition. Yet. while
the CDC does not have a legal responsibility in this regard, they do have a .ll!!l!Jll responsibility.
They are the government agency charged with defining such diseases. Social services agencies,
whether on the federal, state or local levels may not have the capabilities to do such epidemiological
research. nor could other smaller agencies. Obviously, the CDC should be playing a leadership role
in this area. By refusing to include the opportunistic infections women are getting into their
definition, the CDC is ultimately respoDSible for the denial of these benefits and the exclusion of
women from experimental drug trials, their denial of housing and so on.
The lack of acknowledgement of women specific opportunistic infections also has repercussions for
women's ability to monitor their own health and to determine they are ill as well as for health
providers abilities to be alert to and diagnose AIDS in women before they are so sick that they die
quickly. Educational material published by the CDC does not specify these infections. making it
impossible for women to know they may be ill. Instead, the CDC pushed "routine testing",
confidential testing, and mandatory testing, partner notification and contact tracing. These strategies
will not work. Instead of bringing women towards the health care system they will push them away
from it.

One suggestion made is that the CDC should add some of these infections to their classification
system but leave their surveillance defln.ition untouched. However, we should not be willing to
accept changes only at this level While adding some new opportunistic infections to this system
would help alert some health care providers to look for new symptoms, and might catch some cases
earlier, this is not enough! Wby?
The Cu~nt CDC surveillance definition is actively keeping the number or cases or AIDS artificially
lowered.
The CDC admits that, even using their current definition they undercount cases by 40%. They admit
there are people who are HIV + who are severely ill but whose symptoms are not in the current
defmition. We know that there are no women-specific symptoms included in the definition.
Right now. the people who are being excluded are overwhelmingly women and intravenous drug
users, who are poor and disproportionately people of color due to institutionalized racism in this
country.
The CDCs unwillingness to change their surveillance definition will also affect gay men, even those
with access to health care. Over the last year there have been articles claiming that the rate of new
AIDS cases is dropping among gay men. This doesn't mean there are no new cases, just that the
number being added each month is lower than in earlier years and the total number is rising more
slowly. In these articles several explanations are offered. One is that gay men are practicing safer
sex. Another is that they are using prophylaxis and treatments so that they are not yet showing up
as AIDS cases, according to CDC definition.
This last point relates directly to the surveillance definition. PCP has been the major presumptive
and definitive opportunistic infection at diagnosis for AIDS in the U.S. (TB is the major one
worldwide but is not in the CDC definition). In New York, PCP accounts for 16,629 out of 26,205
cases. Since many gay men have access to PCP prophylaxis and will not have PCP as their first OI,
they will not be counted as having AIDS until they have a more "severe" condition, one that occurs
later in illness. KS is the second most frequently reported diagnosis in N.Y. (4,038), although it is
substantially lower in number. However, KS is also declining, perhaps because it is an opportunistic
infection that is linked to other co-factors. (We have been given hardly any information at all by the
CDC as to whether specific opportunistic infections are associated with different modes of
transmission). The safer sex explanation for lowered cases is beginning to be countered bv papers
presented at the VIth International on "relapse" behavior in relation to safer sex practices.104
Given this information, refusing to change the current defmition bas three outcomes:
1)
2)
3)

It keeps the overall scope of the epidemic lower than it is.
It keeps the number of cases of other than gay men lower than they should be and it
keeps the number of cases of women extremely low.
It keeps the rate of inaease for gay men lower than it is.

This combination of effects is a perfect rationale for overall lowered funding for this epidemic. The
fate of the Care Bill is a prime example.- It avoids the issue of the need for national health care. It
can divide one community against the other in flghting for the funding that does not exist. It still
keeps AIDS an overwhelmingly "gay disease• and current studies of "relapse" behavior can be the
104 When we raised this point during our meeting at the CDC we were told that the rate among gay

men was llQ1 deaea.sing; that there was a "trend toward a deaease in urban areas with large numbers of
eases but that elsewhere in the country the rates were increasing". When asked why they had not
countered newspaper repons about the deaease, they finally admitted that they should have but did not.
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basis for another homophobic attaclc in the future.
In order to get the type or funding needed for health care, re.searc:h and treatment and education It

is essential that the true scope of this epidemic be recorded. This can only happen if the
opportunistic infections/indicator diseases affecting..il! people be represent~d in the CDC surveillance
definition of AIDS.
Other Problems with CDC Research and Policy

a. The CDC is not collecting data on the progression of HIV disease,
that ~ its natural history in all people affected. Nor is it collecting data on the entire spectrUm
of dise~ after diagnoses. Progression stUdies do not require the abandonment of anonymous
testing. We can find ways to gather this data.
b. Without data on disease progression and Ols after diagnosis we:
L do not really know how HIV is being transmitted and bow
transmission routes relate to opportUnistic infections/indicator diseases and cannot focus
the development of preventative treatments and protocols where they are needed
2. cannot develop standards of care because we don't know why some
people are living while others are dying. Of particular ·1terest here is research showing
that women with HIV who receive primary health care iive longer than those who don't.
regardless of specific medical treatment.
3. cannot effectively educate people, both people with HIV who
don't know it and health care providers who don't recognize it. A woman reading the
usual pamphlet describing symptoms of HIV disease will not recognize herself unless she
is desperately ill. (An exception here that I know of is a pamphlet put out by the New
Jersey Women and AIDS Network which lists likely opportunistic infections in women). A
doctor reading the CDC classification system (let alone the AIDS Surveillance definition)
will no.: recognize a woman who is HIV positive.
c. Instead of doing the type of epidemiological research and massive

education they should be doing, the CDC is instead focusing on ·routine" testing of pregnant
women, and moving towards confidential, rather than anonymous., testing, partner notification
and contact tracing. These are not preventative strategies that work.
d. Furthermore, the CDC is still focusing on women as "fetus carriers•
and seem more concerned about the fetus than the woman. In addition to the spectrum of
diseases studies discussed earlier, the CDC bas two other major studies now:

1) a study to assess behavior in "high-risk" women in decisionsabout contraceptive and
pregnancy choices; and
2) a study of biological markers of pregnant women that correlate with the outcome of the
fetus (U.S. and Africa). We were told that only if they get more funding this year will they look
at "non-pregnant" women. In reality they are not looking at the woman at all-they are looking
at the fetus.
e. The CDC epidemiology still relies on "risk groups" and does not
explicidy describe modes of transmission. If you look at their tables you see a ctegory for
"homosexual/bisexual sexual contact". Is this meant to imply "anal intercourse without a
condom"?

f. Women are listed as the sex partners of men (sex partner of an
IVDU, for example). Men are presumed to be their sex partners since none of the studies or
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questionnaires ask explicit questions about woman to woman sexual behavior, Yet.
o From ·1981 to 1984 there were 101 reported cases of AIDS in
which the women self-identified as lesbians or bisexuaL The CDC decided not to collect
this information any longer because there "weren't enough cases."
o While many cases of lesbians with AIDS are among lesbians who
are also or were intravenous drug users, there have been documented cases of
woman-to-woman sexual transmission (Rlbble, D. HIV Infection in Lesbians. Poster
presented at the 5th International AIDS Conference, Montreal, 1989; Cohen, J.B., Hauer,
LB. and Wofsy, C.B.: Women and IV Drugs: Parenteral and Heterosexual Transmission
of Human Immuno-Deficiency VJ.rUS: The Jourpal of Drui Issues. 1989, 19:39-56; Marmor,
M., Weiss, L.R., Lyden, M., Weiss, S.H., Saxinger, W.C., Spira, TJ., and Feorino, P.M.
POSSible female-to-female transmission of Human Immunodeficiency Virus (letter): Annals
of Internal Medicine: 105: 969; Mondanaro, J .: Treating Chemically Dependent Women.
Lexington Books, 1988.
o The percent of •undetermined risk• cases for women nationally
is twice that of men: 7% vs. 3% in New York: 10% vs. 5%. The CDC recendy
acknowledged that this is where woman-to-woman cases would be listed.
o Cunnilingus is not listed as a poSSible mode of transmission
(female-to-female or male-female) even though there was a letter last year in one of the
major medical journals documenting a case of a man who apparently became HIV + and
had only cunnilinguaJ sex with a woman for 13 years.
o Without detailing all possible ways that a woman might
transmit HIV to another woman sexually, the most obvious way is through oral-vaginal
unprotected sex during menstruation. Somehow no one puts menstrual blood in the same
category as ·blood•.
o Even now, NIAID is beginning what they call a ·heterosexual·
transmission study in women. When we confronted Dan Hoth about his inability to say
these women were definitively heterosexual because no one is asking questions about
woman-to-woman sexual behavior, he finally replied that they would add a question asking
•Have you ever had sex with a woman?·. This may allow him to separate the two groups
but it will provide no information about what type of woman-to-woman sexual behavior
occurred. It's goal is to keep their sample ·clean· and not to provide transmission
information about aU women.
g.

The CDC Surveillance definition places people hierarchically. For
example, if a woman has ever used drugs she will be placed in the IVDU category even if she
has also had unprotected vaginal intercourse with a man who was mv positive, or who fits
some other ·suspect• group. Surveillance reports list overlaps between categories, although
the only one which forms its own separate category is homosexual/bisexuallVDU.
o Of 18,469 cases for which they list overlapping categories in
August 1990, 13,201 are counted in their main surveillance statistics as homosexual/bisexual
contact (men), of whom 8.714 were also IVDUs; 1,7'..6 bad heterosexual contact in addition
to homosexual contact and are listed under homosexual/bisexual (these must be men
because no women are listed under bisexual). Of 6,572 cases of heterosexual contact
which overlap, 3,499 also were IVDUs but are listed in the main surveillance report under
IVDU (the report does not divide these overlapping categories by sex).
o Given that the CDC often relies on local reporting and given the
sloppiness of its own categories, how do we know what the real story of transmission is,
especially for women?

Obviously the CDC deOnitlon or AIDS as
I! well 15 medical issues.

~II

as its epidemiology are bad science and are political
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What the CDC Must do in Order to Save Lives
November 25, 1990
Memorandum
TO:
FROM:
RE:

Gary Noble, M.D., Centers for Disease Control
Maxine Wolfe for the ACI' UP Network
Demands for Changes in the CDC Epidemiology and AIDS Policies

1.

We demand that the CDC's surveillance definition of AIDS
immediately be revised so that opportunistic infections and/ or indicator diseases with atypical
outcomes in immunocompromised people, presendy being diagnosed, be added. These include
but are not limited to: chronic pelvic inflammatory disease unresponsive to conventional
therapy, including but not limited to repeated episodes of endometritis, salpingitis, tuboovarian
abscesses leading to multiple pelvic adhesions and chronic pelvic pain; chronic refractory
vag:in.a1 thrush (candidiasis); chanaoid., unresponsive to conventional therapy; anal, vulvar or
vag:in.a1 condylomas (caused by Human Papillomavirus), unresponsive to con"Yentional therapy;
genital ulcers of undetermined etiology which last for more than 4 weeks and which are
unresponsi"Ye to empiric therapy; vulvar, vaginal, cervical and anal squamous cell neoplasias of
the lower genital track; chronic, refractory urinary tract infections unresponsive to conventional
therapies; neurosyphilis, with laboratory evidence of HIV, or definitively diagnosed reactivation
of syphilis; renal failure with laboratory evidence of HIV and with exclusion of other causes;
pulmonary tuberculosis with laboratory evidence of HIV; endocarditis' unresponsive to
conventional treatment; neutropenia (non-AZT related); bacterial and atypical pneumonias
unresponsive to conventional therapy; chronic or fulminant hepatitis; thrombocytopenia.

2.

We demand that the CDC immediately institute a mechanism for
regular periodic review and revision of its surveillance definition on a quarterly basis to include
newly discovered or developing opportunistic diseases in all affected people. Representatives
from all communities must be included in this process of review and revision.

3.

We demand that the CDC immediately revise its system of
collecting and publishing AIDS statistics:
o The CDC must abandon its system of collecting and publishing
statistics by "risk group· and, instead, collect and disseminate statistics based explicitly
described modes or transmission. For example, "anal-intercourse -no condom" should be a
mode of transmission which can occur for both men and women.
o The CDC must collect and publish statistics on modes of
transmission which do not now appear in their surveillance reports, for example, •cun.nilingus
-no latex barrier", and this data should be collected for both female-female and male-female
sexual partners.
o The CDC must stop listing women according to the behavior of
their presumed male sex partner and, instead, list both men and women according to specific
modes of transmission.

4. We demand that the CDC abandon their misguided strategies and
intentions for "routine• and mandatory testing, partner notification and contact tracing, as well as
their policy of counseling women with HIV disease to delay pregnancies. These strategies and
policies protect no one. Instead,

o The CDC must direct its resources towards developing and
widely disseminating educational materials which include explicit descriptions of all
transmission routs and poss1ble opportunistic infections/symptoms, especially those affecting
women and intravenous drug users. These would include but not be l,imited to repeated
chronic and severe urinary tract infections, refractory pelvic inflammation, genital warts,
chronic refractory vaginal yeast infections, syphilis or venereal ulcers (chancroid), frequent
herpes outbreaks, abnormal pap smears, chronic fatigue and loss of appetite
o The CDC must instruct counselors and health providers to give
womea accurate information on which they can base their decisions about pregnancy.
o The CDC must audit grants given to State and local governments
for educational purposes to insure that they are being used in a timely and appropriate
fashion. The CDC should publicly report State or local governments which leave such funds
unspent and reallocate them to agencies who will use them appropriately.

5. We demand that the CDC malce opportunistic infection diagnosis and prevention a priority:
o The CDC must research and collect statistics on the types of
opportunistic infections people with HIV have from diagnosis through their course of illness
and collect statistics on the causes of death of all persons with HIV disease. All of this must
be done in a manner which protects the anonymity of people and the CDC must include
substantial numbers of women, intravenous drug users and people of color in this research.
o The CDC must provide, free of charge, the most up-to-date
immune system monitoring along with appropriate counseling and referral services at all HIV
testing sites.
o The CDC must publish, on a timely basis, standards of care for
the prevention and treatment of all opportunistic infections and/or indicator diseases with
atypical outcomes in immunocompromised people or associated with HIV disease. These
standards should include but not be limited to: a minimum of two pap smears annually for
detection of possible cervical cancers; on site or rapid referrals for colposcopic examination
and definitive therapy for all abnormal paps; testing for chlamydia at every gynecological
screening; accurate testing for syphilis; viratyping for genital and anal warts; and health
maintenance appropriate to age including but not limited to mammography.
o The CDC must advocate, within HHS, to Congress. and to State
and local governments and health departments for the provision of programs and funding to
make preventative treatments available to all persons with HIV disease.
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HIV INFECTION AMONG CHILD-BEARING WOMEN
Sta~e

Health Direc-:or

anr.c~r.ced

t~e

Depar-:~ent

Kenne~~

W. Kizer, M.D., M.P.H, today

release cf final results frcm a California

cf Eealth Services study of Human Immunodeficiency

Vir-.:.s (HIV) i::.fection among California women who gave birt!'l i:l
1989.

After anonymously
bir~~s

tes~ing

bleed

from 144,284 live

speci~ens

among California women during July, August and September

of 1989, depart=ental

researc~ers

found the HIV infection rat:e

statewide to be 6.4 per 10,000, or one in every 1,568 women who
gave birth in the study period.

However, there was significant

variability among the rates based on race and geographic
loca"t:ion.

For example, among the 10,802 black mothers, 32 tested positive,
for a rate of 29.6 per 10,000 women.

The rate for the 58,667

whii:e women who gave birth i::. the study period was 3.9 per
10,000.

Thus, the rate for black women was more than seven i:imes
-MORE-
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that for white women.

The rates for Hispanic, Asian and women of

other racial/ethnic groups did not differ significantly from that
"These results underscore the seriousness of the

for whites.

epidemic in California's African-American community," Kizer said.

Twenty-one of California's 58 counties had at least one HIV
positive
smaller

birt~

during the study period.

coun~~es,

had no HIV positive

The remaining, typically

birt~s.

Compared to the

rate for the rest of the State (3.8 per 10,000), the
San Francisco Bay Area rate (11.8 per 10,000) was

six-coun~y

thr~e

times

higher, and the Los Angeles county rate (7.9 per 10,000) was
twice as high.

However, high rates are not limited to these two

densely populated, urban areas.

Other counties with rates higher

.than six per ten thousand were Merced, Sacramento, San Luis
Obispo, santa Barbara, santa cruz and Sonoma Counties.

"HIV

infection is by no means limited to California's largest urban
centers,"

Director Kizer remarked.

Women under 20 at the time that they gave birth were slightly
less likely to be HIV infected, as were those 35 years of aqe and
over.

However, these differences are relatively small and they

are not consistent throughout the State.

The Department's Office

of AIDS is engaged in further exploration of the relationship
between mother's age and HIV infection.
-MORE-
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regardless of age, need to avoid high-risk behaviors such as
unsafe sex and intravenous drug use, if they are to

protec~

themselves and their children from this deadly disease, " Kizer
advised.

T~e

1989 rate was essentially unchanged from 1988: 7.4 per 10,000

in 1988 compared to 6.4 per 10,000 childbearing women in 1989.
''T~e

lack of a significant change in this measure of the

in:ec~icn ra~e

holding the

is encouraging.

li~e

on the spread of HIV infection in childbearing

women and their infants.
believe

tha~

It indicates that California is

We are encouraged, and

importan~ly,

we

California's prevention programs are working," added

Kizer.

The study used blood samples routinely taken from infants shortly
after

bir~h

for the purpose of screening for several genetic

diseases that is required by law.
from their mothers.

Infants acquire HIV antibodies

Thus, a positive HIV test for a newborn

infant means that the mother has HIV infection.
infants will develop the disease themselves.

Not all of the

currently, experts

predict that about one-third of the infants born to HIV infected
women will eventually develop HIV infection themselves.

In order

to protect the mothers' and infants' rights to privacy, the H!V
test results were not linked to any individual baby or mother.
~ou-

ryi~

~~'
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However, using standard "unlinked survey" techniques, the
researchers were able to link the mother's age group,
racejethnicity, and area of residence to their HIV status,
these analyses possible.
-ooo-
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HIV Test Results for Mothers of Newborn Californians
Third Quarter 1989

Area of Residence and Age

Positive Negative

Percent
Positive

statewide

92

144192

0.064

S.F. Bay
under 20
20-24
25-29
30-34
35 and over
Unknown

25

21192

2
8

2

1726
4054
6259
5230
2924
999

L.A. County
under 20
20-24
25-29
30-34
35 and over
Unknown

39
4

Rest Calif.
under 20
20-24
25-29
30-34
35 and over
Unknown

4
6
3

11
12
7
5
0

28
2

11
6
9
0
0

95% Confidence
Interval
Lower
Upper

1 in
Every

0.052

0.079

1568

0.118

0.078

0.177

0.116
0.197
0.064
0.115
0.102
0.200

0.020
0.092
0.021
0.047
0.027
0.035

0.465
0.404
0.175
0.263
0.326
0.802

849
864
508
1566
873
976
500

49315

0.079

0.057

0.109

1265

5615
12594
14061
9929
5098
2018

0.071
0.087
0.085
0.070
0.098

o.ooo

0.023
0.046
0.046
0.031
0.036

0.196
0.161
0.153
0.152
0.243

1405
1146
1173
1419
1021

73685

0.038

0.026

0.056

2633

8542
19094
22063
14620
6511
2855

0.023
0.058
0.027
0.062
0.000
0.000

0.004
0.030
0.011
0.030

0.094
0.106
0.062
0.121

4272
1737
3679
1625

San Francisco Bay Area includes Alameda, Contra Costa, Marin, San
Francisco, San Mateo and Santa Clara counties.
All HIV positive tests were confirmed by Western blot. Excludes
cases for which the blood specimen was either not available or
inadequate for HIV testing. Only one result included for
multiple births. Excludes mothers who were not residents of
California and those for whom residence was not known.
California Department of Health Services
Office of AIDS
November 1990

HIV Test Results for Mothers of Newborn Californians
Third Quarter 1989
Area of Residence and RacejEthnicity
95% confidence

Positive Negative
Statewide

92

144192

S.F. Bay
Asian
Black
Hispanic
Others
Unknown
White

25

21192
2764
2161
4571
2190
327
9179

L.A. county
Asian
Black
Hispanic
Others
Unknown
White

39

Rest Calif.
Asian
Black
Hispanic
Others
Unknown
White

0
9
4
4

1
7

1

17
16
0
0
5

28
0
6
9
2
0

11

Percent
Positive

Interval
Lower
Upper

1 in
Every

0.064

0.052

0.079

1568

0.118

0.078

0.177

849

0.415
0.087
0.182
0.305
0.076

0.203
0.028
0.059
0.018
0.033

0.816
0.240
0.500
1.955
0.165

241
1144
548
328
1312

49315
3188
5094
26045
2047
268
12673

0.079
0.031
0.333
0.061
0.000
0.000
0.039

0.057
0.002
0.200
0.036

0.109
0.203
0.544
0.102

1265
3189
301
1629

0.015

0.098

2536

73685
3226
3515
25231
4075
846
36792

0.038
0.000
0.170
0.036
0.049

0.026

0.056

2633

0.069
0.017
0.009

0.391
0.070
0.198

587
2804
2038

0.030

0.016

0.055

3346

o.ooo

o.ooo

San Francisco Bay Area includes Alameda, Contra Costa, Marin, San
Francisco, san Mateo and Santa Clara counties.
All HIV positive tests were confirmed by Western blot. Excludes
cases for which the blood specimen was either not available or
inadequate for HIV testing. Only one result included for
multiple births. Excludes mothers who were not residents of
California and those for whom residence was not known.
California Department of Health Services
Office of AIDS
November 1990
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HIV Test Results for Mothers of Newborn Californians
Third Quarter 1989
Area of Residence, Age Group, Racejethnicity

Positive Negative
Area of
Residence
Total
S.F. Bay Area
L.A. County
Rest of Calif.
Age Grou:g
Total
under 20
20-24
25-29
30-34
35 and over
Unknown
Racelethnicit:::t
Total
Asian
Black
Hispanic
Others
Unknown
White

----- ----

Percent
Positive

95% Confidence
Interval
Lower
U:g:ger

1 in
Ever:;l

92

144192

0.064

0.052

0.079

1568

25
39
28

21192
49315
73685

0.118
0.079
0.038

0.078
0.057
0.026

0.177
0.109
0.056

849
1265
2633

92

144192

0.064

0.052

0.079

1568

8
30
22
22
8
2

15883
35742
42383
29779
14533
5872

0.050
0.084
0.052
0.074
0.055
0.034

0.023
0.058
0.033
0.047
0.026
0.006

0.1.03
0.121
0.080
0.11.4
0.1.13
0.1.37

1986
1192
1928
1355
1818
2937

92

144192

0.064

0.052

0.079

1568

1
32
29
6
1
23

9178
10770
55847
8312
1441
58644

0.011.
0.296
0.052
0.072
0.069
0.039

0.001.
0.206
0.035
0.029
0.004
0.025

0.071
0.423
0.076
0.165
0.449
0.060

9179
338
1927
1.386
1442
2551

----

San Francisco Bay Area includes Alameda, Contra Costa, Marin, San
Francisco, San Mateo and Santa Clara counties.
All HIV positive tests were confirmed by Western blot. Excludes
cases for which the blood specimen was either not available or
inadequate for HIV testing. Only one result included for
multiple births. Excludes mothers who were not residents of
California and those for whom residence was not known.
California Department of Health Services
Office of AIDS
November 1.990

HIV Test Results for Mothers of Newborn californians
Third Quarter 1989
Odds Ratios for:
Area of Residence, Age Group, RacejEtbnicity

Positive Negative

Percent
Positive

Odds
Ratio

95% Confidence
Interval
Lower
Upper

Area of
Residence
S.F. Bay Area
L.A. County
Rest of Calif.*

25
39
28

21192
49315
73685

0.118
0.079
0.038

3.10
2.08

1.81
1.28

5.32
3.38

Age Group
under 20*
20-24
25-29
30-34
35 and over
Unknown

8
30
22
22
8
2

15883
35742
42383
29779
14533
5872

0.050
0.084
0.052
0.074
0.055
0.034

1.67
1.03
1.47
1.09
n.a.

0.76
0.46
0.65
0.41
n.a.

3.63
2.31
3.29
2.91
n.a.

RacelEthnicit::t
Black
Hispanic
White•
Other/Unknown

:32
29
23
8

10770
55847
58644
18931

0.296
0.052
0.039
0.042

7.58
1.33

4.30
0.77

13.38
2.29

1.08

0.48

2.41

------- --- --San Francisco Bay Area includes Alameda, Contra Costa, Marin, Sari
Francisco, San Mateo and santa Clara counties.
* Signifies reference groups for computing odds ratios. The odds
ratio is a measure of how much more likely a particular group is
to be HIV infected as compared to the reference group. "n.a."
means that odds ratio and confidence intervals were not computed·
as the expected number of positive tests for one cell was less
than 5. Odds ratios were computed by the computer program "Epi
Info, Version 5," using Cornfeld's approximation, as described by
Joseph Fleiss, Statistical Methods for Rates and Proportions.
New York: John Wiley & Sons, 1981, pp. 71-75.
All HIV positive tests were confirmed by Western blot. Excludes
cases for which the blood specimen was either not available or
inadequate for HIV testing. Only one result included for
multiple births. Excludes mothers who were not residents of
California and those for whom residence was not known.
California Department of Health Services
Office of AIDS
November 1990

HIV Test Results for Newborn Californians
Third Quarter 1989

Area and County of Residence
(page 1 of 2)

Positive Neaative

Percent
Positive

95% Confidence
Interval
Lower
Upper

1 in
Every

0.079

1568

:tatewi.de

92

144192

0.064

0.052

:.F. Bay 'I'ota1
,lameda
:antra Costa
[arin
ian Francisco
ian Mateo
ianta Clara

25

21192

0.118

0.078

0.177

849

0.094
0.135

0.353
0.544

539
362

~os

Angeles County

>ther Counties
3utte
n Dorado
~resno

iumboldt
r:mperial
:<ern
:<ings
'1adera
wterced
~apa

)range
Riverside
Sacramento
San Bernadino
San Diego
San Joaquin
San Luis Obispo
Santa Barbara
Santa Cruz
Shasta
Solano
Sonoma
Stanislaus
Tulare
Ventura
Yolo

-

- - - -------

10
9
0
4
1
1

5380
3252
725
2543
2425
6867

0.186
0.276
0.000
0.157
0.041
0.015

----0.050

----0.431

0.002
0.001

0.267
0.094

637
2426
6868

39

49315

0.079

0.057

0.109

1265

25

68973

0.036

0.024

0.054

2760

0
0
1
0
0
1
0
0
1
0
2
2
3
3
6
1
1
2
1
0
0
1
0
0
0
0

689
429
3701
421
771
2983
491
475
970
393
11995
5807
4383
7508
11375
2463
708
1528
1076
590
1370
1545
1817
1779
3147
559

0.000
0.000
0.027
0.000
0.000
0.034

---

o.ooo
0.000
0.103
0.000
0.017
0.034
0.068
0.040
0.053
0.041
0.141
0.131
0.093

o.ooo

0.000
0.065
0.000
0.000
0.000
0.000

-

California Department of Health Services
Office of AIDS
November 1990

r":J •. "+..,

--------0.002
--------0.002
--------0.006
----0.003

--------0.175
--------0.217
--------0.666
----0.067

0.006
0.018
0.010
0.021
0.002
0.008
0.023
0.005

0.139
0.218
0.127
0.121
0.263
0.910
0.526
0.600

--------0.004
-----------------

--------0.419
-----------------

3702
2984
971
5999
2905
1462
2504
1897
2464
709
765
1077
1546

HIV Test Results for Newborn Californians
Third Quarter 1989
Area and County of Residence
(page 2 of 2)
95% Confidence
Interval
Upper
Lower

Positive Negative

Percent
Positive

0

407

o.ooo

-----

-----

2

1691

0.118

0.021

0.475

0

353

o.ooo

----- -----

1

515

0.194

0.011

0

790

o.ooo

0

575

o.ooo

----- --------- -----

0

381

o.ooo

----- -----

Reqion l. Counties
Del Norte
Lassen
Modoc
Plumas
Sierra
Siskiyou
Trinity
Reqion 2 counties
Monterey
San Benito
Reqion 3 counties
Colusa
Glenn
Tehama
Reqion 4 counties
Lake
Mendocino
Reqion 5 counties
Nevada
Placer
Reqion 6 counties
Inyo
sutter
Yuba
Reqion 7 counties
Al.pine
Amador
Calaveras
Mariposa
Mono
Tuolumne

1.248

1 in
Every

847

516

-- ---- -- - -- - - -All HIV positive tests were confirmed by Western blot. Excludes cases for
which the blood specimen was either not available or inadequate for HIV
testing. Only one result included for multiple births. Excludes mothers wh<
were not residents of California and those for whom residence was not known.
California Department of Health Services
Office of AIDS
November 1990
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DEPARTMENT OF
HEALTH SERVICES
714 P STREET. SACRAMENTO, CA, 95814

OATE: oe~o~er 8, l99l
CONTACT:
Betsy Hite

.'JUMBER:
63-91
FOR RELEASE: IXMEDIA.'!'~

or Jai:e Arteaqa
(916)

657-3064

A.C.D.C.

SAC~N'I'O - ~~~ne .:.n every 1,420 child.l:aar.!.!'lg woman test H!V
:: :::sl. -:::;e ac:~rci::q -:.o ~ California De;>ar-::men-: of Health services
s~udy on s~atewide HIV prevalence in child~aaring woman conduc~ea
d.-:.;.r:.::q :..990." sa~d Sta~e Heal~"l Di.re.c-:or Molly .Joel coye, M.D.,

X. :?.H.

CRS

anonymous blood specimens f~om lS0,494
~~fan~s born ~o California women durL~q July, Auqus~ and Septam=ar
: : 1990.
one-hundred and six tasted positive, !or a stataw~de HIV
~~evalence rate o! seven per 10,000, or one in ever; 1,420 women
~ho gave bi=-:~ dur:::q the study pericd.
raeearc~ers ~es~ea

Atr!::a:n-Amer!:an mot±ers .:.n the
infection, !or a ra~e of 48.7 per
:o,ooo ~others. For white mothers, the rate was 3.4 per lO,OOO or
~o H!V .:.~fec~ad mo~hers out of ~9,189.
Thus the rata tor AfricanAmerl.can ~o~hers was 14 ti~es higher than that !or white mc~ars.
::1 adai":!on, t.he i::!ec-:ion rata is hiqher for .Afri::an-American
~ethers in every age qroup studied.
This shows that the high ::ate
:or At::~can-Ame=ican mothers is not a ret!ac-:icn or di!!arences in
~~e ages of wo:an gi~ir.g birth.
Fi!~y-seven of the ll, 703
~ested posi~ive for HIV

sample

"'!'he .consi.stent!y higher rata ot HIV .!.ntec-:.1o:n !or Afr!canA.merican mothers gives us qreat concern," !:)r. Coya said.. "!ut the
:::.sk of HIV intec~icn is widespread: no rac:.al/ethn.:i.c group is
:.::t:nune ~~om tha~ r!.sk ...

"At l.aast:. one ::~o~her ~asted posit!.ve tor HIV i.nfactl.on :..n :!6
of Cali!ornia's 58 counties," said Mary Jess Wilson, ~.o., !i.?.H.
?u~lic Healt.~ Medical ot:icer with tha state Ot!!.ce of AIDS.
•'RIV
in!ect:ion was more prevalent in the State • s ~._.o larqes~ urt=an areas
-- the San Francisco Bay Area and Los Angeles County -- ~han it ~as
.::..~the =est of the St~te."
....

_-

-2-

c:cun-eies in those areas d.it:ered great'.! y i:'l
among t~amselvas.
In Alameda Coun~y, one out'. of
eva~i SlO ~as in!ec~ed, q~vinq ~ham the highest'. rata ot infac~!on.
7ha next highest rates were in San Joaquin County with one out'. o!
~ve:y 777 ana contra Costa county with one out ot every Bll.
However,

~~:fac~ion

''Mos~

cf t!la HIV infected mothers were ::-om the larqer, more

counties,

~==~n
~re

tha

ra~e

::o~

~ut mot~ers

::-om smaller ana leas ur=an
or. ccye remarltec1.

coun~ies

immune t=om in:fec'Cion,"

=ate !or 1990 was slightly niqher than that'. :or 1989 and
lower than i~ was in 1988. OHS researchers concluded that
~~ese di!!e:ences were net :arqe encuqh to sugqest any siqni!~cant
=::.anqa in the prevalence ot HIV infection amonq :ali!ol:"'nia 's
=nildbeari~g women.
~he

s~i;ht~y

"While tha absence of

an increasing t::-enc:l is welccma,. we
:annot oe sure of the reasons !or it," Or. Coye c:aut1cned.
''Although HIV intec-eion amonc; Ca.li:ornia women ot ch1lc1l;:)aarinq aqe
:ay ~ct be increasinq, it could mean that mora in~ac-eed women may
:e chcosinq no~ ~= have children. Thia could make the rate appear
-:.o be s~eady, while t.~e act'Ual =ate amonq all woman ot child,J:,aarinc::r
age could oe inc::-easing."
·
Finally, since the projee~ beqan in l988, ~· rata has bean
:or Afr~can•Amarican mothers in the San Francisco Bay Area,
:.os Anc;eles county and all ot.~ar counties, th.e three areas the
3 ~a ::e was broken in~o to cond.uc-: the s-eudy. on the other hanc:l, the
:ates amonc; Lat~~a, Asian, Pac~!ic Islander, and mothers ot other
:acial;e~hnic oackqrcunQs did not'. di!:ar siqni!icantly from that'.
:or ·..;hitas.

~iqhe:

s~ud.y uaeci :Cleoci samples :cu~inely taken !::'om in~ants
attar birth to screen tor seve::"al qene~ic diseases.
3ecause infants acquire H:IV antibodies from their mothers , a
:ositive HIV tast tor a newborn intant means that the mother is
lnfected. To protect'. each mot'.her•s and intant•s r1qht to pr~vacy,
':he HIV test results ware not linkaa to any identified mother or
:::aJ:2v. For the same reason, aqe and. race/ eth.nicity ware qrouped and
s~ailer counties combined.

':'ha

sho~:y

Not all t."1e intan-ea whc tea-cad posit'.:!.va wll~ d.avelop Hr;
disease themselves.
currently, expe~ predict that about one!!!~~ to one-thi=c:l of the in!an-es born eo Hrv in~actad mcthara will
beco~e ill themselves.
Separa~e stuc:lies are bainq ccnducted to
denti!y
the
staqes
of
HIV
disea~e in Chil~an under tha aqe of 13.
1

t.

I") ...
4_,,),1

HIV seroprevalence among California Childbearing Women
Third Quarter 1990
Office of AIDS
Depar~men~ of Health
Sep~ember 1991

California

Statewide
San Francisco Bay Area
Alameda
Con~ra Cost:a
Marin
San Francisco
San Mat:eo
sant:a Cl.ara
~os
~est:

Angeles

3utt:e
E:l Dorado
.:resno
2umi:lold'=
!.:nper.ia.i
.Kern
.Kings
Madera
Merced

!:!2.:.

Pet .

150494

106

0.0'704

0.0579

0.0855

1420

2139'7
5512
3245
743
2438
:2369
6990

23
ll

0.0698
0.1032
0.0396

0.1640
0.3620
0.3384

930
510
8ll

0.0144

0.3302

:::..9

5

0.1075
0.1960
0.1233
0.0000
0.0820
0.0000
0.0858

0.0349

0.!969

:.:ss

52

0.0997

0.0752

0.1318

1003

76931
S58

31

0.0279

o.osso

..;31

0

0.0403
0.0000
0.0000
0.1034

0.0332

C.2839

96'7

0.0027
0.0124
0.0169
0.0097
0.0320
0.0334

0.0624
0.1526
0.20'72
0.1.195
0.1414
G.4094

6461
2086
1536
:664
l-*53

0.0041
0.0040

0.4643

l394

':;.4458

:.;52

:..7306

_,_
"':'-,

3869

..;40

~apa

Orange
Riverside
sacrament:o
san Sernarc::ii::.o
San Diego
San Joaquin
San Luis Obispo
Sant:a Barbara
Sant:a Cr".l::
Shast:a
Solano
Sonoma
Stanislaus
Tulare
·;ent:ura
Yolo
Reaion l

327
3225
490
554
1043
331
:2922
6258

4607
7993
::624
:330
752
:638

1020
579
:394
l452
:986
.:..846
328'7
549
371

4

0
2
0

0

....
0

o.aooo

0
0

0.0000
0.0000
0.0000

0
0
0
0

3
3
3
8
3
0
0
0

0
1
0

0
0
0

Sterra.

Sisk1~ou.

1 in
E:ve:ry

o.oooo
0.0000
0.0000
0.0155
0.04'79

0.0651
0.03i5
0.0688
0.1288
0.0000
0.0000
0.0000
0.0000
O.Oi1'7
0.0689
0.0000
0.0000
0.0000
0.0000

0.2695

Oe1 Nor~•. ~ass•"· ~oooc. ?1~s.

Reg~on

95\ Cont. :nt.
:::..ower «; Uoper '

Total
Test:ed

Coun~y

of California

H!V ?ositi•:e

Services

Iii

T~1n1ty

2

::1.055'7

1794

'J.OOJ:

'J.3510

'J.:o7:

~.7964

Monterey. San ien1to

Region 3
Colusa. Glenn, Te"a-.

~eg~on

4

.361

0

0.0000

460

0

0.0000

0.1233

Reg~on 5
Hew•••. Placer

311

~eg~on

571

0

J.OOOO

458

0

0.0000

St.&t ter.

Reg~on
~lo•••·

6
l'YII&

7
~-.aor.

C~l•v•r••·

Inyo. Har1oos•. Mono.

-----------HIV ::os.:.t:ive t:est:s were
s~ec~mens were omitted.

=,.,

;wo•w~•

con:fi::ned by West:ern Blot:. Cases wit:h r:u.ssing or i.:'laciecuat:e ;:;.:..cc
Only one result is present:ed for ~ult:.:.ple oirt:hs. ~xci~ces
.. ._ ..... _ .....

-1"'-'\~~,.....o...,,-o

•J.::~c::

11nknnwn.

r"\"''~

HIV Seroprevalence among California Childbearing Women
Third Quar~er 1990
California

Statewide

Office of AIDS
of Health Services
Sep~ember 1991

Depar~ment

Total
Tested

~

Pet.

150494

106

0.0704

0.0579

0.0855

1420

0.1075

0.0698
0.0195
0.0183
0.0816
0.0553
0.0019

0.1640
0.4467

930
901
1419
623

HIV ?ositive

~5\

Conf.

:ower '

:~t.

Uc~er

'

l in
Eve~r

Area of State and Aqe Group
San Francisco Bay Area
under 20
20-24
25-29
30-34
35 and over

Unknown
~os

Angeles County
under ::;

23
2
3
10

5553

7

3010
544

l
0

0.0705
0.1605
0.1261
0.0332
0.0000

52166

52
3
11

0.0997
0.0478
0.0799

0.0752
0.0124
0.0420

27

O.lBOl

0.1211

6
3

0.0555
0.0540
0.2601

0.0226
0.0140
0.0456

0.0403
0.0537
0.0243
0.0440
0.0321
0.0553
0.1316

5272

20-24
25-29
30-34

35 and over
Unknown
Rest of California
under

21397
1801
4258
6231

13766
l4990
10813
5556
769

31

20-24

20540

25-29

22739

5
10

30-34
35 and over

l5584

Unknown

7237
:520

5

s

...,

0.22~2

0.3055

0.2720

793

0.2:54

3010

0.1318

1003

0.1.523

~091

0.1477

0.2659
0.1.273

555
1802

0.1719

:as2

.:..0428

385

0.0279
0.0198
0.0090
0.0224
0.0118
0.0178
0.0231

0.0580
0.1331
0.0604
0.0838

=·U2
1862
4108
2274
3117
lS09

0.1075
0.0000
0.5419
0.0748
0.0646
0.0000
0.0000

0.0698

0.1640

0.3017
0.0240

0.9511

:as

0.2054

0.0263

o.:.;a1

:.338

0.0997
0.0337
0.5738
0.0539
0.0242
0.0000
0.2101

0.0752
0.0019
0.3969
0.0319
0.0063

0.1318
0.2.:!.83
0.8240
0.0896
0.0770

0.0121

:.3521

0.0403
0.0000
0.3332
0.0238
0.0293
0.0000
0.0000

0.0279

0.0580

8.1855
0.0104
0.0154

8.5854
0. 0513
0.0542

2

76931
9311

.:o

0.1110

0.0795
0.1519
0.5290

750

Area of State and RacefEthnicity
San Francisco Bay Area
Asian/?. I.
Black
Hispani:;
'..Jhite
Other
Unknown

21397
2741

23

2399

13

5350
9294
llSl
462

4
6
0

Angeles County

52166
2970
5403
29692
12409
:216
476

52

76931
2543
3901
29448

31

~os

.~sian/P.

I.

Elacx
Hispanic
White
Other
Unknown
Rest of California
.~sian/

P. I.

Slack
Hispanic
White
Other
Unknown

-san- Francisco
- - - - - -Bay- Area
- -- includes
c;anta Clara Counties.

37486
2813
740

0

0

...,
0

--.
~

7
!l
0
0

930

1549

1003

:370
174

1856
41.35
~76

~00

4207
3408

Alameda, Contra Costa, Marin, San Francisco, San Matec

..... h,
t ) ··Q

HIV Sercprevalence among California Childbear~ng Women
Third Quarter 1990
California

Office of AIDS
of Health Services
Septemeer 1991

Depar~men~

Odds

Total
'::'ested

!!2..:..

Pc~.

150494

106

0.0704

0.0579

0.0855

1420

21397
52166
76931

23
52
31

0.1075
0.0997
0.0403

0.0698
0.0752
0.0279

0.1640
0.1318
0.0580

930
1003
2482

3lack
Hispanic
White•
Other
Unknown

8254
11703
64490
59189
5180
:578

1
57
27
20

0.0121
0.4871
0.0419
0.0338
0.0000
0.0596

0.0007
0.3724
0.0281
0.0212

0.0786
0.6353
0.0618
0.0532

8254
205
2389
:959

0 • .36
14. 41•

0.0034

0.3859

:578

:.76

Age C":"Ot!'C
under 20
20-24
25-29
30-34
35 and ever•
Unknown

17384
38564
43960
31950
15803
2833

10
19
47
18
8

0.0575
0.0493
0.1069
0.0563
0.0506
0.1412

0.0292
0.0305
0.0794
0.0344
0.0236
0.0453

0.1096
0.0785
0.1434
0.0910
0.1040
0.3876

1738
2030
935
::.775
1975
708

Statewide
Area of State
San Franc~sco Bay Area
Los Angeles County
~est: of California•

HIV Positive

95\ Conf. :::1t.

Lower

~

Uooer

Ra~':::

i:

2.57
2.~7

~ace !Et!':~ici t.·:
Asian1Pac~::ic

-

- --

- - - -

!slander

-.

0

.-·

- - - - - - - - - by

HIV ocsitive tests were

confi~ed
Western Slot. Cases with miss4ng or ~~adequate
soeclmens were omitted. Only one result is presented for multiple oir~hs. ~xcluaes
mot:hers who were not res~dents of Califcrn4a or whose residence was unknown.

.

........
...

..;..

.-·-. ....

0.97
2 ~·~

--..
_.........
~

2.79

o~cc

•

Designates the reference group for computing relative risks.

••
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SHERIFF•s D&PARTM~NT MEDICAL SERVICES
•
AIDS CASELOAD STATISTICS*
•

1.

2.
3.
4.

s.

Number of Confirmed c~~e= of AIDS (Inelu~es ARC)•• .•••••
•
Males.........
506
Females.......
15
Number of AIDS Related Dea~hs••• .••••••••.•••••••••.••••
Number o! Employee/Possible HIV Exposure InJury Repo~: .•
Ethnicity of the Confirmed Cases:

I

•

e.

9.

:.o.
ll.

12.
13.
14.
lS.
16.

17.
16.
19.

20.

523

2S
215

a)

Cauea!:ian •••••. .••.•••••••••..••... ·•

260

b)

e)

Bla-c 1:. •••••••••••••••••••••••••••••• • •
Hispanic . • . . . . . . . . . . . . . . . . . • . • . . • . . . .

d)
e)

Other •••••••.•••..••••..••.••.•••••••
Unknown • •••••••••••••..••••••••••••••

168
87
04

Risk Group Districutlon ot Confirmed Cases:
a)
b)
c)

6.
..,

•.

Gay Males •...••..•..•••••.•......•..•.
Lesbians ••.••••••••••.•.•..• ••••••.••
I.V. Drug User.l!i ••••••••••••••••••••••
T~ansfUSlOns

o)

elooo

e)

Ot-her • •••••••••••••••• ••••••••••••••••

.•••.•••.••.•••....

Averag~ Daily Census c! PWA (Mcn~h ot Novemoer, l9i0) •••
Average Daily Census o! known HIV Positive Inmates ••••••
Sercprevalence raLe in New Entrants··~··················
Number of HIV Teat done in Month of January, 1991 ••..•••
Number o! HI V Te.s t do.ne in Month of December, 1990 ••••••
Number of HIV Teat done in Montn of Novemoer, 1g9o •.••••
Number of HlV Test done in Month of October, 1990 •••.•••
Number of HIV Test done in Month of September, 1990 ••••.
Nuwber of HIV Ttst done in Mon~h of August, 1990 ••••....
~umber of Positive Test !or Month of January, 1991 •••••
Number of Positive !est for Month of Oecember, l990 •••••
Number of Positive Test for Month of November. 1990 •••••
Number ot Positlve Test for Month of October, 1990 ••••••
Number of Positive Test for Month of September. l990 ••.•
Number of Posi~ive Test fer Month of August, 1990 •••••••

*Aa of ~anuary 3l, l99l
••cumulative from May 2, 1985
**•Includes LCMC Jail Ward
••••1966 Blind Study of 1,000 New Bookings

04

--'l , ,

0
l62
l~

02
04
39
2.6\
194

lSi
165
164
!89
167
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20
29
30
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SHERIFF'S

D&PARTM~NT

MEDICAL SERVICES

AIDS CASELOAD STATISTICS*

l.
2.
3.
4.

Number of Confirmed Cases of AIDS (Includes ARC)*• .•••••
•
Males •••.•..•• Sll
Females.......
lS
Number of AIDS Related Deaths••• ••••••••••••••••••••••••
Number of Employee/Possible HIV Exposure Injury Report ••
Ethnicity of the con!irmed Cases:
a)
Caucasian ••••••••••••••••••••••••••••
b)

c)

5.

Black ...•.•...•.....•.•...•.•••..••.•
H is pan i c . . . • • . . . . . . . • . . . . . . . . . . . . . . . .

d)

Other .••....•..•.••••••••.•••••••••••

e)

Unknown ••••••••••••••••••.•.•••••••••

e.

9.
10.
ll.
12.
13.
14.

.....
16.
, c

l7.

lB.
l9.
20.

262

169
87
04
04

Gay Males ••••••••• •••••••.•••••••••••
Lesbian!' .•.••••••.•.•••••.•••.••••••••

3ll

I.V. Oru9 Users ••••••••••••••••••••••
Bloo~ Transfusions •••••••••••••••••••
e) Other .•••••••••••••• ~ ••••••••••••••••
Average Daily Census of PWA (Month of November, 1990) •••
Average naily Census of known HIV Positive Inmates •.••••
Sercprevolence rate in New Entrants•••• •••••••••••••••••
Number of HIV Tes~ done in Month of February, 1991 •••••.
Number of HlV Tes~ done in Month of January, 1991 •••••••
Number of HlV Test done in Month ot December, 1990 ••••••
Number of HIV Test done in Month of November, 1990 ••••••
Number of HlV Test ~one in Month of October, 1990 •••••••
NYmber of HIV Teat ~one in Month of September, 1990 •••••
Number of Positive Test !or Month of February, 1991 ••••
Number of Positive Test for Month of January, 1991~·····
Number of Positive Test for Month of December, 1990 •••••
Number of Positive Test for Month of November, 1990 •••••
Number of Positive Tast for Month of October, 1990 ••••••
Number of ·positive Test for Month of Sep~ember~ 1990 ••••

183
13
04
04

e)
d)

6.

25
222

Risk Group Distribution of Confirmed Cases:
a)
b)

7 •

526

*As of February 28, 1991
**Cumulative from May 2, 198~
***Includes LCMC Jail Ward
• •••'1988 Blind Study of l, 000 Nev Bookings
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I

(;

i

1991

1990

%Change
90 to 91

232
2.450

301
2.180

-23%
+12%

13.6471
9,534 1
70%

10.7562
7,3222
68%

+27%
+30%

38.0183
25,98<Y
68%

30.422"

+25%
+31%

195.718s
126.1!igs
64%

152.1266
93,7i56
62%

Los Angeles County
New cases reported in October
New cases reported year-to-date

I

i

I
I

l
·I

Cumulative cases
Cumulative deaths
Cumulative case-fatality rate

II

r

I

!,

California

\I

Cumulative cases
Cumulative deaths
Cumulative case-fatality rate

tl

IIij

19,89~

65%

'I

!I

United States
II,

ii

II

Cumulative cases
Cumulative deaths
Cumulative case-fatality rate

I

II

1

Includes all cases reponed to the AIDS Epidemiology Procram 81 or October 31. 1991.
Includes all cases reponed to the AIDS Epidemiology Progn~m 81 or October 31. 1990.
California Office of AIDS. California AIDS Update. October 31. 1991.
4
California Office of AIDS. California AIDS Update. October 31. 1990.
s Centers for Disease Control. HIV/AIDS Surveillance Repon. October 1991:1-18.
6
Centers ror Disease Control. HIV/AIDS Surveillance Repon. October 1990:1·16.
2
3

+29%
+35%

i\I.
'I
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1.

REPORTED AIDS CASES AND D£4THS BY DIS£4SE C4.TEGORY
Disease
Cateaory1

Adult

No.
6499
2037
975

No.
4579
1431
803
2653

13537
(99]

9466

( %)
(48)
(15 )
(07)
4026 (30)

PCP W/0 KS
KS w/o PCP
KS and PCP
Other 01
Total
[%of Total]

2.

Cases

(CFR 4)
(70)
(70)
(82)
(66)

No.
47
1
1
61

Total

Pediatricl
Deaths

( %)
(43 )
(01 )
(01 )
(SS)

No.
31
1
1
35
61

110
(01 ]

(CFR 4)
(66 )
(100)
(100)
(57)

Deaths

Cases

No.
6546
2038
976
4087

( %)
(48)
(15 )
(07)
(30)

No. (CFR 4)
4610 (70)
1432 (70)
804 (82)
2688 (66)
9534

13647

[100)

REPORTED AIDS CASES BY AGE AND RACE!ETHNIC11l'
Age at Diagnosis

less than 13
13- 19
20-29
30-39
40-49
so- 59
Greater than 60
Total
[%of Total)

3.

Deaths1

Cases

White

Black

( %)
(02)
(00)
(21)
(46)
(21)
(08)
S6 (03)

No. ( %)
30(00)
10 (00)
1229 (15)
3745 (44)
2244 (27)
877 (10)
325 (04)

No.
37
9
461
1018
457
174

3460

llll
[16}

(62]

Hispanic

No.
39
12
612
1189
556
2D7
57

( %)
(01 )
(00)
(23)
(44)
(21)
(08)
(02)

1611
[20 1

Asian 5

Total'

No. ( %)
4 (02)
0 (00)
28 (14)
71 (36)
68 (35)
19 (10)
7 (04)

197

No.
110
31
2356
61}67
3353
1283
447

( %)
(01 )
(00)
(17 )
(44)
(25 )
(09)
(03)

13647
[100}

(01 ]

REPORTED ADULT/ADOLESCENT AIDS CASES BY SEXUAL ORIENTATION AND INTRAVENOUS DRUG USE
History of Intravenous Drua Use
No
Yes
Unknowu

Sexual Orientation

Male, homosexual
Male, bisexual
Male, heterosexual
Male, orientation unknown
Female, heterosexual
Total
[%of Total}

No.
4298
953
326
82
199
5851

(43

1

( %)
(73)
(16)
(06)
(01 )
(03)

No.
731
216
253
257
131
1511
(12}

( %)
(46)
(14)
(16)
(16)
(08)

No.
4937
638
123
260
133

C %)

(81 )
(10)
(02)
(04)
(02)

Total

No.
9966
1807
702
599
463

13537
(100}

6091
(45 1

1 ~ cafe&Oria are onlered ~n:aically; KS•ICapoai'surcoaa. PCP•Pn~umOCYStis c:arinii paeuaoaia. Ol•opponni&lic: ia(ec:tiotl.
Reportia' of dca!M il '--pletc.
3
IKJadel all palieall • dlaa 13 at tile tiae of diapoai&.
4
CfRac.e.fa&ality rate.
S IKJadel 1 Buna-=. 3 Caabocliaa, 23 Cilia-. 60 filipiao, 3 lDdoaesiaa, 37 Japaa-. 7 K.orua, 3 Mayalaa. 11 Pacifac: blaaclen., 4
Taiwaa-. 13 'Illai. aad 11 Vietuaae; :Zt are of uDkllowa etllaicity.
' Total iadadel 16 ~~~ ladiaDIIAlauu NatiYes, aDd 90 ~ wbolc raceletluaicity iiUDkDowa.
1

2GG

4.

REPORTED AIDS CASES BY EXPOSURE CATEGORY AND GENDER
Exposure Cateaory7

No. ( %)

Adult/Adolescent
Homosexual/bisexual male contact
Intravenous drug use (IVDU)
Homosexual or bisexuaiiVDU
Hemophilia or coagulation disorder
Heterosexual contact
Transfusion recipient
Undetermined

10826 (83)
510 (04)
947 (07)
59 (00)
87 (01 )
142 (01 )
503 (04)

Adult Subtotal
[% of Adult Subtotal]

4
26
33
1

PedUllric Subtotal
[% of Pediarric Subtotal}

Total
[%of Total]

s.

(06)
(41 )
(52)
(02)

No. ( %}

No. ( %)
0
131
0
5
152
105
70

(00)
(28)
(00)
(01 )
(33 )
(23)
(15 )

10826
641
947
64
239
247
573

(80)
(OS )
(07)
(00)
(02)
(02)
(04)

13537
[100]

463
{03 I

13074
[97 I

Pediatric
Hemophilia or coagulation disorder
Parent with or at risk: of AIDS8
Transfusion recipient
Undetennined

Total

Female

Male

(02)
(72)
(24)
(02)

1
33
11
1

5
59
44
2

64
[58 I

46
[42 1

110
[100/

13138
[96)

509
[04)

13647

(05)
(54)
(40)
(02)

[100]

REPORTED AIDS CASES BY EXPOSURE CATEGORY AND RACE/ETHNICI7l'
Exposure Cateaory7

Adu It/Adolescent
Homosexual/bisexual male contact
Intravenous drug use (IVDU)
Homosexual or bisexualiVDU
Hemophilia or coagulation disorder
Heterosexual contact
Transfusion recipient
Undetennined
Adult Subtotal
[% of Adult Subtotal]

Pediatric
Hemophilia or coagulation disorder
Parent with or at risk: of AIDS8
Transfusion recipient
Undetennined
PedUllric Subtotal
[%of Pediarric Subtotal}

Total
[%of Total)

White

No. ( %)

Black

No. ( %)

8 ladadel oae c:aae ua...illed by breul ailk.

No. ( %)

7233 (86)
217 (03)
572 (07)
38(00)
81 (01 )
137 (02)
152 (02)

1425
254
213
10

1930
160
154
9
67
58
255

8430
[62 I

2175
[16 1

2633
[19 1

2
12
16
0

(07)
(40)
(53)
(00)

(66)
(12)
(10)
(00)
81 (04)
34 (02)
152 (07)

0
25
10
2

30
[27 I

37
[34 1

8460

llll
[16]

[62]

7 Ellpolare c:atqoriel are ordered laienn:~cally. Ell:ept (or Ole coabiulioll lialed. fin&.

Hispanic:

(00)
(68)
(27)
(OS)

2
22
15
0
39
[35

1

l67l
[20]

(73)
(06)
(06)
(00)
(03)
(02)
(10)

Other

No. ( %)
238 (80)
10
8
7
4
18
14

(03)
(03)
(02)
(01 )
(06)
(OS)

299
102

(OS)
(56)
(38)
(00)

I

1
0
3
0

(25)
(00)
{15)
(00)

4

/04 I
303

[02]

widt aalliple risk W:ton are aabulaled ia dte catecory listed

•
6.

REPORTED AIDS CASES BY EXPOSURE C4TEGORY AND YEAR OF DIAGNOSIS
Before
Exposure Cateaory'

Adult/Adolescent
Homosexual/bisexual male contact
lntraYenous drug use (IVDU)
Homosexual or bisexual IVDU
Hemophilia or coagulation disorder
Heterosexual contact
Transfusion recipient
Undetermined

Adull Subtotal
[% of AduJJ SubtottJll
Pediatric
Hemophilia or coagulation disorder
Parent with or at risk of AIDS 11
Transfusion recipient
Undetermined

Pedialric Subtotal

No. ( %)

1987

1988

No. ( %)

No. ( %)

1989
No. ( %)

1990
No. ( %)

1991"
No. C%)

2707 (83) 1600 (81 ) 1749 (80) 1901 (79) 1860 (77) 1009 (76)
83 (06)
79 (04) 122 (06) 126 (OS ) 151 (06 )
80(02)
71 (OS )
262 (08) 147 (07) 164 (07) 165 (07) 138 (06)
10 (00)
11 (01 )
3 (00)
14 (01 )
4 (00)
22 (01 )
34 (03 )
53 (02)
43 (02)
35 (01 )
34 (02) 40 (02)
18 (01 )
42 (02)
32 (01 )
65 (02)
48 (02)
42 (02)
97 (07)
71 (02)
52 (03) 65 (03) 122 (OS) 166 (07)
1964
[15 J

3242
[24 I

0
12
20
0

(00)
(38)
(63)
(00)

32

I% of Pediatric SubtottJJI

[29

Total

3274

(%of Total)

1.

1987

2196
[16 I

(17 )
(50)
(33)
(00)

2
6
4
0

[24]

0
19
4
1

(00)
(79)
{17)
(04)

0
8
6
0

[10

(00)
(57)
(43)
(00)

J

1
8
4
1

[II I

14
[13 J

24
[22 J

14
[13 I

14
[13 J

1976

2210

2416

2434

1337

12

J

(14)
(43)
(43)
(00)

2
6
6
0

1323

2420
[18 I

2392
[18 J

(14

1

[16

1

[18]

(18)

(07)
(57)
(29)
(07)

(10]

REPORTED AIDS CASES BY RACE/ETHNICJTY AND YEAR OF DIAGNOSIS
Before
Race/Ethoicity

1987

1987

1988

1989

1990

No. ( %}
No. ( %) No. ( %)
No. ( %)
(70) 1328 (67 ) 1322 (60) 1433 (59) 1356 (56)
(14) 290 (15 ) 412 (19) 389 (16) 427 (18)
(15 ) 319 {16) 439 (20) 535 (22) 564 (23)
52 (02)
(01 )
23 (01 ) 27 (01 )
46 (02)
16 (01 )
10 (00)
13 (01 )
35 (01 )
(00)

No. C%)
White, not Hispanic
Black, not Hispanic
Hispanic
Asian/Pacific Islander
Other/Unknown

2287
464
482
30
11

Total

3274

[%of Subtotal]

(24

1

1976

2210

[14]

[16

2416

1

(18]

2434
(18]

1991l'

No. ( %}
(55 )
(17 )
(25 )
(01 )
(02)

734
230
333
19
21

1337
(10

1

9 &ponre cale~Griea are ordered ILieran:llically. E:rl:ept for tile combiutioo listed. tuea witll more tbao oae risk factor are tabulated ia tbe catqory listed firsL
10 Cues di.apoled tlli.a year aod reported to the AIDS EpidemioiOC)' Pro&ram aa of tbe date of this report; tllese data are provisioaal
11
lodudea oae cue rrauairted by breaat milk.
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8. .REPORTED AIDS CASES AND FATA.Un' BY HALF-YEAR OF DIAGNOSIS

1400

Cases

1200
1000
800
600
400

--

200
0
85

85

86

86

87

87

88

88

89

89

90

90

91

91 .•

Half-Year of D1agnos1s

Half-Year of Diagaosis

Deatbs

Case-Fatality
Rate

Before 1985

851

788

93%

1985

January • June
July· December

425
513

400

94%
92%

January • June
July - December

689

640

796

740

1986

474

93%
93%

January - June
July - December

991

881

985

821

89%
83%

1988

January- June
July - December

1080
1130

852
863

79%
76%

1989

January· June
July- December

1266

874
7'1/J

69%
63%

January - June
July • December

1323

674
472

51%
42%

294

30%
12%

1987

1990
1991

Total

January - June
July - December 12

1150
1111

988
349

41

70,.

13647

12 Cua diapOMd tllis year aad reported 10 die AIDS Epideaiolo&Y Procraa u of die date of tllis report; t.11ae dau are prcMaloul
a:chacla 851 c:asa aad 71& claiM prior to 1985.
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REPORTED AIDS CASES BY MONTH AND lE4R OF DIAGNOSIS
Before

Moath

1986

1986

1987

1988

1989

1990

1991 13

January

112
102
128
117
145
167
154
183
162
168
149

178
157
141
168
174
173
157
146
183
192
130
177

174
170
184
190
189
173

197
174
232

231
189

187
180

202

106
98
116
113
125
131
133
121
152
131
106
153

1789

1485

1976

February
March
April
May

June
July
August
September
October
November
December

Total

10.

Alhambra
Bellflower

Central
Compton
East Los Angeles
East Valley
El Monte
Foothill
Glendale
HarbOr
Hollywood-Wilshire
Inglewood
Long Beach
Nonheast
Pasadena
Pomona
San Antonio
San Fernando
South
Southeast
Southwest

Torrance
West
West Valley
Whittier
Unknown
Total
14

223
234

178
181

253
190
194
212
199
194
161

215
231
201
218
184
167
169
172

1110

1416

1434

202

200

213
186
172

REPORTED AIDS CASES BY HEALTH DISTRICT OF RESIDENCE AT ONSET
Healtb District

13

208

No. (

193
138
1329
201
153

'>

(01 )
(01 )
(10)
(01 )
(01 )
804 (06)
169 {01)
138 (01)
576 (04)
99 {01)
3700 (27)
369 (03)
1136 {08)
377 (03)
143 {01 )
230 (02)
163 (01)
205 (02)
160 (01)
158 (01)
547 (04)
190 (01 )
853 (06)
642 (05)
129 (01 )
845 (06)
13647

Rate per

1oo,ooo'•

60
43
448

74
80
248
44

52
168
56
821
86

295
151
114
56
47
54
120
130
174
58
163
99
47
NA15

170

C.. diaplOIMid IU year aad reported to tlw AIDS l:.pide•ioloa,y Prop-a• aa of t1w date of tlaia report; t1aae datA are proviaioaal.
19&5 poptialioa estiaa• baed oa 1980 Ceaaua.

15 NA•aot applicable.

172

190
149
llO
134
121
72

22
0
0
1337

11. ANNUAL ADULT/ADOLESCENT AIDS C4SES AND RATES11 PER 100,000 BY RACE!ETHNICJTY AND GENDER
Black

Hispanic:

No . .B,rus
349 22
637 41
991 64
1295 84
1286 85
1396 93
1323 89
712 48

No. Rate
61 19
121 38
196 62
268 84
380 119
355 111
388 122
208 65

No. .B,rus
7
56
129 16
225 26
297 34
414 45
511 54
523 53
313 32

~Rate

1984
1985
1986
1987
1988
1989
1990
1991 18

0
4
5
6
7
11
12
4

~~
469 16
900 30
1433 47
1897 61
2114 67
2317 73
2315 72
1269 39

~
1984
1985
1986
1987
1988
1989
1990
1991 18

No. .B,rus
4
0
18
1
15
1
30
2
35
2
31
2
2
28
17
1

No. .B,rus
5
1
3
1
4
16
19
5
7
26
23
6
35
9
4
16

~Rate

~.B.rus
0
0
0
0
0
1
2
1
0
2
1
3
4
1
3
1

~~
0
10
25
1
42
1
67
2
82
2
75
2
105
3
54
2

~

12.

Totall7

Other

White

Year or Diagnosis

1
4
10
16
19
18
36

17

0
0
1
2
2
2
4
2

1
13
17
21
27
46
51
17

REPORTED AIDS-INDICATOR CONDITIONS
Condition"

No.

Bacterial infections, multiple or recurrent20
Candidiasis of bronchi, trachea, or lungs
Candidiasis of esophagus
Coccidioidomycosis, disseminated or extrapulmonary
Cryptococ:cosis, extrapulmonary
Cryptosporidiosis, chronic intestinal
Cytomegalovirus disease other than retinitis
Cytomegalovirus retinitis
HIV encephalopathy
Herpes simplex: chronic ulcers, pneumonitis or esophagitis
Histoplasmosis, disseminated or cxtrapulmonary
lsosporiasis, chronic intestinal

35
283
1216
33
939
499
791
514
619
409
85

Kaposi's sarcoma

3014
18
115

Lymphoid interstitial pneumonitis20
Lymphoma, Burkitt's
Lymphoma, immunoblasti<:
Lymphoma, primary in brain
Mycobacterium avium or M. kansasii, disseminated
M. tuberculosis, disseminated or extrapulmonary
Mycobacterium, other or unidentified species
Pneumocy$tis carinii pneumonia
Progressive multifocal leukoencephalopathy
Salmonella septicemia, recurrent
Toxoplasmosis of the brain
Wasting syndrome

94

306
87
976
324
216
7522
99
42
544
1331

(

~)

(0.3 )
(2.1 )
(8.9)
(0.2)
(6.9)
(3.7 )
(5.8)
(3.8 )
(4.5 )
(3)
(0.6)
(0.7 )
(22.1)
(0.1 )
(0.8)
(2.2)
(0.6)
(7.2)
(2.4)
(1.6)
(55.1 )
(0.7 )
(0.3)
(4)
(9.8)

16 Aa..al popwlatiotl •tiaatcs baaed oa 1980 Ceasua.
17
Tocal iad*"- penou wllole rac:elethai(il)' ia ualul-..
11 C.U. diapoeed IU year aad ~poned to the AIDS Epidoliolo(y
19
Palinll aay Uw thaa oae cotlditioa.
lD Palintal- tllaa 13 II Ole ti- or diapoaia.

f'rova• aa oliM date or Ibis report; lbele data •~ pi'O'Iisioaal.
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AIDS • LOS ANGELES COUNTY
SURVEILLANCE SUMMARY
DEATHS DURING SEPTEMBER 1991*
AS OF 10/31/91

PLACE OF DEATH
County Facility
Private Facility
Home
Nursing Home/Hospice
OUtside Los Angeles/Unk
Total

NUMBER OF DEATHS
13
52
24
18
12
119

PERCENT
10.9
43.7
20.2
15.1
10.1
100.0

*These data are provisional due to delays in mortality reporting.

LOS ANGELES COUNTY STD CONTROL PROGRAM
Gonorrhea Data
(Annual Report 1/1/89 - 12/30/89 And Third Quarter 1990)
Reported by Public/Private Sector/Military/Other Jurisdictions
Gonorrhea

Los Angeles County 1/1/89 - 12/30/89

Total Reported Cases= 25,719

Male
Female
TOTAL:

Black

Hispanic

White

10,602
5' 178
15,780 (61%)

3,036
1 '283
4,319 (17%)

1,170
928
2,098 (8%)

Gonorrhea

South Area

1/1/89 -

12/30/89

Tota1 Reported Cases= 8,047 (31% of County Wide Total)

Maie
Female
TOTAL:

B1acl\

Hispanic

3,813

562
283
845 ( 11 ~)

2' 176

5,989 (74%)

Wh1te
as
12 1

209

(3~)

Gonorrhea Los Angeles County Third Quarter 1990 (7/1/90- 9/29/90)
Total Reported Cases = 4,650

Male
Female
TOTAL:

Black

Hispanic

White

1 '822
802
2,624 (56%)

529
249
778 (17%)

260
167
427 (9%)

Gonorrhea Metro South Area Third Quarter 1990 (7/1/90 - 9/29/90)
Total Reported Cases= 1,844 (40% of County Wide Total)

Male
Femaie
TOTAL:

Black

Hispanic

White

916
447
1,363 (74%)

92
61
153 ( 8%)

29
21
50 ( 3%)

NOBCO/King- Drew
5/91 C. Davis
'~'"''10

-.:.;, I t. I

LOS ANGELES COUNTY STD CONTROL PROGRAM
Syphilis Data
(Annual Report 1/1/89- 12/30/89 And Third Quarter 1990)
Reported by Public/Private Sector/Military/Other Jurisdictions
Syphilis

Los Angeies County

1/1;'39-12/30/89

Total Reported Cases = 2,844
Maie
Female
TOTAL:

Hispanic
566
159
725 (25%)

Black
957
740
1,697 (60%)

Syphilis

South Area

White
185
95
280 (10%)
1/1/83-12/30/69

Total Reported Cases = 9 ':''7 (33% of County Wide Total)
... f

Maie
Female
TOTAL:

Black
397
307
704 (75%)

Hispanic
125
50
175 {19%)

White
18
15

33

(4~)

Syphilis Los Angeles County Third Quarter 1990 (7/1/90 - 9/23/90)
Total Reported Cases = 466

Male
Female
TOTAL:

Black
142
115
257 (55~)

Hispanic
94
·-: .,
......

127 (27%)

White
3"".:.
15
48 (10%)

Syphilis Metro South Area Third Quarter 1990 (7/1/90- 9/29/90)
Total Reported Cases= 176

Male
Female
TOTAL:

Black
58
67
125 (68%)

NOBCO/King-Drew
5/91 C. Davis

(37~

of County Wide Total)

Hispanic
17

6

2

9

26

White

(14~)

s ( 5~)

Table 1.1. Demographic characteristics
of STDs In Los Angeles County during
1986.
Demographic
0\aracter 1st lc

Percent

....

Sex

,

63.7
35 ••

Race

,,o.•..

Male

9.7

Wh It•
Hispanic

14.7

Black

Aslan/Aa. Indian
Other/Unknown
Report Source
Pub I lc
Private

18.8

60.1

39.9

·Of the cases reported by publfc sources 11 percent were froa custOdial
facilities. The nuaber of positive cultures fro• these facilities fs
preseni'ed 1n Table 1.2.
Table 1.2. Positive gonorrhea cultures froa custodial facilities fn Los
Angeles County during 1986.
Number of
Cultures

Fee lllty

Number of Positive
Cultures (percent)

Men

•• ( 8.9)
139 (31.2)

Los Padrlnos Juvenile Hall
Men's Central Jail
Hall of Justice Jail
Central Juvenile Hall
Wanen
Sybil Brand Institute
Central Juvenile Hall
Los Padrlnos Juvenile Hall
54

• ( 7.1)
0 ( 0.0)

.

,,,

17,585

1,239

275

1,989 (11,4)

139 ( •••• ,
137 ( 17.6)

Tlble 1.3. Annual rate of gonorrhea Jn Los Angeles
County during 1986, by health district.
Heelth District

Num&»er
of Cases

South
Southe••t

SouthwesT

Ccalpton
lnglhood

Central
Hoi Iywood-W II shIre
East Los Angeles
NorthNst
HaM> or

-

Annual Rate
Ccases/100,000)

A,828
A,36•
8,452
,,730
6,889

3,631 .:s.
3,593.1
2,686. 7
2,102.0
1,610.7

3,109
3,770
725
915
6A7

1,041.1
136.2
379.1
367.3
363.5

El Monte
foothill
East Valley
San Antonio
West

t ,351

879
1,255
f ,063
1,593

351.1
329.4
326.0.
305.1
303.9

Torrance
Pceona
Be I If Iower
West Val ley
San fernando

821
967
696
1,39'
1AO

2A9.9
234.2
211.9
214.9

41.

176.0
129.5
122.0

Whltff.,..

"'

Alhl&lbra

•ta

Glendale

55

tt•.a

..

Race-specific rates Indicate that Slacks not only had the •lghest
percentage of reported cases, but the highest Incidence rltl <Figure
1.2).

21-----

oL-~~~~~~~~L-----~
WotTE

a...c<

~

~.,..tO

Race

·-

Figure 1.2. Annual rate of gonorrhea In Los Angeles County during 1986,
by race.
The age-specific Incidence Is presented In Figure 1~. Persons betw ..n
the ages of 15 and 29 accounted for 73., percent of all reported cases.
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Figure 1~. Annual rate of gonorrhea In Los Angeles County during 1986,
by age.
•

The apparent decrease In gonorrhea Is In contrast with an rnorease
during 1986 In the rate ot penfcllllnas... produclng NIISSICI' gonocrb••
(PPM;). The rata of gonorrl'tea lftay have decreased a110ng W"te
homosexual aales as a result of altered sexual practices Ia response to
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LOS ANGELES COUNTY DIPA~TMIMT or IIALTR II~VIC&I
IIXOALLt TRAMSMITTID DISIAII PAC~ SRI&T
IPO~,.KC

JIIOliiD%1'! Tl&.DI

-

1982

949,237
109,860
39,834•

nit.ed Stat••
a11tora1a
cu Aa9elea County
MPIC~%00S

SYPHILIS

-

1983

900,435
108,066
48,115

1985

178,556
110,208
49,807

911,419
118,579
59,387

895,781
110,849
52,604

(Priaary & Secondary)

nit.ed St.at.ea ·
al1tora1a
08 Aa9elea COUilt.y
!PIUI.%1

-

31,613
5,096
1, 195•

12,698
5,290
1,896

28,607
4,503
1,571

·27,131
4,370
1,854

26,678
4,893
2,687

75,579
11,272
5;121•

74,637
11,681
4,988

69,888
11,204
5,000

67,563
10,747
5,735

67,929
12,600
6,813

(All St.a9ea)

att.ed Stat••
alitornia
oa Anqelea Couaty

OMPLICA,.IOMS • LOS ANGELES COON1'T S1'A1'ISTICS • ILAIORATIOM
~~COCCAL

1982
1983
1914
1985
1986

PILVIC INFLAMMATORY
1,176
1,161
1,659
1,826
1,881

reported
reported
reported
reported
reported

DIS!A§~_(G/PID)

ca•••
ca•••
ca•••
ca•••
ca•••

REPORTED CHILD SIXOAL AIOSE
(STDa in
year oldal_

g.,,

•EWICILLIMASE-PRODOCIMG NEISSERIA GONORRROEAI CPPWGl
1982
1983
198 ..
1985
1986

139
169
286
489
942

reported
reported
reported
reported
reported

1982 69
1983 93
1984 107
1985 124
1986 80

ca•••
ca•••
ca•••
ca•••
c••••

:OWGEWITAL SYPHILIS (Aaon! childrell leaa than
1912
1913
1984
1985
1986

10
8
5
10
31

reported
reported
reported
reported
reported

1

reported caaer

•
•

•
•

year of •!e)

caaea
caaea
caaea
caaea
c••••

•Aat.oaated record keepin9 ayatea introduced in Loa An9elea Coull~ ill 1982.
••aat£aated/pro•1a1onal data tor 1986.
•
!Or 4£a:aae illforaatioa or clillica tor dia9aoa1a aad treat.aeat call
~b• •~o Botlille.
Monday - Tburaday 8 a.a. to 6 P••• alld Friday I •·•·
tbl'oa•b 5 P•••
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7he M1nor1tv AIDS Conso~t1um was establ1shea 1n ~ebruarv l3b9. 7~e
ou n:;ose of the Censor~ 1 um 1 s ~o oromo~e ana ;nnance ri I,;,: AIDS
acucat1cn. creven~1on and 1n~ervent1on oroqrams ~n e~hnlc m1nor1~v
commut11t1es

tt1rouohout

L.OS

~rtcales

Cour1t·,..

. ne

·,:or-;scr-tlurn·:.:;

membersn1o 1s ccmor1sed of aqenc1es and ~na1v1duais irom ~he cuol1c
.:ina :.;r-lvat.e sect:.ot-s ..;no ar-e ot-cvldH1Q serv1ces to ct1e i-ii'·.f/AIDS
-;ryfected ano,.or- aTfacted ccmmun1~·l.
Add1t1onail·,., .nanv ;nemoer-s
;.:;er·ve as aavoca~es =or- HI·w· :nt'ected/affec~ea ··nOlvlcuais. Uie-.r,-·amli1es a.na the .::;cmmunl~·.--a-c-iar-qe.
The Ccnscr--c.ium·;::. c •.n-r-ent.
r;iernoer-sn;o cor..a;s ~ft1r;:,v-s1x. 1na1v1auais r-eor-eserit,1no c.•vecat,-,.-c~. . o
t .:.~;
commurtl I.-,-Caseo or-oar-i 1 za·c; or1s..
t'tt~e 1 \;e
._ j..;. 1 ;:;ubi -i c se~ ~~r

·.:ioenc1es ana,-or- ..:.r-oqrams; Cecar--c.ment oT Heaiti-; Ser--.-,ce:;; t...o:;; ;:..nqe 16-S
Count.v. Deoar~menc of Heaith Serv1ces Lonq Seacn. 0CLA. Cai1torn1a
Stat.e Unlver-sltv i..os Anqeles. :alifor-nla State i..;nlvers·;t.v i...cno
3eacn a.na two 12; ~avoerscns.
riemoer aqenc1es of the Consor~1um have worKed col iaborat.lvelv on
1umerous cccas1ons to cromote and suooort. riiV/AICS-reiat.eo
cr-oorammlnq be1no 1molementea throuqhout i..os Anqles Count-;.
:n
add1t1on. the Consor-t1um ouolishes and d1ssem1nat.es a auartet-1·;
ca1endar of HIVIAIDS-related events and orcqrams to 1ts membersn1o
as weil as over two hundred 1200l aqenc1es and 1na1v1auals from the
cubl1c and cr1vate sectors 1n i..os Anqeles Ccuntv.
For the cast e1qhteen months. member aqenc1es nave oeen act1ve1v
1 nvo I ved
1n
t.he deve I cement. of the AIDS Req 1 ona 1 Soard of ~.-..:.s
~noeies Count.v to ensure that the unmet ~IV/AICS-related sarv1ca
needs of ethn1c m1nor1tv commun1~1es are aaeauatelv addressee.

MINORITY AIDS CONSORTIUM ROSTER
Community Based Organizations

Services Provided

Ms. Collette Jacques
Executive Director
S.O.A.P.
945 S. Prairie, Ste. #103
Inglewood, CA 90301
(213) 671-1185

HIV/AIDS Outreach Targeting
the Caribbean Community:
Referrals

Mr. Phill Wilson
Community Development Dept.
215 W. Sixth Street, 6th Floor
Los Angeles, CA 90014
(213) 485-6320

Directs the City of Los
Angeles Education and
Prevention Programs targeting
city employees and L.A. City
residents.

Mr. Alvin Ransom, Coordinator
ATTN: Mr. Johnnie Johnson
AIDS Program Office
600 S. Commonwealth, 6th Floor
Los Angeles, CA 90005
(213) 351-8076

Coordination of services and
technical assistance to
community-based
organizations.

Dr. Perry Brown, Director
Population Studies
ATTN: Lisa Clements
1621 E. 120th Street
Los Angeles, CA 90059
(213) 563-5843

HIV/AIDS related planning,
coordination, development and
research: epidemiology and
prevention.

Mr. Michael Puentes
Health Educator
Cara A Cara
Latino AIDS Project
3324 Sunset Blvd.
Los Angeles, CA 90026
(213) 661-6752
(213) 660-1408 FAX

Education and prevention
programs targeting the Latino
community.

Mr. Andre Cunningham
Director
ATTN: Msadiki Gray
Blanca Hernandez
Southern California Youth and
Family Center
101 N. LaBrea Ave, Ste. #100
Inglewood, CA 90301
(213) 671-1222

Teen pregnancy prevention and
HIV/AIDS education targeting
school age, out-of-school
youth and the general
community.

1
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Ms. Ramona Hall
The Gathering Place
3536 W. Slauson Avenue
Los Angeles, CA 90043
(213) 295-2687

Services targeting HIV
infected individuals and
their families: emotional and
spiritual support groups:
massage therapy; AIDS
referral: library. Lunch is
served and a safe environment
to "hand out" is provided.

Ms. Nola Thomas
T.H.E. Clinic for Women
3860 W. Martin Luther King
Blvd.
Los Angeles, CA 90008
(213) 295-6571

OB/GYN clinic: health care
for women and children:
pregnancy testing; prenatal
care: pediatric services:
family planning; STD
treatment; counseling;
physical check-ups:
multilingual staffing.

Danita Henderson
Program Mananger
Case Management
AIDS Project Los Angeles
6721 Romaine Street
Los Angeles, CA 90038
(213) 962-1600

Assists people affected by
AIDS through advocacy and
providing vital human
services like food,
counseling, support groups,
referrals, dentistry and
transportation: helps reduce
the incidence of HIV
infection through educational
programs.

Ms. Yealanda Charles
Metro South HIV Program
Florence Firestone Health
Center
8019 S. Compton Avenue
Los Angeles, CA 90001
(213) 586-6588

Confidential and anonymous
HIV testing; pre and post HIV
counseling; referrals,
community outreach.

Rev. Carl Bean, Director
Minority AIDS Project
ATTN: Mr. Paul Davis
5149 W. Jefferson Blvd.
Los Angeles, CA 90016
(213) 936-4949

Assists with rent, food,
utilities and transportation:
give anonymous HIV antibody
testing; early intervention:
case management: in-home
nursing care. Dignity House
and housing referrals:
outreach to Black gay men and
Black and Latino women:
psycho-social support.

Ms. Rochelle Jefferson
P.O.Box 4763
Diamond Bar, CA 91765-0763

Community layperson
interested in HIV/AIDS
advocacy.

2

Ms. Cynthia Davis
Drew University/NOBCO AIDS
Information & Education
Projects
1631 E. 120th Street, Bldg. C
Los Angeles, CA 90059
(213) 567-7799

HIV/AIDS Education,
prevention and control
programs targeting youth,
women of reproductive age;
incarcerated individuals and
the general community;
material development;
training programs: community
outreach and referrals.
Program has national and
local funds.

Mr. Milton Ortega
Comprehensive AIDS Resource
Education (C.A.R.E.)
St. Mary Medical Center
1050 Linden Avenue
Long Beach, CA 90813
(213) 491-9050

Services to the South Bay
community; comprehensive case
management; services to
people with HIV, ARC and AIDS
for ambulatory health status
clients; support groups.

Dr. Betty Jackson, Director
AIDS Education and Prevention
Center
3737 Martin Luther King Blvd.
Lynwood, CA 90262
(213) 638-0460

HIV/AIDS education and
executive prevention program
targeting the Black, Latino
and Haitian community.

Mr. Robert Ming
Cal State University, Long
Beach AIDS Research &
Education Project
Psychology Dept.
Community Site:1229 Cedar Ave.
Long Beach, CA 90813
(213) 985-7508

Health and family services
for women; referrals; HIV
testing and counseling;
research targeting female sex
partners of injection drug
users: has component for
outreach to Black churches,
community groups within the
greater Long Beach area, to
do presentations.

Ms. Guadalupe Carreon
Milagros AIDS ProjectEl Centro
Mujeres Project
741 S. Atlantic Blvd.
Los Angeles, CA 90022
(213) 261-2722

Crisis Intervention; Case
Management; Support Groups;
Education and Prevention;
Consultation.

3

2R~

Ms. Ruth Slaughter
Prototypes/WARN
5601 W. Slauson Ave.
Suite #200
Culver City, CA 90230
(213) 641-7795

Outreach and education
program that assesses women's
needs holistically; gives
referral: counseling and
information.

Ms. Janet Rochester
Clinic Manager
Family Planning AIDS Education
and Prevention Project, UCLA
22-222 CHS
10833 LeConte Avenue
Los Angeles, CA 90024
(213) 825-2753

Education and Prevention
program for Latino and other
women of childbearing age.
Provides basic AIDS
information: sex negotiation
workshops: referrals to
testing sites: anonymous and
confidential testing;
provides info for pregnant
women with AIDS; community
programs, including some
presentations.

Mr. Levi Kingston
Community Consortium
3109 1/4 s. Western Avenue
Suite B
·
Los Angeles, CA 90018
(213) 731-9227
(213) 591-1261

HIV/AIDS education targeting
the Black/Hispanic community.

Ms. Melvina Luke
Minority Council on AIDS
1133 Rhea Street
Long Beach, CA 90806
(213) 591-3381 (office)
(213) 591-8334 (home)

HIV/AIDS education targeting
the Black/Hispanic community.

Ms. Laurie Aronoff
Hospice/AIDS Project
L.A. Bar Association
617 S. Olive Street
Los Angeles, CA 90014
(213) 896-6436

Free legal referrals to
attorneys for terminally ill,
indigent clients.

'
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Rev. Carl Bean, Director
Minority AIDS Project
ATTN: Mr. Paul Davis
5149 W. Jefferson
Los Angeles, CA 90016
(213) 936-4949

Assists with rent, food,
utilities and transportation:
gives anonymous HIV antibody
testing; early intervention:
case management: in-horne
nursing care. Dignity House
and housing referrals:
outreach to Black gay men and
Black and Latino women:
psycho-social support.

Connie M. Wynn
People Who Care Youth Center
1504 W. Slauson Avenue
Los Angeles, CA 90047
(213) 778-8905

Graffiti Abatement Program:
AIDS outreach to Black and
Hispanic youth aged 18-21;
Youth Advocacy Senior
Citizens checking and sharing
program: parenting education
and Black parenting
education.

Ms. Mbete Kiarnbe
10636 Woodley Ave.,Suite #81
Granada Hills, CA 91344

Community layperson
interested in HIV/AIDS
advocacy.

Ms. Pamela Coleman
10215 S. Dixon Ave., #1
Inglewood, CA 90303

Community layperson
interested in HIV/AIDS
advocacy.

Cleante Stain
Watts Health Foundation
4116 E. Compton Blvd.
Compton, CA 90221
{213) 639-3068

The South Los Angeles AIDS
Community AIDS Program
(SLACAP) Drug Abuse AIDS
Outeach Services: Case
Management Referral Services.

Ms. Carolyn Williams
11107 Lamaida, Suite #107
North Hollywood, CA 91601

Community layperson
interested in HIV/AIDS
advocacy.
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Vanessa Parker
Program Manager
Tobacco Control Program
12012 s. Compton Avenue
I&R Bldg., Room #211, MP. 31
Los Angeles, CA 90059
(213) 603-3558 or 3559 & 3561

Hospital clinic-based tobacco
prevention and cessation
educational program. The
target populations include
current smokers, parents of
children 6 years/younger and
nurses.

Mr. John Morant
Health Center
Cal State University, L.A.
5151 State University Drive
Los Angeles, CA 90032

AIDS Education and Prevention
Program; provide limited
medical services. College-age
18 years and older.

(213) 343-3346

Mr. Howard Eley, Director
Institute of Alternate
Attitudes
Substance and Chemical Abuse
Consultants
856 South St. Andrews Place
Los Angeles, CA 90005

Substance and chemical
abuse/use counseling for
adults: multicultural.

(213) 385-1847

Mr. Mike Sims
Early Intervention Project
Hospital Social Services
Martin Luther King Jr Hospital
12021 s. Wilmington Avenue
Los Angeles, CA 90059
(213) 603-4218 or 603-3467

Services for people who are
HIV infected.
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Ms. Fay Nugent
Hubert Humphrey Comprehensive
Health Center, Room #2030
5850 So. Main Street
Los Angeles, CA 90003
(213) 235-7401

Free HIV testing, T-cell
count, Psychosocial
counseling, physician
evaluation and referral
services.

Dr. Wilbert Jordan, Director
Graduate Medical Education
Augustus Hawkins Bldg. MP. 56A
Martin Luther King Jr Hospital
1720 East 120th Street
Los Angeles, CA 90059
(213) 603-8166

Testing, counseling, social
support, and clinical services
for HIV+ persons.

Barbara Walker
YWCA of Los Angeles Executive
Offices
1125 W. 6th Street, #400
Los Angeles, CA 90017
(213) 482-3470

AIDS Information and Education

Rue Thais Williams
Rue's House
P.O. Box 37036
Los Angeles, CA 90037
(213) 295-9575 (Office)
(213) 734-2467 (Fax)

Provides residential housing
to HIV+ women and their
children.

Mike Neeley, Director
Homeless Outreach Project
846 E. 6th Street
Los Angeles, CA 90021
(213) 683-8304

Provides HIV testing,
counseling and referral to
homeless individuals in the
City of Los Angeles. Also,
provides drug abuse counseling
and referral.

Stephanie Farrington
6238 Haas Avenue
Los Angeles, CA 90047
(213) 751-3030

HIV/AIDS Consultant.

Cornelia Owens
3707 Coliseum Street
Los Angeles, CA 90016
(213) 298-5526

Los Angeles Unified School
District staff implementing
AIDS Education, Risk Reduction
Program targeting students and
teachers.

Marcus Kuilard
Community Outreach Worker
c/o JWCH Institute
2829 S. Grand Avenue
Los Angeles, CA 90007
(213) 744-3916

Operate women's clinic on skid
row; provide medical outreach
to the homeless; referrals;
HIV/AIDS community outreach to
the community.

7

Ray Johnson
Long Beach Comprehensive
Health Center
1333 Chesnut Avenue
Long Beach, CA 90813
(213) 599-8711

The clinic provides the full
range of services to the HIV
positive client, including
early intervention care,
management of infections or
complications related to HIV,
ongoing follow-up, and
referral as needed, for
further evaluation or
management.

Calvin Williams
Public Policy Department
APLA
6430 Sunset Blvd, Suite 421
Los Angeles, CA 90028
(213) 962-1600 ext. 505

Assists people affected by
AIDS through advocacy and
providing vital human services
like food, counseling, support
groups, referrals, dentistry
and transportation: helps
reduce the incidence of HIV
infection through educational
programs.

Sue Crumpton
Executive Director
L.A. Shanti Foundation
6855 Santa Monica Blvd.
Los Angeles, CA 90038
(213) 962-8197

Services targeting HIV
infected men and women and
their families; one on one
volunteers and emotional
support groups. A speakers
bureau on Education and
Prevention; 7-week
Education/Support Group; and
positive Living for Us
seminars for those recently
tested or testing for HIV
positive.
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TESTIMONY
"FUNDING AIDS PROGRAMS•
HEARING OF THE SENATE COMMITTEE ON HEALTH AND HUMAN SERVICES
OF THE CALIFORNIA STATE LEGISLATURE
DECEMBER 17, 1991
WAYNE E. SAUSEDA, CHIEF
OFFICE OF AIDS, DEPARTMENT OF HEALTH SERVICES

MADAM CHAIRWOMAN, MEMBERS OF THE COMMITTEE, DR. TATE, ON BEHALF
OF THE DEPARTMENT OF HEALTH SERVICES, THANK YOU FOR YOUR
INVITATION TO

DISCUSS THE STATE'S AIDS PROGRAM.

DURING MY

TESTIMONY, I WILL OVERVIEW: (1) PROGRAMS ADMINISTERED BY THE STATE
OFFICE OF AIDS; (2) EPIDEMIOLOGIC TRENDS; AND (3) STATE FUNDING FOR
EDUCATION AND PREVENTION, TESTING, CARE AND TREATMENT AND
RESEARCH.

OVERVIEW OF STATE OFFICE OF AIDS
THE OBJECTIVE OF THE OFFICE OF AIDS IS TO PROVIDE INFORMATION AND
EDUCATION, TESTING, EPIDEMIOLOGICAL INVESTIGATION AND SURVEILLANCE,
RESEARCH, AND TREATMENT TO ADDRESS THE PUBUC HEALTH PROBLEMS
RESULTING FROM ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS).

THE OFFICE OF AIDS PROVIDES A COMPLETE AND TIMELY REGISTRY OF AIDS
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CASES, EDUCATIONAL INFORMATION FOR HIGH-RISK GROUPS, HEALTH
PROFESSIONALS,

AND

THE

PUBUC

AND

POUCY

DIRECTION

AND

DEVELOPMENT OF PILOT PROJECTS FOR THE CARE OF PEOPLE WITH AIDS
AND

EARLY

HIV-INFECTED

INTERVENTION
PERSONS.

PROJECTS

TO

ADDITIONALLY,

PROVIDE
THE

SERVICES

OFFICE

TO

CONDUCTS

SURVEILLANCE ACTIVITIES TO IDENTIFY RISK GROUPS AND PATTERNS OF
TRANSMISSION, AND EPIDEMIOLOGY FOR SELECTED CASES.

THE OFFICE

ALSO ADMINISTERS A PROGRAM WHICH TESTS FOR THE ANTIBODY TO THE
AIDS VIRUS AT OVER 100 ALTERNATIVE TEST SITES, WHICH ARE FREE AND
ANONYMOUS. LOCAL ASSISTANCE BLOCK GRANTS ARE PROVIDED TO LOCAL
AGENCIES FOR AIDS EPIDEMIOLOGICAL INVESTIGATION AND SURVEILLANCE.

THIS PAST YEAR, FIVE SIGNIFICANT LEGISLATIVE MEASURES WERE PASSED
BY THE CALIFORNIA STATE LEGISLATURE AND SIGNED BY GOVERNOR
WILSON.

THESE MEASURES REFLECT THE GOVERNOR'S COMMITMENT TO

PREVENTION, PATIENTS' RIGHTS, INTEGRATION OF SERVICES, AND EXPANDED
ACCESS TO HEALTH CARE.

AS 11 (HUGHES) • AIDS IN.SCHOOL EDUCAnON • COMMENCING WITH THE
1992-93 SCHOOL YEAR, INSTRUCTION FOR THE PREVENTION OF AIDS WILL
BE PROVIDED BY ADEQUATELY TRAINED TEACHERS TO STUDENTS IN GRADES
7·12, AT LEAST ONCE IN JUNIOR HIGH OR MIDDLE SCHOOL AND ONCE IN

·2-

HIGH SCHOOL AB 11 FITS INTO THE CURRENT CAUFORNIA DEPARTMENT OF
EDUCATION HEALTHY KIDS/HEALTHY CALIFORNIA PROJECT WHICH IS FUNDED
BY THE OFFICE OF AIDS TO PROVIDE TRAINING TO TEACHERS AND SCHOOL
ADMINISTRATORS ON PROVIDING INSTRUCTION ON HIV TRANSMISSION TO
STUDENTS IN THE 7TH AND 8TH GRADES, AS WELL AS HIGH SCHOOLS.
STUDIES ON YOUTH SHOW INCREASES IN DRUG USE AND SEXUALLY
TRANSMITTED

DISEASES,

WHICH

ARE

MAJOR CO-FACTORS

FOR HIV

INFECTION. SURVEYS ON YOUTH OUT OF MAINSTREAM SCHOOLS INDICATE
THAT NEARLY ALL OF THEIR HEALTH AND HIV/AIDS RELATED KNOWLEDGE
WAS OBTAINED FROM THEIR SCHOOL EXPERIENCES.

SB 1070 (THOMPSON) - PATIENT PROTEcnON ACT OF 1991 • THIS BILL
REQUIRES THE DEPARTMENT OF HEALTH SERVICES TO DEVELOP WRITTEN
GUIDELINES AND REGULATIONS AS NECESSARY TO MINIMIZE THE RISK OF
TRANSMISSION OF BLOOD-BORNE INFECTIOUS DISEASES FROM HEALTH CARE
WORKER TO PATIENT, FROM PATIENT TO PATIENT, AND FROM PATIENT TO
HEALTH CARE WORKER. SB 1070 REINFORCES THE DEPARTMENT OF HEALTH
SERVICES'

LEADERSHIP

ROLE

IN

ESTABUSHING

CONSENSUS-BASED

RECOMMENDATIONS FOR THE PREVENTION OF TRANSMISSION OF HIV AND
HEPATITIS B VIRUS BETWEEN HEALTH CARE WORKERS ANI) PATIENTS.

AB 305 (FRIEDMAN) - DEFINITION OF AIDS • REDEFINES THE TERM CHRONIC,
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LIFE-THREATENING ILLNESS TO MEAN HIV DISEASE OR AIDS. AB 305 ALSO
PROVIDES THAT THE DEPARTMENT OF HEALTH SERVICES MAY PROVIDE
SUPPLEMENTAL FUNDING

TO

RESIDENTIAL AIDS

SHELTERS

AND

TO

RESIDENTIAL CARE FACILITIES.

AB 1281 (RLANTE)- HIV ANTIBODY TESTS/INSURANCE· UPDATES CURRENT
lAW WHICH PROHIBITS THE USE OF HIV ANTIBODY BLOOD TESTS AS A
PREREQUISITE FOR DETERMINING EUGIBIUTY FOR HEALTH INSURANCE.
AB 1281 REDEFINES HIV TESTING AND DISCLOSURE STATUTES TO BE MORE
REFLECTIVE OF CURRENT MEDICAL TECHNOLOGY, THEREBY SERVING TO
PROTECT THOSE PEOPLE AT RISK FOR HIV INFECTION FROM BEING DENIED
HEALTH

OR

DISABILITY

INSURANCE BASED ON

OTHER •LEGAL•

HIV

LABORATORY TESTS.

AB 1287 (VASCONCEU.OS) • HIV TEST DISCLOSURE- INSURES THAT HIV/AIDS

VACCINE CLINICAL TRIAL VOLUNTEERS WHO TEST HIV ANTIBODY POSITIVE OR
NEGATIVE AS A RESULT OF THEIR PARTICIPATION IN HIV/AIDS CUNICAL
TRIALS WILL NOT BE DENIED HEALTH CARE, DISABIUTY, WELFARE, OR UFE
INSURANCE COVERAGE.

EPIDEMIOLOGY
TO PLACE MY TESTIMONY INTO PERSPECTIVE, I WOULD UKE TO GIVE YOU

SOME FACTS AND FIGURES ABOUT THE SCOPE AND COURSE OF THE AIDS
EPIDEMIC IN THE STATE AND LOS ANGELES COUNTY.

AS OF NOVEMBER 30, 1991, 38,660 CUMULATIVE CASES OF AIDS AND 26,369
AIDS-RELATED DEATHS HAVE BEEN REPORTED IN CAUFORNIA. AS OF THIS
DATE, 13,672 CASES
LOS ANGELES

AND

COUNTY.

9,576
7,683

DEATHS
NEW

HAVE BEEN

CASES

WERE

REPORTED

DIAGNOSED

IN

AND

6,036 DEATHS WERE REPORTED DURING THE MOST RECENT 12·MONTH
PERIOD. DURING THIS TIME PERIOD, AN AVERAGE OF 640 NEW AIDS CASES
WERE DIAGNOSED AND 503 AIDS-RELATED DEATHS WERE REPORTED TO THE
OFFICE OF AIDS, AIDS CASE REGISTRY EACH MONTH.

AS THE EPIDEMIC IN CALIFORNIA CONTINUES TO GROW, THE REGIONS OF
THE STATE WHERE CASES ARE REPORTED FROM CONTINUES TO CHANGE.
CUMULATIVELY, LOS ANGELES COUNTY HAS ACCOUNTED FOR 35 PERCENT
OF ALL AIDS CASES REPORTED IN THE STATE.

SAN FRANCISCO HAS

ACCOUNTED FOR 27 PERCENT; OTHER BAY AREA COUNTIES 13 PERCENT;
SOUTHERN

METROPOLITAN

COUNTIES

(ORANGE,

RIVERSIDE,

SAN BERNARDINO, AND SAN DIEGO) 16 PERCENT; AND THE REST OF
CALIFORNIA 9 PERCENT.
DIAGNOSED

OUTSIDE

THE PROPORTION OF NEW AIDS CASES BEING

SAN

FRANCISCO

AND

LOS ANGELES

COUNTIES

CONTINUES TO INCREASE. DURING 1986, SAN FRANCISCO AND LOS ANGELES
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.
COLLECTIVELY ACCOUNTED FOR 68 PERCENT OF ALL CASES DIAGNOSED IN
THE STATE.

FOR THE YEAR ENDING JUNE 30, 1991, lOS ANGELES

ACCOUNTED FOR 38 PERCENT OF All NEW CASES REPORTED IN THE STATE.
THE SOUTHERN METROPOLITAN COUNTIES ACCOUNTED FOR 12 PERCENT OF
ALL AIDS CASES REPORTED IN CALIFORNIA DURING 1986. BY THE END OF
NOVEMBER 1991, THEY WERE REPORTING 24 PERCENT OF All NEW CASES.

AN ESTIMATED 12,500 CALIFORNIANS WERE LIVING WITH AIDS AT THE END
OF 1990. AT THE END OF 1993, THERE Will BE AN ESTIMATED 16,200 PEOPLE
ALIVE WITH AIDS.

THE INCIDENCE OF AIDS CONTINUES TO INCREASE IN All ETHNIC AND
RACIAL GROUPS WITHIN THE STATE.

OF THE CUMULATIVE TOTAL AIDS

CASES REPORTED IN CALIFORNIA THROUGH JUNE 1991, WHITES HAVE
ACCOUNTED

FOR 71 PERCENT OF THE TOTAL; AFRICAN AMERICANS

13 PERCENT;

LATINOS

2 PERCENT.

14 PERCENT;

AND

ASIANS/PACIFIC ISLANDERS

IN CONTRAST TO STATEWIDE RACIAUETHNIC DISTRIBUTIONS,

62 PERCENT OF AIDS CASES REPORTED IN LOS ANGELES COUN1Y HAVE
BEEN

AMONG

WHITES;

16

PERCENT

AMONG

AFRICAN

AMERICANS;

19 PERCENT AMONG LATINOS; AND 1 PERCENT AMONG ASIAN/PACIFIC
ISLANDERS.

BETWEEN 1986 AND 1991, THE PROPORTION OF NEW AIDS

CASES REPORTED AMONG WHITES IN CALIFORNIA DECREASED FROM
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77 PERCENT TO 65 PERCENT.

CONVERSELY, AMONG AFRICAN AMERICANS

THE PERCENTAGE OF NEW CASES INCREASED FROM 10 PERCENT IN 1988 TO

14 PERCENT IN 1991. LATINOS ACCOUNTED FOR 11 PERCENT OF NEW CASES
REPORTED IN 1986 AND 18 PERCENT IN 1991.

THE PERCENTAGE OF NEW

CASES REPORTED AMONG ASIAN/PACIFIC ISLANDERS INCREASED FROM

1 PERCENT IN 1986 TO 2 PERCENT IN 1991 (SEE ATTACHMENTS I AND II).

THE PROPORTION OF NEW AIDS CASES AMONG DIFFERENT TRANSMISSION
CATEGORIES HAS REMAINED RELATIVELY STABLE OVER TIME. THE MAJOR11Y
OF NEW AIDS CASES CONTINUE TO BE REPORTED AMONG GAY AND
BISEXUAL MALES. APPROXIMATELY 83 PERCENT OF CAUFORNIA AIDS CASES
DIAGNOSED IN 1991 WERE AMONG THIS GROUP.

CUMULATIVELY, NEARLY

NINE OUT OF EVERY TEN CALIFORNIA AIDS CASES HAVE BEEN DIAGNOSED
AMONG GAY AND BISEXUAL MEN.

THE NUMBER OF CASES ATTRIBUTABLE TO HETEROSEXUAL INJECTION DRUG
USE CONTINUES TO INCREASE. NEARLY 1,250 OF THE 2,211 CASES IN THIS
TRANSMISSION CATEGORY HAVE BEEN REPORTED IN THE LAST TWO YEARS.
NOTABLY, AFRICAN AMERICANS ACCOUNT FOR 12 PERCENT OF ALL AIDS
CASES, BUT 40 PERCENT OF CASES AMONG INJECTION DRUG USERS.

THE NUMBER OF NEW CASES ATTRIBUTABLE TO HETEROSEXUAL CONTACT
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WITH AN INFECTED PERSON ALSO CONTINUES TO INCREASE.

AS OF

NOVEMBER 30, 1991, A TOTAL OF 702 AIDS CASES HAVE BEEN REPORTED
AMONG PERSONS WHO CITE HETEROSEXUAL CONTACT AS THEIR PRIMARY
RISK FOR INFECTION. MORE THAN HALF OF REPORTED CASES HAVE BEEN
DIAGNOSED IN THE PAST TWO YEARS. TO DATE, 204 CASES OF AIDS HAVE
BEEN

DIAGNOSED

AMONG

HEMOPHILIACS.

802 CASES

HAVE BEEN

DIAGNOSED AMONG TRANSFUSION RECIPIENTS.

A TOTAL OF 258 AIDS CASES HAVE BEEN DIAGNOSED AMONG CHILDREN IN
CALIFORNIA.

CASES HAVE BEEN ALMOST EVENLY DISTRIBUTED AMONG

WHITE (34 PERCENT), AFRICAN AMERICAN (29 PERCENT), AND HISPANIC
(33 PERCENT)

CHILDREN.

BECAUSE

OF

UNDER-REPORTING

AND

MIS-DIAGNOSIS, THE ACTUAL NUMBER OF CHILDREN WITH AIDS MAY BE AS
MUCH AS 50 PERCENT HIGHER (SEE ATTACHMENTS Ill AND IV).

IT IS ESTIMATED THAT THERE WERE ABOUT 146,000 CAUFORNIANS UVING
WITH HIV INFECTION IN 1990. AN ESTIMATED 83 PERCENT OF THE PEOPLE
WITH HIV INFECTION ARE GAY OR BISEXUAL MEN; 9 PERCENT ARE
HETEROSEXUAL INJECTION DRUG USERS; 2 PERCENT ARE WOMEN INFECTED
THROUGH HETEROSEXUAL TRANSMISSION; AND 6 PERCENT TRANSFUSION
RECIPIENTS, HEMOPHILIACS, MEN INFECTED THROUGH HETEROSEXUAL
TRANSMISSION, OR INFANTS INFECTED PERINATAL
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THE CENTERS FOR DISEASE CONTROL (CDC) ESTIMATES THAT THERE ARE AT
LEAST 40,000 NEW HIV INFECTIONS OCCURRING PER YEAR NATIONALLY; THIS
COULD IMPLY THAT AS MANY AS 8,000 NEW HIV INFECTIONS WERE
OCCURRING ANNUALLY IN CALIFORNIA, ASSUMING THE PROPORTION OF
RECENT AIDS IN THE UNITED STATES FROM CAUFORNIA IS THE SAME AS
THAT FOR HIV INFECTIONS.

AN ESTIMATED 100.150 NEW INFECTIONS

OCCURRED ANNUALLY IN NEWBORNS AS THE RESULT OF PERINATAL HIV
TRANSMISSION IN 1988 AND 1989.

THE CDC ESTIMATES THAT ABOUT 60 PERCENT OF THE 1 MIWON
HIV-INFECTED PERSONS IN THE UNITED STATES MAY HAVE T-HELPER
LYMPHOCYTE (CD4+ CELL) COUNTS BELOW 500 CUBIC MIWMETERS OF
BLOOD AND

MAY BENEFIT FROM EARLY TREATMENT WITH AZT.

IN

CALIFORNIA IT IS LIKELY THAT AT LEAST 60 PERCENT OF THE ESTIMATED
146,000

HIV-INFECTED

PERSONS

WOULD

BENEFIT

FROM

EARLY

AZT

TREATMENT SINCE THE HIV EPIDEMIC BEGAN EARLIER IN SAN FRANCISCO
AND LOS ANGELES COMPARED TO THE REST OF THE UNITED STATES.

THE NUMBER OF AIDS CASES REPORTED IN CAUFORNIA WILL CONTINUE TO
INCREASE THROUGH 1993, WITH PROJECTIONS OF 8,600 CASES TO BE
DIAGNOSED IN 1990; 9,200 IN 1991; 9,500 IN 1992; AND 9,700 IN 1993. BY 1993,
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THE CUMULATIVE NUMBER OF AIDS CASES DIAGNOSED IN CALIFORNIA IS
EXPECTED TO REACH 68,000.

THESE PROJECTIONS ARE BASED ON THE

METHOD OF BACK-CALCULATION, WHICH USES THE DISTRIBUTION OF TIME
FROM HIV INFECTION TO AIDS TO ESTIMATE THE NUMBER OF PAST HIV
INFECTIONS MOST CONSISTENT WITH OBSERVED AIDS INCIDENCE. THESE
PROJECTIONS ARE ADJUSTED UPWARDS TO ACCOUNT FOR AN ESnMATED
15 PERCENT UNDER-REPORTING OF AIDS CASES AND ALLOWS A MORE
ACCURATE REFLECTION OF THE EXTENT OF SEVERE HIV DISEASE.

AIDS CASE PROJECTIONS ARE INFLUENCED BY THE SLOWING OF THE RAPID
UPWARD TREND IN AIDS INCIDENCE THAT OCCURRED IN 1987 AMONG
HOMOSEXUAUBISEXUAL MEN IN SAN FRANCISCO AND LOS ANGELES. THiS
SLOWING HAS ALSO OCCURRED TO A LESSER EXTENT AMONG WHITE
HOMOSEXUAUBISEXUAL

MEN

IN

SAN FRANCISCO AND LOS ANGELES.

THE

COUNTIES

SURROUNDING

INCIDENCE AMONG INTRAVENOUS

DRUG USERS AND HETEROSEXUAL CONTACT CASES IS STILL INCREASING
STEADILY.

POSSIBLE EXPLANATIONS FOR THE SLOWING OF INCIDENCE IN CERTAIN
POPULATIONS INCLUDE ADVANCES IN MEDICAL THERAPY, A DECUNE IN
INCIDENCE OF NEW HIV INFECTIONS AMONG HOMOSEXUAUBISEXUAL MEN IN
THE EARLY 1980'S, AND DECREASED TIMEUNESS AND COMPLETENESS OF
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AIDS CASE REPORTING. THE RELATIVE CONTRIBUTIONS OF THESE FACTORS
REQUIRE FURTHER INVESTIGATION.

STATE AIDS FUNDING
OVERALL, FUNDING FOR AIDS PROGRAMS ADMINISTERED BY THE STATE
TOTAL $124,626,000.

OF THIS AMOUNT, $76,595,000 IS STATE FUNDS AND

$48,031,000 IS FEDERAL FUNDS AS REFLECTED IN ATTACHMENTS V AND VI.

FUNDING FOR EDUCATION AND PREVENTION PROJECTS BEGAN DURING
FY 1983-84.

AT THAT TIME, A TOTAL OF $450,000 WAS AVAILABLE FOR

EDUCATION AND PREVENTION PROJECTS. SINCE THEN, THE EDUCATION AND
PREVENTION BUDGET HAS GROWN TO $16 MIWON FOR FY 1991·92. WHILE
THE SPECIFIC NUMBERS OF CLIENTS SERVED ARE UNAVAILABLE, THE
NUMBERS OF EDUCATION AND PREVENTION CONTRACTORS HAVE INCREASED
FROM 15 IN FY 1983-84 TO 137 IN FY 1991-92.

THE OFFICE OF AIDS BEGAN DISTINGUISHING BETWEEN EDUCATION AND
PREVENTION SERVICES TO MINORITIES AND OTHER GROUPS DURING
FY 1988-89.

DURING THAT FISCAL YEAR, THE TOTAL EDUCATION AND

PREVENTION BUDGET WAS $16 MILUON, OF WHICH 38 PERCENT WAS
TARGETED FOR MINORITY PROJECTS. IN FY 1991·92, THE AMOUNT AVAILABLE
AGAIN IS $16 MILLION. OF THE 137 CONTRACTORS FUNDED, 52 PERCENT ARE
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MINORITY OWNED AND/OR SERVE MORE THAN 50 PERCENT MINORITY
POPULATIONS.

STATE-FUNDED HIV ANTIBODY TESTING IS PROVIDED THROUGH VARIOUS
SOURCES IN THE STATE.

FREE AND ANONYMOUS TESTING IS PROVIDED

THROUGH THE ALTERNATIVE TEST SITE (ATS) PROGRAM.

ADDITIONALLY,

CONFIDENTIAL HIV TESTING IS PROVIDED THROUGH VARIOUS COUNTY
PRIMARY CARE CLINICS AND OTHER FREE STANDING COMMUNITY PRIMARY
CARE CUNICS, SUCH AS FAMILY PLANNING AND RURAL COMMUNITY CUNICS.
OF

ALL

TESTING

AND

COUNSELING

SERVICES

PROVIDED

DURING

JANUARY-DECEMBER 1990, 25 PERCENT WERE RECEIVED BY LATINOS AND
13 PERCENT WERE RECEIVED BY AFRICAN AMERICANS.

THE TESTING

PROGRAM IS ALSO CONDUCTING AN OUTREACH CAMPAIGN TO PROVIDE
INFORMATION ON TESTING AND THE SERVICES AVAILABLE TO THE PUBUC.
OF THE $300,000 EARMARKED FOR THE CAMPAIGN, ONE-THIRD IS BEING USED
IN THE LATINO COMMUNITY AND ONE-THIRD IS BEING USED IN THE AFRICAN
AMERICAN COMMUNITY.

THE

EARLY

INTERVENTION

INTERVENTIONS,

PROGRAM

PROVIDES

BEHAVIOR

CHANGE

PSYCHOSOCIAL SUPPORT, HEALTH EDUCATION, CASE

MANAGEMENT SERVICES, AND EARLY MEDICAL ASSESSMENT AND TREATMENT
TO HIV-INFECTED PERSONS. THE GOAL OF THE PROGRAM IS TO PROLONG
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THE HEALTHY AND PRODUCTIVE LIVES OF THOSE INFECTED WITH HIV.
STATEWIDE, 22 PERCENT OF EARLY INTERVENTION PROGRAM CUENTS ARE
LATINO AND 11 PERCENT ARE AFRICAN AMERICAN. THESE PERCENTAGES
ARE EVEN HIGHER AT SOME LOCATIONS SUCH AS THE EARLY INTERVENTION
PROGRAM IN SAN FRANCISCO WHERE 52 PERCENT OF THE CUENTS ARE
LATINO AND SOUTH/SOUTH-CENTRAL LOS ANGELES WHERE 49 PERCENT ARE
AFRICAN AMERICAN.

THE TOTAL 1990-91 STATE FUNDING OF THE EARLY

INTERVENTION PROGRAM IS $2.6 MILUON.

FUNDING FOR PILOT HOME AND COMMUNITY-BASED CARE PROJECTS BEGAN
IN FY 1985-86.

AT THAT TIME, THE PILOT CARE PROJECT BUDGET WAS

$1.6 MILLION. SINCE THEN, THE BUDGET HAS GROWN TO $6.6 MIWON FOR
FY 1991-92. PILOT CARE PROJECTS HAVE OFFICIALLY TARGETED 25 PERCENT
OF THEIR FUNDS FOR SERVICES TO MINORITIES; HOWEVER, THE ACTUAL
PERCENTAGE HAS BEEN OVER 35 PERCENT SINCE FY 1988-89 (SEE
ATTACHMENT VII FOR PILOT CARE CLIENT SERVICES BY RACE/ETHNICITY).

THE

OFFICE

OF

AIDS

FUNDS

A

VARIETY

OF

MINORITY

PROJECTS

THROUGHOUT THE STATE WHICH ADDRESS ETHNIC MINORITY GROUPS
INCLUDING LATINOS, AFRICAN AMERICANS, ASIAN/PACIFIC ISLANDERS, AND
AMERICAN INDIANS. ALL MINORITY-BASED PROJECTS PROVIDE EDUCATION
AND MATERIALS IN THE TARGET GROUPS' NATIVE LANGUAGE WITH A SPECIAL
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EMPHASIS ON CULTURAL VALUES.

SOME EXAMPLES OF OFFICE OF

AIDS-FUNDED MINORI1Y PROJECTS ARE:

MINORI1Y AIDS PROJECT- OPERATES HOME AND COMMUNITY-BASED

•

CARE

PILOT PROJECT.

APPROXIMATELY TWO-THIRDS

POPULATION SERVED ARE AFRICAN AMERICAN.

OF THE

MINORITY AIDS

PROJECT ALSO OPERATES A RESIDENTIAL AIDS SHELTER, DIGNITY
HOUSE, WHICH SERVES PRIMARILY AFRICAN AMERICANS AND LATINOS.
SERVICES INCLUDE:

COMMUNI1Y OUTREACH, HEALTH EDUCATION,

BIUNGUAL SERVICES, SERVICES FOR THE HOMELESS, MENTAL HEALTH
(PSYCHOLOGY AND PSYCHIATRY), WOMEN-SPECIFIC SERVICES, AND
SUPPORT GROUP SERVICES FOR SIGNIFICANT OTHERS.

•

ASIAN AIDS PROJECT· PROVIDES OUTREACH EDUCATION TO GROUPS
OF HARD-TO-REACH GAY MEN IN SAN FRANCISCO CLUBS.

THIS

PROJECT ALSO PROVIDES GENERAL EDUCATION TO COMMUNITY
LEADERS IN AN EFFORT TO REDUCE FEAR AND OVERCOME THE MANY
BARRIERS OF DISCUSSING SEXUAUTY AND DRUG USE.

•

LA FAMILIA COUNSELING SERVICES· PROVIDES SPECIAUZED BIUNGUAL
(ENGLISH AND SPANISH) AIDS EDUCATION AND PREVENTION TRAINING
TO •peeR• YOUTH EDUCATORS TO ASSURE EFFECTIVE COMMUNICATION
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WITH THE TARGET AUDIENCE. THE PEER AIDS EDUCATORS PROVIDE
OUTREACH EDUCATIONAL ACTIVITIES TO SELECTED COMMUNITY YOUTH
GROUPS IN THE HAYWARD AND SAN LEANDRO AREA.

YWCA. OAKLAND • TRAINS PEER EDUCATORS (PRIMARILY AFRICAN
AMERICAN). THIS PROGRAM DEVELOPED THE FIRST PEER EDUCATION
TRAINING MODULE (WHICH INCLUDES A VIDEO AND LESSON PLAN) FOR
AFRICAN AMERICAN YOUTH.

FAME· SERVES AFRICAN AMERICANS IN THE SOUTH CENTRAL AREA OF
LOS ANGELES PROVIDING EDUCATIONAL ACTIVITIES TO MEN WHO HAVE
SEX WITH MEN, YOUTHS, JAILS, AND SUBSTANCE ABUSERS VIA
COMMUNITY

CENTERS,

DETENTION

NEIGHBORHOOD YOUTH CENTERS.

CENTERS,

CHURCHES,

AND

A YOUTH RAP CONTEST IS ALSO

SPONSORED.

•

AVANCE HUMAN SERVICES. INC. • PROVIDES HIV EDUCATION AND
REFERRAL SERVICES THROUGH THE SOUTHERN CAUFORNIA HIV/AIDS
SPANISH HOTLINE.

•

SALUD PARA LA GENTE/PROYECTO ALARMA SIDA <PAS) PROJECT •
SPECIALIZES

IN

PROVIDING

AIDS

EDUCATION
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AND

PREVENTION

INFORMATION TO MONOLINGUAL SPANISH-SPEAKING FARM WORKERS,
YOUTH, INJECTION DRUG USERS, AND WOMEN OF CHILDBEARING AGE
IN THE PAJARO VALLEY AREA (SOUTHERN SANTA CRUZ COUNTY).

•

NIPOMO FAMILY HEALTH CENTER. NIPOMO. SAN LUIS OBISPO COUN1Y •
THIS PROJECT HAS DEVELOPED AN AIDS EDUCATION, PREVENTION, AND
INFORMATION CAMPAIGN SPECIFICALLY TARGETING MONOUNGUAL
SPANISH-SPEAKING MIGRANT FARM WORKERS AT THEIR WORK PLACE
(FIELDS, MIGRANT WORK CAMPS, AND CANNERIES).

•

CENTRAL VALLEY INDIAN HEALTH PROJECT • PROVIDES HIV/AIDS
EDUCATION AND PREVENTION ACTIVITIES TO AMERICAN INDIAN YOUTH,
INJECTION DRUG USERS AND OTHER SUBSTANCE ABUSERS,

WOMEN~

AND HOMOSEXUAUBISEXUAL MALES. THESE SERVICES ARE PROVIDED
IN FRESNO, MADERA, AND KINGS COUNTIES.

•

SOUTH LOS ANGELES COMMUNI1Y AIDS PROGRAM (WATTS HEALTH
FOUNDATION) • PROVIDES HOME AND COMMUNI1Y·BASED SERVICES TO
PREDOMINANTLY AFRICAN AMERICAN AND LATINO PERSONS WITH AIDS
IN THE SOUTH-CENTRAL LOS ANGELES AREA.

ADDITIONALLY, THE

STAFF DEVELOPS AND IMPLEMENTS WRITTEN HEALTH PLANS DESIGNED
TO REACH WOMEN AND SUBSTANCE ABUSERS IN TREATMENT. THE
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PRIMARY

GOAL

IS

TO

INFLUENCE

BEHAVIOR

THROUGH

THE

IDENTIFICATION OF KNOWLEDGE, ATTITUDES, AND BEUEFS ABOUT
HIGH-RISK BEHAVIORS AND HOW IT RELATES TO HIV.

-

OTHER OFFICE OF AIDS SIGNIFICANT ETHNIC MINORITY ACHIEVEMENTS
INCLUDE:

THE OFFICE OF AIDS BEGAN WORKING LAST FAU.. TO DEVELOP A
COMPREHENSIVE

PLAN

IN

RESPONSE

TO

THE

RYAN WHITE

COMPREHENSIVE AIDS RESOURCES EMERGENCY <CAREl ACT OF 1990.
EVERY EFFORT WAS MADE TO ADDRESS THE NEEDS OF ETHNIC
MINORITIES. A 41-MEMBER WORKING GROUP, REPRESENTING A BROAD
DIVERSITY OF PERSPECTIVES WAS APPOINTED TO HELP DEVELOP THE
RESPONSE.

LATINO, AFRICAN AMERICAN, ASIAN/PACIFIC ISLANDER,

FILIPINO, AND NATIVE AMERICAN REPRESENTATIVES WERE APPOINTED
TO AND MADE UP 50 PERCENT OF THE WORKING GROUP.
CONSIDERING

AN

EQUITABLE

DISTRIBUTION

OF

THESE

IN

FUNDS

THROUGHOUT THE STATE, A FORMULA WAS DEVELOPED THAT TOOK
INTO ACCOUNT EPIDEMIOLOGICAL DATA, IMPACT TO HIGH INCIDENT
AREAS, RURAL AREAS, AND COMMUNITIES OF COLOR. SPECIFICAU..Y,
A •NON-WHITE• INDEX FACTOR WAS ADOPTED AND WEIGHTED AT
20 PERCENT.
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THE MINORITY AIDS RESOURCE CENTER PROVIDES INFORMATION,
TRAINING, AND TECHNICAL ASSISTANCE TO OFFICE OF AIDS EDUCATION
AND

PREVENTION

CONTRACTORS.

THE

INFORMATION

CENTER

INCLUDES A LIBRARY, COMPUTER DATABASE, BULK LITERATURE, ANp
A RESOURCE GUIDE. THE TRAINING CURRICULUM INCLUDES A BASIC
AIDS

INFORMATION

COMMUNITY
TRAINING.

CLASS,

DEVELOPMENT,
TECHNICAL

CONTRACTORS.

ORGANIZATIONAL
GRANT WRITING,

ASSISTANCE

IS

DEVELOPMEN.T,

AND

LEADERSHIP

AVAILABLE

TO

ALL

THE FOCUS OF THE ASSISTANCE IS TO HELP

CONTRACTORS TO OVERCOME CULTURAL BARRIERS THAT PREVENT
DELIVERY OF QUALITY EDUCATION AND PREVENTION SERVICES TO
ETHNIC MINORITY COMMUNITIES.

•

THE OFFICE OF AIDS PROVIDED FUNDING TO THE MULTICULTURAL
TRAINING RESOURCE CENTER (MTRC) TO SPONSOR MULTICULTURAL
AIDS

CONSENSUS

AND

COLLABORATION

WORKSHOPS.

THE

PARTICIPANTS ARE OFFICE OF AIDS CONTRACTORS PRESENTLY
PROVIDING DIRECT EDUCATION AND PREVENTION CLIENT SERVICES.
THE PURPOSE OF THE WORKSHOPS IS TO DISCUSS BARRIERS AND FIND
SOLUTIONS TO PROVIDING QUALITY AIDS EDUCATION AND PREVENTION
SERVICES TO MINORITY COMMUNITIES.
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WORKSHOPS FOCUS ON

BARRIERS AS THEY PERTAIN TO RURAL, URBAN, COMMUNITY-BASED
ORGANIZATIONS, AND HEALTH DEPARTMENT ISSUES.

THE OFFICE OF AIDS PROVIDED FUNDING FOR A STATEWIDE •peOPLE
OF COLOR• CONFERENCE IN THE SUMMER OF 1991 WITH THE GOAL OF
IMPROVING

THE

"SURVIVABILITY-

OF

SERVICE

PROVIDERS

IN

MINORITY-BASED COMMUNITIES AND FOCUSING ON STRATEGIES TO
IMPROVE OUTREACH AND PREVENTION ACTIVITIES TO ETHNIC MINORITY
POPULATIONS.

AT

THE

CONFERENCE,

THE

GROUP

ELECTED

REPRESENTATIVES TO SERVE ON THE NEWLY FORMED OFFICE OF AIDS
MULTICULTURAL LIAISON BOARD. THIS ELECTED GROUP WILL SERVE
AS AN EFFECTIVE AND IMPORTANT LIAISON BETWEEN THE OFFICE OF
AIDS AND MULTICULTURAL PROVIDERS/COMMUNITIES.

CONCLUSION
IN CLOSING, THE OFFICE OF AIDS IS COMMITTED TO STOPPING THE AIDS
EPIDEMIC IN COMMUNITIES OF COLOR. WE RECOGNIZE THAT THIS MUST BE
DONE NOT IN ISOLATION, BUT IN CONCERT WITH A COMPREHENSIVE
APPROACH TO OVERALL HEALTH CARE ACCESS.

THANK YOU FOR THIS

OPPORTUNITY TO APPEAR BEFORE YOU TODAY. I AM AVAILABLE TO ANSWER
QUESTIONS YOU MAY HAVE.
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ATTACHMENTS

· ANNUAL INCIDENCE OF CAliFORNIA AIDS CASES
BY RACE-ETHNICITV 1981 - 1990
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ATTACHMENT III
Annual Incidence of California AIDS Cases and Deaths 1981-1991
by Year of Diagnosis and RacejEthnidty

Format: Cases/Deaths
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ATTACHMENT IV

Annual Incidence of Los Angeles County AIDS Cases and Deaths 1981-1991
by Year of Diagnosis and RacejEthnicity

Format: Cases/Deaths
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5/5

1987
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0/0
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1328/1029

417/323

I l.42/343
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1431/948
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17.7

1990

1352/622

424/213

563/276

52/26

3/1

32/4
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19/0

1309/330

1991 •

710/176

Total

8469/6071
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I 16.2 I 19.6
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I
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TOTAL CASES: 136nt9576
Source: California Oept. of Health Services, Office of AIOS, December 1991
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FEDERAL FUNDING

$48,031,000
(38.5%)
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$76,595,000
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SOURCE: California Department of Health Services, Office of AIDS
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S'"f A'"fE 01? CALIFORNIA
FISCAL YEAR 1991-92 AIDS FUNDING
(In Thousands of Dollars)
COUNSELING AND TESTING $15,514 (12.5%)
CARE AND TREATMENT $29,649 (23.8%)
EDUCATION AND PREVENTION
$15,633 (12.5%)

~
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RESEARCH $12,438 (10%)

AIDS DRUG PROGRAM
$14~00 (11.5%)
PROGRAM SUPPORT $7,060 (5.7%)
>
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>

BLOCK GRANT $5,298 H.2%)
DEPT. ALCOHOL AND DRUG J>ROGRAI\IS
$20,885 (16.8%)

DISEASE ~IONITORING $3,789 (3.0%)
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Source: California Department of Health Services, Office of AIDS
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GGREGATE TOTALS OF PROJECTS FUNDED IN LOS 1\IIGELE:; t:OUII'I'Y
ENDER AND RACE/ETIUIICITY
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482
82
79

86.0
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24
47
6
1
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9.0
7.0
1.0

31
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41
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17.0
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47.0
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88
116
25
18
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22.0
28.0
23.0
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22
11

30.0
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25.0
14.0

1
5
0
2

1.0
1.0
0.0
2.0
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6
0
1
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1.0
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0
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EIP is for a seven month period - Jan 91 thru July 91.
CHC is for FY90/91.
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Medi-Cal Waiver is for the a ten month period - Jan 91 thru oct 91.
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TESTIMONY
SENATE HEALTH AND HUMAN SERVICES COMMITTEE
December 17, 1991

Good morning. I am Dr. Jim Kooler, Deputy Director of the Division of Alcohol and Drug
Prevention at the California Department of Alcohol and Drug Programs. Senator Watson, thank
you for inviting me to participate in today's hearing regarding HIV I AIDS. With me today is
Eddie Yamamoto, Program Analyst for the Department's HIV/AIDS Counselor Program.

The Department's formal mission statement is based upon the principle that in order for alcohol
and drug-related problems to be eliminated in Ca1ifornia, a comprehensive, statewide effort must
be made in partnership with county governments, private and public agencies, organizations,
groups and individuals. The cornerstone of our efforts is the California Master Plan to Reduce
Drug and Alcohol Abuse. The objective of the Master Plan is to foster the involvement of the
community in the determination of local service policies. This emphasis reflects an awareness
that effective policies require the commitment and involvement of local communities in
determining their own priorities. It recognizes that the needs of one part of California may
differ considerably from those of another, necessitating that governmental policies be tailored
to appropriately and effectively address those local needs.

Curr~ntly,

55 counties are

participating in the Master Plan process, including Los Angeles County, which is a phase six

county (Master Plan due in June 1992).

Thirty one counties are in phases one and two; one-

third of them have identified HIV/IVDU populations as a priority for their county.

In regards to HIV I AIDS, the Department first formally addressed this issue in December 1986
when emergency regulations were passed authorizing exceptions to existing methadone program
eligibility requirements for clients in response to the AIDS crisis. These exceptions improved
treatment services by allowing programs to:

o

exceed licensed capacity by ten percent when the need is documented;

o

upon the Department's approval, waive the requirement that the client provide
documented history of at least two years of narcotic addiction; and,

o

also with the Department's approval, waive the requirement that the client provide
documented history of two or more unsuccessful attempts in withdrawal treatment
with subsequent relapse to regular narcotic use.

By the following year, the Department began allocating to counties federal Alcohol and Drug
Abuse and Mental Health Services (ADMS)

Block Grant funds, specifically to target

intravenous drug users (IVDUs). These federal dollars are allocated by the Department via the
county subvention process.

This process reflects a state/county partnership in the field of

alcohol and drug abuse services. The counties are given maximum flexibility in determining
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their program priorities as long as federal requirements are met. In this manner, alcohol and
drug abuse services are relevant to the needs of each community. During 1987-88, a total of
five million dollars was allocated to the counties, of which, Los Angeles County received nearly
two million dollars. Currently, 35% of the Department's total ADMS Block Grant Award is
dedicated to drug programs, and half of that is· "set-aside" for treatment programs for
intravenous drug abuse as prescribed in the federal Public Health Service Act. For 1991-92,
IVDU set-aside monies available to counties totaled over $23,000,000, a 360% increase from
just four years prior.

Of this, Los Angeles County will receive over $8,000,000, a 300%

increase since 1987-88.

In addition to IVDU set-aside, other funds targeting IVDUs have become available to the
Department over the past few years and are as follows.

o

Augmentation of the Budget Act of 1988: Since 1988, general funds have been
allocated to counties with the highest number of AIDS cases with a history of
intravenous drug use. This increased treatment for IVDUs at risk of contracting
and spreading HIV. Currently, over 1.2 million dollars is allocated to counties,
of which, Los Angeles County receives nearly $400,000.

o

HIV/AIDS Counselor Program: In late 1988, the federal Centers for Disease
Control offered funding to state health departments to coordinate with state drug
abuse authorities in establishing HIV counseling and testing services in drug
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treatment programs.

In response to this initiative, the Department of Health

Services, Office of AIDS and the Department of Alcohol and Drug Programs
collaborated to establish the HIV I AIDS Counselor Program. Approximately 1. 8
million dollars was subvened to 20 counties throughout the state during 1991-92.
Los Angeles County receives funds directly from the federal Centers for Disease
Control to administer their own HIV I AIDS Counselor Program.

o

Statewide AIDS, Alcohol and Drug Abuse Training: In September 1990, the
Department convened a forum to develop a statewide AIDS, alcohol and drug
abuse training system for program providers, administrators and staff.

The

primary purpose of the training is to ensure that HIV I AIDS training is available
to all alcohol and drug service providers to minimize the risk of HIV infection
among California's alcohol and drug using populations. County alcohol and drug
program administrators, recovery and treatment providers and key experts on
AIDS, substance abuse and training as well as recognized experts from other state
agencies were in attendance.

As a result, California was divided into twelve

regions and local representatives were utilized to develop their own training
curriculum based on their local needs. The Department used ADMS Block Grant
funds to contract with Valley Community Counseling Services to coordinate and
facilitate the training in each of the regions. The contract was in the amount of
$100,000, expiring December 31, 1991. The Department is preparing a Request
for Proposals to continue the training for the next three years.
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o

Continuation Waiting List Reduction Grant Programs: The intent of this grant
program is to rapidly expand drug abuse treatment capacity in California.
Expanding drug abuse treatment was one of the recommendations put forth by the
National Commission on AIDS earlier this year. Approximately $13,000,000 in
continuation funding is available for the Waiting List Reduction Grant Program
for 1991-92, of which, $2,000,000 must be targeted to serve IVDUs. For 199192, Los Angeles County received 3.7 million dollars of continuation funding, of
which, nearly $750,000 must be targeted to IVDUs.

In closing, the Department funds over $28,000,000 in programs targeting IVDUs throughout the
state. Los Angeles County receives over $9,000,000 of this total. The state total represents a
significant increase (460%) in resources dedicated to IVDUs since 1987-88 when $5,000,000
was committed. At this time, The Department looks forward to not only continue its existing
efforts, but explore areas of potential collaboration with the State Department of Health Services
to jointly focus on the twin epidemics of HIV and alcohol/drug abuse.
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Test~ony

of Alan Barris: PBS AIDS Regional Coordinator

California Senate Committee on Health & Welfare
Inter~ Bearing on AIDS Funding in Ethnic Minority Communities
Los Angeles: December 17, 1991
I want to thank Senator Watson and her staff for the invitation to
share with the Committee preliminary Public Health Service (PBS)
Fiscal Year (FY) 1991 AIDS financial data for California recipient
organizations. This information should be of some interest as the
State government, local governments and local AIDS planning
agencies prepare their budgets for 1992.
Based on preliminary data, for Federal FY 1991 (10/1/90 - 9/30/91)
the PBS awarded nearly $191M to support AIDS program activities in
348 CA organizations.
CA received slightly more than 10% of the
$1.8858 FY' 91 national PBS AIDS appropriation.
PBS support
includes new financial and direct (personnel, equipment, supplies)
assistance for a prospective 12 month budget to support AIDS/BIV
and related activity.
Assistance was provided through grants,
cooperative agreements and contracts. In some cases, particularly
for some research projects, the financial assistance includes
program funding from appropriations' other than AIDS. In all cases,
the financial assistance does not include previously awarded and
unused funds which PBS generally reauthorizes to support subsequent
years of a 3 to 5 multi-year project.
I have prepared two exhibits that describe the preliminary PBS
FY'91 CA AIDS funding:
* One exhibit indicates the PBS funding agency and general
purpose;
* The other exhibit compares fuaaiag levels ia PBS AIDS
funding levels in CA for FY 1989, 1990 and 1991.
For the Committee, I am presenting copies of PBS computer printouts
which detail all of the CA recipient organizations and their
preliminary funding levels (Grants and Cooperative Agreements;
Contracts) •
I am also sharing a separate printout of PBS AIDS
grants and cooperative agreements awarded in Los Angeles County.
Of the three FY '89-'91 total $550M inCA PBS AIDS funding, $261M
was awarded by the Rational Institutes of Health (RIB) in support
of a wide range of biomedical and clinical AIDS research projects.
Given the focus of the Committee's hearings today, I want to share
the demographic statistics of the 3, 466 adult and adolescent
volunteers who have enrolled cumulatively in California's 5 AIDS
Clinical Trials Groups (ACTG) and the 182 children who have
enrolled cumulatively in California's Pediatric AIDS Clinical
Trials Groups.
AIDS Clinical Trials Groups are University Medical School organized
networks of hospitals and clinics whose participating physicians
accept patient volunteers to enroll in clinical trials of
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experimental
therapies
for
BIV
disease
and
opportunistic
infections. Specific clinical trials of AIDS and BIV exper~ental
therapies are sponsored and supported by the National Institute of
Allergy and Infectious Disease, a major component of the NIB.
These statistics reflect that adult/adolescent volunteers enrolled
in CA' s 5 ACTGs were generally representative of California's
cumulative AIDS cases with two exceptions: women at 2% vs. 3.5% and
Blacks at 7% vs. 12% were underrepresented.
California's total
ACTG cumulative adult/adolescent enrollment represented 23% of
nationwide ACTG enrollment.
The children who were enrolled in
California's 3 Pediatric ACTGs were fairly representative of the
sex and racial composition of California's cumulative pediatric
AIDS cases.
These children represented 16% of the nationwide
Pediatric ACTG enrollment.
I hope this information has been interesting and helpful. I look
forward to answering any questions you may have now or later.

TESTIMONY TO THE CALIFORNIA SENATE
COMMITTEE ON HEALTH AND HOMAN SERVICES
Tuesday, December 17, 1991
Mr. Robert E. Frangenberg
Director, County of Los Angeles AIDS Program Office
"HIV/AIDS FONDING IN LOS ANGELES COUNTY
AND HIV/AIDS IN COMMUNITIES OF COLOR"
INTRODUCTION

I am pleased to have the opportunity to address the Senate
Health and Human services Committee on the subjects of
governmental funding for HIV/AIDS services in Los Angeles
County and particularly in communities of color.

Los Angeles county is the second-ranking metropolitan area
in the United States in terms of.both its present and
cumulative AIDS caseloads.

As of October 31, 1991, there were approximately 4,000
living individuals in the county with confirmed cases of
AIDS and an estimated additional 36,000 HIV-infected.
cumulative AIDS caseload was 13,647.

our

Given these

statistics, the County is facing enormous challenges on a
variety of fronts.
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THE STATUS OP HIV[AIDS IN LOS ANGELES COUNTY

CURRENT HIV/AIDS FUNDING

The County Department of Health Services has two mechanisms
through which funds are expended for HIV/AIDS-related public
services: the AIDS Program Office and the Department's
medical facilities.

The AIDS Program Office is responsible for policy and
program development for prevention and treatment services.

The Department's medical facilities provide direct patient
care to persons with HIV/AIDS.

The majority of funding for

these services falls under the budget of each individual
facility; however, some funds for dedicated outpatient
services are provided to certain facilities through the AIDS
Program Office.

Projected expenditures in Fiscal Year 1991-92 for AIDS
Programs total $38 million.

Of this, $14 million (37

percent ) are County funds, $18 million (47 percent) are
federal funds, and $6 million (16 percent) are State funds.
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County funds expended through the AIDS Program Office are
spent in the following service categories:
•

HIV/AIDS education and prevention,

•

community-based outpatient clinical services and
case management,

•

home health care,

•

residential care,

•

drug abuse treatment for persons with HIV,

•

day care, dental care, and

The $18 million in federal funds will be spent in two broad
programmatic categories:
•

$10 million in Centers for Disease Control funds
have been allocated for HIV prevention and
surveillance programs, and

•

nearly $8 million awarded through Title I of the
Comprehensive AIDS Resources Emergency (CARE) Act
of 1990 is supporting patient medical and support
services.

Seventy-one percent of the CARE Act funds is being expended
on patient services through contracts with community-based
organizations.

Twenty-four percent is supporting HIV/AIDS

medical services at County facilities, while the remaining
five percent has been allocated for administrative oversight
of the grant and the related contracts.
3
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We already know that our 1992 CARE Act Formula grant will
increase from $3.9 million to $5.4 million.

Our CARE Act

budget will be augmented when the second-year CARE Act
grants are awarded.

The State Office of AIDS allocations to the County are being
spent on the following activities:
•

$737,000 supports anonymous HIV testing and
counseling at seven locations,

•

the AIDS drug program for low income persons in
need of AZT and other HIV/AIDS drugs will receive
approximately $4 million,

•

Martin Luther King/Drew Medical Center has been
allocated $287,000 for primary care, and

•

the HIV/AIDS Block Grant of $1,123,000 will
support epidemiological investigation of AIDS
cases, counseling and HIV testing at juvenile
halls, an HIV/AIDS prevention center at the Gay
and Lesbian Community Services Center, and an
outreach program for injection drug users operated
by the Los Angeles Center for Alcohol and Drug
Abuse.
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HIV/AIDS-related expenditures for inpatient and outpatient
care at the County's medical facilities are supported by
several revenue sources.

The primary revenue supporting

care is Medi-Cal, with smaller amounts coming from Medicare,
patient revenues and insurance.

During Fiscal Year 1990-91,

the medical facilities spent a total of $34 million on
HIV/AIDS-related care, with $9 million spent on inpatient
care and $25 million spent on outpatient care.

$16.0

million of the total expenditures were made at county cost.

It is important to note that a trend toward greater reliance
on outpatient medical services, rather than inpatient
services, has been taking place in the County.

This should

inherently provide a more effective and efficient use of our
financial resources, even though it provides lower
reimbursement from MediCal.

HXV/AXDS XH COMMUHXTXES OP COLOR

Thirty-seven percent of the cumulative adult AIDS caseload
in Los Angeles county is comprised of people of color.

By

racejethnicity, this breaks down into 16% African-American,
20% Hispanic, and 2% "other peoples of color", which
includes Asians, Pacific Islanders, and Native Americans.
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Compared with the 1990

u.s.

Census data for the County, the

percentages are as follows:
Race/Ethnicity
African American
Hispanic
Other non-white
White

1990 Census
11%

AIDS Cases

38%

11%
40%

16%
20%
2%
62%

The behaviors which put adults and adolescents at risk in
Los Angeles County are as follows for all racesjethnicities
combined:

Male to male sexual contact

80%

Male to male sex and injection drug use

7%

Injection drug use

5%

Transfusion recipient

2%

Male to female sexual contact

2%

Hemophilia or coagulation disorder

<1%

Los Angeles is significantly different from East Coast
cities and somewhat different from other cities in
California in the lower percentage of cases which are
related to injection drug behaviors.
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Even when the behavior categories are examined within each
racial/ethnic group, gay and bisexual men comprise the
predominant group affected by the HIV/AIDS epidemic and at
risk for HIV infection.

For example, 66 percent of African-

American adult/adolescent cases, 73 percent of Hispanic
cases, and 80 percent of cases among other persons of color
are attributable to male to male sex.

An additional 10

percent of African-American cases, 6 percent of Hispanic
cases and 3 percent of cases among other persons of color is
attributable to the combined behaviors of male to male sex
and injection drug use.

These statistics are useful in targeting our prevention
efforts.

Particularly important are the trends in

statistics over time.

Although very slowly, the

distribution of AIDS cases in the County by behavior
category has been shifting as the epidemic has progressed.

Prior to 1987, 83% of the adult caseload for all races were
attributable to male homosexual or bisexual contact.

This

figure dropped to 77% in 1990.

Conversely, the percentage of cases linked to injection drug
use rose from 2% prior to 1987 to 6% in 1991.
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Over the same period, cases linked to injection drug use in
combination with homosexual or bisexual contact dropped from
8% to 6%.

The cases attributable to heterosexual contact

rose from 1% of the total caseload prior to 1987 to 2% in
1990.

Thus, though homosexual and bisexual contact may be viewed
as the riskiest behavior for HIV transmission, injection
drug use and heterosexual contact have increased in risk in
recent years.

The racial/ethnic distribution of new cases has also changed
over time.

Prior to 1987, 70% of new AIDS cases in the

County were Caucasian cases.

In 1990, only 56% of the new

cases were diagnosed in Caucasians.

These statistics for African-Americans are 14% prior to 198 ·
and 18% of new cases in 1990.
prior to 1987 and 23% in 1990.
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For Hispanics they are 15%

Another way of looking at these trends is by incidence (the
number of cases each year per 100,000 population).

•

The male caucasian incidence in 1984 was 22/100,000.
This figure rose to 89/100,000 in 1990;

•

For male African-Americans these statistics were
19/100,000 in 1984 and 122/100,000 in 1990;

•

The Hispanic figures are 7/100,000 in 1984 and
53/100,000 in 1990;

•

The "other" category incidence rates have changed
from 0/100,000 in 1984 to 12/100,000 in 1990.

The 1990 incidence rates for women in Los Angeles County
were as follows:

•

2/100,000 for Caucasian women,

•

9/100,000 for African-American women,

•

4/100,000 for Hispanic women, and

•

1/100,000 for "other" women.

Primary behaviors which put women at risk are heterosexual
contact (33 percent of cases) and injection drug use (28
percent).

Transfusion recipients constitute 23 percent of

female cases, most for transfusions occurring prior to
testing of the blood supply.
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As the local face of HIV/AIDS has changed, so has our
approach to HIV/AIDS prevention and HIV/AIDS-related medical
services.

For instance, community-based organizations

serving people of color and women now constitute the
majority of our contractors for our HIV/AIDS education and
risk reduction programs.

We firmly believe that our preventive impact on high-risk
persons of color will be maximized through the expertise of
community-based organizations.

These organizations have

vast experience in targeting programs to their communities
and in providing effective outreach in a culturally adept
context.

FUNDING FOR COMMUNITIES OF COLOR IN FISCAL YEAR 1991-92

HIV/AIDS PREVENTION AND EDUCATIONAL OUTREACH PROGRAMS

The County has contracts with the following community-based
organizations for HIV/AIDS education and prevention programs
for specified target groups:

•AIDS Healthcare Foundation/Gay Men of Color Consortium Gay Men of Color - $255,286
•American Indian Free Clinic - Native Americans - $30,000
10

•Asian Pacific Lesbians & Gays - Asian and Pacific Island
Lesbians and Gays - $28,500
•Avance Human Services Spanish Hotline - Hispanic
Americans - $150,000
•The CORE Program Drop In Center - Hispanic Americans $60,000
•The CORE Program Latino Gay Bar Project - Gay Latino Men $50,000
•Drew University of Medicine and Science - Women of Color $166,800
•El Centro Del Pueblo- Hispanic Americans -·$104,186
•El Proyecto Del Barrio Latino Street Outreach - Hispanic
Americans - $129,978
•Gay and Lesbian Latinos Unidos - Gay and Lesbian Latinos $86,226
•Minority AIDS Project Men of Color Project - Gay Men of
Color - $83,531
•Minority AIDS Project say Sister Program - Women of Color $100,000
•Southern California Youth and Family Center - Adolescent
Women of Color - $100,000
•Special Service For Groups Youth and Men's Program Asians and Pacific Islanders - $75,000
•Special Services For Groups Asian Community Outreach Asians and Pacific Islanders - $144,706
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We also have contracts for programs which do not
specifically target communities of color that do serve
people of color, such as programs targeting high-risk
adolescents.

A total of approximately $1.5 million of HIV/AIDS education
and prevention funding has been allocated specifically for
communities of color.

This is 65% of our total education

and prevention budget ($2.3 million).

ANONYMOUS HIV COUNSELING AND TESTING

The County provides anonymous HIV counseling and testing to
its residents at these following locations:
•

The Edelman Health Center of the Gay and Lesbian
Community Services Center in Hollywood,

•

The Roybal Health Center in Los Angeles,

•

The Valley community Clinic in North Hollywood,

•

The South Bay Free Clinic in both Manhattan Beach
and Gardena,

•

The East Valley Community Health center, and

•

The Minority AIDS Project in Los Angeles.
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Data from the month of october 1991 provide a picture of the
racial distribution of anonymous testing and counseling
services for all locations combined:
•

67% of those receiving services were caucasian,

•

6% were African-American,

•

20% were Hispanic,

•

4% were Asians and Pacific Islanders,

•

2% were Native Americans, and

•

1% were classified as "other" or "unknown".

AIDS DRUG PROGRAM FOR LOW INCOME INDIVIDUALS

HIV/AIDS Drugs are dispensed to qualifying persons with
HIV/AIDS at seven locations in the County.

Available data

pertaining to AZT distribution for October and November 1991
demonstrate the following racial distributions of clientele
by facility:

•

Los Angeles County + USC Medical Center
- 35% of the doses were dispensed to Caucasians,
- 47% were dispensed to African-Americans,
- 12% were dispensed to Hispanics,
- 1% were dispensed to Asians, and

- 5% were dispensed in the "other" and "unknown"
categories.
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•

Hudson Comprehensive Health Center
- 60% were Caucasian,
- 10% were African-American,
- 27% were Hispanic, and
- 3% were Asian.

•

West Hollywood Clinic
- 59% were Caucasian,
- 7% were African-American,
- 33% were Hispanic, and
- 2% were Asian.

•

Harbor/UCLA Medical Center
- 37% were Caucasian,
- 19% were African-American,
- 40% were Hispanic,
- 1% were Asian,
- 1% were Native American, and
- 2% were "other."

our allocation of CARE Act funds for outpatient services
attempted to achieve an appropriate geographic balance of
funding.

CARE Act funding should thus have an impact on the

racial distribution of outpatient services.

Unfortunately,

we do not have the necessary data to evaluate this at the
present time.
14
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Similarly, our unmet needs projections for Fiscal Year
1992-93 account for needs in specific geographic areas, and
hence by racejethnicity.

PROJECTED UNMET NEEDS FOR FISCAL YEAR 1992-93

The County Department of Health Services is facing Fiscal
Year 1992-93 with projected unmet needs for HIV/AIDS-related
services of approximately $29 million, at a minimum.

This figure includes:
•

$3 million for HIV/AIDS educational outreach and
prevention programs targeting high priority
audiences,

•

$23 million for outpatient and inpatient medical
services,

•

$2 million for HIV testing and counseling,

•

$900,000 for residential care for persons with
HIV/AIDS,

•

$800,000 for dental care services, and
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We have stratified our projected unmet needs for HIV/AIDS
educational outreach and prevention programs into priority
groups.

These groups are as follows:

•

Adolescents,

•

Women,

•

Substance Abusers,

•

Gay Men of Color, and

•

Gay White Men.

These priority rankings were established through
consideration of the current behaviors driving the HIV/AIDS
epidemic in the County combination with the volume of
HIV/AIDS education and prevention services each already
allocated for each group.

our primary considerations in setting priorities are the
behaviors which put persons at risk.

Secondary

considerations are the epidemiological data which associate
certain demographic characteristics with the riskiest
behaviors.

The County's unmet needs for HIV testing and counseling may
very well be approaching a critical status.

The demand for

anonymous HIV testing has been steadily rising during the
past year.

This can be attributed, to some extent, to a promotional
campaign for HIV testing which was implemented locally by
the State Department of Health Services.

The demand for testing will surely rise during the upcoming
year as well.

CARE Act-funded contracts for programs

promoting HIV testing are in the initial stages of
implementation.

We expect that these programs will cause

more individuals to seek HIV testing.

Furthermore, the public disclosure by Magic Johnson of his
HIV-positive status is expected to have a increased impact
on our HIV testing programs.

The demand for publicly-funded HIV/AIDS outpatient and
inpatient medical services has grown as this epidemic has
progressed.

studies published in academic and professional

journals have demonstrated that public health care programs
serving the poverty-stricken are assuming an ever-increasing
burden in the financing of AIDS care.

Given this, the County's projected unmet needs figure of $23
million for outpatient and inpatient HIV/AIDS-related care
is not surprising.

It must be remembered that this figure

is in addition to the current expenditure level in these
service categories.
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Although we have made considerable progress in Los Angeles
County in recent years both in terms of prevention and
treatment for HIV/AIDS, particularly in communities of
color, there are still extensive unmet needs for additional
resources.

Thank you for this opportunity to update you on these
aspects of HIV/AIDS in the County of Los Angeles.
happy to answer any questions you may have.

mh91562
rev:12/16/91
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I will be

PRELIMINARY
PUBLIC HEALTH SERVICE AIDS/BIV GRANTS, CONTRACTS & COOPERATIVE
AGREEMENTS AWARDED TO CALIFORNIA ORGAHIZATIOHS IH FY 1991

----------------------------------------------------------------PBS
AWARDING
AGENCY

-------------General Purpose-------------Risk Assessment
Medical Product
Research & Prevention
care
Safety
33,830,998

-0-

-0-

-0-

33,830,998

ABCPR
(2)

1,694,615

-0-

-0-

-0-

1,694,615

ATSDR
(0)
CDC
(82)

-0-

-0-

-0-

-0-

o.oo

-0-

47,995,619

-0-

-0-

47,995,619

FDA
(2)

-0-

-0-

-0-

41,045

41,045

BRSA
(35)

-0-

-0-

44,900,948

-0-

44,900,948

IBS
(1)

-0-

-0-

13,701

-0-

13,701

62,093,314

-0-

-0-

-0-

62,093,314

-0-

351,576

-0-

-0-

351,576

97,618,927

48,347,195

44,914,649

41,045

190,921,816

ADAMBA

(72)

H:IB
(148)
OASB
(6)
TOTAL
(348)
Notes:

(1) Humber of projects are in parenthesis.
(2) $ reflects total PBS financial and direct assistance
to identified AIDS/BIV projects.
For some projects,
total PBS support exceeds AIDS/B:IV appropriations.

Sources:·

PBS Grants Management Information System:
Report I GMS~8A' File I IPF91339.
PBS Contract Information System: Report I CISDISP4

Prepared by: Alan Barris' PBS Regional AIDS Coordinator, 12-9-91

PUBLIC HEALTH SERVICE AIDS/HIV GRANTS, CONTRACTS & COOPERATIVE AGREEMENTS
AWARDED TO CALIFORNIA ORGANIZATIONS
FY'89,'90, &'91 COMPARISON
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~

FY 1991: PRELIMINARY

PHS AWARDING
AGENCY

FY 1989

ADAMHA

$18,415,692
(46)

$29,115,371
(70)

$33,830,998
(72)

CDC

36,118,425
(52)

41 ,219,839
(72)

47,995,619
(82)

FDA

381,735
(2)

515,256
(4)

41,045
(2)

HRSA

11,405,456
(13)

18,132,239
(22)

44,900,948
(35)

NIH

92,041,359
(241)

106 773 161
(241)

62,093,314
(148)

439,941
(2)

13,701
(1)

225,493
(5)

270,389
(5)

351,576
(6)

2,067,953
(6)

2,402,099
(6)

1 ,694,615
(2)

IHS

N/A

OASH

AHCPR

FY 1990

t

t

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

TOTALS: CA

$160,656,103
(365)

$198,868,295
(417)

$190,921 ,816
(348)

us

$1,301,012,000

$1,589,756,000

$1,885,000,000

12.3'1

12.5'1

10.1'1

CA 'I of US

Notes: (1) Numbers of projects are in parenthesis.
(2) $ represent total PHS financial and direct assistance to
AIDS/HIV projects. For some projects, this may exceed the
AIDS appropriated funding.
sources: FY'89: PHS/DHHS FY'92 Budget Justification to OMB
FY'90 & '91: PHS Grants Management Information System;
PHS Contract Information System
prepared by Alan Harris: PHS Regional AIDS Coordinator:
WANG3237g
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COUNTY OF f..OS ANGELES • DEPARTMENT OF HEALTH SERVICES
AIDS PROGRAMS
600 SOUTH COMMONWEALTH AVENUE. SIXTH FLOOR -LOS ANGELES. CALIFORNIA 90005
(213) 351-8000

August 8, 1991

TO:

CARE Act HIV Planning Council

FROM:

Robert E. Frangenberg

SUBJECT:

ESTIMATE OF UNSPENT CARE ACT FUNDS

f('

At the last meeting of the CARE Act HIV Planning Council, AIDS Programs was
requested to prepare an estimate of funds which will be unspent in the CARE Act
Formula and Supplemental grants this year. This is the response to that request.
When all of the contracts which are being developed are approved by the Board of
Supervisors, all of the CARE Act Formula and Supplemental grant funds will be
encumbered. Funds are encumbered in one of three ways: contracts, purchase
orders, and County departmental service orders. Funds which are encumbered by
the end of the budget period {January 31, 1992 and April 3, 1992 for the Formula and
Supplemental grants respectively) are considered as 11Spent" by the Health Resources
and Services Administration, even though actual expenditures under the contract
continue into the second budget year. Therefore, if each contractor or program
spends 100 percent of its contract budget, there will be no unspent funds.
However, since many contract agencies are starting new programs and may not have
full staff on the payroll from the beginning of the contract, potential savings will be
generated in some contracts. At this time it is too early to calculate savings based on
actual cost reports from the contractors. Therefore, we have estimated these savings
by using 15 percent of contracts, with several exceptions. Savings were not projected
in currently operating outpatient clinics and hospitals, dental, residential, and
detoxification programs, and administration.
Attached is a schedule of projected savings by category and contract. Until we have
a longer history of experience with each contractor, it will be difficult to determine a
more reliable estimate. Specific savings must be demonstrated before we can
contract for these savings. The earliest date by which we will have reliable
expenditure data to demonstrate savings is October.

·3··~

l. 'Jf<W

CARE Act Planning Council
August 8, 1991
Page2
We will continue to monitor CARE spending and as soon as savings are
demonstrated, we will propose contract modifications in accordance with the Planning
Council's priorities. Augmentation of existing contracts using savings will be expedited
by a new contract provision which authorizes the Director of Health Services to
augment contracts by 10 percent without going back to the Board for a contract
amendment.
tf you have any questions or need additional information, please let me know.

REF:rbf
unspfund.mem

Attachment

3 ··"

~,l.J

PRIORITIZING FOR UNSPENT FUNDS
Analysis of Supplemental Funding

CATEGORY

-------------·----·--------------------

APPL! CAT I ON
ALLOCATION
..................

ACTUAL
ALLOCATION

DIFFERENCE

. ... .. .. . .. .. . . .

. ..................

75X
861
175X
751
861

.. .....................

PERCENTAGE
FUNDED

Early Intervention & Outpatient Medical
South Central
Hollywood, ~H. WLA
Long Beach, South Bay
San Fernando Valley
East Los Angeles
Central LA

S1DO,OOO
$400,000
$100,000
S200,000
S250,000
0

S75,000
$344,000
$175,000
$150,000
$215,000
S315,000

S25,000
S56,000
($75. 000)
$50,000
$35,000
($315,000)

Special Pooulations
Outpatient
Support Serv1ces
Mental Health (RFP)
Promotion of Services (RFP)

$700,000
$100,000
$100,000
$100,000

$415,949
S86,000
S75,000
S75,000

S284,051
$14,000
S25,000
S25 ,000

861
751
751

4ccess to Alternative TheraPies

S250,000

0

Orug Abuse Treatment
Res1aential Detox
Outpatant Oetox

$300,000
$150,000

S258,000
$129,000

S42,000
S21,000

361
861

o:>rimary Care to Substance Abusers

S150,000

$129,000

S21,000

861

:ase Management

$450,000

S337,500

S112,SOO

75X

wental Health/Psychosocial Support

$500,000

S375,000

$125,000

75X

=iesidentlal Care

$500,000

S375,000

$125,000

75X

~ecruitment/Retention

$100,000

$86,000

$14,000

86%

S50,000

S37,500

S12,500

7'SX

$100,000

S7'5, 000

S25,000

75X

$196,208

S45,897

81X

Transoortat ion
Outreacn for Testing
Ac:lninistration

~ote:

$242,105
........................

. ....................

S4,842, 105

S3,924, 157

5~

Central LA monies derived from Special Populations ($200,000) and Access to Alternative Therapies ($115,000).
Long Beacn received additional S100,000 from Access to Alternative Therap1es.

n ~· t:

,_). )'1c.

COUNTY OF LOS ANGELES • AIDS PROGRAMS
ESTIMATE OF UNSPENT CARE ACT FUNDS · PROJECT BUDGET YEAR ONE
Service

Provider

: Allocation

Projected
Savings

-------------------------:·····-···-----·-----:-------------:-·······-----:

FORMULA GRANT
Outpatient/South Central :King/Drew
Outpatient/San Gabriel
:Pasadena AIDS Coord.:
Outpatient/San Fernando V:Northeast Valley
:Olive View
:Long Beach Comp. Ctr:
Outpatient/Long Beach
CBO CARE to Relieve 5P21 :AIDS Healthcare Foun:
:Alta·Med
:Various CBOs
Case Management
Mental Health
:Various CBOs
:APLA
Dental Care
Residential/Emerg. Relief:Various CBOs
Cross-Training
:Various CBOs
Transportation
:Various
Outreach/Promotion
:Various CBOs
Regional Consortia
:AIDS Regional Board
Aaninistration
:AIDS Programs

765,000
239,000
189,000
50,000
382,000
287,000
287,000
382,000
191,000
96,000
239,000
191,000
143,000
191,000
96,000
196,157

114,7'50
35,850
28,350
0
57,300
0
43,050
57,300
28,650
0
0
28,650
21,450
28,650
0
0

-------------------------:··-----------------·:··-----------:-------------:

TOTAL FORMULA GRANT

SUPPLEMENTAL GRANT
Outpatient/South Central :King/Drew
Outpatient/West
:AIDS Healthcare Foun:
:Gay & Lesbian CSC
:UCLA
Outpatient/Long B, So.Bay:Harbor/UCLA
Outpatient/San Fernando V:Nortneast Valley
Outpatient/East L.A.
:AltaMed
Outpatient/Central
:Hudson Comp. Ctr.
Special Pop.
Outpatient
:Various CBOs
:Various CBOs
S~rt Svcs.
Promotion of Svcs.
:Various CBOs
Mental Health
:Various CBOs
Mental Health
:Various CBOs
Outreach for Testing
:Various CBOs
Case Management
:Various CBOs
Residential
:Various CBOs
Recruitment/Retention
:Various
Transportation
:Various
:Tarzana Treat. Ctr.
Residential Oatox
Outpatient Oatox.
:BAART
HIV Primary Care/Subst. :El Proyecto del Barr:
Administration
:AIDS Programs

3,924,157

444,000

7'5,000
219,000
7'5,000
50,000
17'5,000
150,000
215;000
315,000

11,250
0
0
0
0
22,500
32,250
47,250

415,949
86,000
7'5,000
7'5,000
37'5,000
75,000
337,500
37'5,000
86,000
37,500
258,000
129,000
129,000
196,208

62,392
12,900
11,250
11,250
56,250
, ,250
50,625
0
12,900
5,625
0
0
19,350
0

--------------·----------:--------------------:-------------:-··········--:

TOTAL SUPPLEMENTAL GRANT

3,924,157

367,042

TOTAL BOTH GRANTS

7,848,314

811,042

unspfund.wk1/rev. 8/5/91

LOS ANGELES COUNIY- DEPARTMENT OF MENTAL HEALTII
IDV MENTAL HEALTii NEEDS
IN EniNIC MINORIIY COMMUNTilES

Testimony Presented to the
State Senate Committee on Health and Human Resources

by Elsie Go Lu, Ph. D.
Deputy Director

I.

Lack of funding for:
A.

HIV mental health services
1.
2.

B.
II.

Services for ethnic minority communities

Special HIV mental health needs of ethnic minority communities
A.

B.
C.
D.
E.
F.
III.

State Depamnent of Mental Health - $476,000
L.A. County Depamnent of Health Services - $100,000

Geographic accessibility
Providers familiar to the community (e.g. established agencies)
Providers familiar with the community (e.g. acculturated/culturally
sensitive)
Stigma associated with mental health treatment
Sensitivity to cultural nonns re: sexuality and drug use
Child care

Ethnicity of HIV mental health consumers
A
B.

Program H.O.P.E.
AIDS Project Los Angeles

LOS ANGELES COUNTY

HIV STRATEGIC PLAN
Fiscal Years 1990/91 - 1992/93

Prepared by
The County-Community HIV Planning Council
and the
County of Los Angeles·
Department of Health Services AIDS Programs

March 1990

' 3:;7

Mental Health services
Mental health services for HIV impacted persons are a
critical need throughout the continuum of the illness, from
immediately after testing seropositive to the most advanced
stages of AIDS. They may also be required by those who are HIV
negative, including significant others, families, and the
"worried well." Early psychological evaluation and intervention
are of the utmost importance in order to deal with the many
emotional, physical, behavioral, and psychological impacts of HIV
disease. currently, community-based organizations are providing
the majority of mental health services. These agencies are able
to reach and effectively serve the community via a nonthreatening environment.
Agencies handle clients with a perplexing range of emotional
and psychosocial issues associated with HIV, including: denial,
depression, stress, anxiety, the impact of discrimination, and
suicidal ideation. Persons not infected with the virus, but
still impacted by the disease, may share some of these same
issues. HIV brain disease, in varying degrees and often more
severe in the latter stages of the illness, also affects many
HIV+ individuals.
This section of the plan will discuss the general mental
health needs of the HIV impacted population as well as the unique
needs of special populations. The services currently being
offered are outlined, and the barriers to receiving these
services are described. The Mental Health section also defines
specific needs and offers recommendations for a comprehensive
system of HIV-related mental health care. Lastly, projections of
service utilization and capacity are presented. These
projections demonstrate that additional funding and resources are
necessary if we are to provide psychosocial support to all those
who require it.
Dtsgription of attegte4 pqpulatiop
Those infected with HIV are by no means a homogeneou~.
population. They may be anywhere along the HIV continuum, ·from
asymptomatic to full-blown AIDS. Different stages of the disease
present varying needs and may require different modes of
treatment or assistance. In addition to the dimension of illness
severity, the personal history and background of the individual
must be taken into account.
As discussed in the Prevention
section of the plan, service providers must recognize the needs
of individuals with diverse ethnic/racial backgrounds, cultural
values, sexual orientation, etc.
For mental health planning purposes, HIV affected
populations may be categorized in the following manner:
o

individuals with severe psychiatric complications as a
result of the disease, i.e., advanced HIV brain disease
(commonly referred to as HIV dementia complex):
G-38

o

those with pre-existing psychiatric conditions, i.e., the
chronically mentally ill;

o

persons with multiple diagnoses, i.e., persons with several
primary problems, such as addictive behaviors and a
psychiatric complication; and

o

persons with the significant emotional reactions to severe
stressors, such as a diagnosis with a chronic, lifethreatening illness or the illness or death of a loved one.

Advanced HIV Brain Disease
HIV brain disease is a direct result of infection of the
brain by HIV. The complex is characterized by a host of
cognitive, motor, and behavioral symptomatology. The impact of
dementia ranges from the functional impairment of early cognitive
loss to the profound effects of its severe form in which patients
are rendered nearly vegetative and require full-time
institutional care. Neuropsychological impairments appear to
affect those with AIDS, particularly those at an advanced stage
of the disease (Tross, et al., 1988). The prevalence of HIV
brain disease in otherwise asymptomatic HIV+ persons is very low.
Clinical experience indicates that HIV brain disease is
common and imposes significant morbidity in the late stages of
HIV infection. At least two-thirds of patients eventually
develop dementia before the terminal phase of the disease, and
additional numbers exhibit subclinical evidence of neurological
dysfunction (Price and Brew, 1988).
Chronically Mentally Ill
The severely/chronically mentally ill are especially
difficult to reach in terms of HIV services. Education and
behavior change can be especially difficult for this population.
Mental illness may interfere with their ability to hear, process,
and integrate information. Lack of ability to control behavior
or delay gratification may prevent safer behaviors, even if
educational material is understood or remembered.
Whether the mentally ill population can be mainstrea~ into
the HIV health care system or not depends on the severity of
their mental illness. If their physical ailments are too severe,
the psychiatric wards, concerned about infection control and the
ability to provide needed medical services, will not admit them.
Special protocols and close communication must be developed
between the mental health and HIV health care systems to avoid ·
"bouncing" the patient back and forth between facilities.
Persons with Multiple Diaqno•••
Persons with multiple diagnoses are dealing with many of the
same issues as the chronically mentally ill. Mental health
professionals find working with this population especially
difficult. They may have character disorders and drug abuse
problems that adversely affect attempts at behavioral change.
Unfortunately, HIV service agencies are seeing a high number of
G-39

individuals in this category.
Persons with Siqnitieant Reactions to Stressors
The persons in the last category do not fall into the other
three. They have no pre-existing mental health conditions and
are not experiencing advanced HIV brain disease, but they are
seeking psychosocial support in order to cope with their illness.
Upon learning of their seropositive status, many individuals may
seek short-term counseling in the form of crisis intervention.
Later, they may attend group therapy and remain with this
modality for the long term. Others seek individual psychotherapy
and/or therapy involving loved ones.
Oniyersal Mental Health Needs
The impact of HIV often results in similar or universal
reactions among all populations. General psychosocial issues are
presented to mental health and other professionals by those
affected by HIV. These issues become important when an
individual learns that he/she or a loved one is seropositive, and
cannot wait to be addressed until symptoms appear or an AIDS
diagnosis is made.
These psychosocial issues include: an increase in suicidal
ideation; inadequate social supports; lack of resources; social
isolation; stigmatization; anxiety; depression; negotiations
surrounding implementation of safe behaviors; and factors
concerning the grief and loss process. This list is by no means
an exhaustive one, but it does present several of the common
problems that HIV affected persons face.
Suicidal ideation is an especially common presentation among
persons with HIV. Recent data have revealed that the relative
risk of suicide in men with AIDS ages 20 to 59 years was 36.3
times that of men without the diagnosis, and 66.15 times that of
the general population (Marzuk, et al., 1988). Health
professionals who serve such clients must be constantly alert to
the risk of suicide.
K1ntal 11alth 111d1 of Splcial Populations
The needs of special populations, often overlooked o~.unmet,
are important to recognize in the continuum of HIV-related··
services. Special populations include, among others: gays and
bisexuals, women, intravenous drug users, ethnic;racial
minorities, adolescents, and the incarcerated. The unique needs
of these populations have been discussed extensively in the
Prevention section under "Guiding Principles and Selection of
Target Groups" and "Health Education/Risk Reduction Programs."
In addition to the items discussed under these sections (e.g.,
cultural norms, unique needs, specialized interventions, etc.),
providers must recognize that mental health services for these
groups may require a specialized approach. In all cases,
providers must be sensitive to the needs of these special
populations. Language, culture, social support, and sexual
orientation are some of the variables that must be taken into
account in the.provision of HIV-related mental health care.
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Access tor special populations is an especially crucial
issue. These communities are often unwilling or unable to access
any health services, let alone mental health services. Some
populations may see a stigma associated with accessing mental
health care, e.g., a service only for "crazy people." Often
cultural values do not encourage the focus on self that mental
health care traditionally requires. They may be helped more by
group support than traditional individual psychotherapy.
one confounding factor in attempting to service the HIV
impacted population is the number of individuals who live by
themselves and/or do not have close family or other support
networks. Populations engaging in high risk behavior, such as
IVDUs, prostitutes, street youth, and undocumented persons, are
often those without the stable support network or help-seeking
skills needed to attempt behavior change. Most of these
individuals experience feelings of isolation and abandonment, but
may not have the knowledge, skills, or financial ability to seek
out mental health care.
Minority populations are most often comfortable receiving
care from a member of their own community, someone who is seen as
sensitive to their needs. The level of trust that must be
developed between therapist and client is often more intense in
these communities than in the mainstream population. Without
that trust and sense of caring, the individual may not continue
to utilize the needed services. Consequently, mental health
professionals may need to adapt traditional techniques to make
them effective with special groups.
The following outline is a brief synopsis of some of the
unique needs of special populations:
o

Gays/Bisexuals: This population is often facing issues of
homophobia and the "coming out" process. The nature of HIV
disease may also lead to feelings, originating !rom
themselves and/or others, of blame or responsibility for the
epidemic. They are also facing multiple losses of friends
and loved ones. Those who have tested negative may
experience the trauma of "survivor's quilt." When acqessing
services, this population encounters social service • ;.
providers who are often not accepting of gays and bisexuals
because of their sexual orientation.

o

women: Issues surrounding pregnancy and/or children are
common among women facing HIV disease. Parents must face
how their children will be cared for during illness and
after death. They may be losing their support system at a
time when they need it the most. The risky behaviors of a
spouse or significant other may be at the forefront for the
first time. Many issues, including financial dependence
upon a man, contribute to the woman's fear of changing
behaviors. She may also require assertiveness training and
psychosocial support to handle negotiations around safe sex.
Few programs exist that are designed specifically for women,
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many of whom are uncomfortable with male-dominated settings.
o

IVDOs: The issues faced by drug abusers are only
exacerbated by the presence of the virus. These persons, if
they are in recovery, may relapse upon learning of a
seropositive status. Their sense of isolation may increase
as they are shunned from their drug culture. The number one
priority may be to take care of their drug habit, and the
motivation to change behaviors is often low. The IVDUs'
reactions to the disease are quite dependent on their
initial psychosocial standing, i.e., the less stable before
the positive test result, the more intensive assistance they
will need in facing the disease. Matters are further
complicated by the fact that some residential drug treatment
programs still will not accept HIV+ persons, especially if
they are symptomatic.

o

Bthnic/Racial communities: As discussed throughout this
plan, the needs of people of color may differ according to
language, culture, and religion. Bicultural and bilingual
providers are necessary to deal with clients• deeper social
isolation, rejection, and fear. Many Asians, for example,
feel shame and experience a loss of status for themselves
and their entire families. The risk of suicide may be even
greater than in other populations. Differing approaches may
have to be taken with immigrants versus native-born persons.
Undocumented persons face a host of complications
surrounding their immigration status, including fear of
accessing public systems of care. In some cases, Blacks and
other racial/ethnic minorities are in denial regarding how
they acquired the virus, and are internalizing feelings of
homophobia.

o

Adolescents: Young adults at high risk (homeless/runaway)
may be resistant to accessing health services: many come
from homes which are dysfunctional and abusive. The
behavior that is appropriate for their age group may be in
conflict with the demands of adult decisions necessitated by
HIV. Alcohol and drug usa are especially prevalent.
Adolescents are a particularly difficult population to
educate and produce behavior change because of their
impulsivity, experimentation with their emerging sexuality,
and a belief in their own immortality.

o

Incarceratedl Those in the jail and prison systems may fear
the consequences of their HIV diagnosis. They may have
well-entrenched character disorders that, similarly to the
severely chronically mentally ill, interfere with the
ability to integrate information and change behaviors.
Severe and chronic mental illness may also be a factor in
their HIV-related care. Also, the prison system lacks the
resources to provide comprehensive mental health care for
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HIV-related issues. Once the inmate is released, networking
or "discharge planning" among the prison system and other
agencies rarely exists.
Bange of Stryices
Mental health services may be discussed via several
categories. These categories include inpatient care, residential
care, day treatment, and outpatient services. The following
outline of these services provides a useful understanding of the
mental health care needs of HIV-affected persons in Los Angeles
County.
Inpatient cart
o

24-hour acute hospital care: This care is defined as
hospital beds for: (1) HIV+ mentally ill patients, (2) HIV
brain disease patients with or without medical
complications, and (3) patients experiencing psychiatric
crises in response to the severe stressors attendant with
HIV. current facilities are already completely overwhelmed
and very few beds exist in the private sector.

o

Sub-acute cart: This category of mental health care refers
to locked/unlocked skilled nursing facilities with increased
nursing components, rehabilitative staffing, and mental
health services. Sub-acute care is a high priority because
of current and expected future demand from HIV impacted
patients. Currently, no such facilities accept HIV-infected
clients.

Residential cart
o

Board and cart facility: A residential site of this type
offers structure and access to mental health services while
allowing clients to remain in the community. Medications
are distributed by staff. Frequently, a family and ~everal
staff members are administrators for a small number o.f beds.

o

Residential psychiatric facility: While similar to board
and care facilities in terms of programmatic structure,
residential psychiatric facilities are larger with perhaps
one hundred or more beds.

o

"Our Bouse" aodtl: The AIDS Project Los Angeles• our House
is an important and unique model of a residential facility
for the multiply diagnosed. The 14-bed facility is designed
to accommodate ambulatory HIV+ clients who have a preexisting mental illness, HIV brain disease, and/or a history
of drug/alcohol abuse.
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Day Treatment

o

Day treatment proqrams: This program involves a structured
environment that is an avenue for providing mental health
treatment and socialization for clients, as well as respite
for caregivers. This alternative is more cost-effective
than an inpatient situation or homecare for all affected
individuals. A program in this category should provide
integrated services that are responsive to the psychosocial
and spiritual needs of the client. Life skills improvement,
which gives structure to daily living, and compensatory
strategy development, which helps clients cope with memory
loss, are important components of the program.

outpatient Care
o

Professional services: This category encompasses a wide
range of programs and modalities, including: crisis
intervention; early counseling; support groups; individual,
couple, and family psychotherapy; case management: and
psychiatric medication evaluation. Providers must be able to
treat and refer multiply diaqnosed clients in a sensitive
and competent manner. They must understand both the medical
and psychological aspects of HIV disease, to satisfy client
needs.
Crisis intervention may be provided for such crises as a
clients• deteriorating medical condition, loss of loved
ones, and others• reaction to the client's illness (i.e.,
rejection, discrimination).
Early counseling is delivered as soon as possible following
post-test counseling. This period is a crucial time to
educate, offer support, initiate behavior change, provide
information and referral, initiate/support secondary
prevention efforts and, support positive coping strategies.
Support groups (on-going and drop-in) provide peer emotional
support on both an as-needed, flexible basis without regular
attendance requirements and on a more structured, weekly
basis.
case management provided by mental health professionals
involves referrals to needed resources, psychosocial
assessments, and, often, some form of crisis intervention.
Psychiatric medication evaluations are crucial and a high
priority. The evaluations are designed to determine whether
the client needs to be placed on psychotropic drugs.
Evaluation may reduce the need for inpatient care as the
clients• needs are mora clearly defined.
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o

Paraprofessional/Volunteer Programs (mental health
specific): These programs include the successful "buddy"
programs and peer counseling. Programs may be provided to
individuals, couples, and/or families. Providers must deal
with the training of volunteers, matching volunteers and
clients, and burnout.

Training and Professional support
o

Training, Consultation, and Education: These programs are
targeted to specific disciplines or providers, e.g., board
and care operators, psychiatrists, and students/interns in
different mental health disciplines. Providers cannot be
equipped to handle HIV-related clients without HIV-specific
training. The HIV+ patient presents issues that differ from
the providers' traditional clients. Emphasis on culturally/
linguistically appropriate client needs is necessary.

o

Emotional support services to BIV service Providers:
Support groups and burnout prevention workshops provide
emotional support to HIV service providers. Providers are
often coping with the deaths of clients and loved ones, and
may feel a sense of isolation from their colleagues.

Barriers to Meetipq Needs
The single greatest barrier to meeting the mental health
needs of the HIV-impacted population is, of course, financial.
Patients often do not have the personal funds to access care,
thus placing the onus on the public sector to provide care. The
existing public mental health system is so limited and so
underfunded that the Department of Mental Health cannot serve
populations beyond one target population, the chronically
mentally ill.
Unfortunately, HIV mental health care is multiply
stigmatized--not only does the public associate a stigma with
mental health, but also with HIV disease. consequently, mental
health services, especially for HIV-related issues, are no~ seen
as a priority by the public or public funding sources. Neither
the funding nor the pressure to acquire the funding are
sufficient to meet the current demand for services.
Another significant limitation involves staff resources.
The staff fear the possibility of themselves becoming infected.
Emotional burnout among. HIV service providers is prevalent, and
retaining staff can be difficult. The demands of working
exclusively with severely ill and dying patients are quite high.
This burnout is also due, in part, to the inability to find
support from colleagues who do not see HIV impacted clients.
Also, the environment of long hours, high caseloads, and low pay
makes retaining and recruiting staff especially difficult.
The lack of HIV-related training and information provided to
mental health professionals and the inadequate reimbursement
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rates for the care are the major reasons for inadequate numbers
of appropriately trained staff. Providers are often resistant to
receiving this education because of their reluctance to care for
HIV impacted persons. They are not well-compensated financially
and may not be able to deliver the ethnic and culturally
specificity required. Space in which to provide services is also
an issue. Community organizations do not have the space or rent
to hold all the support groups and offer the peer counseling that
is required.
Access to and development of resources is also hindered by
the discrimination that exists against those who require
services. Potential clients are stigmatized because of their
mental illness, seropositive status, sexual orientation, and/or
substance abusing history. This tendency to "blame the victim"
creates a difficult environment in which to design, develop, and
support HIV-related mental health services.
A serious lack of coordination also exists. Networking is
necessary among and within County departments and between these
departments and the community. Effective referral and case
management cannot take place without formal mechanisms to link
inpatient facilities, CBOs, and other sites. Agencies recognize
this deficiency and many are attempting to correct it through
more open communication, but much work remains to be done.
Naa4s au4 Recogmen4ations
Particularly crucial categories that require expansion are:
medical-psychiatric hospital beds for acute care, sub-acute care
facilities, residential facilities, and day care mental health
programs. Further funding for outpatient services is also
urgently needed to meet both current and projected needs.
Training and education to professionals and paraprofessionals is
necessary in all programs.
Other needs arise from the fragmentation of the health care
system among the various organizations, including the Department
of Mental Health, the Department of Health Services (e.g. AIDS
Programs, Alcohol and Drug Programs), and community-based
organizations, which especially adversely affects the treatment
of the multiply diagnosed patient. Coordination between t~~se
systems must be a priority if clients are to be effectively
served. For example, attempts at early counseling will not work
if improved connections are not made between post-test counseling
and other follow-up services.

Multi-laval

~acilitys

Sub-acute, aasi4antial, an4 Day care

Ideally, sub-acute care should be offered in a single,
multi-level facility. The best situation provides for sensitive
staff in one location to meet the demanding needs of the mentally
ill client. The facility could provide a continuum of mental
health care through the combination of a locked ward with a
skilled nursing component, residential care, transportation, and
day treatment at both the intensive (crisis resolution) and
habilitative (maintenance) levels. If a single facility is not

3GG

established, strong and formal ties must be made with the several
sites providing these services. A patch funding program is
needed to pay sub-acute care facilities for extra services
provided to HIV mental health patients.
case management coordination between mental health and
community-based providers becomes critical when placement of an
HIV-positive chronically and severely mentally ill person in a
community residential setting is necessary. Few facility
operations (from board and care homes to SNFs) are willing to or
comfortable with caring for an HIV-positivejchronically mentally
ill individual who could place other residents at risk of
exposure to HIV. Additionally, residential facility operators
must be educated to deal with issues related to HIV/AIDS.
Acute care
Too often inpatient facilities are not accepting HIV+
patients in direct violation of anti-discrimination ordinances of
the Cities of Los Angeles and West Hollywood and the County of
Los Angeles. These violations should be reported and appropriate
action taken. This situation highlights the need for training
and education to decrease fear and sensitize providers to the
psychosocial need of HIV patients.
Professional services
Professional services such as cr1s1s intervention,
counseling, and support groups require further staff training and
expanded availability. Greater geographic distribution of
programs and services provided in languages other than English
are needed. Development of new models that are culturally
appropriate, based upon what people perceive they want and need,
is necessary. New and innovative models should outreach to
clients and educate them on the benefits of mental health
services. services should also incorporate the provision of
· messages to prevent transmission of the virus and the development
of acute mental health conditions.
A major priority includes the need to increase the
availability of case managers. Increased communication is
necessary between DMH, CBOs, and DHS (e.g. , AIDS Programs,·· .Drug
Abuse Program Office, Alcohol Programs) to decrease overlapping
services and multiple case managers. Some mental health
professionals believe that creative and culturally sensitive
mental health counseling may be provided by mental health
professional case managers, rather than through a more
traditional, formal setting. Clients may feel more comfortable
with this one-on-one relationship in which they have already
developed a level of trust and security.
Medication EValuations
Medication evaluations are an integral part of mental health
care. Unfortunately, very few private providers agree to do
evaluations on a long-term basis or at low cost. Monitoring and
follow-up are important, but most psychiatrists are unwilling or

unable to devote the intensity of effort required. Resources
should be developed in this area through active recruitment and
education.
Psychosocial support for Providers
The need to develop more support groups and burnout
prevention workshops for mental health providers is acute.
Bereavement intervention is also a very real need. These
services should be part of an overall resource development
program that seeks to recruit and retain HIV providers throughout
the various delivery systems.
Pro1ectiopa
The projections of psychosocial services needed by HIV+
adults (Table 18) are made with the use of the estimates
described below. All estimates are derived from the experiences
of the County Department of Mental Health and community-based
organizations providing HIV care.
By definition, the chronically mentally ill and persons with
multiple diagnoses (categories 2 and 3) are not mutually
exclusive. However, the overlap between the two categories is
insignificant given the uncertainty of the seroprevalence
estimate. All numbers have been rounded to the nearest fifty.
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Tllble 18
Mlntal .._lth Service ProjectiON
1990/91 - 1992.193

90191

Esti•t•
91M

92!93

2,900

3,500

4,050

1,700

1,700

1, 700

2,500

2,500

2,500

Persons ~ith significant emotional reactiona
sHking mental health intervention (4)
22,400

22,400

22,400

Cttmrx

Persons ~ith HIV brain disease
needing mental health intervention

(1)

Chronically mentally ill <2>
Persons

~ith

.ultiple diagnoses C3)

Ttble 18 !ota
(1)

It is estimated that 66 percent of patients develop significant symptomatology related to HIV brain
disease before the terminal stages of the disease. HOMever, approximately half of these individuals
C33 percent> ~ill need mental health intervention. The esti .. tes use AIDS eases per year plus 10
percent to capture the severely symptOMatic. 90/91: (8,845)(.33) • 2,918; 91/92: (10,678)(.33> •
3,523; 92/93: (12,293)(.33) • 4,056

<2>

It is estimated that one and one·half percent of the general population is chronically mentally ill.
Those ~ith a chronically mentally ill diagnosis prior to HIV infection are estimated as 1.5 percent
of the 112,000 infected. <112,000)(.015) • 1,680

<3>

This estimate is the number of HIV infected persons Who are also diagnosed ~ith. several primary
problema, such as a payehiatric complication and addictive behaviors. The total number of infected
persons is ~~a~l tipl ied by 15 percent (the estimated proportion of infected who are IVDUs) and by
another 15 percent to estimate the total nu~Cer of HIV+ IVDUs with a psychiatric disorder.
(112,000)(.15)(.15). 2,520

(4)

This estimate is baed on the APLA figure of 66 percent of """ clients receiving counseling and
group therapy services. The number is reduced to 58 percent when categories 1, 2, and 3 are
excluded. Approximately one·third of these indivic11als Who •ight need mental health intervention
actually seek the care. The bulk of this care is group ther~. Therefore, 20 percent of the HIV·
infected were placed in category 4. (112,000)(.20> • 22,400

..

Acute Hospital Care
Approximately five percent of mentally ill patients
(categories 1-3) need acute inpatient care, according to
Department of Mental Health statistics. This figure may be
applied to the HIV+ population to determine the number of
hospital psychiatric beds needed for their care. Five percent of
categories 1-3, and 5 percent of half of category 4 (they are not
considered mentally ill, but half may be suicidal) require such
care each year. Average length of stay is two weeks.
Sub-acute care
In order to determine the number of beds in a locked mental
health skilled nursing facility (SNF) that are required by HIV+
individuals, only categories 1, 2, and 3 are considered. Fifty
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percent of those entering an acute hospital setting will be
discharged into sub-acute care. Five percent of persons from
categories l-3 will enter the locked SNF directly from the
community. Average length of stay is two months.
Residential Care
Board and care facilities experience a six-month length of
stay for their patients. Only categories 1 and 2 are considered.
Eighty percent of those entering a sub-acute care setting will be
discharged into board and care. Five percent of persons from
categories l-3 will enter from other sources.
category 3 utilizes the "Our House" model of care.
Individuals with multiple diagnoses remain at our House about six
months before being discharged into hospice or other care. It is
estimated that 8 percent of persons with multiple diagnoses
require an our House facility. That is, 200 HIV+ persons per
year need 100 "Our House" beds. This figure reflects seven times
as many beds as currently exist.
Day Treatment
Individuals with HIV brain disease and those who are
chronically mentally ill are the most appropriate clients for a
day treatment program. Approximately 15 percent of categories l
and 2 require such care. Five percent of those with multiple
diagnoses would benefit from day treatment. currently, DMH's
Program H.O.P.E. can handle a case load of twenty-five,
significantly less than what is needed.
outpatient care
For outpatient care, projections are made for four
professional services: individual therapy, group therapy, case
management, and medication evaluation. The percentages described
below are estimates provided by a working group comprised of Los
Angeles county mental health professionals.
HIV-infected persons require individual therapy at the
following percentages: 7 percent of category 1; 66 percent of
category 2; 60 percent of category 3; and 33 percent of category
4. The chronically mentally ill utilize long term individual
psychotherapy while persons with multiple diagnoses are more
likely to seek intervention intermittently, during times of
crisis.
Group therapy is the most utilized mental health
intervention, especially by persons in category 4. However,
chronically mentally ill patients are not placed in group therapy
settings. Persons with multiple diagnoses are often disruptive
in group settings, but they will seek such care on a drop-in
basis for crisis resolution. Approximately 7 percent of category
1, 25 percent of category 3, and 66 percent of category 4 seek
these services.
Case management projections consider those individuals who
need this service within the mental health system. The Case
Management section of the Plan captures the HIV+ population
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receiving non-mental health specific case management in
community-based agencies. One hundred percent of the chronically
mentally ill and 25 percent of those with multiple diagnoses
should receive case management in the mental health sector.
Medication evaluation for psychotropic drugs is required by
a large number of individuals in our categories. One-hundred
percent of the chronically mentally ill patients, 50 percent of
persons with multiple diagnoses, and 6 percent of category 4
require such services.
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Mntal ._lttt servtc. C:.t Projec:tiana
1990191

if 11rv;;1

Acute Hospital Care

35 psych bedS

Tgttl Costs
I 6,591,900

Sub· acute care

86 SNF bedS

I 2,511,200

R.. identlal care

240 board and care bedS
100 "'ur House" bedS

I 1 '752,000
I 1,785,714

Day Treat-.nt

815 HIV+ individuals/year

110,866,664

OUtpet I ent Care
Individual cCU~Sel ino
Group ccuwelino
case ..,.....nt
Medication evaluation

10,200 HIV+ Individuals/year
15,600 HIV+ individuals/year
2,325 HIV+ individuals/year
4,300 HIV+ individuals/year

114,203,800
128,315,!32
I 1,453,000
378.400
I

'ISIIRtx

~s needed

167,858,510

TOTAL:
1991/92
~ISIIRtx gf 11rvi51
Acute Hospital Care

36 psych bedS

Total Coati
I 6,826,680

Sub· acute care

93 SIIF bedS

I 2,715,600

R.. ldential care

261 board and care beca
100 IIQur Hous.- beca

I 1,956,400
I 1 '785, 714

Day Treat-.nt

905 HIV+ Individuals/year

112,066,664

outpetient care
Individual ccuwel ino
Group ccuwelino
c... Jlllnllg-.nt
Medication evaluation

10,260 MIV+ individuals/year
15,654 MIV+ individuals/year
2,325 HIV+ Individuals/year
4,300 HIV+ individuela/year

114,400,360
128,442,504
I 1,453,000
3ZJ.400

~s

needed

TOTAL:

'

170,025,322

1992/9S
~ISIIRtx Rt ltrvisl
Acute Hoapltal Care

37 plych bedl

Tosat c91sa
I 7,043,916

Sub· acute care

100 SIIF becla

I 2,920,000

a.. tdentlal care

'1!17 board and care beca
100 IIQur Houa.- beds

I 2, 168,100
I 1,785,714

Day Treet-.nt

9tl MIV+ lndivlduala/year

113,166,338

OUtpetient care
Individual courwel ino
Group ccuwel I no
c... ..,.._,t
Medication evaluation

10,297 MIV+ lndividuala/year

15,693 HIV+ individuals/year

114,582,880
128,560,128
I 1,453,000
3ZJ.400

Mru!S

I'IHded

2,325 HIV+ indlviduala/year
4,300 HIV+ lndivlduela/year

TOTAL:
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172,058,476
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1991 CARE/CDC REQUESTS FOR PROPOSALS FACT SHEET

TOTAL NUMBER OF PROPOSALS RECEIVED: 47
RFP MENTAL HEALTH & PSYCHOSOCIAL SUPPORT SERVICES (191-003)
RECOMMENDED FOR FUNDING:
AIDS PROJECT LOS ANGELES
EAST VALLEY COMMUNITY HEALTH CENTER
PACIFIC CENTER FOR COUNSELING
MINORITY AIDS PROJECT
HOLLYWOOD-SUNSET COMMUNITY CLINIC
*GAY AND LESBIAN COMMUNITY SERVICES CENTER
TARZANA TREATMENT CENTER

AMOUNT
$93,000
75,000
55,000
111,000
66,000
133,000
108,000

TOTAL NUMBER OF AGENCIES RESPONDING: 20
TOTAL AMOUNT OF FUNDING REQUESTED: $2 1 517 1 958
TOTAL FUNDING AVAILABLE:
CARE supplemental
$450,000
CARE Formula
191.000
TOTAL
$641,000
RFP HIV OUTREACH AND PROMOTION OF SERVICES (f91-004)
RECOMMENDED FOR FUNDING:
JWCH INSTITUTE, INC.
THE LOS ANGELES FREE CLINIC
CITY OF LONG BEACH DEPT. OF HEALTH
CALIFORNIA DRUG CONSULTANTS, INC.
*AIDS HEALTHCARE FOUNDATION/
GAY MEN OF COLOR CONSORTIUM

AMOUNT
$42,538
40,000
35(000
42,000
255,286

NUMBER OF AGENCIES RESPONDING: 18
TOTAL AMOUNT OF FUNDING REQUESTED: $1,845,610
TOTAL FUNDING AVAILABLE:
CDC (Supplemental) $ 73,824
CARE Formula
191,000
CARE Supplemental
150.000
TOTAL
$414,824
RFP TRAINING & CROSS-TRAINING (191-005)
RECOMMENDED FOR FUNDING:
*PROTOTYPES/W.A.R.N.
LOS ANGELES HOMELESS HEALTH CARE PROJECT
*AIDS HEALTHCARE FOUNDATION/
GAY MEN OF COLOR CONSORTIUM
NUMBER OF AGENCIES RESPONDING: 9
TOTAL AMOUNT OF FUNDING REQUESTED: $1,046,087
TOTAL FUNDING AVAILABLE:
CDC
$244,127
191, 000
CARE Formula
TOTAL
$435,127
* Represents group/consortium proposals
t ca~.2 :rr.a: <:~gain

3 (t..J
~--~n

AMOUNT
$235,700
93,127
106,300
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name i s C y n -r,h i a ~avis and
.......
t-he
i-iI'-.·/ A I CS educat-ion, pre ·.Jerlt ~ or'1 ana
reaucLion programs being
imp i emenLed under- t-he aus::n c~s of t-he .:.en~e r f c r Ccmmurn t.,. and
Preventive Medicine of the Charles R. Drew university of Meaicine
and Science, the National Organization of o1aCK Count.y 0fficia1s.
Inc. :NOBCC~ and the Canters for ~isease Cont.rc1; The purpose of
the projec0s are cwofoid:
1)

-.~

to develop a model HIV/AIDS r1s~ reduct1on orogram t-argeting
school-age, out-of-schoo1 and college-age )outh which can be
repi icat.ed in t:.he Afncan American communiLl .;;n a nat.ior.ai
basis and
to increase the HIYiAICS-reiaLed ~now~edge ana awareness or
alack elected and appointed cour.Ly officia1s so cna~ Lhey can
more effectively advocate
for
increased ana/or
.anhance
HIV/AIDS-related services targeting the "'fr-ican American
communit-y on a national basis.
I
have
been
involved
in
developing,
1mpiementing
and
evaluating family life education (FLE) and HIY/AIDS education
and r1sk reduction programs targeting e~nnic maJori~y youth
and young adults in Los Angeles County since 1984.

My testimony will focus on the overall HIV/AIDS-reiated educational
needs of African American youth on a national as wei i as local
ievel.
BACKGROUND
As of uc~ober
1991,
on a
national
level
~here
have
been
approximateiy 758 cases of AIDS among 13-19 year olds reported to
the Centers for Disease Control (CDC). vf these 7Sa cases, 42~ are
White (322), 37% are Black (280) and 19~ are Hispanic (142).

Gf

cases repor~ed among Black you~h. 53~ are male (166~ and
are fema 1e ( 114). ihe exposw-e ca~egor 1 es tha~ ilave been
reccn:.ed for ail you~h aged 1.::.-19, ~ 11respec~ive of race. ind1ca~e
that ~6~ were infec~ed due to homosexual/bisexual con~act . .:;c~ were
infectea cue to hemophilia/coagu1atlon disorders: 14% due to
he-c.ercsexua i ccntac~, 12% due to :::vuu, 7 ~ due to rece i ct. of
contaminated biood products; for /:it. their exposure ca~egory is
unknown
and
4~
due
to
the
multiple
ris~
factor
of
homosexuai/bisexuai contact and IYDU.
~nose

41;;,

Gut. of a cumulative total of 139,405 cases reported to date. the
numcer of 13-13 year aids recor-c.ed w1-c.h AIDS accoun~s for less -c.han
~~ i • .::.6:it.) of the to~ai cases. ~owever, this fac~ shcuid not give
In ~-~s ~nge i ~s c~~:-,-cy, :.c cate ( ~ePLember 1 S~ 1 i cnare nave baer-i a
cc-c.a i of .:;c ;..:;::cs cases naoor~ed among 1 outh aged i 3- i 9; 3 among
Siaci"s (30:it.;, 11 among riisoanics ,.:;7.ib) and 1C among whi~es. (3.::.;;:.1
Whi~a

adolescents (age 13-13~ account for less than i.ib of the to-c.a1
numcer of ,.:..rr;s cases. bo~h nat. i ana i 1 y and i oca i i y, ~0% of a i 1
repcr~ed AIDS cases are among persons 20-29 years of age. ~ivan the
eAt.ended 1atency period from the time of initial infection wi~h ~IV
un~ii manifes-c.ation of s;mptcms which result in an AIDS diagnosis,
usually from one to ten years. it can be concluded tha~ most or -c.ne
ind1viduals in the ~0-29 age category were infected with riiY during
the1r teen age years.

For far -c.oo long i'"'iiY infection and AIDS has been • ;awed as a
ga:u:::i1sexuai white male disease". !his my-c.h s-c.iii pre·..;aiis .... n
iieu of the fact tha~ -c.he incidence and prevaience of rii; infec~ion
ana ~IDS 1s relatively 1ow among the adolescent. ooou1aticn.
aaoiescen~s are a-c. serious risk for riiV 1nfecticns.
lhe number of reported cases of AICS among adolescents aces no~
accurately reflect the risk that this dead1y virus cases ~o you~h
in ~his nation. iO understand the full impact of AIDS among
adolescents we must lock beyond these seeming1y iow statistics to
ctner sources wn1cn suggest tha~ adolescents are a-c. h1gn risk for
contracting HIY because of their behaviors.
WHY ARE .;.OUTri AT RISK FOR ril'-/ INFECT:ON·?

Adolescents and young adu~ts are at increased risk for
infection due to numerous factors. These factors include:
1i
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According to the 1930 Census, t..here are iO.S m1iiion Si.:;,.c~-_ youth
under the age of 19 in the 0.5. with nearly ~ mi11ion aged 15-;S
and ~ mi 1 i ion aged 20-24.
This under 24 age group comonses
accrcxima~eiy ou% of the to~al U.S. Slack co;:;uia~ion. Thus. we have
a whoie generation at increased risk for HI~ infec~ion.
SiacKs and riisoanics currently account.. for approxima~aiy 44~ of a;'
ca~ient..s diagnosed wi~h AICS. 7~~ of women. anc 76~ of ali ohi1dren
w1t..h cenna~ai acquired infection. Ti-.e -.:;·.-er-wneiming ma.}or1t'f OT
minor1t..~es who have con~ract..ad ~ICS are 1nner =~t..y ras;dant..s of ~ow
socioeconom1c status.
;·~umercus hea i th
SOCiai problems
hea i th and we 11 be illg of
numoers of Slac~ and o~her
e~hnic minori~y adoiescents and young acuits across t..ne u.S.
The
fo11owing statistics present a general overview of the seriousness
of the problems:

Nationaiiy,

LOW
>

..,.

___

•

-·.

i....i.lt:ii .... l..f

1981, 15.4ib of Siaci-_ 10u~h aged ;6-24 were high
school dropouts: anot..her survey es~ima~ea that over
20% of Slack males aged 12-17 couid not.. read a~ a
fourth grade reading levei.

In 198~, 4.3. ~;;, of 3 i ack yout..h agee
unempioyed. more than twica the 21.6~
teens.

i 6- i;;,
;·a~e

••er-e

for all

INCARCERATED - In 1973, 15% of ail Black ;outh (456,636~ .:;,.ged 1519 had an arrest record. :n aadition, .:;;::.:. of aii
juvenile offenders in pub1ic or pri~a~e rasiden~ia~
facilities were alack.
DRUG USC:
AND ABUSE

In 1979, a National Institute on ~rug Abuse (NIDA)
survey indicated that non-white youth aged 18-25
have nigher or equal rates of drug abuse than white
youth in every major drug category except for
inhalants and hallucinogens. ~hereas a decreasing
trend in marijuana use has been noted among white
youth aged 12-17 and iS-25. this trend 1s not
paralleled by a decreasing trend among minority
youth in the same age ca~egories. Another NIDA s~udy
predicts an 1ncrease in drug abuse among Black and
3

Hispanic youth through 1995 because they constitute
the fastest growing segment of the J.S. popu~ation
and because
of
t.hei r drug
use
patterns.
A
conservative estimate is that. :oo.ooo adolescents
have used drugs 1ntravenously.
UNilHENDEu
?RE:GNANCIE.S-

cARL·i·

Over one million teenage gir1s become pregnant
annually in the U.S. The rates of teenage pregnancy
for Black and Hispanic teens in Los Ange1es County
are 2-4 times greater than for White teens. A 19a1
report of the Population Counci~ inaicated that 62%
of babies bor-n to 51aci\ teens were born our--ofwedlock, compared r.o 22% born r.o nhite teens.

St:>~u;:...L.

C:~PE~IMENTATION

-5y age 15, ;6~ of boys and 5~ of g1r;s ~n the u.~.
have engaged in sexual intercourse at ~ease once.
5y age 17, these rates are almost three times nigher
for boys and five times higher for g1r:s. 1ne rates
of sexual activity for Black youth ~iving in urban.
inner cities are est i matad to be higher than for
white youth and st~dies indicate that Black youth
begin en9a.g i ng in sexua i intercourse at ear 1 i er ages
than ~hite youth.

SE~<uAi...L.(

TRAt-JSHITTED
DISEASES

-Sexually transmitted diseases (STi::s1 have reachea
epidemic proportions in the U.S. In 19S5. the
Centers for Disease Controi (CDC) reported that 25~
of a:: individuals infected with gonorrhea or
syphiiis were agea 10-19 ana 27tt. or ;na1viduais
infected were aged 20-24. The rates of STus for nonwhites in Los Angeies County have been at epidemic
proportions for several years.

On a local levei, Cai ifornia ieads the nation in the number of
teenage pregnancies. In 1981, there were a total of 143,730 teen
pregnancies of 15 to 19 ·year olds in the State, for a rate of 145
births per 1,000 teenagers age 15-19. In Los Angeles County this
rate was 148 birth per 1, 000 teenaged gi r i age 15-1 9 or 4 7, 091
pregnancies.
In 1988 in California, there were 284 births to Black giris less
than 15 year olds; 3,504 births to Blacf" girls aged 15-17, and
5.832 for Black girls aged 18-13. Los Angeles County had. a tota~
of 6.659 births for ail ethnic groups who were ies's than 20 years
old and who were unwed teens.
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These high r-ates of teenage pregnancy and .=.res indica1:.e that
preadolescent. adolescents and young adults are not using barrier
methods of birth control when engaging in sexual intercourse. It's
obvious that many teens and young adults are having sex: bu~ unsafe
sex.
CURRENT STATUS OF HIV/AICS
IN LOS ANGELES COUNTY

~DUCATION

IN THE AFRICAN

A~ERICAN CO~NT~·

Los Angeles Unified Schooi uis-.rict (LAUSD) .,.,1-;ich 1s ~he second
1argest schoo~ dis't.rict in 1:.he nation with o~er 600.CJO s-.uden't.s
[-,as been involved in HI'l/AICS education since 1S2.4. -:-;-,a dis-.:-ict..
r-eceived iimi-r,aa fur;Cing fi-Cfn ~he puolic atld pr1-.;at-e S8Ct,Or fCiFamliy Life ~ducation which included ~I~/AIC.=o eauca-.ion beginning
na't.ionaiiy to rece1v·a CDC f:. mding
expand and ennanca :.he1r
i-ii"'i/AIDS educat..ion programs for teacher training ana cur-,-icuium
deveiopmen't..
Currently, -.he Cls't.rict.. implements a comprehensive haa~~h education
curriculum which includes a component on STDs/HI~. Th1s curricu1um
is targeted to the upper elementary (5th-6th) graces and secondary
grades (7-12). Beginning in 5th and 6th grades stl.iden-. :-ecei·.;e
Family
Life
Education
and
ril'-•'/AIDS
education
within
the
comprehens1ve neaith education curricl.iium. STus/AI:JS covet-s a-10
~esson and can be implemented over a ~-6 week ceriod depenaing uocn
the needs of class.
Parental consent is reouirad for both -.ha
school stuaents.

e1amen~ary

and secondary

LAUSD is Cl.irran't.iy upaating .ts STi:Js;A~uQ Cl.irrlcu~um. 7ha ~ist..r1c~
for the pas-. several years has been 1ooking a-. changes in know1edge
and at..titudes concerning HIV/AIDS: and not beha~iors.
For gay identified youth there are specia1 peer counseling programs
offered by ~he district's psychological services departmen~ at. each
school. And at Fairfax riigh, Project. 10, a progr-am for gay
identified youth has been implemented for approximate~y 10 years.
rcu't.h can be r-eferred to this program from ether schcois. The
district is currently developing a Senior ~xit program for 17-18
year oids. Prior to graduation, they wiii receive additional
HIV/AIDS related information.
This past fiscal year over 1 ,662 secondary teachers were trained
to use the STu/HIV curriculum. A staff of three persons ccordina't.es
the program and the· program is in its 5th year of :J years of
funa1ng. The district also works with 1oca1 CBOs to crain their
staff in the use of its HIV/AIDS curriculum. (Urban ~eague, Asia
Pacific Project, AVANCE, and WARN Project)
5
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!here are severai local C80's target-:ng schooi-age ana
scnool population in South Centra1 Los Angeles:

out-of-

'

N08CO AIDS Information and Education ?reject
Drew University Information and Education ProJect
Watts Health Foundation
"(outh and Family Center of Inglewood
Feop i e ·~-4ho Care
FAME Project
Minority AICS ?reject
Func1ng for these proJects 1s primari1y from tne .....,u....,
sec~cr (LACDHS-AFU. ~ta~e Cffice cf AIW~ and CCC)

r-.• ' . -• •
I

r.I\' /AIDS-rei a ted

..;: •

I

I .. - ,

,-I ..;

\,o,lf\..A

lr\ ,"""\
1a1~

targe"Ling

Afr-~can

-

,-\meri.::~n

private

.......

women,

,.outh

a.nd ,.oung a.du 1 ts has oeen nomi r-,a l .
LOS

Angeles County AIDS Program Office

lS90-~1

Frevention/Educat1cn Contracts
El Centro da1 Pueblo - Central/Echo

:1275.651
Par~.

Siivari.:l.ke

El Froyecto del Barrio- Northeast San Fernando

~alley

AIDS Awareness Campaign - Countywide
Gay ~ Lesbian Community Service Center Valley Community Clinic

~~u~

AIDS Project

Health Education/~isk ~eduction
~APO contract with ioca1 C8Cs;
.;ay/bisexuai mates

CORE Program

-·.:utreacn

Children's hospital

-Hollla i ass/Runaway

AVANCE

-Spanish

~anguage

iOUth

riiV /AIDS

~ot1ine

Minority Initiative
$96,700
(Targeted Education/Prevention)
Asian, Latino and Black Comm~nity Outreach
Los Angeles City AIDS Coordinators Office funding for education,
prevention and risk reduction totals $70,000: $17,500 of these
doiiars are targeted for South Central Los Angeles.
Incarcerated Populations (Juvenile Court Health Services)
Individuals who traditionally have been underserved are homeless,
incarcerated and street youth.
Approximately 20-25,000 minors are in some form of custody in the
Juvenile Halls and Camps in Los Angeles County annua~iy. A majority
of these youth are Hispanics and Blacks.
5
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During 1990, approximately 1,754 minors .-eceived n.;..:,· ant.ibody
testing and pre/posttest counseling for ~IV. Of the 1.754 tested.
2. were HIV "~"·
DHSJCHS provides HIV/AIDS education

Tr-..r
I

VI

~hesa

;·out:.h:

State AIDS ?rogram - 1987
CDC HIV detection program - 1989
CDC/State AIDS Video Project - 1989
A survey of risk behaviors of these youth det.erm1nad that.:
97~

are sexually active

7~.S~

o o:;o

use drugs
get. d runi-;. ..

Since ;386,

~cHS

(6~

(1S~

usa IV

use ccndoms frequent:.1y;

drugs~

has nad 21 cases of

n~~

T

m1nors.

Of the 250 females tasted, 21 were pregnant. upon admi~s1~n: SO had
a prev1ous pregnancy; ~0 had children and 34 haa report:.ea history
-...
of ~iUS.

-

Of the 1504 rna 1es tested. i 20 had a partner who was pregnant.. ..:. t;.;
had a part.ner with a previous pregnancy; 221 had children and 268
had a hist.cry of STDs.
Of the 1,754 surveyed. 51~ were r.ispanic: ~5~ ~ere ~frican
American: 7~ were White: .33:{. r..;ultiethnic: ; .5~ As 1 an: l • s;;, Other-:
.22.% Nat.ive American and .05~ Undetermined.
Of the l .754 minors tested, ~1 females and ~So ma~es report.ed zip
codes in Sout.h Cent.ra1 ~os Angeles as we11 as ot.ner areas of the
city/counr..y copulated by ethnic majority populat1ons.
EFFECTIVE

STRATE~IES

The key issues we have had to address in developing effect.ive and
cuituraily relevant and sensitive programs include the foilowing:
1) Developing culturally relevant programs; 2) gaining widespread
community
involvement
and
acceptance:
3)
target
group
accessibility; 4) developing program 1egitimacy: and 5) having
adeauate resources. On another level, we still have to deal with
a great. deal of fear, denial, ignorance and apathy 1n cur
ccmmun1r..:;·. Early on, in our educational our..:-each effcr-r..s. women
adolescents and young adults verbalized that they were immune t.o
AIDS and HIV infection. They repeatedly stated, "It can't happen
to me". : don~t know anyone with AIDS'', and "0n1y prostitutes and
drug users have AIDS." Many of them believed that AIDS was only a
"gay/bisexuai White male disease." However, after repeatediy
7
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exposing commun1ty residents to accura~e informa~ion on ~IDS and
infection, as well as· focusing on the fac~ &haL i~'s no~ r1sK
groups but one's behavior Lha~ places one at increa~ed r1sk for nLv
infec~1on, many individuals overcame ~heir iniLia1 den1al. fear ana
apachy.

~I~

One cannot over i ook the impact of poverty, i i 1• teracy, i aci\ of
access to medica i /soc i a i hea 1 th care, and a genera i sense of
hopeless, powerlessness and lowered seif-esteem and self-worth tha~
comes into play when considering people's knowledge levels
concerning AIDS and HIV, as wail as their a~tit.LJdes. beliefs and
values concern1ng maintenance oT good hea~t.h and mental ana
sp1ritual wellbe1ng in general. In addition, communiLy norms. mores
.:;.nd values play a key r-oie 1n ~-.ha~ is commoni y "accec~able" ·..-ersus
··non-accep~ab1e"
benavior. ir1Us, educating -indi•1dua~s ana Lne
communiLy-at-iarge aione 1s not enougn and ~11~ never be enougn.
iher-e has to be a concer-ted effort to -:.nanga the ;;.oc~ai norms.
values and mores of a commun1~y if we are co have a 1as~ing effecc
in (educing r-lsk taking behaviors for AIDS and rii··.:, as weii as
reducing ~he· incidence and prevalence of adolescen~ pregnancy, STi:,
I~ drug use. aicohoi and cocaine abuse, and a hosL of other healLh
and socially related problems that have for genera~ions plagued our
communities.

---T""". ---··"'*'-

.::ilr<Ait:\.l.lt:,j

It has only been wi~h1n the iast four years Lha~ there has been a
and iocai effort LO educate e~nnic m1nor1~y commun1~1es
about HIV and how to stop its spread. Los Angeies :oun~y as wei:
as the res~ of the na~ion is 6-6 years behind Lhe gay community in
developing and implementing effecLive and successful educa~ion ana
risk reduc~ion campaigns. ~e need to learn from Lhe gay communi~1·s
success 1 n reducing the
inc i dance of HI '-.1 i nf action among
gay/bisexual men. However, models developed in the gay communiti
may no~ be replicable in minority communities. Jn~i1 recently, ~he
vas~
majority of educa~ionai
programs being deveioped and
implemented were not targeting ethnic minority communities nor were
they culturally relevant or sensitive in their approach.
na~ional

We have found, to insure greater efficacy, it is incumbent tha~
HIV/AIDS educationaiiinformational campa1gns focus on community
development.
Effective
programs
are
comprehensive
and
multidisciplinary in their approach and focus on prevention, are
skills and values based, are peer mediated and work towards
community empowerment.
tJe have been very successfu i in using the mode i of community
development. In the area of program development, utiiizing this
model, the following steps should be taken:

8

1)

formation of a broad-based community advisory counci~ which
wi11
provide
ongoing
input
concer-ning
the
plann1ng,
implementation and evaluation of the projecL.

2)

developing models that include skills buiid1ng, anhancemenL
of social competency and deveiopmenL of problem-solving
ski11s.

3)

administration of a comprehensive communiLy needs assessmenL
survey of Lne target groups, as we 1 i as the i oca 1 serv 1 ce
providers, in order Lo i denL i fy unmet needs, b r "i dge gaps • n
services and avoid duplication of services.

4}

deveiopmenL of a process for eva1uaL10n ;:.haL ~nc1udes
formaLive, as wei~ as summative evaluaLion of the program.

5)

incorporation of ~IV/AI~S educaLian inLo e~1sL1ng family ~if6
educaLion and/or sex educaLion programs wn1cn are school or
communlty-based.

01

working in concert and collaboration with publi~ and privaLe
sector organizations such as schools, youth service agencies,
probation departmenLs, children~s serv1ces, county health and
social service departments, county drug abuse programs,
colleges,
civic and business organizations,
~he
mec1a,
religious institutions, the gay/bisexual communiLY and parenL
groups.

·.l

RECOMMENDATIONS
These recommendations are based upon the Women and ~IV/AIDS ~ublic
Hearlng held on February .:a. 1991 aL exPOSition ~an;. ln i...os
Angeles, California.
~hat held true ten monLhs ago, SLl l i
holds
true today.
~IV/AIDS affecLed women, youth and young adults are in dire need
of the following services and programs in Los Angeles CounLy and
in Metro South Health Area (South Central) in particular.

..

1

....-

Comprehensive
and
multidisciplinary
Eariy
Intervention
Programs (EIP) which provide culturally spec1r1c, gender
sensitive and linguistically appropriate services including
case management, mental health, social support, respite, child
care and public benefits counseling and advocacy. These
services are needed immediately.
5pec i a 1 i zed ·women ' s C 1 i n i cs based on the \-fes L rio 11 y wood moae 1 ,
need to be deve 1 oped. These c 1 in i cs wou 1 d provide care rom
initial diagnosis to full blown AIDS. Further deve;opment of
the adolescent clinic in the Oasis program at MarLin Luther
King Jr. Hospital. This clinic provides medical services to
HIV + youth and young adults.
9
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A well coordinated and integrated residential and shelter
program for HIV infected women and ~ne1r cn1 :oren is needed
immediate1y. The type of housing needed includes: emergency
she 1 ~er. and 1ong -cerm res 1 aen~1 a 1 programs. A11 of these
programs should be geared -co promote independent liv1ng for
the women and their children. Child care and respite serv1ces
need to be incorporated into all of these programs.

.....

Women and youth with dual diagnoses, HIV infection and having
mental health and/or addiction problems, have unique special
needs. These women, :;ou~n and their chi i dren and fami 1 i es
require specialized case management services to insure ~hat.
~hey receive the full range of EIF, mental health, substance
abuse and rehabi1ita~ive services.

.I

Many women ana adolescen~s at. risk for M~~ 1nfec-cion can be
charact-erized as be1ng of low 1ncome. low 5ES. 1ow educationa1
attainmen~. iilitera~e and single heads of households. These
women and adoiescen~s are generally in deep dania~ concerning
their risk for HIV infection. A client advoca~e (ombudsman)
needs t.o be integrated into the existing system of care.
He/She would play a key role in advocating for the personal
and 1ega1 rights of HIV infected and affected woman.
Existing HIV/AIDS resources throughout L.A. County are
i nadeoua~e and do no~ fu 11 y address the neat t.n ( men~<l1.
physical and spiritua~) of HIV affected women, ;out.h and their
children and families. A standardized and comprehensive
communi ~Y needs assessment t.o identify unme~ service and
clien~ needs must be developed and admin1stered on an ongoing
basis.
i.

HIV positive women and you~h recen~ly released from an
incarcerated setting and gay/bisexual women and youth need to
receive targeted outreach in order to educate -chem about their
risk for infection as wei1 as the benefits of EI? programs.
Primary prevention programs need to be developed and expanded
to reach pre-adolescent, adolescent and aduit women in order
to stop
the spread of HIV
infection among women
of
childbearing age and their sexual partners. According to the
most recent data from the State Office of AIDS, in Los Angeles
Count}1 , in a recent HIV seropreve 1 ance study of women of
childbearing age (14-44) 1 in 174 African American women of
childbearing age in the study was found to be infected with
HIV (N=5,403).

9.

A comprehensive educational campaign targeting local African
American churches, radio stations, social organiza~ions, the
business community
and elected officials needs
to
be
implemented and maintained to ensure tha~ t.ne public 3nd
private sectors are aware of the problem and can work

co11aboratively to develop solutions ~o solving ~he problem
of HIV infection in the African American communi~y. The issue
of HIV/AIDS and women/youth needs to be a oriori~y and
addressed in the form of public hearings and communi~y forums
on an ongoing basis.
1 0.

Continued lobbying at the state and federai ieveis
manda~e
HIV/AIDS education in grades k-12 and for ~ncreased funding
for primacy prevention funding.

There are no simple solutions for comba~ing the spread of ~IJ 1n
muitiethnic communities national~y or 1oca1~y. Combating the spread
of HIV will reouire complex multidisciplinary approaches and
s~rategies, as weil as greater coliaboraticn be~ween pubiic and
priva~e sector organizat1ons throughout ~he na~1on. AIDS and ~IV
have to be looked at in ~arms of the in~erconnec~ing ~inks be~ween
one's 010IOg1ca1, social and psychological envii-onmen~. It can'~
.:>e ~ooi\ed upon in isolation and in a vacuum. In i ieu cf r.ne fac~
that present 1 y, the majon ty of cases are concen~ra~ed among
homosexual and bisexual men and IV drug ~sers, AI~S and HIV
infect1on are related to behavior, not risk groups, and we in the
alack community currently have an entire community of men, Nomen,
children and adolescents a~ increased risk for infection .

•
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DATE:

November 9, 1991

LOCATION:
PRESENTER:

UCLA Faculty Center
Cynthia C. Davis, MPH, CHES
Program Director
NOBCO AIDS Education Projects
1631 E. 120th Street, Bldg. "C"
Los Angeles, CA 90059
(213) 567-7799; Fax: (213) 567-7796

"HIV/AIDS-Related Service Needs of HIV Affected and Infected
Women in Los Angeles County.
In February of 1991, the first public hearing in Los Angeles
County on Women and HIV/AIDS was held at Exposition Park under the
sponsorship of the Los Angeles Commission on the Status of Women,
former Los Angeles City Councilman Robert Farrell, and numerous
community-based organizations which serve and advocate on behalf of
HIV affected and infected women, children and adolescents who are
the most medically unclerserved and under represented constituencies
in Los Angeles County, the state and nation. A summary report of
the public hearing was presented to the Los Angeles City Council in
June of 1991 outlining the numerous gaps in services and the need
for immediate resources for women. To date, nine months after the
·public hearing there has. been no response from city government to
address the crisis situation that HIV infected and affected women,
children and adolescents have to deal with. There has been token
response from local County government, vis-a-vis the nominal
allocation of Ryan White Care Act funds to enhance and/or develop
specialized services for women. As we begin to assess the need for
comprehensive services for women, we must also look to the unmet
needs of the preadolescent and adolescent females (aged 13-19) who
are at just as great a risk for HIV infection, if not more, than
their adult female counterparts. And lastly, we cannot overlook
the infants and children that are apart of the lives of most women
in this society, whether they be married or single, straight or
gay, young or old, of childbearing age or post menopausal, drug
free or drug addicted.
The purpose of this presentation is to focus on existing
HIV/AIDS-related services being provided by community-based
organizations throughout Los Angeles County. Los Angeles County is
a very large county covering over square 4,000 miles and with a
total population over 9 million.
Currently, there are over 300
HIV/AIDS-related service providers in Los Angeles County. These
providers make available a full spectrum of services ranging from
primary prevention (education) services, testing, counseling,
direct medical/clinical services, social support, mental health,
extended care,
residential,
hospice, transportation,
food,
clothing, and legal.
3R5

Because one of the primary the purposes of this conference was
to target HIV infected women, I' 11 be highlighting those few
agencies having specialized services for women.
In looking at the "health" needs of HIV infected women, I feel
it is imperative that we define their health in a wholist manner with health being one's physical, mental and spiritual well being,
not merely the absence of disease or infirmity.
Thus, we must
begin to look at addressing the overall health care needs of HIV
infected women in a comprehensive fashion and it must encompass a
full range of services.
At a minimum, HIV infected women's physical health service
needs would include:
. direct medical/clinical care (inpatient and outpatient)
. ongoing education regarding risk reduction
. fulfilling necessities of life needs (i.e. food, clothing
and shelter)
. residential care (long term and short term; in home or free
standing)
. emergency shelter; drop-in center; crash houses,
transitional housing, permanent housing
• hospice care (6 months or less to live); transportation
• drug treatment and rehabilitation
Mental Health service needs would encompass:
direct medical/clinical services (counseling/treatment individual and family)
• support care for: HIV symptomatic and HIV asymptomatic women
and their affected families, and care givers; and counseling
to couples, individuals and the community .
. comprehensive case management; vocational; legal; respite;
buddy/support programs; volunteers; stress reduction;
counseling referral; financial/benefits counseling;
self-employment programs; and having cultural competent
staff and
multilingual staff
Spiritual Health service needs would include:
• bereavement counseling; spiritual counseling; education
concerning alternative/wholist treatment modalities; burial
counseling; grief resolution
Having a well coordinated and integrated system of care
encompassing all of the aforementioned services will go a long way
towards adequately addressing the needs of HIV infected women.
There are numerous agencies which provide a full range of
services to all individuals impacted by HIV. No agency can legally
discriminate solely on the basis of one's sexual preference or
one's gender. Thus, for the HIV infected woman, there are numerous
agencies throughout the County which could provide a wide range of

"' 3fiG .

services as well as make appropriate referral for services.
Geographically these agencies are located as follows:
Westside

APLA
Pacific Ctr
Tuesday's Child
AHF
Being Alive
Project Angle Food
GLCSC
Act-up LA/Women's Caucus
LAPAN
JWCH Institute
Hollywood/Sunset Ctr. (Cara-a Cara)
Caring for Babies with AIDS

Eastside

ADVANCE
Milagros AIDS Project
Altamed/Buenacare
El Project del Barro
Calif State University Los Angeles

Downtown

HOP
Weingant Center
L.A. Bar Association-Hospice Project
Salvation Army
Chris Brownlie Hospice

Northside/Valley

Southside

All Saints AIDS Service Center
Northeast Valley Health Center
Tarzana Treatment Center
Foothill AIDS Project

MAP
Youth & Family Center
WARN Project
WHF
King/Drew Medical Center
THE Clinic
NOBCO/Drew I & E Projects
Drew Women's Outreach Project/LA Southwest College

Southbay/Lonq Beach

Southbay Free Clinic
Long Beach Minority AIDS Project
Calif State University Long Beach

Los Angeles County Comprehensive Health Centers.
Los Angeles County. Hospitals
UCL:A/Harbor
MLK
County/USC (SP21 and the outpatient clinic)/Maternal/Child
HIV Research Clinic
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Private Hospitals
Cedar's Sinai
UCLA
St. Francis Medical Center
St. Mary's Medical Center
Euchemenical Agencies
FAME Church
St. !rigid's Catholic Church
Unity Fellowship Church
Unitarian Church
Gar/Lesbian Organizations
Asian
Hispanic
Black
Clinical Trials
USC/UCLA
Search Alliance (Community-based trials)
Residential Facilities
Rue's House
St. Francis House
Group One
Dignity House
Hospices (6 months or less to live)
Chris Bronlie (AHF)
City of Angles
West Hollywood (AHF)
Our House (APLA)
Its only been within the last year that there bas been a
"popular" interest in the impact that the HIV epidemic is having
among women. As a result of this interest and the rising number of
women (adult and adolescent females) becoming infected, there bas
been greater lobbying to involve women in clinical trails as well
as changing the CDC case definition to reflect manifestations
commonly found among women, as well as, the demand for more
specialized services for women.
The Women's Caucus of Act-Up (National chapters & LA Chapter)
have been instrumented in advocating for more comprehensive and
gender specific services for women. As a direct outcome of their
advocacy role, women serving in the HIV/AIDS arena have mobilized
to lobby and advocate on a local, statewide and national basis to
insure that comprehensive HIV related services targeted for women
are developed and/or enhanced. All of these advocates for women
who are affected/infected by HIV are to be commended.
Currently, in Los Angeles County there are a few programs
4
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which have or are developing gender specific programs for women.
One joint project is being developed in collaboration with the
Women's Caucus of the Los Angeles AIDS Regional Board and THE
Clinic for Women.
A full time OB-GYN and a mid-level Nurse Practitioner are
being identified to provide Level I & II treatment to symptomatic
and asymptomatic women, using a conmuni ty-based model.
'l'wo
satellite clinics where the Staff will rotate to on a weekly basis
have been identified (Polanco Clinic & Altamed/Buenacare). 'l'hese
women will receive a baseline assessment of their HIV status and be
case managed to insure that they receive adequate follow-up care
and treatment. Another program is the AHP's Palanco Clinic. '!'his
Clinic which provides EIP services and medical treatment to HIV
positive individuals recently developed a specialized program to
treat women. '!'hey have a case load of over 60 women that they have
been treating and following for the pass several months. At County
USC there is a program for women who deliver at USC and test
positive to receive ongoing treatment and care by staff at the
Maternal and Child HIV Research Project. 'l'hese women and their
families receive comprehensive care and support services.
Concerning the extended care needs of women, there are women's
support groups being implemented at AC'l'-Up Women's Caucus, WARN
Project, Gathering Place, APLA and the GLCSC.
Plans are in the
making to develop a women's support group at Minority AIDS Project
and the new Oasis Project at Martin Luther King Hospital will be
having a specialized clinic for women and a specialized clinic for
transvestites.
Search Alliance which is involved in community-based clinical
trials is currently recruiting women to participate in those
trials.
Tarzana Treatment Center which is headquartered in the valley
has two residential detox programs. One program is not specialized
for women, but does take women clients.
It is a 6-9 month
residential drug detoxification program which is comprehensive in
its scope (case management, education, therapy/support groups) and
then a non-residential detoxification program provides the same
services as well as nursing and home health care and case
management. Tarzana's residential treatment center in Long Beach
primarily targets women and their children. '!'his program can take
up to 85 women, not including their children. It is a long term
residential program for drug addicted women.
'!'hey will take
pregnant women and their children up to 3 years of age.
The
program includes parenting classes, a cooperative nursery; AIDS
education on site, HIV testing and counseling, a back to school
program and vocational programs. The ultimate goal is to help the
women to develop the skills to live independently in a supportive
environment.
'!'he women are court referred, physician and selfreferred. They don't have to have insurance to become enrolled;

3S9

they only have to pay a $100.00 admission fee. This program also
has two transitional houses that their clients can graduate to and
they have bilingual and bicultural staff.
Rue's House is the only residential AIDS Shelter program
targeting only women located in the Black community.
These agencies are reflective of the need to develop and
identify more resources for HIV affected and infected women.
The remainder of my presentation will focus on filling in the
gaps in services.
Follow-up Recommendations:
These recommendations are based upon the Women and HIV/AIDS
Public Hearing held on February 28, 1991 at Exposition Park in
Los Angeles, California. What held true nine months ago,
still
holds true today.
HIV /AIDS affected women are in dire need of the following
services and programs in Los Angeles County.
1.

Comprehensive and multidisciplinary Early Intervention
Programs (EIP} which provide culturally specific gender
sensitive and linguistically appropriate services including
case management, mental health, social support, respite, chi 1 d
care and public benefits counseling and advocacy.
These
services are needed immediately.

2.

Specialized Women's Clinics based on the West Boll ywood model,
need to be developed. These clinics would provide care from
initial diagnosis to full blown AIDS.

3.

A well coordinated and integrated residential and shelter
program for HIV infected women and their children is needed
immediately. The type of housing needed includes: emergency
shelter, and long term residential programs.
All of these
programs should be geared to promote independent living for
the women and their children. Child care and respite services
need to be incorporated into all of these programs.

4.

Women with dual diagnoses, HIV infection and having mental
health and/or addiction problems, have unique special needs.
These women and their children and families require
specialized case management services to insure that they
receive the full range of EIP, mental health, substance abuse
and rehabilitative services.

s.

Many women and adolescents at risk for HIV infection can be
characterized as being of low income, low SES, low educational
attainment, illiterate and single heads of households. These
women and adolescents are generally in deep denial concerning
6
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--their risk for HIV infection. A client advocate (ombudsman)
needs to be integrated into the existing system of care.
He/She would play a key role in advocating for the personal
and legal rights of the HIV infected and affected woman.
6.

Existing HIV/AIDS resources throughout L.A. County are
inadequate and do not fully address the health (mental,
physical and spiritual) of HIV affected women and their
children and families.
A standardized and comprehensive
community needs assessment to identify unmet service and
client needs must be developed and administered on an ongoing
basis.

7.

HIV positive
setting and
outreach in
infection as

8.

Primary prevention programs need to be developed and expanded
to reach pre-adolescent, adolescent and adult women in order
to stop the spread of HIV infection among women of
childbearing age and their sexual partners. According to the
most recent data from the State Office of AIDS, in Los Angeles
County, 1 in 300 African-American women of childbearing age
(14- 44) is projected to be infected with HIV.

9.

A comprehensive educational campaign targeting local African
American churches, radio stations, social organizations, the
business community and elected officials needs to be
implemented and maintained to ensure that the public and
private sectors are aware of the problem and can work
collaborati vely to develop solutions to solving the problem of
HIV infection in the African American community. The issue of
HIV /AIDS and Women needs to a priority and in the form of
public hearings and community forums on an ongoing basis.

women recently released from an incarcerated
gay/bisexual women need to receive targeted
order to educate them about their risk for
well as the benefits of EIP programs.

7
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AIDS Rea1onal Board Title II Publ1c Hear1nas
Hubert Humohrey Comorehens1ve Health Center
Auaust 21. 1991
1-3 P.m.
PUBLIC TESTIMONY
Mv name 1s Cynthia Dav 1 s and I worf'- for the Char 1 es R. Drew
UrnversltY of Medicine and Sc1ence.
I have been extensl\tely
1nvolved in HIV/AIDS-related education and prevention orograms
target1nq the Black communitv on a local level since 1984 and on
a nat1ona1 level since 1987.
I currently cha1r the Minor1ty AIDS
Consort1um wh1ch was establ1shed 1n Februarv of 1989 to address the
HIV/AIDS-related
needs
of
med1cally
undeserved
communit1es
throuahout ~os hngeles County and 1n the South Health Area (South
Central Los Angeles) in oart1cuiar.
The South Heaith Area of Los Anaeles CountY cont1nues to lag beh1nd
other Health Areas of the County 1n terms of health. suoport and
ex~ended care services for 1nd1v1auals w1th HIV d1sease and the1r
fam1l1es and s1gn1ficant others. Several months ago the membershlo
of the Consort1um 1dent1f1ed several or1or1ty taraet oooulat1ons
for orogram development and/or enhancement.
These
target
ooou lat1ons were identif1ed as women. adolescents and ch1ldren.
aav men of color. the homeless and undocumented.
The consensus of the Consort1um was to develop orograms that would
comolement and/or augment the ex1st1nq orograms being operated by
the AIDS Cl1nic at Martin Luther King Hoso1tal.
The Consortium
clans to work 1n collaborat1on w1th Mart1n Luther K1ng Hoso1tal to
ensure that an infrastructure of needed outoat1 ent and suooort
serv1ces for HIV oosit1ve 1na1v1duals and their fam1l1es 1s
deve 1ooed 1 n the South He a 1 th Area.
The Consort i urn sees these
services as be1ng comorehens1ve 1n their scooe.
These serv1ces
include:
-Early Intervent1on Programs
-Mental Health Services and Services for the Dual Diagnosed
-Res1dent1al Care Programs (Emergency and Lonq Term)
-Case Management and Referral Services
-Suoport/Advocacy Serv1ces
-Transportat1on Services
Level I. II and III serv1ces are orovided by the EIP and AIDS
Clin1c at Martin Luther Kina Hoso1tal. There is a need to provide
EIP serv1ces at local CBO's wh1ch have a track record for orov1ding
serv1ces to HIV infected indiv1duals.
Currently, M1nor1ty AIDS
Pro1ect is the only local CBO in the reqion provid1nq a full
comolement of EIP and CAse Management services to HIV infected
ind1viduals in the area.
Peoole who test pos1t1ve for HIV need
serv1ces such as: benefits counseling. legal aid. suooort services.
case management. menta 1 hea 1th <drug counse 1 i ng. resoi te care.
residential care (emergency and long term).
transportation.
clothing and food banks and rental ass1stance.

Title II fund1nq will allow several local CBO's with1n the req1on
to excand and enhance the1r ex1st1nq HIV/AIDS related serv1ces. For
examcle:
-THE Clinic for women which currently operates a CTS 1s
crooos1nq to exoand its serv1ces to include early 1ntervent1on
serv1ces tarqet1nq women of color aqed 14-44.
-The Gather1nq Place which cur-rently orov1des supoort and
reso 1 te care is crooos ltiCI to become an ATS as we 11 as to
exoand 1ts benefits counsel1no and outreach and cromo~1on of
EIPs.
-The ~.YARN Fro.1ect 1s orooos1no to orov1de transoortat1on
the HIV 1nfacted women ~hev work w1th.

t.:l

-The M1nor1tv AIDS ProJec~ is oropos1ng to develop
res1dent1al oroqram for dual diaqnosed ind1v1duals.

a

-The Watts Health Foundat1on 1s orooos1ng to
management serv1ces w1th an EIP.

augmen~

1ts case

-The Drew Un1vers1tv I&E Project is orooosin~ to provide food
baskets to HIV infected 1nd1v1duals during the holidays (i.e.
Thanksq1v1ng, Christmas and Easteri.
All of the aforemention serv1ces are needed and currentlY are no~
be1ng orovidad by CBOs in South Central Los Angeles.
There w1ll
be no duol1cat1on or over lao of services because ali of the
orov1ders are qeoqraohlcally d1soersed throuqhout the region ana
enhanc1nq serv1ce 1n one req1on will create greater access1bility
to serv1ces throughout the entire region.
Lonq range orooram clans of some of the orov1ders of the thirtyseven member Consort1um 1nclude:
-develooment of a mob1le unit target1ng
outreach and promotion of EIP services.

adolescents

for

-increase 1n the number of res1dential hous1nq sites for HIV
1nfected women and their children.
-targeted case manaoement at qeoqraphicallv d1spersed s1tas
(i.e. Watts Health Foundat1on, M1nor1ty AIDS ProJect. T.H.E.
Clinic. Gather1ng Place) throughout the region.
-develooment of additional ATS 1n the reg1on.
-develoPment of a req1ona1 transportat1on network
HIV+ ind1viduals and their families

to serve

Allocation of Title II funds to local CBOs 1n the South Health Area
of Los Anqeles County will go a long wav toward ameliorating not
only the serious gaps in HIV/AIDS outpatient and support services
for the tarqeted populations, but for the community-at-large.

I have attached copies of addit1onal public testimony presented to
the Ryan Wh1te Care Council (Title I} as well as other relevant
documentation concerninq the need for HIV/AIDS-related serv1ces in
the Metro South Health Distr1ct of Los Anqe1es County.
Thank vou.

senate Health and Human Services committee
Diane E. Watson
Chairperson

statewide Interim Hearing
December 17, 1991

"HIV/AIDS in Ethnic Minority communities"
Presented by: suzi Rodriquez
Director, Drug Abuse Programming
AltaMed Health services corporation

First

and

foremost,

I

would

like

to

thank

inviting me here to present before you today.

the

committee

for

on behalf of AltaMed

Health Services Corporation, we welcome the opportunity to share
what we have learned, thus far, in our attempt to provide HIV/AIDS
services

to

the

predominantly

Latino

population

of

East

Los

Angeles.

Background:
AltaMed Health Services Corporation began providing primary health
care services in the East Los Angeles Community over twenty years
ago.

We were originally known as the "East Los Angeles Barrio Free

Clinic".

We are a community based, multi-service organization with

diverse programming.
·care

sites,

a

Teen

currently, we operate Four Primary Health
Pregnancy

Program
1

(which

provides

case

management to over 150 pregnant andjor parenting teens), an Adult
Day Health care Center

(which evolved from a National Model we

developed that targets specifically Latino Elderly), a Methadone
Maintenance and Detoxification program, and a community-based HIV
Early

Intervention

counseling,

program

HIV Testing,

that

includes

T-Cell Testing,

pre

and

post

Case Management,

test
and

access to appropriate therapies for HIV+ clients.
our funding sources. for our Drug Treatment and HIV/AIDS Services
come from the Los Angeles County Drug Abuse Program Office, the
Federal Office for Treatment Improvement, the Federal Bureau of
Health Care Delivery and Assistance,

and the Federal Ryan White

CARE Act.
The focus of AltaMed has, historically, been on providing access
to

quality

health

care

to

Latino

populations

who

have

systematically been disenfranchised from access to these types of
services.

When publicity regarding the AIDS epidemic and

its

impact on the Latino populations of New York hit the local press
back in the early 80s, AltaMed decided we had an obligation to take
a proactive position in regards to this disease within our own
community.
Because the initial reports linked HIV positivity with IV Drug Use
within the Latino population, we agreed to accept a sole source
contract with

the County of

Los

Angeles

to provide methadone

maintenance and detoxification services to injecting drug users in
the East Los Angeles Community.
as

the

panacea

to

all

drug

Although we do not see methadone
abuse
2

problems,

we

did

see

its

connection to the HIV epidemic and believed that it would provide
us with an avenue by which to reach and educate this very at-risk
population (the community of East Los Angeles has more injecting
drug

users

than

anywhere

else

in

the

County ... conservative

estimates place the number at well over 10,000).
Our initial efforts were met with resistance on the part of the
Community.

We fell victims to the "NIMBY

(Not In My BackYard)

Syndrome" and were forced to abandon two different identified sites
before, with the help and support of councilman Edmund Edelman, we
were finally able to open our program on the grounds of the County
USC Medical Center.

The availability of additional resources,

through the aforementioned Federal entities, allowed us to pursue
the development of HIV specific programming.
Although fairly new to this arena on the direct service delivery
side,

we have

learned some lessons we feel may be of value to

others who have a desire to provide like-services.

What we have learned:
Although we have operated our program for a short time,

we can

discern some pattern in our population:

*

Most of our patients are of Mexican origin.

*

Most are undocumented.

*

They have a relatively low level of formal
education/schooling.

*

They are alone in the United States.

*

All were infected by sharing needles or by having sex with
3

an infected man.

*

There is a definite gap in culturally appropriate services
for gay and bisexual Latinos, especially those with drug
problems/treatment needs.

*

Clinic staff must be culturally appropriate to the
population they are serving.

Recommendations:
Given our experience, we feel the following steps should be taken:

*

Linkages must be made with historically Gay HIV/AIDS
programs in order to provide appropriate staffing,
training, and service provision for Gay and bisexual
clients.

*

There must be continuous and on-going education forjto the
Community.

*

The Church must be accessed.

*

Intensive training in pre and post test counseling should
be required for all case managers.

*

Clinic personnel should be reflective of the population
they are serving.

*

HIV testing should be encouraged to all program
participants.

*

A system of comprehensive care should be instituted that
includes:
- Pre-test Counseling
- HIV Testing
4

Post test counseling when delivering any results.
If positive, there should be an expeditious way to
admit patient into a medically managed program where
one case manager will follow the patient during the
course of the disease.

*

Increased outreach must be done to the injecting drug
using population (we believe the sero-positivity rates
remain low for this population only because the data being
gathered is reflective only of those IDUs who are accessing
treatment.

Additionally, consideration should be given to

the legalization of needle-exchange programs tied directly
to increased treatment availability).

*

Staffing should include a financial analyst to assist
patients with accessing appropriate programs (MediCal,
MediCare, etc.)
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Good afternoon Senator Watson, Ladies and Gentlemen, I am
very pleased to be able to present testimony on the
subject of AIDS and the impacts on the homeless community.

I am sure that your have heard much testimony on the HIV
Virus and the AIDS epidemic therefore I would like to
focus my testimony on the unique problem of AIDS and the
homeless community.

By definition a homeless individual

has no resources except public resources., however the
majority of the public health resources have gone to
communities which are not poor, are not undereducated or
are not underrepresented.

We must reverse the trend

because society will pay a much greaater price in the long
run.

In Los Angeles county the Central Health District (which
contains the highest concentration of homeless people in
the county) has the second highest rate of infection in
the entire county, however we do not receive monies
proportionate to the severit of our problem.

We also do

not receive any consideration for the complexity of the
problem.

You have probably heard how AIDS is considered a

chronic disorder that is not true in the homeless
community.

We have found tht homeless people generally

have 18-24 months life expectancy from diagnosis to
demise.

The present county system is overloaded with

individuals who would not normally be in that system and

leaves no room for homeless people who have no other
health system.

A person infected by the HIV virus who is homeless is
practically without care in the state of California.

The

current care system is not designed to deal with the
mul~iplicity

of problems a homeless person presents.

The

current system is designed to either take care of the
persons medical problem or to deal with the persons
survival needs generally not both.

In a system of this

nature conflicts orise and the person who suffers is the
one we say we are helping an example is a person goes to
the clinic and receives medication, he/she then returns to
a shelter the shelter takes the medication and gives it to
the personas their schedule or time permits.

The person

has night sweats and cannot sleep the next morning the
person is tired however shelter rules say everyone must be
out of bed by seven O'clock therefore that person must get
up.

the person takes his/her medication but experiences

side effects there is nothing for that person.

The person

makes a decision not to take his/her medication because it
makes life too difficult.

I have tried to portray this

scenario as realistically as possible and not to portray
any party as wrong because no one is wrong we merely have
a system not able to deal with the problem.

We no longer have the luxury of hoping that AIDS will
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somehow go away, we must recognize the clear and present
danger among us.

We must also expand our vision of the

problem for the minority community.

We must also

recognize that the majority of the homeless community are
minority.

I realize tht this is difficult to believe,

because in most cases when you see someone advocating on
behalf of the homeless they are mostly white and mostly
middle class, believe me that although they may speak for
the homeless they do not represent the homeless community,
because unless you share a common bond with your
constituency it is difficult to represent them.

We need

special consideraion because more than any group you may
have heard from today we have the least and have the most
to have to overcome.

We do not have the money to lobby

you, we do not have the political sophistication to defeat
candidates,

We do not have the ability to impact the

planning process, however we do have the ability ot impact
negatively on our entire society.

We want to make

contributions but we do not have the opportunity. We want
some help in changing our destinies that is what we are
denied.

Our needs are very simple, we need the type of

assistance that other communities currently receive but we
need them designed for homeless people specifically.

We

need specialized treatment programs, we need peer-based
counseling, we need specialized housing , we need a strong
political advocate to make changes in public benefits on
federal , state and county levels to force the bureaucrats
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to declare an individual who is homeless and HIV positive
as an emergency case and afford them certain
considerations.

Finally, I am personally a strong advocate of categorical
£unding to solve problesm that are unique or so
longstanding that special efforts are needed to protect
the common good.

Homeless persons with AIDS are a problem

which has serious impacts on all of us.

In order to understand the need for categorical funding we
need to analyze L.A. county's allocation of C.A.R.E. ACT
formula and supplement grants.

The county received $7.8

million in total allocation for year one.
attachment one)

( See

Total monies allocated for homeless

persons is $127,238, this represents less than 2% of the
county funds,

and of that amount 2/3 of the money goes

into cross-training of staff.

(See Attachment II)

Further, no monies were allocated for early
interviention/Outpatient care. (see Attachment III)

The

only clinics which provide early intervention/outpatient
care are not located where there are concentrations of
homeless persons.

Ladies and gentlemen this is the reason why a homeless
person is 100 times more likely to contract HIV than a
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homed person.

The rate of infection in the homeless

community is about 1 in 5.
greatest magnitude.

I

This is an emergency of the

have spotlighted Los Angeles county

but in my travels around the state I have found similar
situations in other large urban counties.
I

appreciate your time and will be happy to answer any

questions.

Thank You.
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COUNTY OF LOS ANGELES • AIDS PROGRAMS
ESTIMATE OF UNSPENT CARE ACT FUNDS - PROJECT BUDGET YEAR ONE
Service

Provider

: Allocation

FORMULA GRANT
ient/South Central :King/Drew
OUtpa~ ient/San Gabriel
:Pasadena AIDS Coord.:
Outpa~ ient/San Fernando V:Northeast valley
:Olive View
OUtpa~ ient/Long Beach
:Long Beach Comp. Ctr:
CBO CARE to Relieve 5P21 :AIDS Healthcare foun:
:Alta·Med
Case Management
:Various CBOs
Mental Health
:Various CBOs
Dental Care
:APLA
Resident i a l/Ernerg _ Rel ief:Various CBOs
Cross-Training
:Various CBOs
Transportation
:Various
OUtreach/Promotion
:Various CBOs
:AIDS Reg1onal Board
Regi~l Consortia
:AIDS Programs
Acbinistration
Outpa~

765,000
239,000
189,000
50,000
382,000
287,000
287,000
382,000
191,000
96,000
239,000
191,000
143,000
191,000
96,000
196,157

Projected
Savings

114,750
35,850
28,350
0
57,300
0
43,050
57,300
28,650
0
0
28,650
21,450
28,650
0
0

·------------------------:---------~----------:-·-----------:-------------:

TOTAL FORMULA GRANT
SUPPLEMENTAL GRANT
OUtpatient/South Central :King/Drew
OUtpatient /\Jest
:AIDS llealthcare Foun:
:Gay & Lesbian CSC
:UCLA
OUtpatient/Long B, So.Bay:Harbor/UCLA
OUtpatient/San fernando V:Northeast valley
OUtpatient/East L.A.
:AltaHed
OUtpatient/Central
:Hudson Como. Ctr.
Special Pop.
OUtpatient
:Various CBOs
:Various CBOs
S~rt Svcs.
:Various CBOs
Promotion of Svcs.
:Various CBOs
Mental Health
:Various CBOs
Mental Health
:Various CBOs
OUtreach for Testing
:Various caos
Case Management
:Various CBOs
Residential
:Various
Recruitment/Retention
Transportation
:Various
:Tarzana Treat. Ctr.
Residential Detox
:BAART
OUt pet tent Detox.
HIV Primary Care/Subst. :El Proyecto del Barr:
:AIDS Programs
Administration

3, 924,157

444,000

75,000
219,000
75,000
50,000
175,000
150,000
215,000
315,000

11,250

415,949
86,000
75,000
75,000
375,000
75,000
337,500
375,000
86,000
37,500
258,000
129,000
129,000
196,208

0
0
0
0

22,500
32,250
47,250
62,392
12,900
11,250
11,250
56,250
11,250
50,625
0

12,900
5,625
0
0

19,350
0

-------------------------:--------------------:-------------:-------------:
TOTAL SUPPLEMENTAL GRANT
TOTAl BOTH GRANTS

3,924,157:

367,042

811,042

unspfund.wk1/rev.

i/91

'

I·

ALLOCATION OF
Adolescents/,...,. ..Wlts

I

-ring
. . . ired

C~E

ACT FUNDS BY MODE OF SERVICE & TARGET POPULATION
Pediatrics

Cay """ of Color

Stbotance Abo.a:urs

Peq>l e of Col or

H.-less

!

~~

.'

~\

~t

•

J

l

w._.

Prewntion and
EcU:ation'
ecu-1 inQilesting•
L.A. Free Clinic S40,ooo'

Gay Men of Col or
Consortluo S181,462

($)

CA Drug Consul tents
142,000 ($)

City of long &edch

JWCH,

S3S,OOO

(S)

(f)

--

Residential
Detoalfleation
services

~

0
...l

Total

Inc. S42,538

(f)

Total • $341,000

....

--1

----·

OUtread> tor
lesting/Pr..,ticro
of S<trvicrs

tarzana Treatment
Center S258,000 (S)

= S258.000

-!------+-----+----~

OUtpet lent
Detoaification

BAART S129,000 ($)

services

I

Total= S129,000

II

Early lnte,._,tiOfl/
OUtpatient tare

11

1--.. --

I

Childrens Hospital
S212,000 ($}

Total • $4,018.000

Dental tare

S96,000 allocated t> all
11 populations

Recrui...,t/
Retention
Crou~trainina

$46,000 allocated
populations

ll

of

all

I

l-'--------+-------+--------11

L.A. Peoiatr•c AIDS

Network St-6, ~00 (5)

El Proyecto del
Barno S129, 000 {5)

.

I
___r
- . -~-----~~~1
I

_I

Gay Men of Color
Cons or""" Sl06, 300

Staff

-1--+-----,
L.A.

Homele~s

Healthcare ProJect

$84,100

(f)

Total

HIV Program for
S138, 000 IS l

women

(f)

= "91, 000

lr"""'''rtation
Services

S138,SOO allocated to
all populations.

Case~t

S719, 500 allocated to
all poplllt ions.

"""Ul Ileal th/
Ps-,dlosoc:ial
$<.4lpaf't

Total • Sob41,000

Minority AIDS ProjeCt
1111,000 (S)
East valley COOft.
Kl th. Ctr. S7'.i,OOO

GLCSC Sb¢. SOO
PacifiC Cr.tr. for
C0<1>sel1ng S55, 000

(f)

APLA S46, SGO ( S J

Mol\ ywood Sunset

conn•. Ct 1n1c SU,OOO
(f)

(f!S)

1ar zane 1 reetment
Center $108,000 (S)

APL A S46, 500 ( S l
GLCSC SU,500 (SJ

II

p /I /I r. -! (, t-f c'
AdDiesc:.... t a / - .... u.
So4>Port Services
Total

= S86

Residontial

000

care

(CUf 'lAS)

TOTAL:

•

w.
::>

1J

NOTE:

Pediatrics

-ing
I~ ired

C.Oy """ of COl or

AIDS Education
for the Deaf
125 000 ($)

Cay Htn of Color
Consorti,. $36,000
($)

People of Color

St..Ds t ance Abusers

Hc:J~Meless

Asian Pacific AIDS

-

"I

"-./1

T
.

I

Ecsucat ton Project
S25 000 (S)

•

1613,969 allocated to
all population~.

1294,000

S25,000

157'5, 762

166,000

1228,000

1624,000

,.S127,238

1251,000

CARE Act flllds cannot be tltilir:ed for prevention and testi"9 services. The agencies plctced wHhtn thiS taot~ tnclude only those programs specifically charged wtth serv1ng <l parttcular target
populatlon(a) and does no: Include progr- that aarve all c-.nitias. Thia table adclresaes only the special populations as defined t>y the CARE Act Plaming Council. Th1s does not e.clude the
fact that all other orotr:- not I is ted are responsible for serving all populations.
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COMPREHENSIVE AIDS RESOURCES EMERGENCY (CARE) ACT
BIV HEALTH SERVICES PLANNING COUNCIL
600 S. Commonwealth Ave., 6th Floor, Los Angeles, CA 90005

December 9, 1991

TO:

CARE Act Interim HIV Health Services Planning Council Members

FROM:

Suzi Rodriguez, Co-Chair
Pb.ill Wilson, Co-Chair

SUBJECT:

MEETING DATE

DATE:

LOCATION:

Thursday, December 19, 1991
1:00 p.m. - 4:00 p.m.
American Red Cross
Fredrick G. Larldu Board Room
Mezzanine 2
2700 Wikbire Blvd.
Las ADgelfs

The building is located at the comer of Wilshire Blvd. and Rampart Blvd.
Parking is limited. If the Red Cross lot is full, park on the street or at the Sheraton
Town House Automate lot at 6th and Commonwealth.

If you have any questions or need additional information, please contact Cherie
Orilonise at (213) 351-8130.

·109

COMPREHENSIVE AIDS RESOURCES EMERGENCY (CARE) ACT
HIV HEALTH SERVICES PLANNING COUNCIL
600 S. Commonwealth Ave., 6th Floor, Los ADgeles, CA 90005
AGENDA
December 19, 1991
1:00 p.m. -4:00p.m.
American Red Cross
Fredrick G. Larkin Board Room
Mezzanine 2
2700 Wilshire Blvd.
I.

Review of Handouts and Pre-meeting (15 min.)

II.

Opening and Roll Call (5 min.)

m.

*Approval of Agenda & Minutes (5 min.)

Council

IV.

*Priorities for Unspent County Funds (60 min.)

Council

v.

*Report on Council Priorities (45 min.)

Suzi Rodriguez
Phill Wilson

VI.

Adjournment

Suzi Rodriguez
Pbill Wilson

Suzi Rodriguez
Pbill Wilson

*Handout

NEXT MEETING:

Council

January 8, 1992
Orthopaedic Hospital
1:00- 4:00p.m.
Crowe Seminar Room

DEC19.AGN

·! i 0

PRIORITIES POR UNSPENT CARB ACT TITLB I PUHDS
Total

NOTE:

=$1

1

000,000

This document reflects changes agreed upon at the
November 13, 1991 meeting of the CARE Act Planning
Council.
If actual unspent funds total less than $500,000, then
APO will perform budget modifications, budget
augmentations, and contract extensions.
If actual unspent funds exceed $1 million, 50% of the amount
over $1 million will go to priorities which received zero
funding on this sheet (#5-10). The remaining 50% over $1
million will be divided proportionally among priorities on
this list which have been allocated unspent funds (#1-4).
If unspent funds exceed $2 million, the Council will meet
again to allocate those funds over $2 million.

1)

Level III HIV Outpatient Care / Specialty Consults
•

2)

Level III care is required by HIV infected patients who have
reached a level leas than 200 CD4+ cells 2£ who have
developed HIV related symptoms, and who may receive medical
and/or psycholoqical services in non hospital basad
outpatient clinics.

AIDS Drugs
•

$300,000

$300,000

CUrrently, the State has allocated $12 million state-wide
this year for AIOS druqa. APO is billinq the State at a
rata of 300,000 per month. With the CARE Act, additional
centers will be billinq to the State AIOS druq proqram
throuqh the County. Also, more druqs have bean added to the
proqram.

NOTE: Due to the increase in State dollars for AIDS drugs,
should this category remain #2 on this list?
3)

Residential Detox Slots
•

4)

L.A. county has an estimated 190,000 IDUs and 35 residential detox
slots. With an estimated aeroprevalence rata of as much as 10,,
19,000 HIV+ IOUa need druq treatment. The Council allocated
$258,000 to Tarzana Treatment, which only pay• for 3.5 beds or 90100 parsons par year (10-day averaqe stay). 50' of this money
will qo to Residential Detox, with the other 50' qoinq to
rehabilitation facilities.

Primary HIV care for Undocumented
•

5)

$300,000

Of the oriqinally prioritized populations, the undocumented is the
only qroup not directly receivinq funds. Providers can no lonqar
rely on the IRCA/SLIAG fundinq.

Primary HIV care to Special Populations
•

$100,000

$ 0

Special populations include women, pediatrics, and adolescents.

·' : 1_

6)

•

7)

10)

$ 0

The Planning Council passed a motion on May 15 to consider
residential care a priority for unexpended funds.

Adult Day Health Care -- City of West Hollywood
•

$ 0

The City of Wast Hollywood requested funds from the Planning
Council for an adult day health care program for parsons with
AIDS. It is scheduled to open January of 1992 at the L.A. Free
Clinic.

Case Management
•

$ 0

The HIV Strategic Plan names this group as a priority for outreach
services. Gay men of color are not always reached in effective or
culturally specific ways. More than three-quarters of AIDS cases
among man of color are tr~nsmitted through gay/bisexual contact.

Residential Care
•

9)

The need to make testing available to all persons entering
county STD and TB clinics has long bean a priority.
Individuals being treated at STD clinics have already placed
themselves at high risk. Experience in TB clinics shows
that a high proportion are HIV-infected. Currently,
resources do not allow this service to be universally
available.

outreach/Promotion of Services to Gay Men of Color
•

8)

$ 0

counseling/Testing in County STD and TB Clinics

$ 0

If unspent funds are available, the Case Management Consortium will meet
and recommend allocations.

·mprior .una
November 19, 1991

........

~
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LOS ANGELES COUNTY CARE ACT PLANNING COUNCIL
PRIORITIES
Priorities for Planpinq Council Fupdinq Decisions
•

Programs and services must focus on underserved and indigent
populations with little access to health care.

•

Program and service staff must be linguistically competent
and culturally sensitive to ethnic populations, gay and
bisexual communities, and other special populations.

•

Consortia are encouraged and given priority in funding
allocation decisions.

•

Programs and services must be provided by indigenous
community-based organizations whenever possible prior to the
County providing such programs and services.

•

Programs, services, and agencies with existing
infrastructure(s) must be given preference.

Priorities for the Coptractors in tbe Provision of care
•

Programs must have advisory committees comprised of clients,
providers, and persons with HIV.

•

Providers and programs must have internal HIV workplace
policies for staff and volunteers.

•

For those contractors providing training on human sexuality,
the training will attempt to present human sexuality as a
normal, positive aspect of the human experience.

•

Contractors must rely on paid professional staff for program
administration, direction and guidance, and services;
trained volunteers may be used to supplement services
provided by paid staff.

•

Programs and services must meet the community standard of
care provided to HIV-infected individuals.

Priorities for the Planning Council and the Contractors
•

Programmatic, service, and staffing information on the needs
of women and how they will be met must be detailed in each
program and service recommended, unless women are not an
appropriate target group for the contractor or if women are
not included in the specific target population(s) under the
Agreement.
~~ ".3

•

Programs and services must have specific linkages to other
service sectors, i.e., homeless and substance abuse
services, with cross-training of staff.

•

Contractors must coordinate services with other service
providers of the same service(s) and other providers of any
AIDS/HIV services located in the same geographic region, and
must participate in regional consortia.

care\snprior.lst
10-29-91

DRAFT

DRAFT

PRIORITIES FOR UNSPENT NET COUNTY COST FUNDS
Total = $2,000.,000
NOTE:

Based on approved decisions at the December 4, 1991
meeting, dollars were allocated to 1 and 3 which
totaled $750,000. Decisions are pending for 2 and 4
through 10. The total available is $1,250,000.
Previous Formula: If actual unspent funds exceed $1
million, 50% of the amount over $1 million will go to
priorities which previously received zero funding (#510). The remaining SO% over $1 million will be divided
proportionally among priorities on this list which have
been allocated unspent funds (#1-4).

$450,000

$300,000

1)

Level III HIV Outpatient care/Specialty Consults

2)

Primary HIV care for Homeless/Skid Row Area

3)

Residential Detox and Residential Rehabilitation
Slots (funds split 50-50 between these slots)

4)

Primary HIV care for Undocumented Persons

5)

Primary HIV Care for Special Populations (women,
pediatrics, adolescents)

6)

counseling/Testing in county STD and TB Clinics

7)

outreach/Promotion of Services to Gay Men of Color

8)

Residential Care

9)

Adult Day Health Care (City of West HollywoodfL.A.
Free Clinic)

10)

case Management

snunspen.ncc
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Headquarters: 440 First Street, NW • Suite 500 • Washington, DC 20001 • (202) 347-6953 • Fax: i202) 39~-0096

February 16 ~ 1990
Th1s project is part of a national grant from CDC. Its purpnse is to
Increase the availability of HIV/AIDS education and informatioit tc
Black and minority youth in urban and rural communities. It is 1
nat1onal project, and it will be managed out of our office in Washir1gton,
D.C. Project technical focus will be provided at the Charles R. D~ew
University of Medicine and Science located at the King/Or~~ Meciical
Center in Los Angeles County, Los Angeles California.
NOBCO PROJECT OPERATIONS GROUP
Webster J. Guillory - Chairman of the Board, NOBCO Office of the Ora11gc
County Assessor
(714) 834-2734

Crandall Jones - Executive Director, NOBCO
(202) 347-6953

Westley Sholes - Western Regional Director, NOBCO, Project Coordinatcr/
Department of Health Services, Los Angeles County
(213) 974-8136

Mary Ashley - Technical Assistance, Charles R. Drew University of
Medicine and Science
(213) 603-4755

Cynthia Callahan Davis - Program Director, NOBCO AIDS Education Pro1e:t
(213) 567-7799

AIDS TASK FORCE
Commissioner .John Stroger - Cook County, IL
Commissioner Mary McAllister - Cumberland County, NC
Ralph Mitchell, Director Health Services - Fulton County, GA
Paul Simms, Deputy Director Physical Health Services, San Diego
County, CA
Supervisor Doris Ward - San Francisco County, CA
Commissioner Bernard Kilpatrick - Wayne County, MI
Commissioner J.W. Scarborough - Natchitoches Parish, LA
David N. Dinkins, Mayor, New York, ~ew York
Caswell Evans, D.D.S., Asst. Dir. Programs Dept. of Health Services,
Los Angeles County, CA
Commissioner El Franco Lee - Harris County, Texas
Commissioner Virgil Brown - Cuyahoga County, Ohio
NATIONAL LIAISON TEAM*
National Medical Association (NMA)
National Conference of Black Mayors (NCBM)
National Forum ior Black Public Administrators tNFBPA)
National Black Caucus of State Legislators (NBCSL)
National Black Caucus of Local Elected Officials (NBC-LEO)
~ATIONAL

*Partial Listing

Corinne Tanon, M.S.H., C.A., tiea.Lcn

9500 Artesia Blvd., Bellflower, CA

.c..uucctLuL

90706

~xE1J:»x4~i.x-xx~~M.~Jtx~~~~~~~
P;hone (21:3) :i:~QS:: 920-7227

A.

Agency Background

1.

Briefly describe the scope of services your agency provides.
The American Indian ClinLc is located in Compton, California, in
a buildin~ that once was a motel. The American Indian Clinic. Inc.
was founded in 1969 to serve the health and social needs of
American Indians in ehe Los Angeles area. It has provided continuous
care t::- the community for over n;ency years and is the oldest American
Indian. service agency in the Los Angeles area. The clinic department
are medical. dental, ~IC. ~amily planning, pre-natal, outreach,
health education. two alcohol ~ecover~ programs and a food box program.

~.

Communit·: Demographics
According to 1980 census. California has the largest Indian population.
There are approximately 225.000 American Indians from 200 different
tribal affiliations. In Los Angeles County alone there are over 90.000
Urban -~'11erican Indians. And is the largest Urban Indian community
in the nation. The American Indian communit:: is ·.;ell dispersed and 54,000
of the A~eric3n Indians ~ive below povertv leve~. ~etropolitan
Los Angeles :ndian unemplo:~ent is ~5~.
The Indian peculation is a youn~ population. ~ationwide the average age
is 20.~. The average age 0f Indians in Los Angeels is l7.J. Sixt~-se~en
oercent ~i the Indian popuiat~on are 2S ~ears o~d or youn~er.
Ina1ans are
3 times ~ore likely to die young (between ages :- and ~0) than non Indians.
Average life expectancy for Indians is ~~ (this :s lower than the aver~ge
life excecrancy for migrant farm workers).
Accordi~g

to the Los Angeles Unified School Dist=ict. Indian Hi~h School
drop out rate is 23:. This figure increases when you include those ~~at
never enrolled in high school. Average age of Indians living in
Los Angeles is 17.3 vs 20.~ for Indians nationwide. Sixty seven percent
of Urban Indian adolescents drink or use drugs moderately to heav?;
whereas the non-Indian urban adolescent rate is :J:.

t

~

....

·~ .l (

Health Issues
Indian suicide rate is 7 times that of the national rate.
Indians have
the hi~hest rate of heart disease and diabetes.
20-25 percent of all
American Indian children suffer from mental illness. Adjusted alcoholism
mortality rate for Indians is 41.3 deaths/100,000 vs 17.4 deaths/100,000
for Afro- Americans and 6.4 deaths/100,000 for Whites or 2.3 times that of
Black ?Opulation and 6.5 times that of White population.
Gaps in Health Care

Health care is expensive to nearly all segments of the community but especially
to many Indian people.
They may not be able to afford health care due to lack
of insurance or other needs that are more pressing. They will go to a health
care facility only when the need is acute. Therefore, they might hear the
message about AIDS, Diabetes, Hypertension prevention at a health facility.
There is a pressing need for outreach at those places where they may congregate;
community functions, pow wows, sports events.
:>tzU·t: c ~ (1-+f, 17With the high rates of sexually transmitted ~isases and alcohol and IV drug use
among .\merican Indians, ilopefully, hid:·
H11a_ic l!hrviee may understand the
importance of • a:r&iRued funding as a preventative T.easure.
We are the only peoples who have a treaty, or trust ~elationship with the
United States Government. That is, we have a contractual agreement whereby
the Government is to provide free and "Adequate" health care as ratified by the
Snyder ~ct of 1921 to Indian people regardless of location-this is not being done!
Since

the Indian Health Service (IHS) cannot be counted on to provide
health services we must continually seek out other funding sources.

3dequat~

The source of continued funding is always contingent upon the outcome of
census, demographics, and socioeconomic and political strategies.
Becaus~ we are a small population of 90,000 American Indians in Los Angeles
County, t"e are sometimes mistaken for hispanics, filipino, white, and Afro American.
Tl1e communitv is well dispersed and this may contribute to the political
under~epresentation and social misrepresentation in the communities.
We are
poorlv represented in every segment of society.
I can only speak for myself-we
have no political clout, and our voices aren't being heard. This theme is
reflected in the decision making of our city fathers and government.

Source:

Kathy Grandstaff, American Indian Counseling Center

0

PO. Box 4068 • 1330 South Long Beach Blvd. • Comoton. Calif. 90221
Phone: (213) 537-0103

According to the HIV-AIDS and American Indians handbook for Tribal Leaders
stated the following:
"Since September, 1991 the Center for Disease Control has approximated
305 American Indians diagnosed with AIDS.

Dr. Emmett Chase AIDS coordinator

for Indian Health Service estimates that there are 12 to 13 new Indian AIDS
cases identified each month.

The fact is the annual rate of increase of

new AIDS diagnosis is greater for Indian people than for any other racial
group.

The number of Indians diagnosed with AIDS grew by 91% from 1989 to 1990.

While other racial groups have a higher number of individuals with AIDS, the
number of Indians with AIDS is rising at a rate proportionately faster than
for other groups.
PERCENTAGE INCREASE IN AIDS CASES FROM 1989-1990
Whites
African Americans
Hispanics
Asian/Pacific Islander
Indian/Alaska Native
The time of PREVENTION

IS NOW.

8%
13%
5%
17%
91%

Indian people can benefit from the experiences

of other populations which have dealt with the AIDS virus for the past eight
years.

We must ACT

now, before the virus wipes us out like the smal1pox epidemic

disease of the early 1800's.

According

to the study for the Centers for Disease Control found that

Indians and Alaskan

~atives

experienced higher rate of gonorrhea and syphilis

than did non-Indians from 1984 to 1988 in 13 selected states with large
Indian populations.

This study indicates that we are at risk.

The transmission categories for these cases are 54% homosexual/bisexual
transmission, and the rest by" blood or blood product transmission.

This

contrasts with White Transmission which is 76% homosexual/bisexual and 15%
shared needle and 2% heterosexual .. The percentage of Alaska Native and
American Indian women with AIDS is 13% of the total number of American Indian
and Alaska Native cases, in contrast to 47. of White women.

According to

CDC has been working with IHS to evaluate the HIV in the American Indian
population.

It is estimated that for every 1 million American Indians and

Alaskan Natives approxia~tely 1,000 individuals are currently HIV infected.
Then it could be estimated that over 85% of these individuals do not know
they are HIV infected.

